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Abstract 
 
Physiological mechanotransduction experienced by the vasculature affects the 
expression of many actin-binding proteins that play an important role in endothelial cell 
function and the patho-physiology of cardiovascular disease (CVD). The expression of 
one such protein - Palladin – plays an important role in cell cytoskeletal regulation, 
acting as a mediator for the regulation of vascular homeostasis through its unique 
protein-actin and protein-protein interactions. This study aims to elucidate the role for 
Palladin within the actin dynamics of the vasculature.  
Models mimicking the haemodynamic forces of cyclic strain and shear stress, acting on 
Human Aortic Endothelial Cells (HAECs) reveal that Palladin expression and 
localisation is mechanically altered within the vasculature. Protein expression increases 
especially as a result of both acute and chronic shear stress stimulation of the cell. 
Cellular fractionations of HAECs document the translocation of Palladin from the 
membrane to the cytoskeleton under laminar shear. Investigation of Palladin expression 
following culture of cells with extracellular matrices also suggest an integrin-mediated 
signalling of the protein.  
Following the shear stress-induced inflammatory response, the endothelial cells appear 
to export excess protein within secreted microparticles, complex structures which have 
been previously implicated in playing a role in inflammation and coagulation leading to 
impaired vascular function in CVDs. The presence of Palladin and two other proteins - 
LASP-1 and Drebrin- within these shear-induced microparticles is investigated here.  
Palladin appears to show an interaction with Drebrin (developmentally regulated brain 
protein), an actin-binding protein which itself is characterised in HAECs. Furthermore, 
the actin-binding, haemodynamically regulated protein - LASP-1 (Lim and Sh3 domain 
protein) was also investigated. Palladin is previously known to mediate the binding of 
LASP-1 to actin stress fibres. Here, we discuss the interactions between the three 
proteins, and also investigate the response of LASP-1 and Drebrin to haemodynamic 
force, namely shear stress. 
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1.1 THE CARDIOVASCULAR SYSTEM 
The human body is dependent on the circulatory system to allow for the constant flow 
of blood, which in turn facilitates the cellular exchange of essential nutrients and gases, 
and disposal of wastes. This circulatory system can be divided into two subsystems: 
lymphatic and cardiovascular. The lymphatic system has many roles, including the 
transport of interstitial fluid and antigen presenting cells around the body. The other 
system - the cardiovascular system – is arguably the more important, as it facilitates the 
distribution of blood around the human body. The cardiovascular system is also 
responsible for many other functions such as maintaining homeostasis, e.g. temperature, 
pH, and in the immune response to diseases and infections (Aird, 2011). This system 
consists of the heart, blood vessels, and the approximately 5 litres of blood that the 
blood vessels constantly transport around the body. 
 
1.1.1 Cardiovascular disease 
Cardiovascular disease (CVD) is a general term to characterise dysfunction of the heart 
or circulatory system (Kelly, 2010) and is widely regarded as one of the leading causes 
of death in developed countries (Gaziano et al., 2006) (Table 1.1). A 2010 study on 
mortality rates in the US (the most recent complete study available) showed that over 
2150 Americans die of CVD-related illnesses daily – one death every 40 seconds (Go et 
al., 2013), with 34% of these deaths occurring before the age of 75. Within the countries 
of the EU, the latest available statistics from 2012 indicate how CVD-related illnesses 
claimed the lives of over 4 million people annually, almost half of which are people in 
the EU member countries. Overall in Europe, CVD causes 47% of all deaths (Nichols et 
al., 2013). Moreover, in highly populated countries such as China and India, CVD is 
also a leading cause of death (Joshi et al., 2008) - highlighting how CVD affects all the 
major population groups in the world. 
CVD itself can encompass a broad spectrum of disorders that includes arteriosclerosis, 
heart failure, hypertension and stroke. Many lifestyle-dependent risk factors exist that 
can exacerbate this condition, including smoking, lack of physical activity or poor diet. 
Healthy diet and regular exercise have long been observed to aid in reducing incidents 
of CVD events (Hellenius et al., 1993), as they help reduce resting heart rate (Green et 
al., 2008). Furthermore, a healthy lifestyle is commonly known to slow down the 
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progression of atherosclerosis (Zagura et al., 2012). Exercise can also lower the resting 
blood pressure in patients with hypertension (Pal et al., 2013) and help improve health 
in patients with peripheral vascular diseases (Haas et al., 2012). Several in vivo studies 
suggest that the exercise-induced haemodynamic forces alter the endothelium blood 
vessel tone and reactivity in a healthy and beneficial manner (Johnson et al., 2011; 
Laughlin et al., 2011; Tinken et al., 2010). 
Although some of these risk factors show increasing trends in high income countries, 
the rate of increase in risk factor prevalence is higher still in developing countries 
(Celermajer et al., 2012). Cigarette smoking in particular is a well-established risk 
factor for CVD, exacerbating endothelial dysfunction and haemostatic imbalance 
(Virdis et al., 2010). Many studies have proven a link between these factors and CVD 
with respect to the endothelium (Reriani et al., 2010; Hadi et al., 2005). 
The imbalance of vascular homeostasis that leads to dysfunction, and subsequent 
development of CVD, can arise due to dysregulation of the endothelium. This 
ultimately leads to impairment of endothelial function and adverse tissue remodelling 
(Endemann and Schiffrin, 2004). Importantly, certain regions of the vasculature are 
more prone to endothelial dysfunction than others (Cicha et al., 2008), namely areas of 
low shear and/or flow disturbances at arterial bifurcations and curvatures (illustrated in 
further detail in Chapter 1.2). Studies also demonstrate that this aberrant shear stress and 
disturbed flow pattern modulate not only the clinical manifestations of disease but also 
enhances the progression of atherosclerotic lesions (Chiu and Chien, 2011). The altered 
morphology and function of endothelial cells under these varied haemodynamic 
conditions are mediated by a number of well, and not so well, characterised cellular and 
molecular mechanisms, including signalling GTPases signalling cascades involving Rac 
and Rho (Hirase and Node, 2012; Mazzag et al., 2003; Wojciak-Stothard and Ridley, 
2003).  
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Table 1.1: Total cause of deaths worldwide for the year 2011. The table documents the 
estimates of mortality throughout the world in 2011 – the most recent full statistics available. 
Mortality estimates are based on analysis of latest available national information on levels and 
causes of mortality grouped together with the latest available information from the World 
Health Organisation WHOSIS database. Cardiovascular disease accounts for approximately 
11% of total deaths for the year – the largest individual cause of death (World Health Statistics, 
2013). 
Cause of Death Death Toll 
 (In Millions) 
Heart Disease 7 
Stroke 6.2 
Lower Respiratory Infection 3.2 
Chronic Obstructive Pulmonary Disease 3 
Diarrhoeal Diseases 1.9 
HIV/Aids 1.6 
Trachea, Bronchus, Lung Cancers 1.5 
Diabetes 1.4 
Road Injury 1.3 
Prematurity 1.2 
 
1.1.2 The Vasculature 
The cardiovascular system consists of the heart pumping blood along a vast network of 
vessels (Hahn and Schwartz, 2009). The classification of these vessels, based on the 
direction that the blood flows relative to the heart, shows the convergence of several 
vessels (the veins) into one vein, the vena cava, that returns blood to the heart. In 
contrast, the outgoing vessel, the aorta, diverges into several vessels carrying 
oxygenated blood away from the heart. The points of such divergence are known as 
arterial bifurcations (Hahn and Schwartz, 2009; Lusis, 2000). 
The vasculature refers to the arrangement of blood vessels in the body which itself can 
be sub-divided into microvasculature and the macrovasculature. Microvasculature refers 
to the arrangement of smaller vessels of the circulatory system, such as capillaries, 
arterioles and venules. Macrovasculature refers to the larger blood vessels, such as veins 
and arteries, containing an internal diameter greater than 100 microns. All blood vessels 
of the vasculature share a common three-layered structure (Figure 1.1). These three 
layers are: 
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(i) Tunica Externa 
The tunica externa, also known as the tunica adventitia, is the outer layer covering of 
the blood vessel, mostly consisting of elastic and collagen fibres. The collagen serves to 
anchor blood vessels to nearby organs. The elastic fibres separate the tunica externa and 
the tunica media. The tunica externa also contains nerves and tiny blood vessels to 
supply tissues of the vessel wall. These blood vessels are called vasa vasorum, which 
translates as “vessels to the vessels”. 
(ii) Tunica Media 
The tunica media is the middle layer of the blood vessel. It is made up of more elastic 
fibres, and smooth muscle cells. The smooth muscle cells are spindle shaped, and have a 
circular arrangement around the vessel which is perpendicular to the direction of the 
blood flow. Here, the lumen is regulated, and as a direct result, so is the blood pressure 
of the vessel. 
(iii) Tunica intima 
The tunica intima refers to the innermost layer of a vessel. It is made up of a 0.2-4 μm 
thick monolayer of endothelial cells which is in direct contact with the blood flow as it 
passes through the vessel. It plays an important role with regards to exchange of 
materials. The tunica intima also possesses a framework of collagen fibres which give 
the basal lamina significant tensile strength, while also providing resilience for pulsatile 
stretching and recoil. 
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Figure 1.1: The Human Blood Vessel. This illustrates the three main layers of the blood vessel 
- Tunica intima, Tunica Media and Tunica Externa. © Fox, Stuart I. Human physiology 4th 
edition, Brown Publishers. 
 
1.1.3 The Endothelium 
The endothelial cell layer of the tunica intima appears as a cobblestone morphology that 
elongates and aligns in the direction of the flow of blood. However, at arterial 
bifurcations and veins, they appear to show a cuboidal, or plump, morphology. 
Research has shown how the endothelial cell layer is vital in regards to its multiple 
functions within the vascular blood vessel (Tao et al., 2012). These functions include 
growth regulation, coagulation, production of extracellular matrix (ECM) components, 
the immune response and modulation of blood flow and blood vessel tone (Sasaki and 
Toyoda, 2013; Sumpio et al., 2002). Normal endothelial function is pivotal in vascular 
homeostasis and cell functions that limit development of atherosclerosis (Lusis, 2000).  
During embryonic development, a common precursor cell called the angioblast is 
derived from the mesoderm. These angioblast cells differentiate into endothelial cells 
and, depending on their interactions with surrounding cell areas, acquire organ-specific 
properties. Such interactions may occur through cell-cell or cell-matrix signalling. 
Palladin (as discussed in greater detail in Chapter 1.5) is a protein encoded by the 
PALLD gene, and is responsible for cell structure, adhesion and migration (Goicoechea 
et al., 2010) as well as playing a vital role in embryonic development (Luo et al., 2005). 
Palladin has been identified within endothelial cell nuclei in human coronary vessels 
with atherosclerosis (Jin et al., 2010). The work presented here in this thesis aims to 
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characterise the Palladin protein in greater depth through investigating its expression 
within Human Aortic Endothelial Cells. As it is an actin-binding protein responsible for 
cell adhesion and migration, and considering it localises to different areas within the cell 
(Jin et al., 2010; Rachlin and Otey, 2006; Goicoechea et al., 2010) it was hypothesised 
that this protein displays differential expression levels in response to the haemodynamic 
forces that the endothelial cell layer is subjected to. A notable binding partner of 
Palladin is the LASP-1 protein (Rachlin and Otey, 2006), a crucial protein involved in 
cell motility which itself is described in detail in Chapter 1.5.4. A further objective of 
the work presented here is the investigation of the expression of this and other binding 
partner proteins of Palladin in response to haemodynamic force. It was hypothesised 
that the force-induced patterns of expression may be characterised as being similar to 
that of Palladin. Later, the release of protein in Endothelial Microparticles is also 
investigated. As discussed in Chapter 1.6, these particles are released from cells 
following the onset of haemodynamic force. A hypothesis for reduction in protein 
expression after later time points of haemodynamic force was the expulsion of excess 
protein encapsulated in the microparticles. Further investigation lead to observing the 
release of binding protein partners of Palladin through these particles. 
The healthy endothelial cell layer can respond to the wide variety of both 
biomechanical/ haemodynamic forces (cyclic strain and shear stress) and biochemical 
(e.g. growth factors, hormones, cytokines, and oxygen) forces in order to regulate the 
functions of the endothelium. These functions include the regulation of vascular tone, 
regulation of the endothelial cell barrier and permeability, regulation of vascular growth 
and vessel formation, and regulation of inflammatory and immune reactions 
(DeCaterina and Libby, 2007). As discussed further in the next section, the deregulation 
of these functions has severe consequences for many cell fates and functions including 
aberrant migration, proliferation and adhesion. The dysfunction of these endothelial 
processes can also signal the start of atherosclerosis (Lehoux et al., 2006) 
 
1.1.4 Endothelial Dysfunction 
Endothelial dysfunction is a systemic pathological state of the endothelium, which can 
be defined as an imbalance between the dilating and constricting nature of the 
endothelium (Aird, 2007; DeCaterina and Libby, 2007). It occurs as a result of certain 
“stimulation” of the endothelium, be it biochemical or biomechanical. This can 
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encompass injury to the endothelium, the action of blood-borne constituents, altered 
haemodynamics, etc. It can also result from and/or contribute to several disease 
processes such as hypertension, hypercholesterolaemia or diabetes (Münzel et al., 
2008). Endothelial function has been observed to be inversely associated with the 
number of risk factors (Balbarini et al., 2007) and therefore global cardiovascular risk 
(Versari et al., 2009).  
Within a short time frame of the endothelium being stimulated, normal physiological 
conditions will prevail. However over a longer time frame, endothelial function 
becomes impaired, which leads to endothelial cell dysfunction. Such alterations of the 
endothelial cell morphology and phenotype are considered to be early and crucial steps 
within the development and progression of cardiovascular disease (Deanfield et al., 
2007; Suwaidi et al., 2010). 
Because of the morphology of the vascular system, certain areas are more prone to 
endothelial dysfunction than others, namely areas of low shear (such as the shear 
patterns of atherosclerotic sites) and/or flow disturbances at curvatures in the vessel, or 
at arterial bifurcations – the point where the aorta divides into two smaller arteries 
(Hahn and Schwartz, 2009). This low shear stress and the disturbed flow pattern are 
observed to modulate clinical manifestations of disease and also enhance the 
progression of atherosclerotic lesions (Chiu and Chien, 2011). As stated previously, the 
morphology of endothelial cells under these varied haemodynamic conditions are 
mediated by a number of signalling GTPases such as Rac and Rho (Mazzag et al., 2003; 
Wojciak-Stothard and Ridley, 2003). Dysfunction is associated with an increased 
expression of adhesion molecules, altered vascular tone, and release of chemokines, 
cytokines and reactive oxygen species from the endothelium. This results in 
inflammation within the vessel (Endemann and Schiffrin, 2004). 
There are three endothelial responses to dysfunction or injury (Pasyk and Jakobczak, 
2004). First is the immediate transient response, which begins immediately following 
mild injury and lasts about 30 minutes, causing increased vascular permeability. The 
second response, the immediate-sustained response, occurs after severe injury and is 
associated with cell necrosis. The vascular leakage which results from this necrosis can 
last for a long period of time (several days). The third response is the delayed-prolonged 
response, where a delayed but long lasting vascular leakage occurs from direct injury of 
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cells, caused by mild-to-moderate exposure to heat, x-rays or UV radiation (Kumar et 
al., 2009). 
One of the key features of endothelial dysfunction is the impairment of arterial dilation 
prohibiting proper blood flow. The endothelium can release many vasodilators such as 
Nitric Oxide (NO) to allow for dilation. Other vasodilators include prostacyclin and 
bradykinin (Giannotti and Landmesser, 2007). Changes in the ability to release such 
vasodilators are linked to the development and progression of CVD. Many of the 
vasoprotective responses of the endothelium are mediated by NO. Moreover, NO is 
responsible for regulation of vascular permeability, platelet aggregation, monocyte 
adhesion, cytokine expression and tissue oxidation (Esper et al., 2006). It is formed 
from endothelial cells from the endothelial NO synthase enzyme (eNOS) acting on L-
arginine precursor. The eNOS is found in the caveolae of the cell membrane; there, the 
protein caveolin-1 is displaced by the binding of calcium to calmodulin, which activates 
the eNOS and leads to NO production (Davignon and Ganz, 2004). 
NO can also be released into the bloodstream where it is inactivated by oxyhemoglobin. 
However, before inactivation can occur, it may remain close to the endothelial surface 
where it can inhibit leukocyte and platelet adhesion and activation (Hossain et al., 
2012). Haemodynamic forces within the vasculature are very important in the regulation 
of NO. For example, healthy atheroprotective laminar blood flow is capable of 
stimulating NO production (Harrison et al., 2006). 
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Figure 1.2: The Endothelial L-arginine-Nitric Oxide System. This illustrates the pathway 
that leads to vasodilation. Shear stress from blood flow stimulates the activation of Endothelial 
Nitric Oxide Synthase (eNOS). eNOS uses the L-arginine amino acid to produce Nitric Oxide, 
which in turn activates Guanylate Cyclase and leads to vasodilation. Pathological shear stress 
can result in an imbalance of Nitric Oxide, which results in altered vasodilation and subsequent 
endothelial dysfunction (Giannotti and Landmesser, 2007). 
 
1.2 HAEMODYNAMIC REGULATION 
With regards to stimuli regulating endothelial function, haemodynamic forces are highly 
important and dramatically influence the endothelial cells. Haemodynamic forces within 
the vasculature are among the various stimuli which can determine vessel distribution 
and diameter. They are able to do this on a cellular level, while mediating regulatory 
events within the vessels themselves (Gimbrone Jr and Garcia-Cardena, 2013). It is 
through the ability of components in the vessel structure responding to biochemical and 
biomechanical stimuli which make the regulation of blood flow possible.  
These forces are essential to development of the physiology of the vasculature, but the 
de-regulation of them plays a strong role in the development of disease. Alteration of 
force generated cell signalling results in the knock-on alteration of many cellular 
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functions such as cell adhesion, migration or proliferation (Lehoux et al., 2006). Two 
main haemodynamic forces exist: (i) cyclic strain and (ii) shear stress (Figure 1.3). 
 
 
Figure 1.3: Forces affecting Endothelial Cells in the Vasculature. This illustrates the 
haemodynamic forces - P represents the pressure of the cyclic strain, and r represents the shear 
stress – both of which are influential on the endothelial cell layer. Pressure is normal to the 
vessel wall, resulting in circumferential stretching, while shear stress is parallel to the vessel 
wall and exerted longitudinally in the direction of blood flow (Hahn and Schwartz, 2009).  
 
1.2.1 Cyclic Strain 
Contraction of the heart causes pulsatile (a pulsing flow with periodic variations) 
changes in blood pressure on the arterial side of the circulatory network. The aorta 
expands at the peak of this blood pressure cycle (systolic) and then steadily contracts as 
the pressure decreases (diastolic) from the blood flowing downstream. Cyclic strain is 
generated by the pulsation of the blood vessels as blood is pumped through by the heart 
(Collins et al., 2005). It results in the vessel wall stretching in the circumferential and 
longitudinal direction, however the vessel wall becomes thicker or thinner so that force 
per unit of wall is consistent (Lehoux et al., 2006). This equilibrium is described by 
Laplace’s Law (Laplace, 1899): 
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Where T = Wall tension (or force per unit length of the vessel), P = Blood pressure, r= 
radius and h = thickness of the vessel wall. Arteries also remodel in response to change 
of fluid flow so that the vessel diameters are matched to the blood volume (Schaper, 
2009).  
Cyclic strain can affect smooth muscle cells (Qi et al., 2010) but is predominantly 
influential on endothelial cells, playing an important role in cell migration (Von 
Offenberg Sweeney et al., 2005) and permeability (Collins et al., 2005). At 
pathophysiological levels though, cyclic strain results in haemodynamic dysregulation 
leading to atherosclerosis (Ando and Yamamoto, 2011). It has a visual effect on 
endothelial cell morphology, where it increases cell proliferation, results in the 
formation of actin stress fibres, and the cell realignment perpendicular to the force 
vector. The actin cytoskeleton and its regulatory proteins are believed to play an 
important role in the pathogenic effects of cyclic strain. Further investigation is still on-
going, as there are proteins which have a regulatory effect on the dynamic activity of the 
actin cytoskeleton that are still to be fully characterised (Hahn and Schwartz, 2009). For 
example, the LIM proteins, Zyxin and Paxillin, have been recently observed to exhibit 
mechanosensory properties, affecting the actin cytoskeleton in response to strain 
(Watanabe-Nakayama et al., 2013). As discussed later in this chapter, these proteins are 
observed to bind with LASP-1, which itself binds to Palladin. This strengthens the 
hypothesis that Palladin and LASP-1 play a role in force induced cytoskeletal 
remodelling, meriting the investigation into these proteins.  
Endothelial cells subjected to cyclic strain show moderate production of Reactive 
Oxygen Species (ROS), which becomes increased under pathological conditions 
(Bundey, 2007). Furthermore, cyclic strain has been observed to also upregulate Nitric 
Oxide Synthase (NOS) in endothelial cells (Fleming, 2010), where pathological levels 
of strain appear to increase upregulation more than physiological levels. When 
converted, the endothelial-derived Nitric Oxide (NO) can react with the ROS, which 
further reduces the availability of NO in the cell (Rojas et al., 2006). It is thought that 
the accumulation of ROS can also initiate an inflammatory response which plays a part 
in development of atherosclerosis (Kou et al., 2009).  
 13 
 
1.2.2 Shear Stress 
While cyclic strain is a haemodynamic force that can affect endothelial and smooth 
muscle cells in the vessel, shear stress is a force that only affects endothelial cells. This 
shear stress is the frictional force per unit area that blood exerts as it flows over the 
endothelial cell layer. Shear stress is expressed as units of force / unit area (Newton per 
meter squared [N/m
2
] or Pascal [Pa], or dynes/cm
2
; 1 N/m
2
 = 1Pa = 10 dynes/cm
2
). 
Under normal physiological conditions the endothelium is exposed to roughly 10 
dynes/cm
2
. In the case of this atheroprotective laminar shear, shear stress can be 
expressed using the Hagen-Poiseuille formula (Katritsis et al., 2007): 
 
Where τ = shear stress, μ = blood viscosity, Q = flow rate and r = vessel radius. 
The endothelium is subjected to shear stress of approximately 10-70 dynes /cm2 
(Thorin and Thorin-Trescases, 2009). Endothelial cells in vivo exhibit an elongated 
shape that is orientated in parallel to the direction of the blood flow in relatively straight 
regions of the vasculature. The frictional force induces two general levels of molecular 
response exclusive to endothelial cells – the acute rapid response over short time 
periods, or delayed long term changes that are dependent on protein synthesis. In 
disturbed shear – the type seen at branching points and curvatures of the arterial tree 
(Figure 1.4) - the acute response is sustained (Hahn and Schwartz, 2009). 
The immediate response of the laminar shear-induced remodelling is cell elongation, 
wherein actin stress fibre and microfilament formation, and intracellular junction 
disruption are observed within the first three hours of shear (Li, Haga and Chien, 2005; 
Johnson et al., 2011). As a result of this shear, oxidative stress, permeability and cell 
turnover are low (Figure 1.4). Between 6-8 hours following laminar shear stress, 
changes in endothelial morphology occurs and the actin cytoskeleton is restructured. 
Such changes include the partial disassembly and subsequent reassembly of actin 
filaments at adherens junctions and focal adhesions (Osborn et al., 2006). Adherens 
junctions are a dynamic complex present at cell-cell borders between adjacent 
endothelial and epithelial cells. Focal adhesions are structures through which both 
mechanical force and regulatory signals are transmitted. They can mediate the 
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anchorage of cells to ECMs also (Wehrle-Haller, 2012). The actin disassembly is 
augmented with many actin-binding scaffolding proteins localising to adherens 
junctions and focal adhesions also. Delayed or chronic shear mediated responses require 
the synthesis of certain proteins, which in turn may result in changes in the appropriate 
gene expression. The shear induced modulation of gene expression results from the 
binding of specific transcription factors to their target cis-element in the promoter 
region of the gene (Chien et al., 1998; Obi et al., 2009). 
Studies have observed the in vivo alterations of shear stresses (Hahn and Schwartz, 
2009; Cecchi et al., 2010). The many different forms of shear, aside from steady 
laminar flow, include laminar pulsatile flow, or turbulent flow (Figure 1.4).  
           
 
 
 
 
 
 
 
 
Figure 1.4: The effects of shear flow on Endothelial Cells. In regions where the arteries are 
straight, the blood flow is laminar (Blue coloured in this diagram). But in regions where 
branching of arteries occurs, complex flow patterns develop, and shear becomes disturbed (Red 
coloured in the diagram). Endothelial cells in regions of high laminar shear have an anti-
inflammatory phenotype, and align in the direction of flow. However, in disturbed shear 
regions, pro-inflammatory conditions are visible where cells have poor alignment and 
inflammatory genes are expressed – leading to a higher occurrence of atherosclerosis. Cells 
under laminar flow activate various inflammatory signalling pathways, but these are 
downregulated after around an hour. Disturbed shear activates the same pathways, but in a long-
term manner (Hahn and Schwartz, 2009). 
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Many shear responsive genes (e.g. Thrombomodulin, NOS, Prostacyclin and ICAM-1) 
are modulated by the type and rate of shear flow (Resnick et al., 2003; Chien et al., 
1998). However the same type of shear stress doesn’t apply across the whole 
vasculature, with different parts of the network being subjected to different forms of 
shear stress. As a result, some genes are regulated differently at different locations such 
as arterial bifurcations or curvature of the vessel. At such sites, disturbed blood flow can 
lead to transient vortex formations and even flow reversal. In turn this can lead to a 
variety of altered flow patterns. Under disturbed shear, cells have a higher proliferation 
rate, migration rate and deregulated cell morphology, all of which are mechanisms for 
initiation and the progression of atherosclerosis (Chiu and Chien, 2011). Furthermore, 
DNA synthesis has been observed to be significantly higher in areas of disturbed shear, 
as opposed to the areas exposed to laminar shear (Estrada et al., 2011). 
  
1.2.3 Mechanotransduction 
Mechanotransduction refers to the process by which the endothelial cells possess the 
ability to take mechanical force and convert this force into biochemical signals which 
subsequently change the function of the cells (Orr et al., 2006b; Hahn and Schwartz, 
2009). The signals are altered depending on the difference in the force caused. For 
instance, exposure to laminar, disturbed or oscillatory shear flow can generate different 
endothelial responses. A group of receptors known as mechanosensors are utilised here, 
differentiating between physiological and pathological haemodynamic stimuli (Liu et 
al., 2013; Katsumi et al., 2004). Many possible mechanosensors have been suggested to 
function in sensing and being regulated by flow, such as platelet and endothelial cell-
adhesion molecule-1 (PECAM-1), vascular endothelial (VE)-cadherin and various 
integrins (Hahn and Schwartz, 2009).  
Integrins are membrane-associated glycoproteins which are generally found at the 
basolateral surface of endothelial cells. These proteins are composed of an α and a β 
subunit. There are 18 α and 8 β subunits which can be arranged into different receptors 
with alternative binding properties and tissue distributions (Hynes, 2002, Barczyk, 
Carracedo and Gullberg, 2010). Each subunit consists of a large extracellular domain 
(which binds directly to ECM proteins), a transmembrane spanning region, and a short 
cytoplasmic domain (Hynes, 1999). The cytoplasmic domains interact with signalling 
molecules and cytoskeletal proteins in order to regulate cellular events (Shyy and Chien, 
2002). Such cytoskeletal proteins are actin-binding, and include talin, α-actinin and 
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ZASP (Bouaouina et al., 2012). The cellular events include signal transduction, 
cytoskeletal organisation and cell motility. Integrins are unique in their ability to 
regulate “inside out” signalling, where the intracellular signals affect binding affinity to 
ECM ligands, affecting cell adhesion, progression and motility (Shattil, Kim and 
Ginsberg, 2010). Integrins can also regulate “outside-in” signalling, whereby they are 
capable of transmitting signals into the cell from the surrounding matrix and affecting 
cell growth, gene expression and programed cell death (Hynes, 2002). 
Integrins are only able to bind to their binding partners when there are a minimum 
number of them present at focal adhesions. Their affinity is relatively weak - when 
integrins are loosely distributed across the cell surface, there is no strong adhesion 
present. To be more effective, several integrins must localise at the adhesion. The low 
affinity is actually necessary, as otherwise, there would be increased binding of cells, 
which would result in a lack of motility. By making and breaking focal adhesions, the 
cell can move and restructure if needed (Puklin-Faucher and Sheetz, 2011).  
 
Figure 1.5: Basic structure of the integrin heterodimer. Integrins are composed of the 
extracellular domain which binds directly to extracellular matrix proteins, a transmembrane 
spanning region, and a short cytoplasmic domain which binds to actin-binding proteins in the 
cytoskeleton. 
 
It has been observed that integrins are highly sensitive to haemodynamic forces. For 
instance integrin activation plays an essential role in flow-mediated Nitric Oxide release 
(Zaragoza et al., 2012). Under static conditions, the mechanosensitive integrins are in an 
inactive conformation, and various signalling molecules are unphosphorylated or 
assembled as a signalling complex (Shyy and Chien, 2002). Studies have shown that the 
onset of laminar shear stress triggers a conversion of integrins to a high affinity state, 
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followed by their binding to the subendothelial ECM (Orr et al., 2005). This binding is 
specific depending on integrin and matrix, and is important for cellular development, 
cell adhesion, maintenance and repair (Harburger and Calderwood, 2009). For example, 
shear flow is observed to trigger the activation of the Mitogen-Activated Protein (MAP) 
kinase p38 when endothelial cells are coated on collagen, but not on fibronectin. The 
same shear flow can induce activation of the nuclear factor kappa-B (NF-κB) 
transcription regulator on fibronectin, but not collagen (Orr et al., 2005). There is less 
evidence for integrin activation through cyclic strain, but it has been suggested that 
these forces trigger integrin activation in order to increase cell adhesiveness, which 
leads to new binding and signalling (Schwartz and Simone, 2008). 
Kinases are important regulatory proteins with respect to integrins. They respond to 
activation signals from growth factors, and in turn trigger specialised cellular responses. 
Integrin cytoplasmic domains have been observed to bind with protein tyrosine kinases 
(Romer et al., 2006). It has been observed that shear stress is also capable of activating 
many kinases located in the cell membrane, focal adhesions and cytoplasm. For 
example, the PI3-K – Akt and protein kinase-A pathways which regulate the activation 
of endothelial NO synthase are activated following shear. Also of note is the Focal 
Adhesion Kinase (FAK), which is a ubiquitously expressed cytoplasmic protein tyrosine 
kinase that has been observed to regulate numerous endothelial cell functions (Grinnell 
and Harrington, 2012). When activated, FAK is autophosphorylated and associates with 
c-Src, another kinase. Following this, c-Src phosphorylates paxillin and p130cas, which 
act as scaffolds for recruitment of various adaptor proteins and signalling intermediates 
(Donato et al., 2010).  
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Figure 1.6: Focal Adhesion Kinase phosphorylation. The phosphorylation of FAK is Src-
induced and coordinates adhesion dynamics, cell migration, survival, and anchorage-
independent growth. The Src-induced phosphorylation of FAK is required for the rapid 
assembly of actin stress fibres and the formation of focal adhesions that promote initial cell 
adhesion and spreading, events that are in part mediated by calpain activity. Src-induced 
phosphorylation of FAK also promotes focal adhesion turnover and cell motility via calpain 
activation, most likely by linking calpain to upstream regulation by the extracellular signal 
related kinase/MAP kinase pathway (Westhoff et al., 2004).  
 
Phosphorylation of p130cas by FAK associated Src also leads to activation of MAP 
kinase and cell migration. MAP kinases are involved in directing cellular responses to 
an array of stimuli, such as osmotic stress, heat shock and proinflammatory cytokines. 
They regulate many cellular functions such as proliferation, gene expression, 
differentiation, mitosis, cell survival, and apoptosis. There is increasing evidence that 
FAK and Src play a critical role in the interactions between integrins and cadherins, 
where activated Src and/or FAK can regulate cadherin complex stability (Canel et al., 
2013; Koenig et al., 2006). 
 
1.3 EXTRACELLULAR MATRICES 
As discussed in the last section, the integrins can bind to the extracellular matrix (ECM) 
in a specific manner, depending on type of integrin or matrix, which can affect the 
cellular development. The ECM exists to serve many functions, such as providing 
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anchorage for cells, separating different tissues, and regulating cellular communication 
(Orr et al., 2006b; Abedin and King, 2010). ECM formation is essential for other 
processes such as growth or wound healing (Davis and Senger, 2005). The extracellular 
domains of integrins bind directly to ECM proteins such as fibrinogen, fibronectin and 
collagen (Orr et al., 2006). As illustrated in Figure 1.7, some of these ECM proteins are 
capable of altering cellular function and phenotype through the activation of specific 
integrins which support the flow activation of inflammatory pathways such as NF-κB 
(Orr et al., 2005). Activation can promote the migration of cells and the breakdown of 
cell-cell adhesions, which results in elevated endothelial permeability (Mehta and 
Malik, 2006). Integrin responses to mechanical force can be dependent on specific 
integrin-matrix interactions. Localised vascular homeostasis has a direct effect on the 
function of endothelial cells through these interactions of matrices with corresponding 
integrins, followed by specific signal transduction from the activated integrin. 
Endothelial cells plated on fibronectin or fibrinogen matrices activate NF-κB in 
response to flow, whereas cells on collagen do not.  
NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein 
complex that controls the transcription of DNA (Orr et al., 2005). NF-κB controls many 
inflammatory genes, being observed to be chronically active in many inflammatory 
diseases, such as atherosclerosis (Liu et al., 2012). While it is difficult to observe NF-
κB signalling in an in vivo model, it has been observed that endothelial cell-specific 
inhibition of NF-κB results in a reduction of the development of atherosclerosis in an in 
vivo ApoE−/− mouse model (Gareus et al., 2008). Activation of NF-κB is essential for 
the Tumour Necrosis Factor α (TNF-α) response. TNF-α is a potent pro-inflammatory 
cytokine, which triggers endothelial activation resulting in increased vascular 
permeability (Kempe et al., 2005). Flow-induced NF-κB activation is downstream of 
conformational activation of integrins. This results in the binding of new integrins to the 
subendothelial ECM and subsequent signalling events (Orr et al., 2005). 
The inhibitory IkBα subunit is degraded and NF-κB is phosphorylated, which allows 
NF-κB to translocate into the nucleus following flow. Both subunits of NF-κB undergo 
posttranslational modification also. This modification includes the phosphorylation of 
p65 Ser536 in the C-terminal transactivation domain, which is important for expression 
of target genes (Petzold et al., 2009). Changes following shear in the sub-endothelial 
ECM differ depending on matrix (Orr et al., 2006). 
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Figure 1.7: General model of Cell-Matrix Interactions and their downstream regulation. 
The integrin cluster interacts with the extracellular matrix outside of the endothelial cells. These 
integrins recruit cytoplasmic proteins which, along with other cell surface receptors, can control 
and regulate many cellular processes and functions (Berrier and Yamada, 2007).  
 
1.3.1 Fibrinogen 
The ECM glycoprotein (i.e. a protein bound to a carbohydrate), fibrinogen, plays a 
major role within the vasculature. It is a large, complex, dimeric glycoprotein composed 
of three pairs of polypeptides: two Aα, two Bβ, and two γ. These polypeptides are 
linked together by 29 disulphide bonds, some of which are depicted in Figure 1.8. The 
two subunits are composed of a D domain which contains a globular region and an E 
domain which contains disulfide bonds that links the two subunits (Mosesson, 2005).  
Fibrinogen is known for a long time to induce endothelial cell attachment, spreading 
and migration (Suehiro et al., 1997). It is converted into fibrin by thrombin; the fibrin is 
subsequently polymerised to form a haemostatic plug that, together with platelets forms 
a blood clot. Fibrinogen has been identified to be a major independent risk factor for 
CVD with elevation of appearing to correlate with the increasing prevalence of risk 
factors (Tousoulis et al., 2011). There are several mechanisms for this to occur. 
Fibrinogen can bind to activated platelets specifically, via glycoprotein IIb/IIIa - which 
contributes to platelet aggregation. Furthermore, fibrinogen is observed to increase in 
inflammatory states. Interestingly, there is little fibrinogen or fibronectin present 
beneath the endothelium in most of the vasculature, but these proteins are observed at 
sites of disturbed flow in vivo (Orr et al., 2005). 
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Figure 1.8: Fibrinogen. This schematic illustrates the structure of fibrinogen, consisting of two 
Aα, two Bβ, and two γ polypeptides. These polypeptides are orientated in such a way that all six 
N-terminal ends meet and form the central E domain. Two regions of coiled α helices stretch out 
on either side of the E domain, each consisting of one Aα, one Bβ, and one γ polypeptide. Each 
of the coiled regions ends in a globular D domain, consisting of the C-terminal ends of Bβ, and 
γ, as well as part of the Aα polypeptide. The C-terminal end of the Aα peptide then sticks out 
from each D domain as a long strand, where they can interact with each other or with the E 
domain during fibrin clot cross-linking.  
 
1.3.2 Fibronectin 
Fibronectin is a glycoprotein which connects cells with collagen fibres in the 
endothelial cell matrix. The protein works by binding collagen and surface integrins, 
which causes the cytoskeleton to reorganize; thereby allowing for cell motility. It 
consists of a series of modular domains in an inactive unfolded form. When stimulated, 
it undergoes conformational rearrangements; revealing previously concealed 
fibronectin-binding sites and triggers fibronectin matrix assembly (Wierzbicka-
Patynowski and Schwarzbauer, 2003). Adjustments of the contractility or matrix 
rigidity can potentially regulate matrix assembly and structure (Berrier and Yamada, 
2007). It has been shown that fibronectin secreted from endothelial cells could enhance 
the spreading and adhesion of cells on a fibrinogen matrix (Zou et al., 2012). This 
suggests that this cell-matrix interaction could be indirect. Furthermore, it may be 
mediated by fibronectin as a bridging molecule.  
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Figure 1.9: Fibronectin. This schematic illustrates the structure of fibronectin, consisting of 
two heterodimers; the A chain and the B chain, containing the type III connecting segment 
region. The multiple domains of fibronectin have binding affinities for collagen, heparin, fibrin 
and other specific cell membrane receptors. 
 
Following shear stress, fibronectin becomes more uniformly distributed beneath 
endothelial monolayers and organizes into bands of densely packed fibrils. Studies have 
implicated the shear stress stimulation of the integrin αVβ3 through activation of 
endothelial cells seeded on a fibronectin matrix, which results in increased binding and 
cell adhesion (Tzima et al., 2001; delPozo et al., 2000). Studies indicate the integrin 
activation following shear flow is localised to the edge of cellular lamellipodia. The 
αVβ3 integrin has been observed to be highly active at cell-cell junction formations, 
with many of the proteins involved in junction formation also being involved with this 
integrin in actin recruitment, organisation and maintenance. It has also been observed 
that laminar shear stress enhances the migratory properties of endothelial cells via the 
α5β1 integrin. These fibronectin receptor subunits serve as central mechanotransducers 
in endothelial cells (Urbich et al., 2002). The α5β1 and αvβ3 integrins associate with the 
Shc adaptor protein, which is able to couple integrin signalling to the MAP kinase 
cascade and is essential for endothelial cell adhesion and survival (Danen and Yamada, 
2001). Previous studies observe that this interaction of Shc and the α5β1 and αvβ3 
integrins is stimulated through shear stress (Jalali et al., 2001). As α5β1 is upregulated, 
the downstream MAP kinase cascades and FAK are activated, stimulating cell 
migration.  
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1.3.3 Collagen 
Collagen is a major fibrous protein in the ECM and in connective tissue. Multiple types 
of collagen exist which are distinguished by the ability of their helical and non-helical 
regions to associate into fibrils, to form sheets, or to cross-link different types of 
collagen (Lodish et al., 2000). Type I collagen is observed in skin and bone, and the 
Type III collagen frequently associates with it. Type I collagen can be observed to act 
upon endothelial cells, altering their morphology to a spindle shape and aligning cells 
into solid cord-like assemblies (Whelan and Senger, 2003). Type IV is the type mainly 
seen in the basement membrane of the vasculature however (Hohenester and 
Yurchenco, 2013). Type IV collagen is a sheet-forming type which is observed to have 
a critical scaffolding function in basement membranes. This particular type of collagen 
promotes cellular adhesion and proliferation (DeCaterina and Libby, 2007). It forms a 
network structure that involves its interaction with other basement membrane 
components (Genové et al., 2005). Collagen IV molecules consist of two α1 (IV) chains 
and one α2 (IV) chain. These chains can interact indirectly with cells through low 
affinity laminins (Hohenester and Yurchenco, 2013), or by strong interactions mediated 
by nidogen, a glycoprotein which binds to laminin (Mokkapati et al., 2011). Both of 
these proteins are basement membrane components (Liliensiek et al., 2009). Each of the 
α-chains consists of three domains: an N-terminal 7S domain, a middle triple-helical 
domain, and a C-terminal globular non-collagenous (NC1) domain. It is speculated that 
the α-chains self-assemble to form sets of triple-helical molecules which self-associate 
via the NC1 domains and their middle triple-helical domains to form spider web-like 
scaffolds which interact with the laminin network in forming a basement membrane 
scaffold (Tanjore and Kalluri, 2006). 
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Figure 1.10: Collagen. The type IV collagen α-chains have three similar domain structures: an 
amino-terminal 7S domain, a middle triple-helical domain, and a carboxy-terminal globular 
non-collagenous (NC-1) domain. The NC1 domains are thought to associate together, leading to 
protomer trimerization. This trimerization proceeds like a zipper from the carboxy-terminal end, 
resulting in a fully assembled flexible protomer. Two type IV protomers associate via their C-
terminal NC1 trimers to form an NC1 hexamer. Afterwards, four protomers interact at the 
glycosylated N-terminal 7S region to form tetramers. These interactions form the nucleus for a 
type IV collagen scaffold. The scaffold evolves into a type IV collagen super structure, with the 
help of end to end associations and also lateral associations between type IV collagen protomers 
(Kalluri, 2003). 
 
ECM composition remains relatively stable in healthy adult tissue, but this balance is 
subject to change (Wight and Potter-Perigo, 2011). Degradation of Type IV collagen 
can occur in the basement membrane under both physiological and pathological 
conditions (Kalluri, 2003). Under these conditions, the triple helices of collagen can 
unfold, enabling other matrix proteins such as fibronectin to interact with native 
collagen in vivo. Such fibronectin-collagen interactions may mediate the adhesion of 
cells to collagen, form non-covalent crosslinking of fibronectin and collagen in 
migratory pathways, and also regulate the removal of denatured collagenous materials 
from blood and tissue (Pankov and Yamada, 2002). 
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Endothelial production of collagen also appears to be inhibited with increased cyclic 
strain (Wilson et al., 2009). Studies on cells seeded onto a glycosylated form of 
collagen have observed the halting of the alignment of endothelial cells normally seen 
during shear stress (Kemeny et al., 2011), suggesting that collagen expression in 
endothelial cells may be hindered with exposure to both kinds of haemodynamic force, 
affecting the balance of matrix composition. It has been observed that shear stress is 
capable of inducing NF-κB activation on fibrinogen and fibronectin matrices, but not on 
collagen. Despite the production of ROS during shear, there is a lack of flow-induced 
NF-κB activation when endothelial cells are seeded onto a collagen matrix, which is 
suggestive that collagen somehow regulates cellular sensitivity to ROS (Orr et al., 
2005). Certain integrins fail to be activated on nonpermissive matrices such as collagen. 
The ligation of one integrin can affect activation of other integrins in a knock on effect 
(Gonzalez et al., 2010). It was hypothesised then that expression of Palladin or its 
interacting proteins may be affected by the specific ECM related signalling mechanisms 
following mechanical stimulation of the endothelial cell. The results of this are 
discussed in Chapter 3. 
 
1.4 THE CYTOSKELETON 
The structure of the endothelial cell in response to mechanics are largely determined by 
the alteration of the cellular cytoskeleton, which itself is mainly composed of 
microtubules, intermediate filaments and actin (Choi and Helmke, 2008). The 
microtubules are the largest, having a diameter of about 25nm, the intermediates 
filaments are roughly 10nm, and the actin microfilaments are the smallest component at 
approximately 8nm in size (Insall and Machesky, 2001). These structural filaments are 
each assembled from monomeric precursors that are reappropriated through the exact 
spatial and temporal control of multiple cellular processes (Osborn et al., 2006). The 
cytoskeleton is capable of building a scaffold to define cell shape, but is still flexible so 
as to tolerate haemodynamic forces. It is not a constant structure though, as actin fibres 
re-align in the direction of shear (Oberleithner et al., 2007). It follows that the 
cytoskeleton plays an important role in the modulation of haemodynamic forces, 
whereby it transmits them through the cell, and transduces the mechanical force into a 
bio-chemical signal which finally leads to an alteration of cellular function. The 
disruption of the actin cytoskeleton in such a way can sufficiently negate the effect of 
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shear stress mediated signalling and changes in gene expression (Imberti et al., 2000). 
Cell migration and tissue remodelling require a co-ordinated cross talk between the 
intermediate filament, microtubule and actin cytoskeletal networks. Recent studies have 
indicated that the intermediate filaments and their associated proteins such as Myosin 
IIa are important components in mediating this crosstalk (Even-Ram et al., 2007; Chang 
and Goldman, 2004).  
  
1.4.1 Microtubules 
Microtubules act as rigid reinforcing rods which sustain both tension and compression. 
Actin filaments act along with them to resist the breaking down of the cell and facilitate 
the transmission of forces which allows the cytoskeleton to determine cell shape and 
structure (Abu Shah and Keren, 2013). They also play a role in the mitotic division of 
cells, where they aggregate and form a mitotic spindle, which assists in chromosome 
partitioning and cell division (Woolner et al., 2008). Microtubules possess a uniform 
structural orientation, by where the wall of a microtubule is composed of a helical array 
of tubulin heterodimers, each composed of one α-tubulin and one β-tubulin molecule, 
arranged in an alternating manner (Hu et al., 2006). These heterodimers polymerize end 
to end, giving the filament polarity. The actual tubules are composed of 13 
“protofilaments” composed of heterodimers, all encircling a hollow core. This results in 
the microtubules possessing a rigid structure, contrary to the other filament systems.  
These microtubules work as tracks for motor proteins such as myosin (Lyle et al., 
2012). By using the microtubule motors to travel along actin filaments, many molecules 
of myosin generate enough force to contract muscle tissue. The proteins are also able to 
move vesicles and organelles through using this function (Thompson and Langford, 
2002). There are also a number of proteins which regulate microtubule stability, mostly 
by binding along the length of the microtubules, as opposed to capping the ends 
(Tirnauer and Bierer, 2000).  
  
1.4.2 Intermediate Filaments 
Intermediate filaments are flexible but strong polymers that work to prevent excessive 
stretching of the cells by external forces, as well as providing mechanical support for 
the cells. When structural integrity is disrupted, repair and re-establishment is 
accomplished by the microtubules and actin microfilaments, being mediated by the 
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intermediate filaments until the cell reverts to a more structurally sound state (Chang 
and Goldman, 2004). There is a continuous network of intermediate filaments from the 
nuclear envelope to attachments known as desmosomes and hemi-desmosomes on the 
plasma membrane. Mechanical forces are transmitted through these desmosomes from 
cell to cell, and through hemi-desmosomes from cell to ECM (Delva et al., 2009). 
In contrast to the highly conserved actin microfilaments and tubulins, the protein 
subunits of intermediate filaments are varied in sequence and size (Chang and Goldman, 
2004). Another difference is the lack of polarity they have, which facilitates 
spontaneous self-assembly under physiological conditions (Godsel et al., 2008). During 
filament assembly, the monomers intertwine as they organize into a rope-like structure 
with considerable tensile strength (Kreplak and Fudge, 2007). The subunits are encoded 
by multiple different genes, but do share some characteristics, such as a general size of 
around 10nm in diameter.  
  
1.4.3 Actin 
Actin is a highly conserved, ubiquitous and vitally important protein in the cell. The 
human vasculature displays six actin isoforms, which can be divided further into three 
groups: alpha (α), beta (β) and gamma (γ). The α-actins are found to be mainly 
expressed in muscle cells and function in the cellular contraction whereas the other 
isoforms can be found in non-muscle cells as cytoskeletal components (Borisy and 
Svitkina, 2000). Actin contributes greatly to the function of cells through formation of 
cytoskeletal structures and localisation of actin-binding proteins which play other roles 
themselves in cell motility. Such actin-binding proteins have multiple domains for the 
organisation of actin, as well as protein scaffolding and signal transduction (Hu et al., 
2006). An imbalance in actin dynamics is indicative of a cell’s pathological state. Actin 
carries out its main functions through rounds of polymerisation and de-polymerisation 
in a network of actin filaments (Cooper and Schafer, 2000). The filaments extend and 
form various structures, such as lamellipodia, pseudopods or filopodia. Furthermore, 
actin filaments bind to specific actin-binding proteins to form other structures (Figure 
1.11). For example, the protein myosin and other actin-binding proteins will combine 
with actin to form bundles called stress fibres which apply tension between structures 
on the plasma membrane (Bershadsky et al., 2006). These structures are then either 
bound together, or to the ECM, so by manipulating the filaments, the adhesive 
formations can be modulated. The actin cytoskeleton is organised into microfilaments, 
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which themselves have actin monomers as their core subunits. These monomers exist in 
a globular form – referred to as G-Actin - which associates together in long filamentous 
forms, known as F-Actin (Figure 1.11). These F-Actin strands group together in a 
helical shape to form microfilaments. Actin microfilaments possess a defined polarity, 
with the faster growing ends known as “barbed ends” and the slower growing ends 
known as the “pointed ends”. The barbed end is favoured for growth, with actin 
filaments in cells strongly orientated with the barbed ends facing outward to the cell 
surface. 
 
 
Figure 1.11: Actin and binding proteins. This figure demonstrates the various functions actin 
filaments may have, along with the different proteins that interact with them. Actin-binding 
proteins can be loosely grouped into categories that function in sequestering G-actin into F-actin 
filaments, anchoring actin to membrane adhesion complexes, severing or depolymerisation of 
actin filaments, cross-linking or bundling actin, or capping the ends of filaments. The Palladin 
protein plays a role in bundling and crosslinking.  
 
Actin-binding proteins regulate the organisation of cellular actin filaments. These 
proteins can be organised into families that are able to bind the monomers, sever 
filaments, cap filament ends, cross-link filaments or stabilise filaments (Dominguez, 
2004). Such proteins possess actin-binding sites to enable the cross-linking of proteins 
and filaments as well as providing stability for other higher order assemblies of actin 
filaments. For example, the actin-binding α-actinin is found in the cortical actin 
network, at intervals along stress fibres and on the cytoplasmic side of cell adhesion 
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plaques. It is vital for the attachment of actin filaments to the Z-lines in skeletal muscle 
cells, and to the dense bodies in smooth muscle cells (Klaavuniemi et al., 2004). It also 
plays a role in the binding of actin to the membrane in other cell types. The Palladin 
protein, as discussed later, is also as an actin-binding protein, localising to stress fibres, 
focal adhesions and z-lines (Mykkänen et al., 2001; Parast and Otey, 2000; Dixon et al., 
2008). 
Another actin based structure is the stress fibre. Stress fibres consist of roughly 10-30 
actin filaments grouped together in straight bundles, along with cross-linking proteins 
and Myosin II motors. These structures transverse the cell, and terminate in dense 
plaques at the cell base (Pellegrin and Mellor, 2007). Within stress fibres, the individual 
actin filaments are bundled together through the cross-linking proteins. The myosin 
motors move, sliding the actin filaments past one another, allowing the fibre to contract. 
The proteins also facilitate the transmission of the contractile generated forces they 
produce to the ECM via focal adhesions. Contraction against the focal adhesion 
structures allows the force generated by myosin motors and filament growth and 
rearrangement to move and reshape the cell. Under normal conditions, cells are 
protected and reinforced by the ECM. When this support matrix in compromised, or 
when haemodynamic force is increased, the cells are stimulated into rapidly forming 
stress fibres. They then become aligned in the direction of flow within the vessels. The 
molecular mechanisms underlying the regulation of stress fibre thickness in response to 
mechanical stimuli is still under investigation (Tojkander et al., 2012; Hotulainen and 
Lappalainen, 2006). 
There are three classes of stress fibre, defined by their subcellular location: dorsal stress 
fibres, ventral stress fibres and transverse arcs (Hotulainen and Lappalainen, 2006). 
Dorsal stress fibres are formed by formin-mediated actin polymerisation at focal 
adhesion sites. They are attached to focal adhesions at one end, which tethers them to 
the cell base. The other end displays a loose matrix of actin filaments. These fibres 
elongate from focal adhesions to form short filaments containing α-actinin (Pellegrin 
and Mellor, 2007). Myosin then associates to these filaments, displacing the α-actinin. 
Because of the single polarity they possess, dorsal stress fibres are not contractile in 
nature. Instead they work by providing rigidity to the cell, and allow the cells to spread 
out in the blood vessel in an adaptive response to shear stress. 
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Ventral stress fibres are the most common subtype of stress fibre; found lying along the 
base of the cell and attached to focal adhesions at each end. The ventral stress fibres can 
form from the joining of two dorsal stress fibres to form a structure anchored at each 
end with the focal adhesion. Ventral stress fibres are contractile in their central region. 
At this localisation, the fibres from the opposing ends meet and generate a tension 
across the entire structure, on account of them being tethered to the focal adhesions at 
either ends. This allows for the resulting force to be transmitted to the substratum (Noria 
et al., 2004).  
The dorsal stress fibres may either join each other directly, or else meet at a transverse 
arc which then disassembles (Pellegrin and Mellor, 2007). The transverse arcs are 
formed through the end to end joining of actin bundles to myosin bundles beneath the 
dorsal surface of migrating cells directly behind the lamella. Transverse arcs are not 
anchored to the plasma membrane by focal adhesions so they transmit their force to the 
ECM indirectly via dorsal stress fibres (Ciobanasu et al., 2011). 
 
 
Figure 1.12: Actin Stress Fibres. This figure summarizes the distribution of the three classes 
of stress fibres in cells. The ventral fibres are formed when two dorsal fibres fuse together with 
a transverse arc. (Lord, 2011). 
 
Stress fibres structures contain regularly spaced “thickenings” called dense bodies. 
These dense bodies consist of several actin-binding proteins, scaffolding proteins and 
signalling kinases. One such protein observed within dense bodies is Palladin, the 
investigation and characterisation of which forms the major aim of this thesis. As the 
cell is subjected to haemodynamic force, the expression of actin will change on account 
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of the remodelling of the cell inducing a change in the fibres. It was theorized that the 
expression of Palladin would follow, changing in its expression levels in response to the 
same haemodynamic forces.   
 
1.5 THE PALLADIN PROTEIN 
The actin-binding protein Palladin, and its hitherto unknown characterisation within the 
aortic endothelial cell, form the main aim and focus of this thesis. Discovered in the 
year 2000, this member of the Myotilin-Myopalladin-Palladin family plays a role in 
cytoskeletal organisation (Parast and Otey, 2000). It is also involved in cell 
development, scar formation, embryonic development and cell motility. Mutations in 
Palladin have been shown to play a role in diseased states (Pogue-Geile et al., 2006). 
While alterations in Palladin expression are characteristic in these diseases, changes in 
expression are not exclusive to pathological states. The protein appears to be responsive 
to haemodynamic forces, with upregulation being observed in human adipose-derived 
stem cells subjected to cyclic strain (Wall et al., 2007). As stated previously, the only 
characterisation of Palladin in endothelial cells was the observation of the protein within 
the endothelial cell nuclei in human coronary vessels with atherosclerosis (Jin et al., 
2010). A major aim was therefore to observe the expression of protein within 
endothelial cells subjected to haemodynamic force.    
 
1.5.1 Isoforms of Palladin 
The Palladin protein itself exists in multiple cell type specific isoforms, arising from 
alternative splicing of the PALLD gene (Table 1.2). The PALLD gene is unusually large 
and complex, spanning 400kb in size and containing at least 25 exons (Goicoechea et 
al., 2010). Three of these exons – the first, third and twelfth – are 5’ noncoding exons, 
that are specific for one of three possible transcription start sites (Rachlin and Otey, 
2006). It has been proposed that the different isoforms may serve distinct cellular 
functions. While the 200kDa isoform is the largest (and the isoform of which all the 
smaller isoforms can be considered to be derived from), it is the 90kDa isoform which 
is generally the most commonly observed isoform in cell types (Parast and Otey, 2000; 
Rachlin and Otey, 2006; Henderson-Jackson et al., 2011). 
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Table 1.2: Palladin isoforms in specific cell types. The table lists some of the specific cell and 
tissue types which display different specific isoforms of Palladin.  
Isoform Cell Type References 
200 Heart/ Smooth Muscle Wang and Moser, 2008 
 Bone Rachlin and Otey, 2006 
140 Developing Epithelial derived cell lines, Adult 
tissues rich in muscle / cardiac muscle 
Rachlin and Otey, 2006 
90 Smooth Muscle Jin et al., 2007 
 Fibroblasts  Goicoechea et al., 2010 
 Lung and Bladder Wang and Moser, 2008 
 (Ubiquitously expressed in most tissues) Parast and Otey, 2000 
65 Pancreas Goicoechea et al., 2010 
 Uterus Wang and Moser, 2008 
 
The multiple isoforms possess different combinations of proline-rich domains in the N-
terminal end of the molecule, which are sites for protein-protein interactions (Figure 
1.13). These regions are flanked by numerous serine residues (predominant 
phosphorylation sites in Palladin) and are homologous to the ones contained in zyxin, 
vinculin and VASP family members (Parast and Otey, 2000). In the C-terminal, 
Palladin has Ig-like domains which mediate filamentous actin (F-actin) cross-linking 
(Goicoechea et al., 2008). The Ig domain is involved in protein-protein interactions, 
appearing in both extracellular and intracellular proteins (Barclay, 2003). These 
domains generally contain about 100 amino acids, and consist of seven to nine beta 
strands folded in a sandwiched beta sheet fold form (Otey et al., 2009). The Ig domains 
have been observed previously to associate with the actin cytoskeleton in a number of 
protein families, including myosin light chain kinase and Myotilin (Heikkinen et al., 
2009). The Ig domains of Palladin show a homology to those found in these protein 
families. Sequence comparison indicates that Palladin is most homologous to Myotilin, 
displaying similar domains in both the C-terminal and N-terminal regions (Mykkänen et 
al., 2001). However, despite these very close similarities, the two proteins are 
differentially expressed in tissue, with Myotilin expression being much more restricted, 
being found within the Z-disc of skeletal muscle and cardiac muscle (Otey et al., 2005). 
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Figure 1.13: Isoforms of Palladin. This schematic is representative of the major palladin 
isoforms, palladin family members and their domain organization. Myotilin contains two C-
terminal Ig domains, while Myopalladin has two N-terminal and three C-terminal Ig domains, 
similar to the Ig domain structures of Palladin. Palladin isoforms are composed of a 
combination of between three to five Ig-like domains, and at most two proline-rich domains. 
While the diagram lists the main 90,140 and 200 kDa sized isoforms, to date there are 7 fully 
categorized isoforms in total, with preliminary data on an 8
th
 and 9
th
 being investigated. These 
main three isoforms contain proline-rich domains that the other sizes do not (Goicoechea et al., 
2008). 
 
Palladin has been observed in structures containing contractile actin filament bundles, 
such as stress fibres or sarcomeres (Parast and Otey, 2000; Mykkänen et al., 2001). The 
Ig3 domain, but not Ig4 or Ig5 domain, is observed to bind to F-actin in a salt-dependent 
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manner, suggestive of an electrostatic interaction (Goicoechea et al., 2008). Notably, 
while the Ig4 domain does not bind to F-actin, fragments that contain both Ig3 and Ig4 
appear to exhibit a greater affinity for actin when compared to the Ig3 domain alone 
(Dixon et al., 2008). It appears that this is so because of actin-binding residues in the 
Ig3-Ig4 linker region enhancing the electrostatic interaction between the Ig3 domain and 
F-actin. However this linker region alone is unable to bind to actin. The Ig1 and Ig2 
domains are still under investigation, as they only appear in certain isoforms - the 
140kda sized form has the Ig2 domain near the N-terminus, while the canonically “full” 
200kDa form has the Ig1 and Ig2 domain, as well as Ig3, Ig4 and Ig5. The alterations in 
these Ig domains in different isoforms can result in the isoform specific binding of 
Palladin to other proteins (Rachlin and Otey, 2006).  
 
1.5.2 Protein Interactions of Palladin 
Palladin can associate with many other proteins. It co-localises with α-actinin (Beck et 
al., 2011; Grooman et al., 2012), another prominent actin-binding protein which itself 
assists in organization of the cytoskeleton, and acts as an adaptor in multi-protein 
complexes associated with actin filaments (Figure 1.14). α-actinin also plays an 
important role in cell-matrix and cell-cell adhesion (Otey and Carpen, 2004). The 
Palladin protein co-localizes with α-actinin in focal adhesions, dense regions and cell-
cell junctions as well as recruiting α-actinin to stress fibres via its poly-proline segments 
(Rachlin and Otey, 2006). Studies show that a short sequence of Palladin, in amino 
acids 222-280, specifically mediates the interaction with α-actinin with the binding site 
in α-actinin located within the C-terminal domain (Rönty et al., 2004).  
 
Figure 1.14: Interaction of Palladin with other proteins. This diagram illustrates how 
Palladin could interact with F-actin, and other actin-binding proteins such as Ezrin or α-actinin 
(Pogue-Geile et al., 2006). 
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Palladin is also observed to bind to CLP36, a member of the PDZ-LIM family of 
proteins, which associates to α-actinin and localizes to the actin cytoskeleton (Maeda et 
al., 2009). Palladin also binds to other actin associated proteins such as VASP 
(Boukhelifa et al., 2004), profilin (Boukhelifa et al., 2006), ezrin (Mykkänen et al., 
2001), and Eps8 (Goicoechea et al., 2006). VASP and its related proteins (Mena, Ena 
and EVL) regulate actin filament growth and cell motility, and also function as actin 
cross-linking proteins (Price and Brindle, 2000; Schirenbeck et al., 2006). VASP forms 
complexes with profilin, suggesting that VASP and Palladin may work together in 
recruiting profilin to actin polymerisation sites (Krause et al., 2003; Witke, 2004; 
Boukhelifa et al., 2005). Profilin can also enhance actin growth through the binding 
with monomeric actin, thereby occupying an actin-actin contact site. This can result in 
profilin catalysing the changing of actin-bound ADP into ATP, thereby converting the 
poorly-polymerizing ADP-actin monomers into readily-polymerizing ATP-actin 
monomers. Ezrin, which is a member of the ERM (Ezrin/Radixin/Moesin) family of 
actin-associated scaffolds, is typically a part of the cytoskeleton but in smooth muscle 
cells it is localized along microfilaments (Mykkänen et al., 2001). Fragments of Ezrin 
were observed binding to the Ig2 and Ig3 domains of Palladin in SMCs, however full 
length Ezrin did not interact (Mykkänen et al., 2001). This suggests that Ezrin must be 
activated to bind to Palladin. Activation via phosphorylation and/or phosphatidylinositol 
bisphosphate binding can disrupt the intramolecular association, revealing binding sites 
for actin and several other molecules. Ezrin may also bind to cell surface adhesion 
molecules, cell signalling molecules or cytoskeletal proteins including actin (Neisch and 
Fehon, 2011). Eps8 is a substrate for the EGF receptor and directly binds to actin, 
regulating the length of the filaments. Palladin and Eps8 co-localise in the dorsal 
membrane ruffles that form after cells are treated with certain growth factors, and also 
in the podosomes of vascular smooth muscle cells (Goicoechea et al., 2006). The large 
number and diversity of proteins which bind to Palladin are suggestive that it also has 
an indirect effect on actin organization as a scaffolding molecule, being responsible for 
organising a group of other proteins to ensure that actin assembly, bundling and 
depolymerisation occur in the correct order for cell motility to occur (Dixon et al., 
2008).  
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Table 1.3: Binding partners of Palladin. The table below summarizes the major published 
binding partners of Palladin protein, and their binding sites.  
Interacting Protein Interaction Site in Palladin References 
α-actinin Between amino acids 222-280, 90kDa 
isoform 
Parast and Otey, 2000;  
Rönty et al., 2004 
Eps8 N-terminal poly-proline sequences of 
90kDa isoform 
Goicoechea et al., 2006 
Ezrin 2 C-terminal IgC2 domains of human 
Palladin 
Mykkänen et al., 2001 
Integrin αvβ5 Between amino acids 298-772 of 90kDa 
isoform 
Lai et al., 2006 
LASP-1 N-terminal poly-proline sequences of 
90kDa isoform 
Rachlin and Otey, 2006 
Profilin N-terminal poly-proline sequences of 
90kDa isoform 
Boukhelifa et al., 2006 
Spin90 and Src N-terminal poly-proline sequences of 
90kDa isoform 
Rönty et al., 2007 
VASP FPXPP motifs in 90kDa and 140kDa 
isoforms 
Boukhelifa et al., 2004 
  
1.5.3 Effects of Palladin Expression 
The expression of Palladin is required for many essential cellular functions, with regular 
embryogenesis a prime example. In Palladin knockout mice models, embryos were 
observed to die within 15 days and exhibit developmental abnormalities such as failure 
for the neural tube to close (Luo et al., 2005). It has been demonstrated that Palladin-
null fibroblasts were also lacking in the β1 integrin subunit, with research indicating 
that Palladin is involved in the proteolysis process of the β1 integrin. The integrin itself 
is also known for playing a role in cell adhesion; downregulation of it may be an 
underlying effect resulting from adhesion and migration defects in the cell (Liu et al., 
2007). The expression of Palladin therefore may be necessary for the adhesion of cells 
to the ECM, likely through the stabilization of the β1 integrin by Palladin (Luo et al., 
2005). Palladin also interacts with integrin αvβ5 at the focal adhesions and likely links it 
to the cytoskeleton, but this interaction has not been well characterized (Lai et al., 
2006). Focal adhesions in knockdown cells have been observed to dramatically reduce, 
with only a few peripheral adhesions remaining, correlating with a reduction in number 
and strength of stress fibres (Parast and Otey, 2000). Furthermore, knockdown of 
Palladin has been observed to cause a decreased F-actin to G-actin ratio, disordered 
stress fibres, and a significant delay of wound healing due to decreased cell migration 
(Jin et al., 2009, 2010). 
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Over-expression of Palladin also results in huge changes to the actin cytoskeleton, with 
increase of actin bundles being observed (Rachlin and Otey, 2006). Notably the 
overexpression phenotype appears to differ depending on isoform; overexpression of 
the 140kDa isoform displays compact star-like actin arrays, compared to the robust 
actin-cables of the 90kDa overexpression. Palladin has been observed to be rapidly 
upregulated in response to exposure to the Transforming Growth Factor β1 (TGF-β1) 
cytokine (Rönty et al., 2006). Reviews have pointed out that TGF-β1 stimulation acts 
along with increased matrix rigidity to influence wound healing (Hinz, 2007), as well as 
the induction of podosomes (Varon et al., 2006). Podosomes are dynamic, actin-rich 
structures which are involved in the adhesion of cells to solid substrates, as well as 
playing a role in tissue invasion and matrix remodelling (Buccione et al., 2004; Linder, 
2007). In many adult organs, Palladin is observed to be upregulated after injury near a 
wound site, where cell migration and tissue remodelling occur (Rönty et al., 2006; 
Goicoechea et al., 2009). Palladin is also is upregulated downstream of angiotensin II 
treatment in vascular smooth muscle cells. Angiotensin II influences the hypertrophy of 
the vessel wall which occurs during chronic hypertension, and also increases the 
synthesis of contractile proteins in aortic smooth muscle. The experimental 
overexpression of Palladin in SMCs was shown to increase their migration rate in vitro 
(Jin et al., 2007). When looking at the roles of Palladin in cell migration, a unifying 
theme emerges, as illustrated in Figure 1.15.  
The Rho family of small GTPase signal transduction enzymes has been seen to regulate 
Palladin expression. Investigation of expression following treatment of cells with rho-
inhibitors showed a loss of Palladin along with the loss of stress fibres and focal 
adhesions. This indicates Palladin expression is regulated by RhoA signalling and by 
actin dynamics, but it is unclear as to whether the RhoA-ROCK pathway acts directly 
on palladin or indirectly through its modulation of actin dynamics (Jin, 2011). It has 
been further shown that Palladin interacts with the SH3 domains of the SPIN90 protein, 
and is required for Src induced cytoskeletal remodelling (Rönty et al., 2007). Src is a 
non-receptor kinase which regulates cell adhesion, motility, and invasion by 
remodelling of the actin cytoskeleton, as well as being a key player in the formation of 
podosomes (Brunton et al., 2004). It can also bind to Eps8 (Otey et al., 2009). Palladin 
was observed to phosphorylate in cell expressing active Src, and that Src kinase resulted 
in the translocation of Palladin and SPIN90 to membrane protrusions. The knockdown 
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of Palladin led to inhibition of SPIN90 relocation, suggesting that perhaps Palladin may 
target Src to control Src-dependent events. 
 
 
Figure 1.15: Palladin in Cell Migration. This model illustrates a working model for the role 
that Palladin plays within multiple processes required for cell migration across tissue 
boundaries. Following a stimulation of some kind, Palladin expression is altered, which 
organises the actin cytoskeleton. This has knock on effects on the shape and interactions of the 
cell, which in turn affect cell motility and subsequent functions. The protein can translocate to 
the nucleus upon stimulation, suggesting that it may also have a signalling function in 
excitation-transcription (Jin, 2011). 
 
Knockdown of Palladin also affects the expression of LASP-1, one of its binding 
protein partners. As it localises to actin stress fibres, it has been proposed that Palladin 
also binds to the LASP-1 protein, which in turn binds the proteins zyxin and Ena/VASP 
to co-ordinate the actin organisation events required to re-orientate, and thicken the 
actin stress fibres in order to adapt to haemodynamic stresses (Yoshigi et al., 2005; 
Hoffman et al., 2006; Furman et al., 2007).  
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1.5.4 LASP-1 
The proline domains of the extended N-terminal region of the 140kDa Palladin protein 
isoform contains binding sites for many protein families, including a site for binding of 
Lim and SH3 domain protein 1, better known as LASP-1. LASP-1 is an actin and 
membrane associated protein, which functions as a cytoskeletal scaffold (Chew et al., 
2000). It also contains several conserved domains that function as protein interaction 
sites (Grunewald and Butt, 2008). These domains consist of an N-terminal LIM domain, 
followed by an actin-binding nebulin repeat domain and a C-terminal SH3 domain that 
facilitates its binding to Palladin, as well as other proteins such as VASP (Li et al., 
2004; Rachlin and Otey, 2006) (Figure 1.16). LASP-1 was originally discovered as the 
first member of a newly defined LIM-protein sub-family of the nebulin group 
characterised by the combined presence of the LIM and SH3 domains (Tomasetto et al., 
1995). The SH3 domain appears as 80% identical and 86% conserved to that of nebulin, 
which itself is a characterised binding partner for Myopalladin (Bang et al., 2001). The 
siRNA knockdown of Palladin leads to loss of LASP-1 at actin stress fibres and 
redirection to focal adhesions without changing actin filaments (Rachlin and Otey, 
2006). Thus it appears Palladin is necessary to recruit LASP-1 to actin stress fibres but 
not to focal adhesions. 
The LASP-1 gene is approximately 4.0kb long, transcribing the protein 261 amino acids 
long and 37kDa in molecular weight. The protein is ubiquitously expressed, playing a 
major role in the cytoskeleton architecture, cell migration and proliferation, as well as 
having a major function in embryogenesis (Grunewald and Butt, 2008). It also regulates 
the functions of podosomes in cells (Stölting et al., 2012). LASP-1 in human cells is 
phosphorylated by cAMP- and cGMP dependent protein kinases (PKA and PKG) at 
serine 146 (Terasaki et al., 2004). This renders the protein more cytosolic (Nakagawa et 
al., 2006). It is also phosphorylated at tyrosine 171 by Abelson tyrosine kinase (Abl). 
Phosphorylation at tyrosine 171 is also associated with loss of LASP-1 from focal 
adhesions and furthermore with initiation of cell death, but without changes in the 
dynamics of migratory processes (Lin et al., 2004). 
LASP-1 is a haemodynamic responsive adaptor protein, given that it binds directly to 
actin and plays a role in cell-cell and cell-matrix adhesion. Together with Palladin, it 
localises in actin rich structures in the cell such as lamellipodia, suggesting that it plays 
an essential role in actin cytoskeleton organisation at leading edges of migrating cells 
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(Chew et al., 2002; Lin et al., 2004). In non-motile cells, LASP-1 has been observed to 
localise to the peripheral edge of the cell. Subsequent exposure to migration-stimulating 
growth factors causes a rapid relocalisation to the focal adhesions, followed by a later 
localisation towards the membrane ruffles. Membrane ruffling is significantly increased 
in cells over-expressing LASP-1 which suggests an important role for LASP-1 in 
generating and/or regulating these structures. 
 
 
Figure 1.16: LASP-1. This schematic illustrates the domains of the LASP-1 protein. The 
binding sites of Palladin and other proteins are indicated at the appropriate domains. Palladin is 
observed binding at the SH3 domain. Domains marked R1 and R2 represent nebulin regions. It 
is at these sites where filamentous actin is seen to bind. Known phosphorylation sites at serine 
146 (S146) and tyrosine 171(Y171) are marked with pink boxes (Grunewald and Butt, 2008). 
 
LASP-1 has been observed to be upregulated in many cell cancers (Tang et al., 2012), 
with over-expression correlating with tumour size and lymph node metastasis (Frietsch 
et al., 2010; Grunewald et al., 2007A). The knocking down of LASP-1 therefore 
resulted in a strong inhibition of proliferation and migration of cancer cell lines, also 
showing a reduction in the binding of zyxin – a LASP-1 binding partner – to focal 
contacts (Grunewald et al., 2006; Grunewald et al., 2007B). LASP-1-null mice have 
been generated, which displayed slightly lower body weights but developed normally 
and had no overt phenotypic abnormalities (Chew et al., 2008).  
To date, several research studies have been carried out to investigate its regulatory 
mechanisms. Results have been conflicting however. It was suggested that LASP-1 gene 
transcription was controlled by the p53 tumour suppressing gene, with p53 inactivation 
inducing the overexpression of LASP-1 (Wang et al., 2009). However, overexpression 
of LASP-1 was not observed to be associated with p53 mutations in a breast cancer cell 
line (Frietsch et al., 2010). The same paper also showed that an inverse correlation 
between LASP-1 and the tumour suppressor PDEF (Prostate-derived Ets transcription 
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factor) could not be demonstrated. But then in invasive breast cancer cells, PDEF did 
show an ability to repress LASP-1 expression (Turner et al., 2008).  
The depletion of LASP-1 by RNAi, or overexpression by transient transfection both 
appeared to disrupt the ability of cultured cells to migrate normally (Lin et al., 2004). It 
would appear that the temporary and more permanent alterations (both overexpression 
and knockdown) of LASP-1 alternatively affect the protein expression levels, and that 
levels must be maintained to precise limits. The regulatory mechanisms appear to be 
still a matter of debate.  
  
1.5.5 Drebrin 
Another F-actin-binding protein of interest is the developmentally regulated brain 
protein, more commonly referred to as Drebrin (Grintsevich et al., 2010). It has been 
suggested that it is a likely binding partner to Palladin, but has not been investigated in 
much detail (Li et al., 2011), prompting the investigation of this protein here. Whilst 
mainly found in brain tissue, it has been documented to be found in a diverse range of 
other cell types e.g. renal glomeruli, keratinocytes and basal cell carcinomas (Peitsch et 
al., 2003; Peitsch et al., 1999). The protein appears in different isoforms – Drebrin A 
and Drebrin E1 and Drebrin E2, referring to adult and embryonic forms – which arise 
from alternative splicing of the DBN1 Gene (Jin et al., 2002). The DBN1 gene is 
approximately 2.6kb long, transcribing a protein 649 amino acids long (Toda et al., 
1993). The molecular weight of the protein appears to be 70-72kDa, however due to its 
unusually slow SDS-PAGE mobility it appears at around 120kDa when protein is 
examined on a gel (Peitsch et al., 2001). 
All of the Drebrin isoforms similarly display a single actin depolymerisation factor 
domain at the N-terminal, followed by a non-conserved central region and a SH3 
domain in the C-terminal (Keon et al., 2013) (Figure 1.17). Changes in the non-
conserved region result during development result in the different isoforms. The E1 
isoform is thought to function in migration, and is replaced by the E2 form during 
embryogenesis, where is also functions in migration as well as development of axons 
and dendrites (Keon et al., 2000). This E2 isoform is the only one observed in other cell 
types of a non-neuronal origin (Peitsch et al., 2005). 
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Figure 1.17: Drebrin isoforms. This schematic illustrates the structure of the Drebrin protein 
and its isoforms. Each isoform – the adult form and the two embryonic forms – all contain the 
same actin depolymerisation factor (ADF) domain at the N-terminal, and a SH3 domain at the 
C-terminal. The non-conserved proline-rich regions differ, with the adult isoform containing 
specific regions not observed in the embryonic forms. The E1 isoform differs from the E2 
isoform in that it is truncated within the non-conserved region. 
 
It has been found that Drebrin plays a role in cell-cell interactions and remodelling of 
the actin cytoskeleton (Butkevich et al., 2004). As the protein binds to actin, it has been 
observed to induce helical changes in the actin structure (Sharma et al., 2012). Drebrin 
is mostly observed bound with actin microfilament bundles associated with plaques of 
cell-cell contact sites representing adhering junctions (Majoul et al., 2007), although 
this may be through its association with other actin bundling proteins. Drebrin itself has 
not been found to possess F-actin severing, bundling, capping or nucleating activities 
itself (Li et al., 2011), suggesting that the protein may regulate actin stability by 
interacting with other actin associated proteins instead (Mikati et al., 2013; Peitsch et 
al., 2005). The Drebrin protein has been suggested to also play a role in regulation of 
cell adhesion due to the ability to recruit or modulate the activity of other actin 
regulating proteins, for example the F-actin bundling Eps8 protein (Li et al., 2011). 
Drebrin has been shown to bind via proline domains with profilin, a protein which itself 
prominently binds to Palladin (Witke, 2004; Mammoto et al., 1998) indicating a link 
between the proteins. The Drebrin protein is believed to be involved in induction of 
Podosomes – actin rich adhesion structures which contribute to matrix remodelling 
(Linder and Aepfelbacher, 2003). Palladin also localizes to podosomes (Goicoechea et 
al., 2006), as does LASP-1 (Stölting et al., 2012) reinforcing the idea of a link between 
the proteins, as well as indicating a potential site of interaction. 
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Notably, Drebrin can inhibit the actin-binding proteins tropomyosin and α-actinin, two 
proteins that co-localize together, but generally appear in cells more frequently than 
Drebrin (Mikata et al., 2013; Ishikawa et al., 1994). However, in experiments 
concerning the overexpression of Drebrin, it appeared to perform this function in 
different ways depending on the protein. Drebrin competes with tropomyosin to bind to 
actin, with overexpression observed to cause the dissociation of tropomyosin from actin 
filaments. With α-actinin, Drebrin appears to inhibit its actin-binding and actin cross-
linking activities. The resulting inhibition leads to the actin filaments developing a thick 
and curved phenotype. Overexpression of Drebrin A or E2 isoforms has been observed 
to result in the co-localization of Drebrin with the actin filaments and the formation of 
dendritic-like cell processes (Shirao et al., 1994; Terakawa et al., 2013; Ishikawa et al., 
2007). The overexpression can lead to the change in cell phenotype, with neuronal-like 
protrusions with ruffled membranes developing (Majoul et al., 2007). Investigations of 
Drebrin knockdown using human glioma cells showed the resulting effects to be much 
more modest (Terakawa et al., 2013). This could likely be due to the depletion of 
Drebrin being compensated by other proteins, namely tropomyosin or α-actinin. 
However, some effects can still be observed.  
Drebrin has been noted to be a major component associated with the actin filaments 
located at adherens junctions in regular endothelial cells (Peitsch et al., 1999; Keon et 
al., 2000). Recent studies on the knockdown of shRNA-based knockdown of Drebrin 
E2 in HUVEC cells which were subsequently subjected to shear stress showed potential 
impairments of cell-cell adhesion that did not appear in static cells (Rehm et al., 2013). 
This critical weakening of cell-cell junctions is characterised by the reduced 
transendothelial electrical resistance, rupturing of cell-cell contacts, and the loss of 
nectin (cellular adhesion proteins) from the adherens junctions. 
In a number of cells, a limited amount of Drebrin is observed to be present at the plasma 
membrane, but upon establishment of cell-cell contacts, the endogenous Drebrin is 
redistributed to the plasma membrane in an already pre-assembled form of Drebrin 
particles called “drebrosomes” that are transported along cytoskeletal elements (Peitsch 
et al., 1999). These particles may in fact be analogous to endothelial microparticles.  
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1.6 MICROPARTICLES 
The aforementioned perturbations of haemodynamic conditions (e.g. laminar shear 
stress) affect multiple endothelial functions, including cell apoptosis, permeability and 
remodelling. Brodsky et al., (2004) detail a link between high shear stress and release of 
submicron particles, known as microparticles (MPs), derived from endothelial cells. In 
contrast, Boulanger et al., (2007) demonstrate an inverse correlation between 
endothelial microparticle circulation and baseline shear stress values, suggestive of an 
increased release following apoptosis of endothelial cells triggered by low laminar 
stress. Microparticles are of particular interest as they are complex structures which 
possess a wide array of cell surface receptors, mRNA and proteins (Reich and Pisetsky, 
2009), and are formed and released by various stimuli under numerous (patho-) 
physiological conditions. 
The term “Microparticles” (MPs) is used to describe small vesicles of a varied size, 
from 100-1000nm. First documented in the late 1960s and thought to be “cell dust” 
(Wolf, 1967), microparticles are composed of small fragments of membrane released 
from the cell. Burnier et al., (2009) discussed how published research has subsequently 
shown how they actually play an important role within the vasculature, due to 
possessing various membrane proteins and other intracellular components from their 
parent cell. For example, they are understood to play a role in cell-cell communication 
through the transfer of various components such as microRNA, mRNA and proteins 
(Mause et al., 2010). Microparticles also promote coagulation via thrombin generation 
and exposure of negatively charged phospholipids on their membrane surface, and can 
directly affect endothelial cell function by stimulating cells to produce cell-specific 
cytokines, tissue factors, and cell-adhesion molecules such as PECAM-1, E-selectin or 
vitronectin (Keuren et al., 2006; Diamant et al., 2004). Microparticle function appears 
to be dependent on vesicle components, which itself is dependent on the cell type from 
which they originate (Muralidharan-Chari et al., 2010). 
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Table 1.4: Diseases related to elevated microparticles of different origins. The table below 
summarizes the different cardiovascular diseases related to increase in microparticles. 
 Endothelial MPS Platelet MPS Erythrocyte MPS 
CVD 
related to 
increase of 
MPS 
Hypertension, 
Atherosclerosis, 
Acute Coronary 
Syndrome, 
Acute Ischemic Stroke, 
Impaired angiogenesis, 
 
Hypertension, 
Atherosclerosis 
Acute Coronary 
Syndrome, 
Stroke, 
Myocardial Infarction 
Blood Clotting, 
Pulmonary 
Embolisms, 
Deep Vein 
Thrombosis 
References Burnier et al., 2009; 
Mallat et al., 2000; 
Williams et al., 2007;  
VanWijk et al., 2003 
Burnier et al., 2009; 
Preston et al., 2003; 
VanWijk et al., 2003  
 
Gelderman and 
Simak, 2008 
 
 
Many types of cells including platelets, endothelial cells, erythrocytes and leukocytes all 
produce microparticles, under normal physiological conditions (Reich and Pisetsky, 
2009). Upon cellular activation, or indeed apoptosis, there is a change in the 
composition and number of microparticle sub-populations. While microparticle release 
in a physiological state is relatively low, elevated levels have been observed in the 
circulation of CVD patients (Mikirova et al., 2011). These microparticles have been 
implicated in playing a role in inflammation and coagulation leading to impaired 
vascular function in diseases such as atherosclerosis, hypertension and diabetes 
(Tushuizen et al., 2011).  
  
1.6.1 Microparticle Formation  
Microparticle formation and release has been observed in both the physiological state 
and the pathological state (Azevedo, 2012), but with aberrant levels observed in the 
unhealthy pathological state. This observation highlights the potential of MPs to serve 
as a molecular and cellular ‘vexillum’ for certain diseases such as CVD, metabolic 
syndrome, kidney disease and diabetes. Two mechanisms elicit microparticle formation, 
namely apoptosis and cell activation. Both use different pathways in microparticle 
biogenesis. During apoptosis, the cell will contract and DNA fragment, followed by the 
subsequent observation of membrane blebbing (VanWijk et al., 2003). However, these 
blebs are somewhat different than microparticles formed via cell activation, in both size 
and protein composition. It is thought that the actin-myosin cytoskeleton works in 
creating a contractile force which drives the formation of these membrane blebs (Croft 
et al., 2005). As the contraction occurs, membrane-actin linkages are seen to weaken 
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focally, resulting in bleb formation as the membrane is forced through areas of 
weakness. A myosin counterforce retracts the blebs, and this process repeats in a cycle. 
Actin and myosin become concentrated at the base of the blebs, and they become lined 
with a thin border of membrane-associated actin. The cycle of contractile force and bleb 
formation continues until the cell enters a condensation stage, where it shrinks into 
small apoptotic bodies as dissolution of polymerised actin occurs (Croft et al., 2005).  
Shedding of microparticles is a process that can also occur independently of apoptosis 
(Sapet et al., 2006). The term “cell activation” encompasses both physiological and 
pathological stimuli leading to microparticle release. For example, in platelets and 
endothelial cells, shear stress represents one such stimulus. Stimulation with cytokines 
or thrombin can also elicit release (Bucciarelli et al., 2012) as can an increase in plasma 
homocysteine levels (Sekula et al., 2011). Endothelial cells, monocytes and vascular 
smooth muscle cells have all been shown to release microparticles after activation by 
cytokines, bacterial lipopolysaccharide or reactive oxygen species (Azevedo, 2012). 
Upon cell activation, the release of microparticles is both time- and calcium-dependent 
(VanWijk et al., 2003), with shedding occurring within minutes of agonist stimulation. 
Cell activation, by various stimuli, results in the release of calcium from the 
endoplasmic reticulum stores in the cytosol, which in turn results in downstream 
activation of μ-calpain. μ-calpain is a calcium-dependent cytosolic protease which 
cleaves talin and α-actin, leading to decreased binding of integrins to the cytoskeleton 
and a reduction in cell adhesion and integrity. The inhibition of calpain has been shown 
to prevent the release of microparticles (Azevedo, 2012). Cytosolic calcium increase 
activates certain kinases and inhibits phosphatases. This, coupled with calpain 
activation, ensures the cleavage of the cytoskeleton, leading to disruption of the cell, 
facilitating microparticle release. Loss of adhesion between the membrane lipid bilayer 
culminates in further blebbing of the membrane, which can in turn leading to shedding 
of microparticles. In addition to calpain, other molecules are also thought to be involved 
in calcium-dependent microparticle release (Azevedo, 2012). In support of this, there 
are several mechanisms responsible for the disruption of the membrane. 
Phosphorylation of myosin light chains by myosin light-chain kinase (MLCK) 
stimulates the contractile activity of myosin, with myosin ATPase activation creating 
movement between actin and myosin filaments. It is thought that this movement may 
create tension in the plasma membrane which leads to bleb formation and microparticle 
release (Azevedo, 2012). The precise interaction between cell membrane and 
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cytoskeleton leading to microparticle formation however is still not fully characterised. 
In this regard, recent data implicates a role for the ROCK-II isoform in thrombin-
induced microparticle release from endothelial cells (Sapet et al., 2006).  
  
1.6.2 Apoptotic Bodies and Exosomes 
The formation of microparticles shares some similarity to that of apoptotic bodies and 
exosomes. Following apoptosis of the cells, small apoptotic bodies (also known as apo-
bodies) can be formed as the cell shrinks and subsequently fragments. These bodies 
may contain various subcellular organelles and fragments of DNA. Some microparticles 
can also be released at this point as membrane blebbing occurs. The apoptotic bodies 
are much larger in size than microparticles (Table 1.5), are less regular in shape 
(VanDommelen et al., 2012) and are released in the final stages of apoptosis, unlike 
microparticles which are released earlier by cells (Azevedo, 2012).  
Table 1.5: Comparison of types of vesicle released from cells. The table below summarizes 
the different types of vesicles released from cells, and their individual characteristics. 
Property  Microparticles Exosomes Apoptotic Bodies 
Origin  Plasma Membrane Intracellular 
Endocytotic-lysosomal 
system 
Not determined 
Size  100-1000nm 50-100nm 1000-4000nm 
Appearance  
(via SEM) 
Irregular Cup-shaped Irregular 
Mechanism 
of Release  
Shedding from 
plasma membrane 
Exocytosis of MVB 
 
Apoptosis 
Markers  Tissue Factor, PS, 
Cell Surface Markers 
LAMP1 
CD63 
Genomic DNA,PS, 
Histones 
References Ling et al., 2011; 
Azevedo, 2012; 
Holtom et al., 2012 
Dignat-George and 
Boulanger 2011; 
Keller et al., 2006; 
Holtom et al., 2012 
Ling et al., 2011; 
VanDommelen et al., 
2012; 
Théry et al., 2001 
 
It has been postulated that the exosomes may play an important role in the regulation of 
cardiovascular function (Azevedo, 2012). Exosomes are smaller than microparticles 
(usually less than 100 nm) but they are much more homogenous in size than 
microparticles. Analyses have shown how all mammalian cell exosomes share common 
characteristics including size, density, structure, and protein composition (Keller et al., 
2006). These proteins include many cytoplasmic proteins such as actin, tubulin and 
annexins (Théry et al., 2001). Exosomes also possess the ability to potentiate signalling 
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events that they originally promoted, by similar mechanisms to microparticles. 
Exosomes are believed to have a role in cell-cell communication, via directly 
stimulating cells by receptor-mediated interactions or by transferring varied molecules 
from cell to cell (Camussi et al., 2010). 
Exosome formation is quite distinct from that of microparticles – with their release from 
cells mainly orchestrated by the endocytotic-lysosomal system. Their biogenesis occurs 
when intracellular multi-vesicular bodies are exocytosed and fuse with the plasma 
membrane (Camussi et al., 2010). The exosome displays major histocompatibility 
complex (MHC) Class I or II molecules on its surface, implicating a role in antigen 
presentation (Théry et al., 2002; Clayton et al., 2001). It is believed that through using 
exosome therapies, it is possible to prime the immune system to recognize certain 
tumour-specific antigens, and subsequently launch an appropriate immune response 
toward cancer cells without damaging neighbouring healthy cells (Tan et al., 2010). 
Exosomes released from tumour cells have been shown to stimulate cells of the immune 
system in such a way, reducing tumour growth (Skog et al., 2008), with evidence 
suggesting the exosomes show a function in transporting RNA, which could also be 
utilised as a biomarker and diagnostic tool (Cho et al., 2009).  
  
1.6.3 Endothelial Microparticles 
Recent advances have been made with specific regard to endothelial microparticles. 
These submicron vesicles are released as a result of endothelial cell blebbing, with a 
higher release rate observed in dysfunctional endothelial cells. EMPs vary in size, 
phospholipid and protein composition (Horstman et al., 2004). While they vary in these 
aspects, they exclusively display certain endothelial proteins e.g. vascular endothelial 
cadherin (VE-Cadherin) and E-selectin, which are unique antigenic signatures that 
differentiated them from other microparticles (Dignat-George and Boulanger, 2011). 
They represent a small but important subset of all microparticles (Martínez et al., 2005; 
Mezentsev et al., 2005) but are still found to be quite influential, playing a role in 
inflammation and various other endothelial functions.  
  
1.6.3.1 Microparticles and Endothelial Physiology 
Under physiological conditions, endothelial microparticles can have benefits, displaying 
cytoprotective effects on endothelial cells by reducing apoptosis, presumably acting as 
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an adaptavive response to various stimuli. Moreover, low concentrations of 
microparticles from human umbilical vein endothelial cells (HUVECs) have been 
shown to actually promote the formation of capillary-like structures (Mezentsev et al., 
2005; Burnier et al., 2009). 
Endothelial microparticles are implicated in angiogenesis whereas ones from certain cell 
lines are thought to facilitate the invasion of ECMs, and evasion of the immune 
response. The effect of microparticles on angiogenesis is widely debated, as it seems 
that some microparticles (e.g. platelet-derived) are pro-angiogenic, whereas others, such 
as endothelial-derived, have been reported as both pro- and anti-angiogenic (Burnier et 
al., 2009; Martínez and Andriantsitohaina, 2011; Camussi et al., 2010). One could 
hypothesise that these contrasting physiological effects may be due to various 
permutations and combinations of MP-cellular aggregates, such as platelet-MP. 
The pro-angiogenic abilities of endothelial microparticles have been observed through 
the matrix metalloproteinase activity they contain. Endothelial cells produce these 
matrix metalloproteinases, and store them in secretory vesicles (Nguyen et al., 1998). 
The endothelial cells release these vesicles which are then enhanced by angiogenic 
factors (Taraboletti et al., 2002).  
  
1.6.3.2 Microparticles and Endothelial Dysfunction 
HUVECs decorated with high levels of microparticles in vitro showed an inhibitory 
effect on angiogenesis (Taraboletti et al., 2002). Isolated microparticles in pathological 
concentrations have been observed to affect angiogenesis by uniform shortening of total 
capillary length and branching points (Mezentsev et al., 2005) while also enhancing 
apoptosis (Distler et al., 2011). It has been postulated that one of the mechanisms for 
this occurrence may be microparticle-mediated induction of oxidative stress in the 
treated cells.  
Endothelial microparticles appear to play an important role in immune response, as well 
as having roles in intracellular signalling and cell adhesion events (Philippova et al., 
2011). They have potent pro-inflammatory effects, with deleterious consequences 
(Chironi et al., 2009). These processes are all linked to pathogenesis of CVD, and 
because circulating microparticle numbers are altered in many forms of CVD, a role for 
microparticles in CVD initiation, progression and pathogenesis is therefore likely. 
Elevated levels of endothelial microparticles have been observed to correlate with the 
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loss of flow-mediated dilation and arterial stiffness (Viera et al., 2012). They are also 
known to be elevated in acute coronary syndromes (Bernal-Mizrachi et al., 2003; Mallat 
et al., 2000) and in severe hypertension with end organ damage (Preston et al., 2003) – 
conditions associated with endothelial injury and a pro-thrombotic state. It is suggested 
that they display an ability to also directly affect the endothelial cells of patients with 
myocardial infarction by hindering their nitric oxide pathway (Boulanger et al., 2001). 
The endothelium possesses the ability to release vasodilators such as prostacyclin, 
endothelium-derived hyperpolarizing factors and nitric oxide (NO) (Mostefai et al., 
2008). Changes in the ability to release these factors are fundamentally linked to 
development and progression of CVD. NO is fundamental for proper endothelial 
function, being required for the inhibition of adverse stimuli (e.g. ROS) (Dimmeler and 
Zeiher, 1999). When the vasculature is subjected to hypoxic conditions, cells are 
metabolically compromised which results in cellular dysfunction. Neutrophils adhere to 
the endothelial cell layer (mediated by adhesion glycoprotein surface complexes) and 
are then able to accelerate cell dysfunction through a wide range of cytotoxic 
mechanisms (Vince et al., 2009). The neutrophils in turn mediate a variety of responses 
harmful to the other cells, one of them being ROS production. 
Enhanced ROS production has also been seen very early in the atherogenic process, 
suggesting the link between ROS and apoptosis (Dimmeler and Zeiher, 2000). 
Microparticles stimulate ROS production in endothelial cells in an EGFR-dependent 
manner (Burger et al., 2011) and endothelial-derived NO reacts with these elevated 
level of superoxides (O2-), thereby reducing NO bio-availability (Rojas et al., 2006). It 
has been reported that microparticles are also able to decrease the expression of NO, 
thus altering the balance between the production and release of the NO and ROS 
(Martin et al., 2004) and contributing to increased endothelial dysfunction and potential 
synthesis of microparticles and apo-bodies. 
A study by Holtom et al., (2012) investigated the co-culture of plasma-derived 
microparticles with TNF-α treated HUVECs (which caused them to model endothelium 
inflammation) and observed that the inflammation leads to enhanced levels of ROS in 
cells, causing dysfunction. They further suggest that the inflammation of the 
endothelium caused the release of pro-inflammatory microparticles, which contribute to 
prolonged endothelial cell activation. The increasing ROS production levels lead to 
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elevated cellular oxidative stress, which impairs endothelial function and elicits 
development of vascular remodelling of disease.  
Published data on microparticles point to a repetitive “feed-forward” sequence where 
the release and subsequent elevation of microparticle levels are a result of endothelial 
dysfunction, but also something which exacerbate and potentiate dysfunction (Brodsky 
et al., 2004). It appears that when the number of circulating microparticles reaches a 
certain clinical threshold, that they become an important factor in the pathophysiology 
of disease, impacting the endothelium and other cells. These other cells can include 
monocytes, which endothelial microparticles bind to and activate. Doing so can enable 
the microparticles to migrate further through the endothelium (Horstman et al., 2004).  
  
1.6.3.3 Microparticles and Endothelial Normalisation/Repair 
It is possible though that, under certain conditions, endothelial microparticles could 
contribute to the sorting of factors that prevent cell detachment and apoptosis (Dignat-
George and Boulanger, 2011). There is growing evidence that perhaps endothelial 
microparticles may be released as part of a negative feedback mechanism to counter the 
cellular dysfunction associated with CVD, i.e. underpin a cellular adaptive response 
(Tushuizen et al., 2011). The role of microparticles as a way of normalizing and 
repairing cells following insult is a matter of debate. These pro-survival properties of 
endothelial microparticles have also been documented in the literature. It has been 
suggested that endothelial microparticles might elicit normalisation of endothelial 
dysfunction via two mechanisms: either direct interaction with cells to promote 
normalization, or activation of endothelial progenitor cells to mediate endothelial cell 
repair (Hoyer et al., 2010). It has been demonstrated that microparticle release could 
protect against apoptosis by diminishing cellular levels of caspase-3 via caspase 
“trapping” in the microparticles (Abid-Hussein et al., 2007).  
  
1.6.3.4 microRNA in Endothelial Microparticles 
Diehl et al., (2012) investigated miRNA content in endothelial microparticles and have 
shown that certain miRNAs are present (e.g. miRNA-451 and miRNA-486). miRNA-
451 is known to inhibit the expression of macrophage migration factor, which is a pro-
inflammatory cardiac depressant that can lead to impaired ventricular function (Bandres 
et al., 2009). miRNA-486 meanwhile targets mRNAs that encode the phosphatase and 
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tensin homolog (PTEN) and Forkhead box protein O1A (FOXO1A) genes, which serve 
as negative components of the phosphoinositide-3-kinase (PI3-K) /Akt signalling 
pathway (Small et al., 2010). PI3-K is an important regulator of integrin signalling, and 
prior to cell migration, increases integrin avidity (Trusolino et al., 2000), whilst Akt is 
essential for the eNOS activation (Fleming et al., 2005). By targeting PTEN and 
FOXO1A, miRNA-486 helps enhance the PI-3-K/Akt signalling pathway, leading to 
sustained cell survival.  
  
1.6.4 Microparticles: Clinical Perspectives 
Microparticle research is still in its early stages, but shows great promise and clinical 
relevance. There is much evidence that the levels, composition, and function of 
microparticles can be modified depending on the environment in which they are 
released, pointing to their potential usage in diagnostic, prognostic and therapeutic 
settings (Andriantsitohaina et al., 2012).  
  
1.6.4.1 Diagnostic / Prognostic Potential 
Elevated levels of microparticles from platelets, monocytes, or endothelial cells are 
found to correlate with most cardiovascular risk factors (e.g. hypertension or obesity) 
putatively indicative of a poor clinical outcome (Dignat-George, 2008). As such, 
circulating microparticles isolated from blood show the potential to be utilised as 
biomarkers of overall vascular competence (Table 1.6). Quantifying and qualifying 
microparticle content of blood could also be utilised to detect early signs of CVD, even 
pre-clinical horizon, and as a method of monitoring response to treatments (Viera et al., 
2012). There are various methods to analyse microparticles, but as discussed in Chapter 
1.6.4.3, they are not without issue. 
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Table 1.6: Microparticle source and antigenic signature used in their detection by Flow 
Cytometry. In this table, a list of specific characterisation markers for microparticles of various 
cellular origins is documented. 
Microparticle 
origin 
Markers References 
Endothelial CD31 
CD34 
CD54  
CD51 
CD105 
CD106 
CD144 
Burnier et al., 2009; 
Bernal-Mizrachi et al., 2003; 
Mallat et al., 2000; 
Williams et al., 2007; 
Taraboletti et al., 2002; 
Gelderman and Simak, 2008 
Platelet CD41 
CD41a 
CD42a 
CD42b 
CD61 
CD62P 
Burnier et al., 2009;  
Preston et al., 2003; 
VanWijk et al., 2003 
 
Erythrocyte CD235a 
CD36 
Burnier et al., 2009; 
Gelderman and Simak, 2008; 
VanSchravendijk et al., 1992 
 
1.6.4.2 Therapeutic Potential 
Using microparticles themselves as a treatment is a potential future application. A 
putative role for platelet microparticles in endothelial repair has been noted (Siljander, 
2011). They have advantages over regular drug delivery methods in that they display a 
natural stability in blood and can deliver functional RNA to cells. Furthermore, patient-
derived microparticles have been suggested as a method to potentially overcome the 
obstacle of immune rejection in the host (VanDommelen et al., 2012). 
In employing microparticles as therapeutic tools, it may be possible to engineer custom 
designed microparticles with modified properties (Martínez and Andriantsitohaina, 
2011). They can be employed to induce over-expression of key proteins or molecular 
entities, e.g. miRNA, in cells. Moreover, transfection of microparticle-producing cells 
with certain proteins and delivering them to target cells (e.g., to replace/repair an 
already existing mutated protein) may represent a way of transferring information and 
altering cell function. They potentially could also be used to deliver miRNA/mRNA 
directly to cells to elicit therapeutic effects at the genomic level, i.e. to serve as a micro-
cellular therapeutic.  
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Zernecke et al., (2009) were able to observe miR-126 within apoptotic bodies. In 
theory, it could also be observed in regular microparticles or exosomes. This miRNA 
supports the proliferation, migration, tubule formation and sprouting of endothelial 
cells. When these apo-bodies were incubated with HUVECs, they observed transfer of 
the microRNA into recipient cells followed by production of the anti-inflammatory 
chemokine CXCL12 by the cells. miR-126 mediated CXCL12 abundance enhanced the 
CXCR4-mediated recruitment of progenitor cells, contributing to repairing of the 
vascular wall following injury.  
  
1.6.4.3 Detection Methods and Issues 
As mentioned previously, there are methods to detect microparticles in samples, albeit 
not without some issues. Simak and Gelderman (2006) list and discuss the various 
methodologies commonly employed in the laboratory setting to analyse and characterise 
microparticles in blood samples, ranging from antigen detection by flow cytometry to 
microplate affinity assays employing Annexin V to detect Phosphatidylserine. Nomura 
et al., (2008) noted that an assay method using standard enzyme-linked immunosorbent 
assay (ELISA) protocols may also be a cost effective method in MP analysis. 
Technical issues and sensitivity limitations still exist with diagnostic tests however in 
detecting smaller size microparticles and exosomes, such as distinguishing the different 
types of microparticles (Dignat-George and Boulanger, 2011; Mayr et al., 2009). While 
ELISA-type immunoassays could measure the total amount of a microparticle-
associated antigen, they lack an ability to provide single vesicle information. Annexin V 
assays also show a disadvantage in that they will only be able to detect the subset of 
microparticles with accessible Phosphatidylserine on their surface. There are a large 
amount of endothelial microparticles that do not bind annexin V, rendering such an 
assay uninformative. Furthermore, as annexin V is a natural plasma protein, endogenous 
levels are present on physiological levels of circulating microparticles, masking and 
attenuating aberrant PS detection (Philippova et al., 2011; Gelderman and Simak, 
2008). 
Flow Cytometry is a more robust analysis method, being able to analyse large numbers 
of microparticles in a single sample, based on size, granularity and antigens displayed 
by the MPs. However the small particle size and dim signals still challenge the 
sensitivity threshold of many commercially available flow cytometers. Research is on-
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going regarding the optimal way to separate the individual populations (Robert et al., 
2012), with Flow Cytometry analysis, pre-centrifugation (to separate based on size) or a 
combination of both being the current optimal methods. Nolte-'t Hoen et al., (2011) 
have developed a fluorescence-based, high-resolution Flow Cytometric method for 
quantitative and qualitative analysis of nano-sized membrane vesicles such as 
microparticles and exosomes, highlighting the fact that technology is getting closer to a 
more definitive method of characterisation. 
Following the subjection of the cell to haemodynamic forces (in particular, laminar 
shear stress), the level of Palladin protein in the cell was noted to increase, but then 
decrease over time (Chapter 3). It was thought that the protein may be released from the 
cells via the endothelial microparticles. It was hypothesised that upon investigating the 
amount of protein in microparticles, there would be increases in the amounts of protein 
observed at the different time points.  
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Figure 1.18: Microparticles in the Vasculature. This figure displays the presence of 
microparticles, exosomes and apoptotic bodies, and demonstrates their formation, and how they 
influence other cell types. Key:  
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1) Tunica Media - Layer of Smooth Muscle Cells in the vessel. 
2) Tunica Intima - Monolayer of Endothelial Cells. 
3) Lumen – Contains the blood, which is composed of plasma and various blood cells 
4) Red Blood Cells. 
5) Macrophage. 
6) Neutrophil. 
7) Monocyte. 
8) Lymphocyte. 
9) Platelets.  
9b) Activated Platelets. 
10) RNA inside the cell. 
11) Protein inside the cell. 
12) Exosome release from cells (Via exocytosis of Multi-vesicular bodies in the cell). 
13) Microparticles released from cells. 
14) Apoptotic Bodies. 
Different processes occur in the release of Microparticles: 
A) Shear stress – Flow of blood across the cells. Increased flow stimulates microparticle 
release. 
B) Membrane Blebbing. 
C) Microparticles and Exosomes contain Protein, RNA, miRNA. 
D) Microparticles are able to affect cells downstream, transporting molecules from one cell 
to another. These activate the cell, resulting in release of calcium from the endoplasmic 
reticulum, which results in downstream activation of calpain μ. Calpain cleaves talin 
and α-actin, leading to decreased binding of integrins to the cytoskeleton and a 
reduction in cell adhesion. 
E) The cytoskeleton starts de-stabilising, causing increased release of microparticles. 
F) Red blood cell microparticles facilitate formation of enzyme complexes which cause 
other red blood cells to coagulate together. 
G) Microparticles released from Neutrophils can activate platelets, which stimulates the 
release of platelet microparticles. This in turn causes the coagulation of platelets. 
 
1.7 AIMS AND OBJECTIVES 
The work presented here in this thesis investigates the expression of the Palladin 
protein, and the PALLD gene which encodes it, within Human Aortic Endothelial Cells. 
The protein has been observed in endothelial cells, however it has not been 
characterised fully within this cell type. Experiments were performed to characterise the 
genetic and proteomic expression in response to the haemodynamic forces expressed 
within the vasculature, namely laminar shear stress and cyclic strain. Since the Palladin 
protein is known to be an actin-binding protein, it was hypothesised that Palladin 
expression alters as the cell shape changes in response to haemodynamic stimuli. 
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As stated, Palladin may also interact with the ECM within the vasculature, having been 
seen to play a role in stabilising integrins and linking them to the cytoskeleton (Luo et 
al., 2005; Lai et al., 2006). Integrins are highly influenced by haemodynamic stimuli 
such as laminar shear stress, which converts the integrins to a high affinity state, 
allowing them to bind to the subendothelial extracellular matrix (Orr et al., 2005). This 
binding is specific depending on integrin and matrix, and is important for cellular 
development, maintenance and repair (Harburger and Calderwood, 2009). Certain 
ECMs have been shown to interfere with integrin signalling under shear stress (Orr et 
al., 2006). Based on this understanding, the effects of ECMs on the shear induced 
expression of Palladin within the endothelial cell were investigated. 
Upon extracting the Palladin protein from HAECs and analysing it through mass 
spectrometric methods to further characterise its protein complex, the link between 
Palladin and two other actin-binding proteins – LASP-1 and Drebrin – was highlighted. 
The response of these proteins to haemodynamic forces (namely laminar shear stress) 
was then investigated, as was the expression of these proteins when the cells are 
cultured on ECMs. By doing so, a comparative profile of each protein could be 
observed and compared against the others. Through comparing the patterns of 
expression of each protein under these conditions, it was hoped that an understanding 
could be formed with regards to how Palladin, LASP-1 and Drebrin interact in the same 
network with one another in the vasculature. 
The expression of these proteins was also investigated within the release of endothelial 
microparticles. Following the haemodynamic stimuli of the cells (especially with 
laminar shear stress), an increase in presence of EMPs is observed. It was hypothesised 
that the changes in protein expression at later time points (i.e. where the protein 
expression level decreases a few hours after an initial increase) could be explained by 
the release of excess protein via the microparticles. The particles released from cells 
cultured on the ECMs were also similarly probed. Since the protein levels can be 
affected by culturing of the cells on matrices, investigative experiments were performed 
to observe if the matrices affected the release of proteins of interest from the cells also. 
Following these experiments where the particles were probed for the proteins of 
interest, it was investigated if these particles may also have an effect on expression 
levels of protein in other cells. Since microparticles can be used to signal other cells 
downstream, initial experiments were performed incubating regular HAECs with 
 59 
 
conditioned cell media containing increased volumes of EMPs. Initial experiments also 
to observe the release of Palladin via EMPs taken from human blood samples post-
exercise were performed, in order to characterise the protein release in an in vivo setting 
as opposed to the in vitro nature of the other experiments. 
Finally, experiments to observe the cell migratory patterns of cells where Palladin had 
been knocked down were carried out. They were performed to determine the functions 
of Palladin in cell migration and adhesion. In doing so, a more definitive and complete 
characterisation of the Palladin protein within the vasculature could be presented with 
the work described here. 
  
 60 
 
CHAPTER TWO 
 
 
MATERIALS AND METHODS 
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2.1 MATERIALS 
2.1.1 Reagents and Chemicals  
Table 2.1 below lists the reagents and chemicals used, alongside the company where 
each item was sourced:  
 
Table 2.1: Reagents and Chemicals used in experiments.  
Applied Biosystems,  
CA,USA 
High Capacity cDNA Reverse Transcription Kit, 
Scrambled control siRNA. 
ATCC-LGC Standards,  
Middlesex,UK 
HEK-293 Human Embryonic Kidney cells. 
 
Bio-Rad,  
Hercules,CA,USA 
 
10X Tris/Glycine/SDS Running buffer, 
Laemmli sample buffer,  
TEMED. 
Cell Applications,  
CA,USA 
Rat Aortic Smooth Muscle Cells (RAOSMCs). 
 
Dako,  
CA,USA 
Fluorescent mounting media, 
Polyclonal Rabbit Anti-human VonWillebrand 
Factor (vWF) antibody. 
Eppendorf,  
Cambridge,UK 
50X TAE Buffer. 
Eurofins MWG Operon, 
Ebersberg,Germany 
Gene Specific Primers – 
PALLD, 18S, LASP-1, Drebrin – DBN1. 
Fermentas, 
York,UK 
 
Green dream Taq 10x Buffer,  
Taq polymerase, 
Precision Plus® Protein Ladder. 
GE-Healthcare, 
Buckinghamshire,UK 
Goat monoclonal to Mouse IgG (HRP-
conjugated) secondary antibody. 
Invitrogen,  
CA,USA 
 
AlexaFluor-488 goat anti-Mouse secondary 
antibody,  
AlexaFluor-488 goat anti-Rabbit secondary 
antibody,  
DH5α E-coli competent cells, 
GIBCO™ Distilled Water, 
Phosphate buffered saline (PBS),  
Rhodamine Phalloidin,  
RNase free distilled water,  
SYBR® Safe Solution, 
Trizol® Reagent. 
Lennox Laboratory Supplies LTD, 
Dublin,Ireland 
100% Ethanol, 
100% Industrial Methylated Spirits (IMS). 
Merck Bioscience,  
CA,USA 
ProteoExtract® S-PEK Antibody Control Kit, 
ProteoExtract ® S-PEK subcellular proteome kit. 
Millipore, FlowCellect™ MitoLive Kit, 
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MA,USA Goat derived, Anti-Rabbit IgG (HRP-conjugated) 
secondary antibody, 
Mouse monoclonal anti-LASP-1 primary 
antibody, Rabbit polyclonal Anti-Drebrin A/E 
isoforms primary antibody, 
Rabbit Polyclonal Anti-GAPDH primary 
antibody. 
Pierce Biotechnology, 
IL,USA 
 
BCA assay kit, 
Co-immunoprecipitation kit, 
Restore stripping buffer,  
Supersignal West Pico chemiluminescent 
substrate.  
Promocell, 
Heidelberg, Germany 
 
Cryo-SFM serum free medium for 
cryopreservation, 
Endothelial Cell Growth Medium MV,  
Endothelial Cell Growth Medium MV 
Supplement Mix: (Fetal Calf Serum (FCS) 5.0% 
(v/v), Endothelial Cell Growth Supplement 
(ECGS) 0.4% (v/v), Endothelial Growth Factor 
(EGF) 10ng/ml, Hydrocortisone 1μg/ml, Heparin 
90 μg/ml) 
Human Aortic Endothelial Cells (HAECs),  
Human Aortic Smooth Muscle Cells,  
Human Aortic Smooth Muscle Cell Growth 
Medium. 
Proteintech Group, Inc., 
Chicago,IL 
Rabbit Anti-Human PALLD (Palladin) 
Polyclonal antibody. 
Qiagen, 
West Sussex,UK 
HiSpeed Plasmid Midi-prep kit. 
Roche Diagnostics, 
Basal,Switzerland 
FastStart Universal SYBR Green Master (Rox), 
Protease inhibitor cocktail. 
Sigma Chemical Company Ltd, 
Dorset,UK 
Acetic Acid,  
Acetone,  
Agarose,  
Ammonium Persulfate, 
Ampicillin, 
Bovine serum albumin,  
Collagen, 
Chloroform, 
DAPI Nuclear Stain, 
DMSO, 
Dulbecco’s Modified Eagle Medium,  
Fetal bovine serum,  
Fibrinogen, 
Fibronectin, 
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Goat Serum,  
Hydrochloric acid, 
Isopropanol, 
Kanamycin sulphate, 
Palladin specific siRNA (SASI_Hs01_00197888) 
Paraformaldehyde (1X solution), 
Penicillin/Streptomycin (100X),  
0.1% (w/v) Ponceau S solution, 
RPMI-1640 media, 
Sodium Acetate, 
Sodium Chloride, 
Sodium Deoxycholate, 
Sodium Orthovanadate, 
Tris-HCl pH 7.4,  
Triton X-100, 
Trypsin-EDTA (10X),  
Tween®-20. 
Thermo Fisher Scientific, 
Leicestershire,UK 
Methanol,  
10X PBS solution, 
pH 4.0 Buffer solution (Phthalate),  
pH 7.0 Buffer solution (Phosphate), 
pH 10.0 Buffer solution (Borate).  
 
2.1.2 Instrumentation 
Table 2.2 lists the instrumentation used, and the company where each item was sourced: 
 
Table 2.2: List of instrumentation used in experiments.  
Applied Biosystems,  
CA,USA 
Applied Biosystems 7900HT Fast Real-Time 
PCR machine with sequence detection software 
(SDS). 
Bennett Scientific Ltd.,  
Devon,UK 
Clifton Duo ® Water Bath. 
Bio-Rad, 
Hercules,CA,USA 
 
MJ-Mini gradient thermocycler, 
Mini-PROTEAN Tetra Cell System (4-gel 
system includes electrode assembly, 
Electrophoresis PowerPak®, companion running 
module, tank, lid with power cables, mini cell 
buffer dam, Transfer module) 
BioTEK, 
VT,USA 
Microplate Reader. 
Eppendorf,  
Cambridge,UK 
Centrifuge 5430R, 
Centrifuge 5810R. 
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Flexcell International Corp, 
NC,USA 
Flexercell® tension plus™ FX-4000T System. 
 
Labtech, 
East Sussex,UK 
Nikon® Eclipse TS100 phase-contrast 
microscope. 
Mason Tech, 
Dublin,Ireland 
Nanodrop 1000™ System. 
Medical Supply Company, 
Dublin,Ireland 
Horizontal Agarose Gel Electrophoresis rig. 
Millipore, 
MA,USA 
Guava EasyCyte FACS System. 
Stuart Scientific Ltd,  
Staffordshire,UK 
Block Heater,  
Orbital Shakers, 
Rotator, 
See-Saw Rocker,  
Vortex. 
Syngene,  
Cambridge,UK 
G-Box fluorescence and chemi-luminescence gel 
documentation and analysis system. 
Taylor-Wharton,  
USA 
Liquid nitrogen cryo-freezer unit. 
 
Thermo Fisher Scientific,  
Leicestershire,UK 
Holten LaminAir laminar flow cabinet. 
VWR International Ltd.  
West Sussex,UK 
Haemocytometer, 
Nalgene ® Freezing Container for cryotubes. 
 
2.1.3 Consumables/Plasticware 
The companies listed in Table 2.3 provided the consumables and plasticware used for 
experiments: 
 
Table 2.3: List of consumables and plasticware used in experiments.  
Applied Biosystems, 
CA,USA 
96-well Optical Plates for qRT-PCR,  
Adhesive covers for 96-well Optical Plates, 
Adhesive cover application tool. 
Becton Dickinson,  
NJ,USA 
BD Vacutainer™ Blood Tubes (Buffered sodium 
citrate (0.105 M)  
Bio-Rad,  
Hercules, CA,USA 
Thick mini trans-blot filter paper, 
10X Tris/Glycine/SDS Running buffer. 
Bioo Scientific, 
Austin, TX,USA 
Exomir™ Kit,  
Duo-Syringe Filter Assembly. 
Dunn Labortechnik GmBH, 
Asbach,Germany 
(Pronectin coated) 6-well Bioflex plates.  
GE-Healthcare, 
Buckinghamshire,UK 
Whatman® Filter Paper. 
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Invitrogen,  
CA,USA 
MP-100 Microporator,  
Neon® Transfection System (Microporator 
tubes, Solution E buffer, solution R buffer, 10μl 
and 100μl gold tips). 
Medical Supply Company 
Dublin,Ireland 
0.2 ml PCR tubes, 
0.5 ml polypropylene tubes. 
Pall Life Science, 
NY,USA 
 
Acrodisc 32 mm syringe filter with 0.2 μm super 
membrane, 
Nitrocellulose transfer membrane. 
Sarstedt AG & Co. 
Numbrecht,Germany 
 
6-well Cell+ Tissue Culture dishes, 
100mm Cell+ Tissue Culture Dishes, 
Cell Scrapers, 
Cryotubes, 
Individually Wrapped and plugged Sterile 
Serological Pipettes – 2ml, 10ml and 25ml size, 
Individually wrapped sterile aspiration pipettes – 
2ml size, 
Polypropylene Reagent & Centrifuge Tubes 
(15ml),  
Polypropylene Reagent & Centrifuge Tubes 
(50ml),  
VWR International Ltd.  
West Sussex,UK 
Cover slips, 
Glass slides. 
 
2.1.4 Preparation of Stock Solutions and Buffers 
2.1.4.1 Immunoblotting 
Transfer Buffer (1X) 
Tris-HCl         25mM 
Glycine         192mM 
Methanol         20% 
 
RIPA Cell Lysis Buffer Stock (1.28X) 
HEPES, pH7.5        64mM 
NaCl          192mM 
Triton X-100         1.28% (v/v) 
Sodium Deoxycholate      0.64% (v/v) 
SDS         0.128% (w/v) 
dH2O to final volume       500ml 
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RIPA Cell Lysis Buffer (1X) 
1.28X RIPA Stock        1X 
Sodium Fluoride        10mM 
EDTA, pH8.0         5mM 
Sodium Phosphate        10mM 
Sodium Orthovanadate       1mM 
Protease Inhibitors        1X 
 
Sample Solubilisation Buffer (4X) 
Tris-HCl, pH6.8        250mM 
SDS          8% (w/v) 
Glycerol         40% (v/v) 
β-Mercaptoethanol        4% (v/v) 
Bromophenol Blue        0.008% (w/v) 
 
TBS wash Buffer 
Tris-HCl, pH7.4        50mM 
NaCl         150mM 
 
Coomassie Stain 
Coomassie Brilliant Blue R250      0.2% 
Methanol        45%  
Glacial Acetic acid        10% 
dH2O         44.8% 
Coomassie stain filtered using a 0.25μm filter. 
 
Coomassie Destain Solution 
Methanol        20% 
Glacial Acetic acid        10% 
dH2O         70% 
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2.1.4.2 Molecular Biology Buffers and Medium 
SOC Media 
Tryptone         2% (w/v) 
Yeast Extract         0.5% (w/v) 
NaCl          10mM 
KCl          2.5mM 
MgCl2         10mM 
MgSO4        10mM 
Glucose         20mM 
 
Lysogeny Broth (LB) Media 
Tryptone         1% (w/v) 
Yeast Extract        0.5% (w/v) 
NaCl          171mM 
 
Lysogeny Broth (LB) Agar (1L) 
Agar          15g 
Made up to 1L with LB media 
 
Antibiotics 
Ampicillin        100 μg/μl 
Kanamycin         50 μg/μl 
Antibiotics are dissolved with dH2O and sterilised using a 0.25μm filter. Aliquots may 
be stored at -20
o
C, but kept wrapped in tinfoil to avoid degradation through exposure to 
natural light. 
 
TE Buffer 
Tris          10mM 
EDTA (pH8.0)         1mM 
 
DNA Loading Buffer 
Sucrose         40% (w/v) 
Bromophenol Blue       0.25% (w/v) 
 
 68 
 
2.2 METHODS  
2.2.1 Cell Culture Techniques 
In the culturing of cell types, each technique was undertaken in a sterile environment 
using a Holten LaminAir laminar flow cabinet. All cell types were grown in a 37
o
C 
humidified atmosphere containing 5% CO
2
. Any containers entering incubators or 
laminar cabinet was sprayed with 70% Industrial Methylated Spirits (IMS) to prevent 
contaminants. Items such as pipette tips or micro-centrifuge tubes were first autoclaved 
and cooled to 17-20
o
C prior to use. 
 
2.2.1.1  Human Aortic Endothelial Cell (HAEC) Culture 
Human Aortic Endothelial Cells are a strongly adherent cell line that forms a confluent 
contact inhibited monolayer with distinct cobblestone morphology. HAECs (Promocell) 
were derived from the thoracic aorta of a fifty-nine-year-old human male post-mortem. 
The isolated endothelial cells were maintained in Endothelial Cell Growth Medium MV 
supplemented with a separate SupplementMix® of various growth factors. When added 
to the medium, the final concentrations are 5% (v/v) FCS, 0.004% (v/v) ECGS, 10ng/ml 
of EGF, 90μg/ml of Heparin, and 1μg/ml of Hydrocortisone. These hormones and 
chemicals help in regulating angiogenesis and cell growth. The Penicillin/Streptomycin 
mixed antibiotic was also added to give a final concentration of 100 U/ml penicillin and 
100μg/ml streptomycin. These HAECs were cultured in 100mm x 20mm culture dishes 
along with 35mm 6-well plates. Cells involved in cyclic strain experiments were grown 
in Bioflex® series 6-well culture plates (Dunn Labortechnik GmBH) with a flexible, 
pronectin bonded growth surface. For immunofluorescence analysis involving sheared 
HAECs, cells were seeded onto sterilised glass cover slips in 6-well plates. HAECs 
between passages 5-10 were used for experimental purposes. 
 
2.2.1.2 Trypsinisation of Adherent Cell Lines 
For sub-culturing of cells, trypsinisation of adherent cells was required. Adherent cells 
were passaged in a cell culture dish at 70-90% confluence. For trypsinisation, the PBS, 
1X trypsin and cell culture medium was pre-warmed to 37
o
C in the water bath. Using a 
sterile aspiration pipette, growth media was removed from the confluent monolayer and 
cells were washed with 4mls PBS. The cell culture dish was gently swirled for 30 
seconds in order to neutralize trypsin inhibitors present in serum. This PBS was 
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aspirated afterwards in the same way, following which 1ml of 1X trypsin/EDTA 
solution in PBS was added to the cells. The cells were left for no more than 5 minutes, 
with regular observation of the cells state of detachment on the microscope. At the point 
at which roughly 50% of the cells are loosened, the culture dish was gently tapped on 
the side in order to detach the cells from the growth surface. When cells were observed 
to be detached completely, 8mls of full media was added to the cells to neutralise the 
trypsinisation. The cell suspension was carefully mixed by carefully pipetting up and 
down. This 9mls of suspended cells was split among 3 new sterile culture dishes. Each 
dish had a fresh 5mls of full media also added to them. At 70-90% confluence, a full 
dish contains 1.5-2.0x10
6
 cells, meaning that the plates with new passages will start off 
with roughly 5 – 6x105 cells. Media is changed early the day after splitting and cells are 
then fed every second day with 6mls of pre-warmed fresh media. 
 
2.2.1.3 Cryogenic Preservation and Recovery of Cells 
For long term storage, cells were maintained in a liquid nitrogen cryo-freezer unit 
(Taylor-Wharton, USA). Following trypsinisation, cells were centrifuged at 700 rpm for 
5 minutes at 17-20
o
C. The supernatant was aspirated, and the pellet was re-suspended in 
5mls Cryo-SFM. 1.6ml aliquots of this were transferred to sterile cryotubes and frozen 
in a -80
o
C freezer, at the rate of -1
o
C/ minute using a Nalgene Mr Frosty® cryo-freezing 
container. Following overnight freezing at -80
o
C, the cryotubes were transferred to the 
cryo-freezer unit. For cell recovery, Cryotubes were rapidly thawed in a 37
o
C water 
bath. Following this, they were resuspended in pre-warmed PBS and centrifuged at 
700rpm for 5 minutes to separate the cells from the DMSO. Once this was done, the cell 
pellet was resuspended in 3mls of media and added to a culture dish with 5mls of fresh 
media. Early the next day, the medium was removed, washed with pre-warmed PBS to 
remove DMSO, and 6mls of fresh growth medium was added. 
 
2.2.1.4 Cell Counting 
For healthy cell growth during certain experimental procedures cells needed to be 
seeded at precise numbers and densities. In order to do this, cell counts were performed 
using a Neubauer chamber haemocytometer. 
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2.2.1.4.1 Cell Counting using a Haemocytometer 
For this method, cells were trypsinised and re-suspended in cell media as per protocol. 
The Haemocytometer is cleaned with IMS and left air-dry inside the laminar hood. A 
sterile cover slip is placed over the top of the chamber. The cell suspension is gently 
mixed to achieve a homogenous concentration. 20μl of this suspension is pipetted into 
the groove in the haemocytometer, where surface tension spreads this over the 
haemocytometer’s marked grid for counting (Figure 2.1). Using the 10X objective lens, 
the numbers of cells in the four outer squares were counted. The average count per 
square, when multiplied by 1x10
4
, determines the cells per ml. This number is 
multiplied to adjust for dilution factor, and also by the total volume of the cell 
suspension i.e. x9 if the total volume is 9mls. 
 
Figure 2.1: Haemocytometer. The Haemocytometer grid has four corner squares (S1-S4), each 
containing 16 smaller squares arranged in a 4X4 pattern. Using a 10X objective lens, the cells in 
each corner square were counted. For cells touching the border lines, only the ones on the right 
and upper lines were counted, and ones on the left on the bottom lines were disregarded. 
 
2.2.2 Physiological Assays 
2.2.2.1 Cyclic Strain 
For cyclic strain assays, HAECs were seeded onto six-well pronectin-coated BioFlex 
Plates at a density of 5x10
5
 cells per well. The silicon membrane of the plates allows for 
a controlled physiological strain of the cells using a microprocessor controlled vacuum 
(Banes et al., 1985). 24 hours post seeding, cells were subjected to cyclic strain using a 
Flexercell® Tension Plus™ FX-400T™ System (10% strain; 60 cycles/min) for a series 
of time points (0-48 hours). Following time points of strain, cells were harvested for 
either Western Blotting, or for mRNA extraction and qRT-PCR analysis. Media was 
also retained and stored at -20
o
C for endothelial microparticle analysis.  
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(A)                                                         (B) 
 
Figure 2.2: The Flexercell® Tension Plus™ FX-4000T System. Figure 2.2 (A) shows the 
setup of the Flexercell system, designed for cyclic strain of cells. Figure 2.2 (B) demonstrates 
how the vacuum of the docking setup applies strain on the cells, in an equibiaxial manner, 
stretching the pronectin coated membrane over the loading posts.  
 
2.2.2.2 Non-Pulsatile Laminar Shear Stress 
For laminar shear stress studies, HAECs were seeded into a 6-well cell culture plate at a 
density of 2x10
5
 and allowed to reach full confluency. Prior to shearing, the medium 
was replaced with 4mls of fresh medium. The cells were sheared at 10 dynes/cm
2
 for a 
series of time points (0-48 hours) on an orbital shaker (Stuart Scientific mini orbital 
shaker OS) set to a speed of 230rpm. The speed was determined using the following 
equation (Hendrickson et al., 1999): 
 
Where   α = radius of rotation in cm  
p = density of liquid in g/l  
n = liquid viscosity 7.5 x 10
-3
 dynes/cm
2
 @ 37°C  
f = rotation per second 
 
As a control, plates containing static endothelial cells were maintained. They were 
cultured in the same incubator, but on a different shelf to avoid vibrational interference 
from the orbital rotator. Following shearing experiments, the cells were harvested for 
either (i) protein (ii) mRNA (iii) Immunoprecipitation of protein for Mass Spectrometric 
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analysis; or (iv) fixing in situ for immunofluorescence staining. Media was also retained 
and stored at -20
o
C for future endothelial microparticle analysis experiments. 
 
2.2.2.2.1 Laminar Shear Stress of Cells Seeded on an Extracellular Matrix 
For experiments where the effects of ECMs on protein and gene expression were 
investigated, 6-well plates were pre-prepared. Under sterile conditions, each well of a 6-
well plate was fully covered with 1ml of PBS containing either: 10μg/ml fibrinogen (at 
a pH of 8.0), 10μg/ml fibronectin or 20μg/ml collagen, depending on which matrix was 
being investigated. The plate was then incubated overnight at 4
o
C. The next day, PBS 
was aspirated and cells were seeded, later being subjected to laminar shear stress as 
described previously. 
 
2.2.2.3 Endothelial Microparticle (EMP) Analysis of Media Samples  
In this study, EMPs were isolated and their content was analysed to investigate the 
presence of Palladin or other proteins. Confluent endothelial cells were subjected to 
laminar shear stress or cyclic strain, and equal amounts of culture medium were 
collected into 15ml conical centrifuge tubes. This tube was centrifuged at 2250rpm for 
15 minutes at 4
o
C in order to remove cells and cell debris. Supernatant was collected 
and aliquoted into micro-centrifuge tubes (1ml per tube). Following the extraction 
methods of Vion et al., these micro-centrifuge tubes were spun at 14000rpm for 30 
minutes at 4
o
C (Vion et al., 2013). The media was aspirated, leaving the EMP pellet. 
The microparticle pellets were pooled together in a total of 1ml of 1X PBS. The single 
micro-centrifuge tube was centrifuged at 14000rpm for 30 minutes at 4
o
C. The PBS was 
aspirated, and the pellet re-suspended in 20μl fresh 1X PBS. The samples were stored at 
-80C. Else they were prepared for Western Blotting (Chapter 2.2.5.1) or FACS analysis 
(Chapter 2.2.3).  
  
2.2.2.4 Endothelial Microparticle (EMP) Analysis of Blood Samples 
For samples taken from an in vivo model (i.e. blood samples), the blood was drawn 
from participants using a 19C needle into 5ml BD Vacutainer ® tubes containing 1x 
PBS/ Sodium Citrate (to help stabilise the blood and prevent clotting). Ethics approval 
was granted for this study from the DCU research ethics committee  
(DCUREC/2008/64 and DCUREC/2009/172). Blood was drawn from patients at 2 time 
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points: Post-Exercise, and 1 hour Post-Exercise – designated a relaxed state. This 
exercise was quantified using the Borg Scale of Perceived Exertion. The scale assays 
how the patient perceives the difficulty of activities. The scale starts at 6, characterised 
by “no feeling of exertion” i.e. when the patient is at a resting rate. Moderate activities 
such as a brisk walk (“fairly light” to “somewhat hard”) register 11 to 14 on the scale. 
Vigorous activities, i.e. running on the treadmill up to the highest level of sustainable 
activity, rate from 15 to 20 on the scale (“hard” to “extremely hard”). Multiplying the 
score by 10 gives an approximate heart rate (Borg, 1982). The patients exercise 
consisted of roughly 30 minutes of running on a treadmill, achieving a score from 15-20 
within the last 10 minutes of running. This raises heart rate in the patient, which 
elevates the increase of blood flow; leading to an increase in microparticle release. 
Once blood was withdrawn, each Vacutainer tube was centrifuged at 2250rpm for 15 
minutes. The plasma layer – 2.5mls - was removed and filtered through an Exomir Kit 
dual-filter of 0.22μm and 0.02μm (Bioo Scientific) to trap the microparticles and 
exosomes in separate filters. The filters were separated, with each filter being flushed 
through with 1ml RIPA buffer. The buffer obtained was flushed through the respective 
filter again another 2 times, before being collected into separate micro-centrifuge tubes 
(Figure 2.3). Both tubes were centrifuged at 14000rpm for 30 minutes at 4
o
C. The 
supernatant was then gently aspirated, with care made not to aspirate the EMP pellet. 
The pellet was re-suspended in 20μl fresh 1X PBS and stored at -80oC. 
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Figure 2.3: Extractions of Microparticles and Exosomes from Blood. Blood was withdrawn 
from patients and collected in Vacutainer tubes (A). These tubes were centrifuged in order to 
separate the plasma from the red blood cells and white blood cell/platelet layer (B). Plasma was 
removed and syringed through the Exomir dual filter assembly, with microparticles being 
retained in the 0.22μm upper filter, and exosomes retained in the lower 0.02μm lower filter (C). 
These filters were separated, with each one being flushed through using sterile syringes and 1ml 
RIPA buffer each (D). The RIPA was re-added and flushed through the respective filters a 
second and third time to ensure complete extraction of particles from the filters. The resulting 
samples of RIPA buffer containing either microparticles or exosomes was centrifuged to collect 
the particles (E). Supernatant was aspirated (after taking an aliquot for analysis) and the pellet 
was re-suspended in PBS before being stored at -80
o
C until use. 
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2.2.3 Molecular Biology Techniques  
2.2.3.1 Reconstitution of Plasmid cDNA 
A DNA based plasmid for Palladin-GFP (gifted to the laboratory by Professor Carol 
Otey, University of North Carolina) was presented which was afterwards reconstituted. 
Using flame sterilised forceps and scissors, a 1cm
2
 area of filter paper containing the 
plasmid was cut out and placed within a sterile 1.5ml micro-centrifuge tube. 100μl of 
endotoxin-free, sterile TE buffer was added to the tube before being vortexed for 5 
seconds and incubated at 17-20
o
C for 5 minutes. Following this, the mixture was again 
vortexed for 5 seconds and the tube was centrifuged for 15 seconds at 1000rpm. 
Supernatant was collected to be used in bacterial transformations.  
  
2.2.3.2 Transformation of Competent Cells 
Plasmids were transformed into DH5α electro-competent E.coli bacteria to facilitate 
rapid replication and purification of a higher volume of the plasmid DNA. Under sterile 
conditions, approximately 5-10μl of the reconstituted DNA supernatant was added to a 
vial containing 25μl of competent bacterial cells. The bacteria/DNA mixture was 
incubated on ice for 30 minutes, allowing the bacteria to come into contact with the 
DNA. The mixture was heated at 42
o
C for 30 seconds to disrupt the bacterial 
membrane, allowing the DNA to enter the cell. The heated mixture was placed back on 
ice for 2 minutes to help the bacteria retain the plasmids. Many bacteria will not survive 
the rapid change of temperature, but enough retain integrity to keep the plasmid. 500μl 
of room temperature SOC media is added to the mix before incubating again for 30 
minutes, shaking at 150rpm at 37
o
C. This allows the transformed bacteria to recover and 
divide again. Transformed bacteria were spread on LB agar plates containing 
Kanamycin antibiotic: one plate with 40μl, and the other with 400μl. These spread 
plates were inverted and incubated overnight at 37
o
C. After 12-16 hours, successfully 
transformed colonies were visible for selection. Either plate is usable for picking 
colonies, but using the 40ul plate allows for colonies to be more spread out, assuming 
there were viable bacteria. The 400ul spread plate is retained for backup in case 
bacterial growth is not optimal on the other plate.  
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2.2.3.3 Midi-preparation of Plasmid DNA from Bacterial Colonies 
Under aseptic conditions, colonies were selected from successful spread plates using a 
wire loop and inserted into bacterial tubes containing 5mls of LB broth supplemented 
with 5μl of Kanamycin antibiotic (at a stock concentration of 30ng/μl). Bacterial tubes 
were placed on a rotator at 37
o
C for 6-8 hours to create a larger volume of bacteria in 
the logarithmic growth phase. After reaching this phase, this starter culture was 
incubated at 37
o
C, shaking at 150rpm overnight (16-20 hours) in autoclaved baffled 
culture flasks - containing 145mls of LB broth with the appropriate ratio amount of 
antibiotic (145μl). At 16-20 hours, the culture flask was removed and cells were 
collected in a 50ml conical centrifuge tube. This was achieved by centrifuging 50mls of 
the cells in LB broth mixture at 3000rpm for 20 minutes at 4
o
C. Following this, 
supernatant is discarded and more broth is added; after which the tube is centrifuged at 
the same conditions. This is repeated until all the LB broth is pelleted. A Qiagen 
HiSpeed Plasmid Midi-prep kit is then used to extract the plasmid from this pellet. The 
bacterial pellet is re-suspended in 6mls of chilled P1 buffer (50 mM Tris-Cl, pH 8.0; 10 
mM EDTA and 100 μg/ml RNase A) provided. For  
A further 6mls of Buffer P2 (1% SDS (w/v), 200 mM NaOH), is added to lyse the cells. 
This mixture is shook for 30 seconds before incubating at 17-20
o
C for 5 minutes. 6mls 
of chilled Buffer P3 (3.0M potassium acetate pH 5.5) is added to neutralise the cell lysis 
and the tube is shaken for 30 seconds to ensure uniform mixing. The cell lysate mix is 
poured into a Qiagen Midi-cartridge and incubated at 17-20
o
C for 10 minutes while the 
cell debris settles. A Hi-speed Midi-prep tip is calibrated by allowing Equilibration 
buffer (750 mM NaCl, pH 7.0; 15% isopropanol (v/v); 0.15% Triton® X-100 (v/v); 50 
mM MOPS) to flow through it. Cell lysate is filtered through this tip whereby the DNA 
binds to the resin column. Bacterial cell protein is removed by washing the column with 
20mls of Wash buffer (1.0 M NaCl; 50 mM MOPS, pH 7.0). DNA is eluted with 5mls 
of QF Elution buffer (1.25 M NaCl; 50 mM Tris-Cl, pH 8.5) and 3.5mls of isopropanol 
is added to precipitate the DNA. The mixture was inverted a few times and allowed to 
precipitate at 17-20
o
C for 5 minutes, before getting filtered through the QIA-precipitator 
filter module provided. Plasmid bound to the precipitator filter was washed with 2mls of 
70% (v/v) ethanol, dried by flushing air through, and then eluted with 500μl sterile 
dH2O. The eluted DNA was flushed through the precipitator once again to remove any 
unbound DNA. The sample was subjected to spectrometric analysis using the 
NanoDrop™ system. The quality of the DNA was analysed through measurement of the 
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ratio of absorbance at 260nm and 280nm. Pure DNA with no bound protein impurities 
will have an A260/A280 ratio of 1.8-1.9. 
 
2.2.3.4 Agarose Gel Electrophoresis 
Agarose Gel Electrophoresis was employed to visualise the presence of plasmid DNA 
and reverse transcribed cDNA, and as a means to quality control both standard PCR and 
qRT-PCR samples post amplification. The agarose gel apparatus consists of a horizontal 
gel rig with electrodes, a buffer chamber, a gel plate and a plastic comb. The 1% (w/v) 
agarose solution is prepared as 1g agarose added to 99mls 1X TAE buffer in a conical 
flask. The solution was heated in a microwave to dissolve the agarose until the solution 
went clear. The solution was cooled to a warm temperature but not too cool - otherwise 
the agarose would start setting. After cooling, 10μl of 1X SYBR ® Safe solution – a 
fluorescent DNA stain - was added to the liquid agarose. The gel plate was sealed at the 
sides with autoclave tape to prevent leaking, and the comb was placed in the allotted 
groove in the plate walls. The agarose mix was poured into the gel plate and covered 
with tinfoil while setting, due to the SYBR ® Safe solution’s light sensitivity. At ~30 
minutes later when the gel was set, the tape was removed, and the gel was placed into 
the rig. The chamber was filled up with 1X TAE buffer until it sufficiently covered the 
top of the gel. The comb was removed, allowing the buffer to enter the wells, and 
samples and a ladder marker were loaded.  
For plasmids, ~1-2μg was loaded with 6μl loading buffer. For qRT-PCR samples, 10μl 
of each sample was added to 6μl loading buffer. Standard PCR products didn’t need 
loading buffer, as the Fermentas® PCR buffer allows for straight loading of samples. 
The gel rig is covered in tinfoil and the gel electrophoresed for ~1 hour at 100V - until 
the loading buffer is seen to run at least three-quarters of the way down the gel. Samples 
are visualised using the G-Box fluorescence gel documentation and analysis system. 
 
2.2.3.5 Ethanol Precipitation 
Ethanol precipitation was used in cases where DNA samples needed to be purified and 
concentrated. For every 100μl of DNA Sample, 10μl of Sodium Acetate and 200μl of 
100% ethanol were added. The mixture was gently inverted to mix and incubated for 10 
minutes at -80
o
C, before being centrifuged at 13000rpm for 20 minutes at 4
o
C. The 
supernatant is carefully aspirated and the pellet is washed in 70% ethanol, and again 
centrifuged at 13000rpm for 10 minutes at 4
o
C. The supernatant is removed and the 
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pellet is air-dried at 17-20
o
C. It is then re-suspended in 30μl of sterile RNase free 
distilled water.  
  
2.2.4 Transfections with Plasmids and siRNA 
2.2.4.1 Microporation 
The transfection of siRNAs and plasmids has always been a complicated technique to 
perform, with endothelial cells being a difficult cell to transfect (Yockell-Lelièvre et al., 
2009). The electroporation method uses electrical energy to create pores in the cell 
membrane, and then drives the siRNA/plasmid into the cell to be expressed. However 
this resulted in large percentages of cell death. Kim et al described a method using a 
capillary tip and pipette system which acted as a substitute for a cuvette and 
electroporation reaction chamber which was more effective and resulted in 70-80% cell 
survival. They also indicated that the cell viability depended on the change in pH caused 
by electrolysis during electroporation (Kim et al., 2008). The Invitrogen Neon® 
Transfection System was developed based on these findings. The MP-100 model 
available utilises a gold plated pipette tip as an electroporation chamber to transfect 
cells. The small surface area allows for a uniform electric field to be generated with 
minimal heat generation, pH variation or oxide formation that can be problematic in 
other electroporation protocols.  
(A)    (B)    (C) 
 
Figure 2.4: The Invitrogen Neon® Transfection System. This electroporation technique 
consists of (A) The microporation unit that facilitates the voltage settings needed for 
transfection, (B) the microporation docking station containing the electroporation buffer and 
specialised fixed volume pipette to electroporate the cells suspended in the gold tips; and (C) the 
microporation kit containing the necessary microporation solutions, tips and microporation 
tubes.  
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Prior to transfection, each well of a 6-well plate to be used was pre-incubated with 2mls 
of antibiotic-free growth media in the tissue culture incubator. This equilibrates the 
media in the plate so that the sensitive transfected cells adapt quickly to the media and 
remain viable. Plates of cells at 50-70% confluency were trypsinised, collected in cell 
media and counted as documented previously. This level of confluency works better 
with transfections as the cells are in a dividing phase, making the membrane easier to 
open, without damaging the cell. They were then aliquoted, with each aliquot containing 
550,000 cells (5x10
5
 cells + 10% extra to allow for centrifugation losses) for each 
planned transfection and centrifuged at 700rpm for 5 minutes at 17-20
o
C. Supernatant 
was removed and each aliquoted cell pellet was re-suspended in 110μl of Buffer R, a 
proprietary resuspension solution. The cell/buffer mix was transferred to a sterile 1.5ml 
micro-centrifuge tube and 1.5μg plasmid DNA/50nM siRNA was added. The 
microporation tube was set up in the docking station with 3.5mls E2 buffer, a 
proprietary electroporation solution. The cell mixture was pipetted using a special 
microporation pipette into a 100μl gold tip, with care taken not to have any bubbles 
appear in the mixture (bubbles break the connection in the electroporation and result in 
an uneven charge that destroys all the cells contained in the tip). For HAECs, the 
desired pulse conditions are 1000V voltage, 30ms Pulse Width, and a 3 pulse number. 
The pipette was docked into the microporation station and the program was run. 
Following the microporation the 100μl cell sample was transferred instantly to a well of 
the six-well plate containing 2ml pre-incubated media. Cells were incubated overnight, 
with the media being replaced the next day. 
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Figure 2.5: Electroporation of Cells using Microporator. Figure 2.5 (A) shows the pipette 
with a retractable gold tip, about to collect the R Buffer / Cells and Plasmid mix. As seen in (B), 
care is taken to avoid any bubbles appearing between the mixture and the tip. This tip is placed 
into the microporation tube containing E buffer, which has been set up inside the Microporator 
Docking Station (C). The docking station is connected to a module which facilitates the charge 
used to electroporate the cells. The electrical charge is passed from the station, through the 
Anode in the pipette. The charge (represented in orange) passes through the gold tip, and down 
through the cell mixture until it reaches the cathode at the bottom of the microporation tube. 
This process causes the cells to open pores in their membrane which allows the siRNA/plasmid 
to get transfected into the cell. 
 
2.2.4.2 Cell Migration Assay of Transfected siRNA Knockdown Cells 
Post-transfection, the cells were seeded as described. Controls were also set up, with 
non-transfected cells. At 30 hours post-transfection the cells were determined (through 
Western Blotting) to be at the optimal stage of siRNA knockdown. At this time point, 
the cells were subjected to a scratch wound healing assay. A circle on the underside of 
the plate was marked to mark a zone for imaging. Under sterile conditions, a 200ul 
pipette tip was used to scrape a line through this zone, leaving behind a wound of 1mm 
in diameter. Cells were imaged on a microscope at repeated time points to determine 
cell migration. 
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2.2.4.3 xCELLigence™ Assay of Transfected siRNA Knockdown Cells 
The xCELLigence™ system (Roche, Basal, Switzerland) is a novel system that allows 
monitoring of cell migration or adhesion in real-time without any labelling, or need to 
image the cells at specific time points. The system works by measuring the electrical 
impedance across the integrated micro-electrodes at the base of specialised cell culture 
plates (Ke et al., 2011). These plates – named the E (Electrode) and CIM (Cellular 
Invasion/Migration) plates, respectively measure cell adhesion and cell migration. The 
impedance measurement is used to provide quantitative information about the cells, 
including number, morphology and viability. The presence of the cells on the electrodes 
alters the local ionic environment at the electrode/solution interface leading to increased 
electrode impedance. The impedance is measured using a dimensionless parameter 
called the Cell Index (CI) which is derived from the relative change in electrical 
impedance. The CI is characteristically set at zero when cells are absent or not-adhered 
to the electrodes. Under the same physiological conditions, when more cells are 
attached, the CI values are larger. Thus, CI is a quantitative measure of cell number 
present in a well. Change in a cell status, such as cell morphology, cell adhesion, or cell 
viability will lead to a change in CI. 
On the day of the experiment, the experimental parameters were set up on the RTCA 
software as follows. 
1. Exp Notes tab: Experimental information, purpose, name etc. were entered.  
2. Layout tab: In this tab, wells are highlighted to enter information on the cell 
number, type, treatment etc. within that well. This is what will decide whether 
you are doing individual or multiple well analyses. For the purposes of this 
experiment, triplicates were performed. 
3. Schedule tab: This is what determines the length of the experiment and timing of 
intervals between sweeps – where the impedance is measured. Step one is for 
initial back ground reading to calibrate the software. This is performed first 
before the cells are added. A second cycling step is then added; 300 sweeps at 
5min intervals were selected. This gives a monitoring of adhesion/migration of 
just over a 24 hour period.  
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Figure 2.6: The xCELLigence™ System. This schematic illustrates how the xCELLigence™ 
system functions. The Cell Index value is set to zero when the electrode has no cells present. 
Presence of cells on the electrodes alters the environment at the electrode/solution interface 
leading to increased electrode impedance. Impedance increases as more cells attach or migrate 
across the electrode, which increases the Cell Index value. This value is recorded in five-minute 
increments and graphed with the specialised software. 
 
For migration assays, firstly the HAECs were transfected with siRNA as per previously 
described methods, and incubated for 30 hours – the optimum time for knockdown. At 
approximately 45 minutes prior to the completion of this time point, the CIM-plates 
were disassembled according the manufacturer’s instructions (Figure 2.7). CIM-Plates 
are single use, disposable devices used for performing cell migration assays on the 
instrument. The CIM-Plate 16 comprises a plate cover (lid), an upper chamber and a 
lower chamber. The upper chamber has 16 wells that are sealed at the bottom with a 
microporous polyethylene terephthalate (PET) membrane containing microfabricated 
gold electrode arrays on the bottom side of the membrane. The median pore size of this 
membrane is 8μm. The lower chamber has 16 wells, each of which serves as a reservoir 
for media and any chemo attractant for the cells in corresponding upper chamber wells. 
160 µl of serum-free medium was added into the lower chamber with no air bubbles 
allowed to form, and the upper chamber then placed onto it. Another 50 µl of serum-
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free medium was added into each well ensuring the surface of the well was fully 
covered and no air bubbles were present. The plate was allowed to incubate for 30 
minutes at 37
o
C to allow the plate to acclimatise to the conditions. Meanwhile, cells 
were trypsinised and counted. Upon completion of the incubation, the CIM-plate was 
scanned for one minute - allowing the setting of the baseline value for the plate. 30,000 
cells per condition were added per well into the upper chamber of CIM-Plate. The CIM-
plate was incubated for another 30 minutes at 17-20
o
C while these cells settled and 
adjusted to the media. Initial adhesion of cells was measured at 5 minute intervals from 
0-24 hours. Data was recorded and analysed using the specialised software. 
 
Figure 2.7: The CIM Plate. This illustrates the plate used for cell migration assays on the 
xCELLigence™ system. Left: Lower chamber plate containing the chemoattractant. Middle: 
Upper, electrode containing, chamber plate to which the cell suspension is added. Right: Plate 
cover. 
 
2.2.5 Immuno-Detection Methods 
2.2.5.1 Immuno-Blotting (Western Blotting) 
2.2.5.1.1 Preparation of Whole Cell Lysates 
For the purposes of Western Blotting, cell lysate was prepared in the following manner. 
Cell culture media was aspirated from culture dishes, and the plates were immediately 
placed on ice. They were washed three times with PBS solution – 6mls for a 100mm 
cell culture dish; or 1ml for each well of a 6-well plate. Following the complete 
aspiration of this PBS, cells were harvested with a cell scraper and 1X 
radioimmunoprecipitation assay (RIPA) cell lysis buffer. For immunoprecipitation 
experiments, a cell lysis buffer was provided in the Pierce® Co-immunoprecipitation 
kit. The manufacturer’s manual recommended this buffer for use instead of RIPA, but 
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all other volumes and protocol remained the same. 250μl of buffer per 58cm2 dish (or 
40μl per well of a 6-well plate) was added to the cells and they were left incubate on ice 
for 5 minutes. The cells were then scraped off, with the cell suspension collected in a 
1.5ml micro-centrifuge tube. This suspension was rotated at 4
o
C for 1 hour and 
centrifuged at 10000rpm for 20 minutes at 4
o
C to pellet the triton-insoluble material 
from the sample. A 50μl aliquot of supernatant was taken for immediate use in a BCA 
assay, with the remaining supernatant being also aliquoted and stored at-80
o
C for future 
use in Western Blotting.  
 
2.2.5.1.2 Bicinchoninic Acid (BCA) Assay 
The BCA assay is a biochemical assay used to quantify the total amount of protein in 
solution. It works on two reactions; firstly the ability of peptide bonds to reduce Copper 
(Cu2+) ions under alkaline conditions to produce Cu+. Secondly, the reduced copper 
ions react with bicinchoninic acid to form a complex that strongly absorbs light at 
562nm. A 96-well plate is prepared with a range of BSA standards (from 0.0 to 2.0 
mg/ml, increasing 0.2mg/ml increments) along with protein samples to be measured, 
and the RIPA buffer used. For each sample, 10μl was pipetted per well, and in triplicate. 
Two separate reagents are supplied in the commercially available assay kit (Pierce 
Chemicals); Reagent A (an alkaline bicarbonate solution) and Reagent B (a copper 
sulphate solution). A mixture of one part Reagent B to 50 parts Reagent A is mixed; 
200μl of this is added to every well containing either 10μl of protein lysate, RIPA 
buffer, or BSA standard. The plate is covered and incubated at 37
o
C for 30 minutes. 
Following this incubation, absorbance is read at 562nm using an ELx800 microplate 
reader (Biotek). Results of known standards and unknown samples are graphed on an 
Excel spreadsheet in order to obtain protein concentrations using the known readings on 
a standard curve. 
 
2.2.5.1.3 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE)  
SDS-PAGE resolves cellular proteins based solely on their electrophoretic mobility. 
During SDS-PAGE, proteins are moved by an applied current through a cross-linked 
polyacrylamide gel in the presence of the negatively charged detergent Sodium Dodecyl 
Sulfate. SDS binds to protein molecules and denatures them to their primary structure. 
Electrostatic repulsion between the bound SDS molecules causes the proteins to unfold 
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to a similar shape, removing secondary and tertiary structure as a factor in the 
separation. The amount of SDS bound is proportional to molecular weight of the 
polypeptide. As such, SDS-polypeptide complexes are able to be separated through the 
polyacrylamide gel in accordance with the size of the polypeptide (Laemmli, 1970). 
10x100mm sized glass plates (one flat front plate, and one back plate with 1.0mm 
spacer) were cleaned, rinsed with 70% ethanol and dried completely. The components 
of the BioRad electrophoresis system were assembled according to manufacturer’s 
instructions. The short plate was placed over the long plate, leaving a 1.0mm gap 
between the two, and the assembly was sealed tight using the provided locking frame 
and stand. The stand comes with a rubber base to keep the gel sealed from leaking. A 
10% resolving gel was prepared as listed in Table 2.4: 
 
Table 2.4: 10% SDS-PAGE Resolving Gel composition. The table documents the 
components of the SDS-PAGE resolving gel and the volumes needed to make the gel. The 
given volume for 1 gel when prepared leaves extra solution behind in a 50ml tube (which can be 
used to indicate when the gel has set). For creating two gels, 1.5X the volumes listed for a single 
gel was prepared. This allows for extra solution to indicate when the gel had set.  
 
Reagent Volume for 1 gel Volume for 2 gels 
dH2O 4.0ml 6.0ml 
1.5M Tris-HCL pH 8.8 2.5ml 3.75ml 
30% Acrylamide-Bis 3.33ml 5ml 
10% SDS 100μl 150ul 
10% Ammonium Persulfate 50μl 75ul 
TEMED 5μl 7.5ul 
 
The 10% APS is made in dH2O; excess APS can be aliquoted and stored at -20
o
C to be 
thawed out for single use. Both 10% APS and TEMED are added just before pouring 
the gels, as they start polymerisation of the gel. Having added these, approximately 5-
6mls of resolving gel mix is poured gently between the two plates, avoiding bubble 
formation. Once the gel is filling up ~80% of the way, a layer of isopropanol is then 
poured on top to remove any air bubbles, and to provide an even surface on the gel. The 
gel is then allowed to polymerise for 40 minutes at 17-20
o
C. 
Once polymerisation has finished, the isopropanol is poured off the top of the resolving 
gel, rinsed with dH2O, and dried using filter paper. The 4% stacking gel is prepared as 
documented in Table 2.5 and poured on top of the resolving gel. Any bubbles present 
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are removed with a pipette tip, and the comb is inserted. The gel is then left to set for 
20-30 minutes. 
 
Table 2.5: SDS-PAGE 4% Stacking Gel composition. The table documents the components 
of the 4% SDS-PAGE stacking gel and the volumes needed to make it. As with the resolving 
gel, 10% APS and TEMED are added and mixed just prior to pouring. 
Reagent Volume 
dH2O 3.05ml 
0.5M Tris-HCL pH 6.8 1.25ml 
30% Acrylamide-Bis 675μl 
10% SDS 50μl 
10% Ammonium Persulfate 50μl 
TEMED 5μl 
 
Upon polymerisation of the stacking gel, the gel is inserted into the electrophoresis 
chamber containing the required electrodes, as designated in Figure 2.8. If only a single 
gel is being run, a buffer dam is placed on the opposite side; otherwise the second gel 
plate is inserted. The plate holder is locked into the buffer tank, and ~800mls of 1X 
Tris/Glycine/SDS Running Buffer is added, in such a way that the inner chamber is 
filled to the very top. The gel will fail to run properly if not full, generating an uneven 
electrophoresis indicated with a curve in the sample buffer line in the gel. Once the 
buffer has been added, the combs are removed. Unpolymerised acrylamide in the wells 
is flushed out with a pipette tip and Running Buffer.  
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Figure 2.8: Schematic design of SDS-PAGE Gel orientation inside buffer tank. This figure 
illustrates the orientation of the SDS-PAGE gel when loaded and placed inside the tank full of 
running buffer. The lid of the tank connects the electrodes to the PowerPak™ which regulates 
the electrical charge needed to separate the proteins on the gel.  
 
Protein samples are prepared in 4X sample solubilisation buffer (SSB) to give the 
optimal concentration of protein depending on protein investigated (Table 2.6) and 1X 
SSB in a total volume of 30ul. Samples are boiled at 95
o
C for 5 minutes and held shut 
with micro-centrifuge clips (to prevent pressure opening the sample and the heat 
evaporating it). Samples are immediately placed on ice once boiled, then loaded into 
individual lanes in the SDS-PAGE gel. In a separate lane, 5μl of Precision Plus ® 
protein molecular weight marker is also inserted. The inner chamber is topped up with 
more Running Buffer and the lid is shut and connected to a PowerPak™. Samples are 
electrophoretically separated for 20 minutes at 80V, before being subjected to 100V for 
120 minutes, or until the sample buffer reaches the bottom of the gel. 
 
Table 2.6: Protein loading volumes. This table documents a list of proteins investigated by 
Western Blotting analysis, and the quantity of each protein loaded into the SDS-PAGE gels to 
carry out the investigation. 
 
Protein Name Protein Loaded per lane (μg) 
Palladin 30μg 
LASP-1 30μg 
Drebrin 40μg 
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2.2.5.1.4 Transferring to a Nitrocellulose Membrane 
Following separation on a gel, the proteins then transferred to a membrane whilst still 
maintaining their relative position and resolution. The wet transfer method (Towbin et 
al., 1979) was the method for transfer in all Western Blot experiments. Prior to 
completion of the SDS-PAGE method, a piece of nitrocellulose membrane was cut to 
the same size as the gel. It, along with filter papers and fibre pads are soaked for 15 
minutes in ice-cold Transfer Buffer. This equilibrates the membrane to the transfer 
buffer and also allows for easier dilution of any SDS complexes bound to the gel that 
may impede a successful protein transfer. Once the gels are run, they were removed 
from the gel plates, and the stacking gel was removed. The gel, membrane, filter papers, 
and fibre pads were assembled in specialised cassettes supplied in the Mini-PROTEAN 
Electrophoresis System (BioRad) according to the schematic in Figure 2.9. The cassette 
was checked to be free from air bubbles (which prevent proper transfer of protein) and 
inserted into the cassette holder containing the electrodes required for transferring.  
 
 
Figure 2.9: Transfer Cassette Schematic. This figure shows the schematic of the transfer 
cassette used to transfer the electrophoresed proteins from an SDS-PAGE gel to nitrocellulose 
membrane. The black coloured side is assembled face down, and overlaid with a fibre pad, filter 
paper, resolved gel, nitrocellulose membrane, filter paper and fibre pad in that order before 
being sealed with the cassette clamp. 
 
The cassette holder was placed in the buffer tank with a cooling ice-block and filled 
with ice-cold transfer buffer, as shown in Figure 2.10. The cassette is orientated to allow 
the charge to pass through, transferring the protein from the gel to the membrane. 
Transferring was performed for 2 hours at 100V with the tank surrounded in ice. 
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Alternatively, a stirring bar was placed inside the tank, and the transfer was performed 
overnight at 50V in a cold room at 4
o
C, with the stirring bar rotating.  
 
Figure 2.10: Setup of Transfer of protein from Gel to Membrane. This figure illustrates 
preparation of the gel within a transfer cassette prior to transferring of protein to a nitrocellulose 
membrane. 
 
The tank transfer system was assembled in the illustrated manner. The transfer cassette 
was placed in the correct orientation of the electrode module. The module was placed 
into the buffer tank with a -20
o
C cooling block to keep the buffer as cold as possible. 
The lid was shut in the correct orientation and the transfer was started.  
 
2.2.5.1.5 Ponceau S Staining 
Ponceau S Stain was a method used to validate that protein had transferred to the 
membrane successfully. Ponceau S is a negative stain, which binds to positively 
charged amino acid groups of proteins. Following transfer, the membrane is placed in a 
disposable plastic container and is overlaid with roughly 10mls of Ponceau S stain. It is 
swirled around for 30 seconds before the stain is poured off. Transferred protein is 
visible as a red band on the white membrane. Following visualisation, the membrane is 
overlaid with dH2O and placed on a See-Saw Rocker for 5 minutes with gentle rocking 
and regular changing of water, until the stain has been removed. 
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2.2.5.1.6 Coomassie Gel Staining 
A secondary method to determine transfer of protein is through staining of the SDS-
PAGE gel to visualise protein bands or absence thereof. This technique ensures the 
transfer method worked, as well as determining that immunoprecipitation assay 
techniques work as expected (a minimal number of bands should be observed). The 
SDS-PAGE gel is overlaid with 0.25μm filtered Coomassie Blue solution while 
incubating on the See-Saw rocker at 17-20
o
C for 2-4 hours. Following this, the 
Coomassie Blue solution was removed, and the gel was de-stained, whilst rocking, in 
destain solution until the protein bands appeared clear and visible with no background 
staining, changing the solution regularly. 
 
2.2.5.1.7 Immunoblotting and Chemiluminescence Band Detection 
Following protein transfer, the nitrocellulose membranes are subjected to blocking in a 
5% (w/v) BSA/ TBS with 0.1% Tween solution. For membranes to be probed with 
Drebrin antibodies, the solution used is a 2.5% (w/v) BSA/TBS with 0.1% (v/v) Tween 
solution. Membranes are subjected to 1 hour in transfer buffer on a See-Saw rocker at 
17-20
o
C. Once blocked, the membranes are washed for 5 minutes in TBS with 0.1% 
Tween (v/v) to remove excess solution. Subsequently, the membranes are incubated 
with gentle rocking for 2 hours at 17-20
o
C with the appropriate primary antibody (Table 
2.7) in 6mls of 5% (w/v) BSA/TBS. Alternatively; the antibody was incubated 
overnight, rocking at 4
o
C. 
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Table 2.7: Primary Antibody solutions. This table displays the optimised primary antibody 
dilutions for proteins monitored by Western Blotting, along with the commercial and animal 
sources of these antibodies.  
Type of 
Antibody 
Commercial 
Source 
Animal 
Source 
Initial 
Antibody 
concentration 
Antibody 
Dilution 
in 
BSA/TBS 
Amount of 
antibody 
used per blot 
(6mls) 
Palladin  
Polyclonal 
ProteinTech Rabbit 16μg/100μl 1:1000  0.96μg 
GAPDH 
Polyclonal 
Millipore Rabbit  100μg/100μl 1:2000 3μg 
LASP-1 
Monoclonal 
Millipore Mouse 100μg/100μl 1:2000 3μg 
Drebrin 
Polyclonal 
Millipore Rabbit 100μg/100μl 1:500 12μg 
vWF 
Polyclonal 
Dako Rabbit 100μg/100μl 1:2000 3μg 
 
Upon completion of the primary antibody incubation step, the antibody was removed 
and washed three times for 5 minutes in Wash Buffer (TBS with 0.1% Tween) while 
rocking. The membranes were incubated with an appropriate Horseradish Peroxidase 
(HRP)-conjugated secondary antibody in a 5% BSA/ TBS with 0.1% Tween solution, as 
dictated in Table 2.8. The membranes were incubated at one hour with gentle rocking at 
17-20
o
C. Membranes were then washed three times in Wash buffer for 5 minutes each 
time, while rocking at 17-20
o
C, before being subjected to detection by chemi-
luminescence. Supersignal ® West Pico (Pierce) chemi-luminescent substrate is 
prepared and used to detect HRP-conjugated secondary antibody binding. The HRP 
enzyme catalyses the conversion of the substrate into a sensitized reagent in the vicinity 
of the protein-antibody complex, which produces a carbonyl group that emits light as it 
decays to a single carbonyl. The full reaction takes less than two minutes to occur (the 
prepared substrate is incubated with the membrane for two minutes each time). Once 
this substrate is added, the signal will remain at a plateau level for 30 minutes before it 
slowly shows signs of degrading. Overall light emission will continue for several hours, 
but is no longer optimum after 30 minutes. Following the 2 minute incubation, excess 
substrate was removed and the chemiluminescent signal was detected using the high 
sensitivity camera of the G-Box fluorescence and chemi-luminescence gel 
documentation and analysis system. The system is able to expose the blot to light at 
controlled times, and obtains multiple pictures at different exposure times from the 
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same blot in a single session. These high definition images can also be saved on a 
computer in a variety of formats, providing advantages over dark room methods of 
developing. Western Blot bands were observed at 2 minutes of exposure time unless 
otherwise stated. Scanned blots were examined with ImageJ™ densitometry software 
(http://rsbweb.nih.gov/ij/index.html). The software determines the quantitative 
measurement of optical density which arises from the darkness of the bands on the blot. 
The software measures the density of each band (set within the same size measurement 
area) to determine the comparative amounts of detected protein expressed in each 
sample. The values of the protein of interest are divided by the respective value for the 
control protein (usually GAPDH) and a definitive value is obtained. Results are graphed 
and expressed relative to the baseline, untreated sample value. 
 
Table 2.8: Secondary Antibody solutions. This table displays the optimised primary antibody 
dilutions for proteins monitored by Western Blotting, along with the commercial and animal 
sources of these antibodies.  
 
Secondary 
Antibody 
Source 
Reactivity 
 
Commercial 
Source 
Proteins 
detected 
Initial 
Antibody 
concentration 
Antibody 
Dilution 
in 
BSA/TBS 
Amount 
of 
antibody 
used per 
blot 
(6mls) 
Goat Rabbit Millipore GAPDH 
Drebrin 
Palladin 
100μg/100μl 1:2000  3μg 
Sheep Mouse GE 
Healthcare 
LASP-1 
 
82μg/100μl 1:2000 2.46μg 
 
2.2.5.1.8 Membrane Stripping 
For the purposes of blotting for proteins of similar weights on the same membrane 
(GAPDH and LASP-1 both are in the 35-40kDa range) membranes were stripped using 
Restore ® Western Blot stripping buffer (Pierce). The stripping of both primary and 
secondary antibody from the membranes was carried out in accordance with 
manufacturer’s instructions. The membrane was washed in TBS-T buffer to remove the 
chemi-luminescent substrate. It was incubated, whilst rocking, in Restore ® Western 
Blot stripping buffer for no more than 15 minutes. The membrane was removed from 
the stripping buffer and washed in TBST, before being re-blocked as described in 
 93 
 
Chapter 2.2.5.1.7. After completion of this step, membranes were incubated in the 
appropriate secondary antibody and developed as described above to test for the 
removal of the primary and secondary antibodies from previous blotting procedures. 
Once a clear result on the G-Box system was observed the membrane was washed again 
in TBST washing buffer to again remove the chemi-luminescent substrate. It was re-
blocked again for 30 minutes, and re-blotted with the alternative primary and secondary 
antibodies, following the methods described previously. 
 
2.2.5.2 Immunoprecipitation of Protein  
Immunoprecipitation of intact protein complexes is known as co-immunoprecipitation 
(Co-IP). Co-Immunoprecipitation works by selecting an antibody that targets a known 
protein that is believed to be part of a complex of proteins. The antibody is used to 
immunoprecipitate the protein of interest (also known as a bait protein) and also pulls 
out any other proteins (a.k.a. prey proteins) that may interact with it. 
Co-immunoprecipitation was carried out to extract protein from HAECs, using a 
Pierce® co-immunoprecipitation kit according to manufacturer protocols. The Co-IP kit 
works by directly immobilizing protein-specific antibodies onto an agarose support with 
an amine-reactive resin. This resin prevents co-elution of antibody heavy and light 
chains that may co-migrate with relevant bands, masking results. The association of 
other proteins with Palladin, LASP-1 and Drebrin was investigated in this study.  
Following lysis of cells as described in Chapter 2.2.5.1.1, the lysate was subjected to 
pre-clearing to reduce non-specific protein binding. This meant preparing a spin column 
with 80ul of Control Agarose Resin provided in the kit. This was centrifuged at 1000g 
for 1 minute, before 100ul of 1X Coupling Buffer (0.01M sodium phosphate, 0.15M 
NaCl; pH 7.2) was added. Following another centrifugation, the column was incubated 
with 200ul of cell lysate at 17-20
o
C for 1 hour, with end over end mixing. The column 
was centrifuged, with the pre-cleared lysate collected for use with an antibody bound 
column. 
To prepare the antibody bound columns, the spin columns firstly had 50μl of Coupling 
Buffer added to them before centrifuging for 1 minute at 1000g at 17-20
o
C. Controls 
were also prepared – one with an inactivated control resin, and another with activated 
resin but with Quenching Buffer (1M Tris-HCl) added instead. The resins were washed 
twice with 200μl of 1X Coupling Buffer with the column being centrifuged at the same 
conditions. The columns were then plugged and 75μg of antibody in 200μl 1X Coupling 
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Buffer was added, along with 3μl of 5M Sodium Cyanoborohydride (NaBH3CN) 
solution. The spin columns were screwed shut and rotated gently for 3 hours. Plugs 
were removed and the spin columns were centrifuged, removing excess antibody. The 
spin columns were washed twice by centrifuging 1X Coupling Buffer through them 
twice, before 200μl of Quenching Buffer was centrifuged through. The columns were 
incubated on a rotator for 15 minutes at 17-20
o
C with 200μl of Quenching Buffer and 
3μl of Sodium Cyanoborohydride. The screw cap was removed and the column was 
washed by centrifugation: twice with 200μl of 1X Coupling Buffer, then six times with 
150μl of Wash Solution (1M NaCl). The columns were ready to be used for 
immunoprecipitation. 
The spin columns were washed twice by centrifuging through with 200μl of IP 
Lysis/Wash Buffer (0.025M Tris, 0.15M NaCl, 0.001M EDTA, 1% NP-40, 5% 
glycerol; pH 7.4), before the plugs were inserted and 200μl of pre-cleared cell lysate 
was added. Columns were rotated for 4 hours, or overnight at 4
o
C. Following this, the 
columns were centrifuged (with the flow through kept to determine binding affinity), 
before being washed three times by centrifuging 200μl of IP Lysis/Wash Buffer 
through. The Co-IP protein was eluted by incubating at 17-20
o
C for 5 minutes with 50μl 
of Elution Buffer, and then centrifuged once more at 1000g for 1 minute. 
For storage, the spin columns are washed twice with 200μl of 1X Coupling Buffer, 
centrifuging after each wash. They then are plugged and sealed with 200μl of 1X 
Coupling Buffer and stored at 4
o
C. The Co-IP samples were validated using SDS-PAGE 
and Coomassie staining, or else Western Blotting. Once validated, they were sent to the 
National Institute for Cellular Biotechnology, Dublin (NICB) for Mass Spectrometric 
analysis using MALDI-TOF methods. 
 
2.2.5.3  Proteocellular Fractionation 
Proteocellular fractionation was performed to investigate the localisation of Palladin in 
HAECs following haemodynamic stimulation. The ProteoExtract® sub-cellular 
proteome extraction kit (Merck Biosciences) was used according to manufacturer’s 
instructions to separate the different sub-cellular sections: the cytosolic fraction; the 
membrane/organelle, the nuclear and the cytoskeletal fractions. The extraction kit works 
by taking advantage of the differential solubility of the subcellular compartments in 
different proprietary reagents provided in order to sequentially lyse the different 
fractions from the cells attached to the plate. The other cellular fractions remain 
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attached to the plate until their specific reagent is used to extract them. Early destruction 
of the cell that might occur from cell scraping, or trypsinisation is thereby avoided, 
leaving each fraction intact.  
The translocation of Palladin from the different sub-cellular components under 
haemodynamic forces was documented. For adherent cells, this protocol was performed 
directly onto cells on a six-well culture plate, and all extraction steps were carried out in 
the 4
o
C cold room. Media was removed, and the cells were washed twice with 800μl of 
ice-cold wash buffer per well, being incubated for 5 minutes, while being gently rocked 
each time. Following removal of wash buffer, each of the wells was overlaid with 400μl 
of ice-cold Extraction Buffer 1 and 1X protease inhibitor cocktail. The culture plates 
were incubated for 10 minutes with gentle rocking. Following this incubation, the 
supernatant (Fraction 1 – the cytosolic fraction) was carefully transferred to a 15ml 
polypropylene tube, and stored on ice, or at -80
o
C if being kept for future use. 400μl of 
Extraction Buffer II with 1X protease inhibitor cocktail was then added to each well of 
the plate, covering all the plate. The plates were incubated for 30 minutes with gentle 
agitation. Following this, the supernatant (Fraction II – the membrane/ organelle 
fractions) was transferred to a 15ml tube, and also stored on ice, or at -80
o
C for long 
term storage. Extraction Buffer III with 1X protease inhibitor and 0.5μl benzonase was 
prepared next, with 200μl covering each well. After a 10 minute incubation with gentle 
agitation, the supernatant (Fraction III – the nuclear fraction) was transferred to a 15ml 
tube and kept on ice or stored at -80
o
C until use. Finally, cells were covered with 200μl 
of 17-20
o
C Extraction Buffer IV and 1X protease inhibitor cocktail. Cells were gently 
agitated for 5 minutes, and the remaining cell structures (Fraction IV – the cytoskeletal 
fraction), were collected into a 15ml tube, and stored at the same conditions of the other 
fractions. The protein in the samples was precipitated (Chapter 2.2.5.3.1) to concentrate 
the volume, and then were analysed for Palladin expression in each of the four cellular 
fractions by Western Blotting according to the protocols dictated in Chapter 2.2.5.1.  
Following probing for Palladin, the blots were stripped according to protocol in Chapter 
2.2.5.1.8, and probed using the ProteoExtract® S-PEK Antibody Control Kit. This is a 
set of four monoclonal antibodies, each one specific for one of the different four 
extracted fractions (Table 2.9). These antibodies were used as a control as opposed to 
GAPDH on account of the levels of GAPDH changing dependent on fraction. 
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Table 2.9: List of Control Antibodies for Proteocellular Fractionation. These antibodies 
were used in the detection of protein expression from cells subjected to time points of shear, and 
subsequently fractionated. After probing for the protein of interest, the blot was stripped and re-
probed for the fraction-specific antibody listed. 
 
  
2.2.5.3.1 Protein Precipitation  
Before Western Blot analysis of the fractionation samples could be performed, the 
samples needed to be concentrated and the protein precipitated using acetone. This 
ensured the fractionations were of a manageable volume that would fit into the wells of 
an SDS-PAGE gel. Each fractionation was defrosted, but kept cold on ice. A volume of 
acetone, equal to 5X the fractionation sample, was added, and the mixture was vortexed 
gently followed by centrifugation at 1000rpm and 4
o
C for 15 seconds. The samples 
were incubated at -20
o
C for 1 hour, with regular inversion of the samples every 10-15 
minutes to prevent them from freezing. Afterwards, the mixture was centrifuged at 
15000g for 5 minutes at 4
o
C and the supernatant was removed. The protein pellets were 
allowed to air dry until the acetone was removed. Samples were re-suspended in 20μl of 
SSB loading buffer and run on SDS-PAGE. 
 
2.2.5.4 Immunofluorescence Imaging 
Immunofluorescence imaging was carried out on glass coverslips to determine the 
localisation of Palladin, LASP-1 or Drebrin and their association with actin. The same 
antibodies as listed in Table 2.7 were used to probe the fixed cells. Coverslips were 
made suitable for use by dipping in ethanol and flame sterilising over a Bunsen burner 
flame. Once cooled, they were placed in the sterile well of a 6-well plate, and overlaid 
with approximately 1ml of PBS. Coverslips were incubated overnight at 4
o
C. The 
# Fraction Antibody Type of 
Antibody 
Size of 
Protein 
Initial 
Antibody 
Concentration 
Amount of 
antibody used 
per blot (5mls)  
1 Cytoplasm Anti-
HSP90a 
Mouse 90 1.26mg/ml 5μg 
2 Membrane/ 
Organelle 
Anti-
Calnexin 
Mouse 67/90 2.0mg/ml 5μg 
3 Nuclear Anti-
PARP-1 
Mouse 85/116 0.1mg/ml 5μg 
4 Cytoskeleton Anti-
Vimentin 
Mouse 58 0.5mg/ml 0.5μg 
 97 
 
following day, the PBS was aspirated and the coverslips were blocked for 1 hour at 17-
20
o
C with 5mg/ml of denatured BSA. BSA was denatured by boiling at 60
o
C for 30 
minutes and then sterile-filtering through a 0.25μm filter. HAECs were trypsinised and 
counted according to the previous methods, with 1.5x10
5
 cells in 1ml of culture media 
suspension being plated to each well, and allowed to adhere in the 37
o
C incubator 
overnight. 
On the third day, cells were washed with 1ml of prewarmed PBS, then fixed by 
covering them with 1ml of 3.5% (v/v) Para-formaldehyde/PBS solution and incubating 
at 17-20
o
C for 10 minutes. The coverslips were washed twice with PBS before the cells 
were permeabilised with 0.2% Triton X-100 in PBS. The solution was left on the cells 
at 17-20
o
C for 5 minutes before they were washed twice again with PBS. Cells were 
blocked with 500μl per well of PBS, supplemented with 1% (w/v) BSA and 1% (v/v) 
Goat Serum, for 1 hour, while gently rocking. Blocking solution was removed and cells 
were incubated in 5μl of primary antibody, (0.8μg for Palladin, 5μg for LASP-1) diluted 
1:100 in 500μl of fresh PBS with 1% BSA and 1% Goat Serum, for 2 hours at 17-20oC 
while gently rocking. For Drebrin, the dilution was 1:50 (10μg), as opposed to 1:100 for 
Palladin or LASP-1. 
Following incubation, cells were washed three times in TBS buffer. Secondary goat 
anti-rabbit (or anti-mouse depending on primary antibody) Alexa Fluor 488 (a 2mg/ml 
green FITC-conjugated stain) was prepared in the blocking solution at a dilution of 
1:500, with 500μl being added to each well. The cover slips were incubated in the dark 
at 17-20
o
C gently rocking for an hour, before being washed three times with PBS. 
Cover slips were then incubated with a secondary stain – Rhodamine Phalloidin, which 
stains actin red – at a dilution of 1:40 in blocking solution for 20 minutes at 17-20oC in 
the dark. An optional step at this point was to wash the cover slips, and then incubate 
with DAPI stain at a 1:3000 concentration, in order to stain the nucleus. Otherwise, the 
cover slips were washed three times with PBS to remove excess Phalloidin, before 
being carefully extracted, inverted, and mounted on ethanol-washed microscope slides 
using a drop of Dako mounting media. Slides were covered in tinfoil, and kept at 17-
20
o
C for 1-2 hours to allow the media to set. The slides were examined on the 
fluorescent microscope, or else stored at 4
o
C. 
 
 
 
 
 98 
 
2.2.6 Gene Expression Analysis 
2.2.6.1 RNA Isolation 
In order to investigate gene expression following haemodynamic cell stimuli, RNA 
needed to be extracted. The method employed in the lab involved the use of Trizol® 
reagent in RNAse-free conditions. Trizol ® is a ready to use reagent for isolation of 
total RNA from cells and tissues, maintaining the RNA integrity whilst disrupting the 
cells and dissolving the cell components (Chomczynski and Sacchi, 1987). 
Following stimulus of HAECs, the cells were washed 3 times with PBS before being 
lysed with Trizol ® reagent. 500μl of reagent was added to each well of a six-well plate, 
with care given to make sure the cells were covered with it. The cells were stored on ice 
for 5 minutes to allow complete dissociation of complexes. Trizol ® samples were 
collected and pooled together (if subjected to the same treatment). For every 1ml of 
Trizol ® used, 0.2mls of chloroform was added, and samples were vigorously shaken 
for 15 seconds. They were incubated for 10 minutes at 17-20
o
C and centrifuged at 
13000 rpm at 4
o
C for 20 minutes. The mixture separated into a lower red phenol-
chloroform phase, an interphase and an upper colourless phase (where the RNA 
resides). To precipitate RNA, the upper phase is transferred to a new micro-centrifuge 
tube, where 500μl of Isopropanol for every 1ml of upper phase is added. This is 
inverted 5-8 times and incubated at -20
o
C overnight. The following day, the sample is 
incubated at 17-20
o
C for 10 minutes and centrifuged for at 13000rpm for 15 minutes at 
4
o
C. The supernatant was discarded, and the RNA pellet was washed in 1ml of 75% 
ethanol in RNAse Free dH2O. The micro-centrifuge was vigorously shaken, and 
centrifuged at 13000rpm for 10 minutes at 4
o
C. The ethanol was aspirated and the pellet 
was air-dried before being re-suspended in 50μl of nuclease-free H2O. The RNA was 
incubated at 60
o
C for 10 minutes and immediately kept on ice and prepared for 
quantification on the NanoDrop™ system. Otherwise, RNA was stored at -80oC. 
 
2.2.6.2 Spectrometric Analysis of Isolated RNA 
RNA concentrations were determined by measuring each sample absorbance using the 
NanoDrop™ ND-1000 Spectrophotometer System. The spectrometer was calibrated by 
measuring with RNA-free dH2O as a blank sample. This was dried with lens tissue, and 
the RNA sample was added. 1.2μl was pipetted onto the end of a fibre-optic cable (the 
receiving fibre). A second fibre-optic cable (the source fibre) was then placed into 
contact with the liquid RNA sample, causing the liquid to bridge the gap between the 
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fibre-optic ends. A pulsed xenon flash lamp provides the light source, and a 
spectrometer analyses the light passing through the sample. The data is read and 
archived using special software. The NanoDrop™ automatically calculates the purity of 
the nucleic acid samples by determining the ratio between the absorbance at 260 nm and 
at 280 nm (ABS260/ABS280). Pure DNA - without any protein impurities - has a ratio 
of 1.8 whereas pure RNA has a ratio of 2.0. Lower ratios indicate presence of proteins, 
whereas higher ratios imply the presence of organic reagents.  
 
2.2.6.3 Reverse Transcription of mRNA 
In this process, mRNA was transcribed into double stranded complementary DNA 
(cDNA) by a reverse transcriptase enzyme. A High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems) was used. Isolated mRNA samples are 
aliquoted into 0.2ml PCR tubes but diluted in Ultra-Pure GIBCO water so that the final 
concentration stands at 1000ng of RNA in 10μl of water. Added to this sample was 10μl 
of a master mix, which contained the following: 
 
4.2μl of GIBCO™ water 
2μl of RT Buffer – a standard buffer 
2μl of Random Primers - These are used to produce cDNA from all over the mRNA 
sequence. The cDNAs produced are shorter in length, but there is an increased 
probability that the 5’ ends of the mRNA are converted to cDNA. 
1μl of Multiscribe™ - This recombinant RNA-dependent DNA polymerase uses single-
stranded RNA as a template in the presence of the random primers to synthesize a 
complementary DNA (cDNA) strand. 
0.8μl of dNTPs – These are dGTP, dCTP, dATP and dTTP – deoxynucleotide 
triphosphates which are used in providing bases to synthesise DNA. 
 
The 20μl in the PCR tube was briefly spun down in a centrifuge to ensure the sample is 
mixed and collected at the base of the tube. Using the desktop PCR machine, the 
samples were run at the following conditions:  
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25
o
C for 10 minutes,  
37
o
C for 120 minutes, 
85
o
C for 5 minutes. 
The cDNA products were quantified on the NanoDrop™ to check concentration and 
purity of samples. Products are then ready for use in PCR; or else stored at -20
o
C. 
 
2.2.6.4 Design of PCR Primer Sets 
For Polymerase Chain Reactions, DNA primers were designed using the online Primer3 
website: http://frodo.wi.mit.edu/primer3 in accordance with the standard rules to primer 
design. When given a gene template sequence, this software considers many factors 
such as melting temperature, length, GC content or likelihood of primer-dimer 
formation, in order to evaluate acceptable primer pairs (Untergasser et al., 2012). Each 
primer was also designed to anneal to exon-exon border regions so as to only amplify 
the reverse transcribed cDNA instead of genomic DNA - leading to less genomic DNA 
contamination prone products in qRT-PCR. 
Using another website - http://www.basic.northwestern.edu/biotools/oligocalc.html - the 
designed primers were verified by BLAST analysis, to check the homology and the 
sequence, and also to further ensure there would be no primer-dimer formation. 
Furthermore, mFold analysis on the same website was used to check to make sure the 
chosen primer would not fold with itself. The sequences of primers used, along with 
their optimum temperatures and product lengths are documented in Table 2.10.  
For each qRT-PCR experiment, an endogenous control needed to be selected which 
showed the same level of expression of the gene to be unaffected by the conditions of 
the experiment. This was done to ensure that any changes observed in the expression of 
test genes were not due to changes in the expression of the endogenous control. For all 
qRT-PCRs, the control used was 18S, which is a commonly used control gene (Bas et 
al., 2004).  
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Table 2.10: Table of PCR primers. These were used for the detection of gene expression from 
cells stimulated with haemodynamic forces. The table documents the sequences of the PALLD 
forward and reverse primers, along with those of the 18S “housekeeping” gene. Also listed are 
their resulting PCR product sizes along with the annealing temperature of each set of primers. 
Gene Primer Sequence 5’-3’  Product 
Length 
Annealing 
Temperature 
(C) 
PALLD 
(90kDa) 
Forward GCC TCC ACC CTA 
GAT GAT GA 
215 59.4 
 Reverse GGT CTG AAG AAT 
CGC TCC TG 
  
18S Forward CAG CCA CCC GAG 
ATT GAG CA 
324 60 
 Reverse TAG TAG CGA CGG 
GCG GTG TG 
  
LASP-1 Forward 
 
CCA CGG AGA AGG 
TGA ACT GT 
312 52 
 Reverse 
 
TGA TCT GGT CCT 
GGG TCT TC 
  
DBN1 Forward 
 
TGA GAC GCT GTT 
GCA AAT TC 
151 60 
 Reverse 
 
GAA AAG AGG TGG 
GGG ACA TT  
  
 
 
2.2.6.5 Polymerase Chain Reaction (PCR) 
The standard polymerase chain reaction (PCR) was used as a quicker and cheaper way 
of checking that newly designed primers worked before using them in qRT-PCR 
analysis. PCR is a commonly used technique to amplify a single or a small number of a 
strand of DNA, generating millions of copies of a particular DNA sequence. PCR was 
used to amplify a specific target sequence of DNA within the PALLD and 18S genes 
using gene specific primers (Table 2.10). cDNA was diluted in GIBCO water to a stock 
concentration of 100ng/μl. Samples were kept on ice, and made up to 25μl according to 
the volumes listed in Table 2.11. 
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Table 2.11: List of the reagents required per reaction for Polymerase Chain Reaction. 
Reagent Volume 
Template cDNA (100 ng/μl) 1μl 
Forward Primer (10uM) 1μl 
Reverse Primer (10uM) 1μl 
dNTPs (2.5mM) 2μl 
10X DreamTaq™ Buffer 2.5μl 
MgCl2 (25mM) 0.5μl 
GIBCO Water 16.875μl 
Taq Polymerase 0.125μl 
Final Volume 25μl 
 
This mix was placed into a MJ-Mini gradient thermocycler (Bio-Rad) with hot-lid for 
thermal cycling. Samples were subjected to an initial denaturation step of 92C for 2 
min. This was followed by 30 cycles of: 
92
o
C for 1 minute, 
Primer specific annealing temperature (See Table 2.10) for 1 minute, 
72
o
C for 1 minute. 
Followed with a final extension step of 72
o
C for 5 min. Samples were then stored at 
4
o
C. PCR products were visualised using agarose gel electrophoresis (Chapter 2.2.3.4).  
 
2.2.6.6 Quantitative Real Time PCR (qRT-PCR) 
Following the optimisation of primers by standard PCR, they were used in qRT-PCR. 
This technique follows the same principle of PCR, with amplified DNA being 
quantified in real-time as it accumulates in the reaction. This quantification is facilitated 
using SYBR green dye. This specific dye fluoresces only when bound to the minor 
groove of double stranded DNA. The fluorescence is read by a laser at the end of every 
cycle – hence, the amount of cDNA product formed during the PCR cycles can be 
quantified in real-time and graphed. Relative quantification is used to analyse changes 
in gene expression in one sample relative to the untreated reference sample. This 
method compares the Cycle Threshold (Ct) value of one target gene to another (using 
the formula: 2ΔΔCT)—for example, an internal control or reference gene (18S)—in a 
single sample. The qRT-PCR experiments were carried out using an Applied 
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Biosystems 7900HT Fast Real-Time PCR machine. For each reaction, the reaction was 
prepared in accordance with the recipe in Table 2.12. A master mix of 90μl was 
prepared as triplicates of 25μl each were used for every sample. The 90μl provides extra 
to prevent pipetting error affecting the results. Samples were subjected to an initial 
denaturation step of 95
o
C for 10 minutes, followed by 40 cycles of: 
95
o
C for 15 seconds, 
The Primer Specific annealing temperature for 1 minute, 
72
o
C for 30 seconds. 
After which, there was a final extension step of 72
o
C. Samples were prepared using 18S 
gene–specific primers and run to the same specifics. Quantification of cDNA targets 
was normalised for differences across experiments/samples using the endogenous 18S 
as an active reference gene.  
Table 2.12: List of the components for qRT-PCR reaction. 25μl of this is taken for each of 3 
reactions. 
Component Volume/concentration 
cDNA 300 μg 
Forward Primer 100pmol (roughly 2.0μl) 
Reverse Primer 100pmol (roughly 2.0μl) 
Universal SYBR Green PCR 
master mix 
45μl 
RNase free dH2O To a final volume of 90μl 
 
2.2.7 Flow Cytometry 
Flow Cytometry is a method used for the counting and sorting of cells and particles 
suspended in a fluid stream. Most flow cytometer machines can measure two types of 
light from cells; Light Scatter and Fluorescence.  
Light scatter is the interaction of regular light with materials. The Millipore Guava® 
Flow Cytometer used in experiments possesses light scatter detectors opposite the laser 
and to one side of the laser, keeping in line with the intersection of the fluid flow/laser 
beam. The measurements made by these detectors are respectively called Forward 
Scatter and Side Scatter. Forward Scatter is used in providing information of the relative 
size of individual cells, and Side Scatter gives information on the granularity of cells. 
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Fluorescence is the property of a molecule to absorb light at one wavelength and re-emit 
light at a different wavelength. 
This method was used to characterise the microparticles released from media as being 
endothelial in origin. The Guava® Flow Cytometer uses microcapillary technology in 
order to reduce the number of cells needed for analysis, as well as the amount of waste 
generated. Samples are able to be analysed from a 96 well plate as a result. 
 
 
Figure 2.11: The Millipore FACS Guava EasyCyte System. Samples are loaded on the 96-
well plate at the front. 
 
 
2.2.7.1 Endothelial Microparticle Assay using the Millipore FACS Guava 
EasyCyte System 
The microparticles were tagged with an APC-tagged antibody for VCAM-1 (Vascular 
cell adhesion molecule 1, also known as CD106). VCAM-1 is a noted endothelial cell 
marker, so this was used to indicate that the microparticles observed were endothelial in 
nature. Microparticles were prepared as listed in Chapter 2.2.2.3, following which they 
were resuspended with 0.2% Triton X-100 in PBS. The microparticles were incubated 
at 17-20
o
C for 5 minutes to allow them to become permeabilised before they were 
centrifuged again for 14000rpm for 20 minutes. The resulting pellet was resuspended in 
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450μl of PBS with 2% (v/v) Fetal Bovine Serum added. This suspension was divided 
into two Eppendorf tubes of 200μl each. One had 4μl of VCAM-1 antibody (1 μg) 
added to the sample, while the other was left as a blank negative control. The samples 
were set rocking at 4
o
C for 1 hour and covered in tinfoil to avoid natural light affecting 
the antibody, and centrifuged at 14000rpm for 20 minutes. Each pellet was then 
resuspended in 200μl of PBS. Each 200μl sample was added to a well of a 96-well plate 
before being read on the FACS Guava system. 
  
2.2.8 Statistical Analysis 
Results are expressed as a mean   standard error of the mean, of three independent 
experiments (n=3), unless otherwise stated. Statistical comparisons in experiments were 
performed to determine if data sets were significantly different from one another using 
t-tests or two-way ANOVA where applicable. The t-test is used when the independent 
variable has two levels. ANOVA is used when the independent variable has more than 
two levels. A resulting p-value where p<0.05 indicates a significant change. 
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CHAPTER THREE 
 
 
 
 
PALLADIN AS A 
HAEMODYNAMIC PROTEIN IN 
ENDOTHELIAL CELLS 
  
 107 
 
3.1 INTRODUCTION 
 
The results from many in vitro studies have shown that shear stress and/or mechanical 
strain can modulate the expression of genes involved in actin cellular dynamics and 
polymerisation functions (Kris et al., 2008; Gunst and Zhang, 2008; Osborn et al., 
2006). As stated previously, actin is a vital protein within the cell, and plays a huge role 
in facilitating cell structure and motility. Furthermore, the types of mechanical 
stimulation can also modulate the regulation of many genes that play an important role 
in the patho-physiology of cardiovascular disease (CVD) through the alteration of cell 
fate and function (Chan et al., 2010). The PALLD gene, which encodes for the Palladin 
protein, is one such gene. Palladin is a known actin-binding protein (Dixon et al., 2008), 
having been observed in structures containing actin filament bundles (Parast and Otey, 
2000). However, despite the observation of this actin associated protein in many cell 
types it has yet to be properly characterised within cells of an endothelial nature. The 
protein was briefly identified within endothelial cell nuclei in human coronary vessels 
with atherosclerosis (Jin et al., 2010), but this appears to be the extent of an 
understanding of the presence/role of Palladin in endothelial cells. 
The aim of the work presented in this thesis was to investigate the expression of the 
Palladin protein and the PALLD gene within Human Aortic Endothelial Cells (HAECs). 
The goal of this chapter however, is the cellular and molecular characterisation of the 
gene and protein expression response to the haemodynamic forces experienced within 
the vasculature, namely cyclic strain and laminar shear stress. Cyclic strain affects cell 
proliferation, resulting in actin stress fibre formation and cellular realignment (Von 
Offenberg Sweeney et al., 2005). Shear stress also changes cell morphology, with 
immediate shear inducing stress fibre and microfilament formation, while chronic shear 
results in the partial disassembly and subsequent reassembly of actin filaments at 
adherens junctions and focal adhesions (Orr et al., 2006b; Osborn et al., 2006). Palladin 
has been shown to be an actin-binding protein, localising and functioning in different 
areas of the cell (Otey et al., 2005; Jin et al., 2010). The protein also has been shown to 
have a role in many actin-related cellular functions such as migration (Rachlin and 
Otey, 2006; Goicoechea et al., 2010). Because of these characteristics of Palladin, it was 
hypothesised that this protein may then display differential expression levels in response 
to the haemodynamic forces (cyclic strain and laminar shear stress) that the endothelial 
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cell layer is subjected to. As actin expression changes in response to force-induced 
cellular remodelling, the expression in the actin-binding Palladin should also be altered.  
In this chapter, following the initial characterisation of the Human Aortic Endothelial 
Cell (HAEC) type used in the study, Palladin is then identified in HAECs through 
immunofluorescence methods for visual confirmation of the presence of the protein 
within the cells. However, Palladin is known to exist in multiple isoforms (Rachlin and 
Otey, 2006). There are no commercially available antibodies specific for an individual 
isoform, so while the immunofluorescence images show that Palladin is present, they 
cannot illustrate which isoforms are being stained. The antibodies utilised in the 
immunofluorescence imaging experiments were also used in Western Blotting 
experiments; firstly to reinforce the conclusion that Palladin is present in HAECs, and 
secondly to distinguish the isoforms that exist in the cells. Analyses of lysates from 
other cell types such as HaoSMC or HEK-293 are also provided as a comparative 
control to show which, if any, Palladin isoforms are present in the cells. By doing this, it 
highlights how there are multiple isoforms visible in cell types (as demonstrated in 
Table 1.2), while at the same time confirming that Palladin is present in HAECs, and 
that it exists in multiple isoforms within the cell. The 90kDa isoform was primarily 
investigated; on account of it being the first Palladin isoform to be discovered, and 
because it is the most discussed isoform in literature (Parast and Otey, 2000; 
Goicoechea et al., 2010; Pogue-Geile et al., 2006).  
The genetic and proteomic responses of this isoform in HAECs subjected to cyclic 
strain stimulation are first demonstrated. The cells were strained for a variety of 
different time points under both physiological (5%) and pathological (10%) strain 
models using the Flexercell system as detailed in Chapter 2.2.2.1. The rationale for 
using time points was that they would illustrate the pattern of expression of Palladin in 
the cells following both immediate and long term stimulation, showing when any 
changes may occur in expression over the time period. In doing so, it demonstrates 
whether an immediate increase of Palladin expression is subject to reduction, or if it 
remains elevated. Observation of the Palladin response to these strain models is 
achieved through qRT-PCR and Western Blotting techniques, to validate gene and 
protein expression, respectively. Graphs are illustrated to show the patterns of strain-
induced gene expression compared with strain-induced protein expression, to determine 
if post-strain Palladin expression is correlated.  
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Results were then compared to one another to demonstrate differences in expression 
between the 5% physiologically and 10% pathologically strained cells in order to show 
the effects the different strain models have on Palladin regulation. Pathological levels of 
strain are responsible for haemodynamic dysregulation (Safar et al., 2012; Ando & 
Yamamato, 2011) so was hypothesised that there would be more Palladin expressed in 
the pathological strain, owing to the elevated instances of cell remodelling that occur 
with this condition; necessitating the need for increase of actin-binding proteins to assist 
in restructuring the cell (Collins et al., 2005). 
After showing that Palladin can be expressed in different isoforms across the cell types, 
a brief experiment was performed to show how the patterns of expression following 
haemodynamic stimulation may also be different. Western Blotting is used to 
characterise the response of Palladin to pathological cyclic strain in Human Aortic 
Smooth Muscle Cells, highlighting the difference in expression trends across the 
different layers of the macrovasculature. Cyclic strain affects smooth muscle cells 
(Birukov, 2009; Qi et al., 2010; Salameh and Dhein, 2013) but has been seen to be more 
influential on endothelial cells, where the mechanical force of strain plays an important 
role in cell migration (Von Offenberg Sweeney et al., 2005). The role of Palladin in 
smooth muscle has also already been shown in greater detail (Goicoechea et al., 2006; 
Jin et al., 2011). Hence, experiments stayed investigating endothelial cells rather than 
further investigating Palladin in smooth muscle. Many experiments also dealt with 
investigating responses to laminar shear stress, which smooth muscle cells are largely 
not subjected to, as it causes apoptosis (Fitzgerald et al., 2008). 
Correspondingly to the strain experiments, the expression of the Palladin (both genomic 
and proteomic) response to laminar shear stress (LSS) of HAECs is also investigated in 
this chapter. The presence of Palladin in sheared cells is firstly illustrated with 
immunofluorescence imaging. As stated earlier, under normal physiological conditions 
the endothelium is exposed to roughly 10 dynes/cm
2
 of LSS (Thorin and Thorin-
Trescases, 2009). By subjecting static cells to this force, the changes in expression of 
Palladin can be observed in tandem with the morphological changes of the HAECs. 
When mechanical force is applied to the cell in the form of flow, both the orientation 
and the thickness of the resulting stress fibres has been shown to become altered 
(Gavard et al., 2004; Vasioukhin et al., 2000). As the actin fibres restructure at different 
shear time points – from both immediate and chronic shear stress, it is postulated that 
Palladin expression may be then altered too.  
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The resulting changes in expression observed initially confirm that Palladin responds to 
haemodynamic force, which in turn provided a foundation for further research. The 
characterisation of interacting proteins, and the functional role coupled with shear-
induced microparticle release and are discussed in Chapters 4 and 5 respectively, while 
the rest of this chapter further characterises Palladin expression under shear conditions. 
Following LSS, qRT-PCR and Western Blotting methods illustrated the change in 
expression over time points while immunofluorescence of endothelial cells displayed 
the localisation of Palladin within the cell. However for a more detailed and quantifiable 
approach to characterising the changes in Palladin expression, sheared HAECs were 
subjected to Proteocellular Fractionation, a technique involving the chemical separation 
of the different subsets of the cell - Cytosol, Membrane/Organelles, Nucleus and 
Cytoskeleton. It was hoped that probing each subset separately post-shear would 
contribute to understanding the more precise localisation of Palladin in response to 
haemodynamic force. Palladin has been observed to co-localise in different areas of the 
cell, such as the nucleus, cytoskeleton or the cell membrane (Goicoechea et al., 2006; 
Rachlin and Otey, 2006). Through the fractionation of the cells sheared at the different 
time points, a pattern of adaptive localisation of Palladin can be created; whereby the 
shear-induced regulation of Palladin at different areas of the cell in response to laminar 
shear stress can be characterised.  
The mechanical forces of laminar shear stress and cyclic strain are converted by the 
cells into biochemical signals through the process of mechanotransduction. A receptor 
group known as mechanosensors differentiate between physiological and pathological 
haemodynamic stimuli. As discussed in more detail in Chapter 1, a related group of 
mechanosensitive signalling molecules – integrins - are capable of affecting binding 
affinity to ECM ligands, affecting cell adhesion, progression and motility (Hynes, 2002; 
Shattil, Kim and Ginsberg 2010). Interactions of the cells with the extracellular matrix 
(ECM) are essential for many cell functions including proliferation and migration 
(Hirata et al., 2008). It has long been shown that the cell function is controlled directly 
or indirectly by the substrate on which the cells are resting on (Gospodarowicz et al., 
1980; Lu et al., 2011). Inside the cell, the actin cytoskeleton anchors to a cluster of 
integrins which themselves attach to ECMs. The types of integrins in adhesions can also 
switch as they mature, which may be related to distinct functions (Geiger and Yamada 
2011). For example, the α5β1 integrin is initially present in focal adhesions formed on a 
fibronectin substrate, along with αvβ3, but is lost from these adhesions unless the 
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fibronectin is immobilized, in which case it forms exaggerated α5β1-containing focal 
adhesions (Katz et al., 2000; Huveneers et al., 2008). 
Integrins are highly influenced by haemodynamic stimuli. Laminar shear stress converts 
them to a high affinity state, where they then bind to the subendothelial extracellular 
matrix (Orr et al., 2005). This binding is integrin and matrix specific, and is important 
for cellular development, adhesion, maintenance and repair (Harburger and 
Calderwood, 2009). It has been shown that under shear stress, certain nonpermissive 
extracellular matrices can interfere with integrin signalling (Orr et al., 2006). The 
failure of these integrins to be activated on the nonpermissive matrices is due to active 
suppression by the ligation of integrins, which can suppress the activation of other 
integrins through transdominant inhibition (Calderwood et al., 2004). Permissive 
matrices include fibrinogen and fibronectin, whereas the nonpermissive ECMs include 
collagen and laminin (Decleva et al., 2002). Fibrinogen is observed to increase with 
elevated CVD risk factors (Stec et al., 2000) while fibronectin is also observed to 
increase following elevated shear stress (Steward et al., 2011). The formation of actin 
stress fibres and upregulation of integrins such as the α5 group can enhance the 
permissive effects of fibronectin (Nakamura et al., 2003). It appears that in CVD events, 
certain matrices become more permissive than they would be under normal 
physiological conditions. Conversely, collagen has been observed to reduce and halt 
endothelial cell alignment following shear stress (Kemeny et al., 2011).  
These ECM proteins are therefore capable of altering cell function and phenotype 
through the activation of specific integrins which support the flow activation of 
inflammatory pathways, such as NF-κB (Orr et al., 2005). As a method of investigating 
potential signalling pathways of Palladin, the expression of Palladin following shear 
stress of HAECs is assayed again, but in this case the cells have first been allowed to 
adhere to a variety of different ECMs – fibrinogen, fibronectin or collagen. In theory, 
Palladin expression will be affected by the specific extracellular matrix related 
signalling mechanisms following mechanical stimulation of the endothelial cell. As the 
actin cytoskeleton will change expression and anchor to an integrin cluster as it attaches 
to the ECMs, so too should the Palladin protein. In particular, different expressive 
patterns of Palladin should be observed between the cells sheared on the permissive 
versus the nonpermissive matrices. 
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Through the observation of these expression patterns of the sheared matrix seeded cells, 
coupled with the comparison to cells the patterns on uncoated culture dishes, a possible 
integrin-mediated signalling pathway involved in Palladin expression may be 
discovered or at least suggested. While further work may be needed to pinpoint the 
exact integrins involved in Palladin expression, the results shown here in this chapter 
should provide the foundation for future, more precise investigations. 
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3.1.1 Study Aims 
  
The experiments performed in this chapter seek to determine if the Palladin protein is 
regulated by haemodynamic forces at the gene transcription and/or protein level and to 
determine the proteomic response following cell-matrix interactions. Therefore the 
overall aims of this chapter are: 
 To characterise the presence of the actin-binding Palladin protein and its 
isoforms within Human Aortic Endothelial Cells (HAECs) 
 Determining the specific patterns of Palladin expression when the vascular 
HAECs are subjected to time points of mechanical haemodynamic stimulation, 
namely cyclic strain and laminar shear stress. 
 Observation of the localisation of the Palladin protein in HAECs and 
examination of its translocation following laminar shear stress stimulation. 
 Investigation of the potential integrin signalling pathways involved in Palladin 
expression through interactions of the cells with permissive and nonpermissive 
extracellular matrices – fibrinogen, fibronectin and Type IV collagen - following 
laminar shear stress. 
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3.2 RESULTS 
 
The first experiment presented here was a simple Western Blot using the lysates from a 
variety of cell types. These cell types were Human Embryonic Kidney-293, Rat Aortic 
Smooth Muscle cells, Human Aortic Smooth Muscle cells and Human Aortic 
Endothelial Cells. Lysates were probed using an antibody specific for vonWillebrand 
Factor. This glycoprotein is produced in the Weibel-Palade bodies in the endothelium; 
therefore it can be utilized as an endothelial specific marker to validate the 
commercially bought cell type. A band is shown to be present at 300kDa in size within 
the endothelial cell lysate but is absent in the other samples. This confirms the 
endothelial nature of the HAECs for use in the other experiments. 
 
 
 
Figure 3.1: Characterisation of HAECs with vonWillebrand Factor. Western Blotting of 
lysates from four different cell lines (HEK-293, RaoSMC, HaoSMC and HAEC) was performed 
to specifically detect vonWillebrand Factor, an endothelial protein marker. The other non-
endothelial cell types were used as a negative control. The endothelial cell stock analysed here 
was subsequently used for later experiments. 
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The HAECs were then probed to show the presence of Palladin – the protein of interest 
investigated within this thesis. Results of immunofluorescence imaging indicate that the 
protein is indeed present. Palladin (stained in green) can be observed in the below 
images localising in both the nucleus (designated as N), and to stress fibres (designated 
as SF). Images at closer (400X) magnification show the precise localisation of Palladin 
within the cell nuclei and stress fibres. 
 (i)      (ii)    
  
 
(iii)      (iv)    
  
Figure 3.2: Immunofluorescence imaging of Palladin in static HAECs. In Figure 3.2 (i), the 
cells are stained with DAPI (a blue, nuclear-specific stain), Phalloidin (which stains actin red) 
and an AlexaFluor-488 conjugate that binds with the Palladin antibody (Green in colour). These 
cells are viewed at 100x magnification. The cells in Figure 3.2 (ii) are prepared according to the 
same conditions - but without DAPI or Phalloidin stain, to allow better viewing of Palladin. 
Palladin can be observed localising in the nucleus (N), and to stress fibres (SF). Figure 3.2 (iii) 
shows HAECs at 400x magnification and stained in the same manner, but without the DAPI 
stain. Figure 3.2 (iv) displays just the Palladin conjugated stain on the same cells as in (iii). 
Again, localisation of Palladin in the nucleus (N), and to stress fibres (SF) is highlighted.  
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After confirming that the cell stock being used was indeed endothelial in nature and that 
Palladin is present within them, the lysates were then probed via Western Blot to detect 
the separate isoform types. As before, alternative cell type lysates are probed at the 
same time as the HAEC lysate. Figure 3.3 below shows how Palladin is present in 
different combinations of isoforms depending on cell type. Presence or absence of 
isoforms in the cell types is summarised in Table 3.1. The 90kDa Palladin isoform - the 
isoform mostly discussed in literature – is notably the only type present across all the 
cell types examined. In HAECs, three of the other isoforms – 122, 128 and 140kDa - are 
also observed. These isoforms are also seen in HaoSMCs, highlighting that these are the 
main isoforms in the vasculature. Subsequent studies focused on the 90kDa isoform. 
Fainter bands are also seen in HAECs at 43kDa and 60-65kDa indicating further 
Palladin isoforms, albeit in lesser quantities. Protein marker is illustrated along the side 
to indicate the molecular weights of each of the bands. While the diagram accounts for 
the known isoforms listed, there appears to be light bands visible at roughly 50-55kDa. 
There are still undiscovered isoforms of Palladin which have yet to be fully 
characterised, which could account for the visibility of these bands. 
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Figure 3.3: Observation of Palladin isoforms in cell types – HaoSMC, RaoSMC, HEK-293 
and HAECs. Western Blotting of lysates from the four different cell types was performed to 
distinguish the different Palladin isoforms in cell types. The fourth cell type - HAECs - are 
primarily utilized within the remainder of the results, with the 90kDa isoform (the strongest 
band) being the primary isoform studied.  
 
 
Table 3.1: List of isoforms of Palladin present in cell types. The table below summarises the 
data from Figure 3.3. It illustrates whether any of the known Palladin isoforms are determined 
to be present in the analysed cell type (Y) or absent (N). 
 
Cell type    Isoform     
 43 60-65 90 122 128 140 200 
        
HaoSMC N N Y Y Y Y N 
RaoSMC Y N Y N Y Y N 
HEK-293 N N Y Y N N N 
HAEC Y Y Y Y Y Y N 
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The HAECs were subjected to haemodynamic forces, similar to those experienced 
within the vasculature, to investigate their effects on Palladin expression. Since Palladin 
is an actin-binding protein, it was hypothesised to change in expression following force-
induced cell remodelling. HAECs were subjected to cyclic strain at physiological (5%) 
and pathological levels (10%) of strain. Following this, expression of the PALLD gene 
was analysed using qRT-PCR methods. Results are expressed by the relative 
quantification values deduced from the analysis software. 
Figure 3.4 illustrates the gene expression after cells were subjected to physiological 
strain for a series of time points. Within 1 hour of strain, there is over a 50% increase in 
PALLD gene expression. However, at 2-3 hours, the expression levels decline to below-
static baseline levels. At 6 hours, expression has become upregulated again, where it 
reaches a similar peak to that seen at 1 hour. There is a slight decline at 24 hours, 
suggesting that gene expression may be declining again.  
The effects of pathological strain on gene expression are shown in Figure 3.4.1. In this 
figure, gene expression is shown to only slightly increase within the first 2 hours of 
strain, staying at a plateau. It is only at 3 hours when it rises to a larger level, with a 
spike in the relative quantification value. Gene expression declines at 6 hours, but is still 
greater than baseline levels. Following this, at 24 hours expression spikes again, 
reaching its peak value at roughly at 2.5x the value of the static control cells. 
The data for both physiological and pathological gene expression is compared in Figure 
3.4.2. Here, the relative-to-baseline values are expressed alongside one another. At 1 
hour, gene expression is higher at 5% strain than 10%. However, following this, the 
levels of 10% strain gene expression overtake that of 5% - slightly at 2 hours, but 
massively at 3 hours. At 6 hours, that the sample values balance to a similar, above-
baseline, level. But at 24 hours, the pathologically induced gene expression outweighs 
the physiologically induced, with there again being a huge difference in relative gene 
expression between the two samples. 
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Figure 3.4: Expression of the PALLD gene in HAECs at 5% Cyclic Strain. mRNA was 
extracted from cells subjected to 5% physiological cyclic strain at varied time points, and 
synthesised into cDNA. qRT-PCR was performed on this cDNA to observe expression of the 
PALLD gene – the 90kDa isoform - and results were normalised against the 18S gene. 
Histograms represent fold change in gene expression relative to the unstrained zero hour cyclic 
strain control and are averaged from three independent experiments ± SEM. Statistical analysis 
failed to show P<0.05. 
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Figure 3.4.1: Expression of the PALLD gene in HAECs at 10% Cyclic Strain. mRNA was 
extracted from cells subjected to 10% pathological cyclic strain at varied time points, and 
synthesised into cDNA. qRT-PCR was performed on the cDNA to observe expression of the 
PALLD gene, and results were normalised against the 18S gene. The fold changes in expression 
are shown on the graph relative to zero hour cyclic strain. Data is representative of three 
independent experiments ±SEM. Statistical analysis showed that P=0.06, showing that results 
were not significant. 
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Figure 3.4.2: Comparative trends of PALLD gene expression in 5% vs. 10% Cyclic Strain. 
In this figure, Figures 3.4 and 3.4.1 are compared against each other to show the differential 
effects in a physiological (5% - Light Red) vs. pathological (10% - Dark Red) strain of HAECs.  
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Protein was next extracted from similarly strained HAECs, quantified and run on a 
Western Blot gel. The resulting membrane was probed with antibodies for Palladin and 
GAPDH (as an endogenous control to normalise protein expression). Figure 3.5 below 
shows expression within cells subjected to 5% physiological strain, where there appears 
to be protein bands present across all time points. The densitometric analysis of the 
90kDa isoform bands show that, when normalised against GAPDH and compared to the 
unstrained control sample, Palladin appears to increase in expression immediately 
following 1 hour of physiological strain. However, expression declines steadily after 
increasing time points of strain, resulting in the Palladin protein becoming 
downregulated by 24 hours. At this point, protein expression is lower than in static cells 
(0 hours).  
Figure 3.5.1 compares the PALLD gene expression and Palladin protein expression of 
HAECs both subjected to 5% cyclic strain. The expression patterns for both 
experiments appear similar, immediately increasing following stimulation of the cell 
within the first hour. However, they reduce by 3 hours of strain. There appears to be a 
difference in the gene and protein expression then at 6-24 hours. Even though it appears 
to be on a declining trend, PALLD gene expression still stays above static levels at this 
time. Meanwhile, at the same time points, the comparative protein expression reduces 
below the static baseline level. It should be noted that statistical analysis of the protein 
expression did not prove it to be significant (standard error between repeat analyses was 
too large, resulting in p-values greater than 0.05). However, a decline is shown in both 
gene and protein expression following the initial 1 hour peak. Taking the results 
together suggests that there may still be a decreasing trend of Palladin expression 
existing after physiological cyclic strain. 
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Figure 3.5: Expression of the Palladin protein in HAECs at 5% Cyclic Strain. Cells were 
subjected to time points of 5% physiological strain on the Flexercell system. Following each 
allotted time point, cells were lysed and Western Blot analysis of the protein was performed, 
probing for Palladin and GAPDH (as a normalizing control). Protein marker is illustrated along 
the side to indicate the molecular weights of each of the bands. Following Western Blotting, the 
blot was analysed using ImageJ densitometric quantification software. The values given for 
intensity of each 90kDa-sized Palladin band is given here, following normalisation against the 
GAPDH control bands and expressed in relative quantities compared to the zero hour unstrained 
cells. Data is representative of three independent experiments ±SEM. Statistical analysis 
however showed p>0.05, indicating that the resulting changes in expression are not statistically 
significant. 
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Figure 3.5.1: Comparative trends of Palladin protein expression and PALLD gene 
expression in HAECs subjected to 5% Cyclic Strain. This figure is added to compare the 
expression of Palladin expression following prolonged time points of 5% physiological cyclic 
strain. The relative-to-static cell gene expression (Red) is plotted against relative-to-static 
protein expression (Blue). 
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HAECs were next subjected to time points of pathological (10%) strain using the 
Flexercell system and protein was analysed as before. Figure 3.6 demonstrates how 
there is Palladin expressed across the different time points of pathological strain. The 
densitometric and statistical analysis of the 90kDa sized bands of Palladin shows that 
following normalisation, there is a significant two-fold increase in Palladin expression 
following the immediate 10% strain. The protein appears to remain around this level up 
to 6 hours, before the rate appears to decline. This decline still remains above the 
baseline (zero hours) level by 24 hours. However, it should be noted that the values for 
3 hours or more of strain did not prove to be significant (p is <0.1, but greater than 
0.05). This lack of significance was caused due to a larger standard error between 
triplicate samples affecting the analysis.  
Figure 3.6.1 compares the PALLD gene expression and Palladin protein expression of 
HAECs subjected to the pathological 10% cyclic strain. The expression patterns for 
both experiments show a mildly similar pattern. Both expression levels immediately 
increase following stimulation of the cell within the first hour. However, the relative-to-
baseline protein expression is greater than the relative-to-baseline gene expression. At 3 
hours, and again at 24 hours, gene expression becomes greater than the relative protein 
expression. 
Figure 3.6.2 illustrates the comparison of relative protein expression between the 
physiologically and pathologically strained HAECs. Both treatments show increase of 
expression within the first hour of strain, followed by a downward trend as the 
expression rates decrease. However, the decline is shown to be faster within the 5% 
strained cells, as the pathologically strained cells still express more Palladin at all the 
time points than the baseline static cells.  
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Figure 3.6: Expression of the Palladin protein in HAECs at 10% Cyclic Strain. Cells were 
subjected to time points of 10% pathological strain. The lysates obtained were probed using 
Western Blotting methods for Palladin and GAPDH (as a control). Following this, the blot was 
analysed using ImageJ densitometric quantification software. The values given for intensity of 
each 90kD-sized Palladin band is given here, following normalisation against the GAPDH 
control bands and expressed in relative quantities compared to the zero hour static cells. Data is 
representative of three independent experiments ±SEM. *p<0.1 – the results are not significant. 
**p<0.05.  
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Figure 3.6.1: Comparative trends of Palladin protein expression and PALLD gene 
expression in HAECs subjected to 10% Cyclic Strain. This figure serves to compare the 
expression of Palladin expression following prolonged time points of 10% pathological cyclic 
strain. Relative gene expression is plotted (Red) against relative protein expression (Blue). 
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Figure 3.6.2: Comparative trends of Palladin protein expression in HAECs subjected to 
5% vs. 10% Cyclic Strain. In this figure, Figures 3.5 and 3.6 are compared against each other 
to show the differential effects of physiological (5% - light blue) vs. pathological (10% - dark 
blue) strain of HAECs.  
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Palladin has been shown here to be upregulated in response to cyclic strain within 
endothelial cells. A brief experiment was devised, highlighting how Palladin is 
haemodynamically regulated in other cells while also showing that protein expression 
following haemodynamic stimulation may show different patterns across the 
vasculature. HaoSMCs were subjected to cyclic strain (at a 10% pathological level) for 
different time points. Palladin has been already been shown in the literature to be highly 
expressed in smooth muscle, playing an important role in cytoskeletal organisation (Jin, 
2011; Wang and Moser, 2008), while previous experiments (Figure 3.3) confirmed its 
presence here. 
Protein was obtained from the HaoSMCs and probed via the same Western Blotting 
methods as used before. Figure 3.7 shows strong Palladin bands for all the time points, 
with multiple isoforms displayed. Densitometric analysis of the 90kDa sized bands 
shows Palladin increasing in HaoSMCs following pathological strain. The increase 
following 6 hours of cyclic strain is almost two-fold. This stays increasing over 12-24 
hours, where the relative expression is even greater. At 48 hours, the expression begins 
declining when compared to the previous 24 hour sample, but it still remains higher 
than the baseline sample. 
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Figure 3.7: Expression of the Palladin protein in HaoSMCs at 10% Cyclic Strain. 
Following the Western Blotting of strained HaoSMC lysates as per previously described 
methods, the blot was analysed using ImageJ densitometric quantification software. The 
comparable values given for intensity of each of the 90kDa-sized Palladin bands are given here, 
following normalisation against the GAPDH control bands. The values given are expressed 
compared to a baseline zero hour strain. *p<0.05.  
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Experiments stayed investigating endothelial cells rather than further investigating 
Palladin in smooth muscle on account of the role of Palladin in smooth muscle having 
been already documented in much detail by other research groups. Furthermore, smooth 
muscle cells are generally not subjected to the laminar shear stress that endothelial cells 
are. It was theorised that if Palladin is shown to change in expression following the 
haemodynamic cyclic strain stimulation, then it should also change when subjected to 
laminar shear stress. Subsequent experiments therefore continued investigating the 
expression of Palladin in sheared HAECs. Figure 3.8 shows the results of sheared cells 
that were investigated for Palladin using immunofluorescence. Palladin is visible in the 
cells where there is green fluorescence in the cell. Actin protein has been stained red 
with a Phalloidin stain. Images are provided with or without this actin stain. Following 
LSS, the morphology of the cells has changed, and a pattern of flow across the cells can 
be observed. This is illustrated by the white arrows signifying the direction of flow. As 
expected, Palladin is still expressed by the cell following shear. The expression of 
Palladin in the nucleus and stress fibres is highlighted by the letters N and SF, 
respectively in the figures. 
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(i)      (ii)
  
(iii)      (iv)     
  
Figure 3.8: Immunofluorescence imaging of Palladin in HAECs subjected to Laminar 
Shear Stress at 10 dynes/cm
2
. HAECs here have been subjected to either (i) 3 hours of shear or 
(ii) 24 hours before staining. Cells are viewed at 100x magnification. Figure 3.8 (i) and (ii) 
shows cells stained with AlexaFluor-488 conjugate bound to the Palladin antibody (Green), as 
well as staining for actin with Phalloidin (Red). The cells in Figure 3.8 (iii) and (iv) are prepared 
according to the same conditions as (i) and (ii) respectively - but with only the AlexaFluor-488 
stain, to allow better observation of Palladin.  
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The response of Palladin to laminar shear stress was investigated further. Figure 3.9 
demonstrates how expression of PALLD gene appears to increase immediately 
following shear stress, with the relative gene expression increasing after 1 hour of shear, 
and peaking at 3 hours, where PALLD gene expression has increased two-fold in 
comparison with the static baseline sample. Following this time point, expression 
appears to slightly decline over 6-12 hours. At 24 hours, expression increases again, but 
doesn’t reach the early peak expression observed at 3 hours. By 48 hours, expression 
has returned to just below baseline levels. 
 
Figure 3.9: Expression of the PALLD gene in HAECs Sheared at 10 dynes/cm
2
. This graph 
displays the expression of the PALLD gene. Following time points of shear stress at 10 
dynes/cm
2
, the mRNA is extracted and synthesised into cDNA which is then analysed using 
qRT-PCR with PALLD specific primers. Results are expressed relative to a zero-hour shear, i.e. 
static cells. Data is representative of five independent experiments ±SEM. Statistical analysis 
showed p<0.05 for all samples. 
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The proteomic response of Palladin to laminar shear stress was next investigated, so as 
to observe if the protein expression correlated with gene expression. Western Blotting 
illustrated in Figure 3.10 indicated that there was an upregulation of Palladin expression 
following shear, as the bands showed an increase in intensity over time points, 
especially at 3-24 hours. Subsequent repeat experiments and normalisation against the 
GAPDH controls provided a more concise understanding of expression following shear. 
Densitometric analysis of the 90kDa isoform indicates that Palladin is indeed 
upregulated immediately following shear, with expression increasing over two-fold 
within the first hour. At 3 hours, a drop in expression is observed, while it remains 
above static levels. However, by 6 hours, it has once again peaked – this time almost 
being three times the static protein expression. At 24 hours, this reverses, with the rate 
of expression appearing to decline once more. By 48 hours, Palladin expression has 
reduced back down to the same levels observed in static cells. 
Figure 3.10.1 compares the post-shear expression of protein to gene expression, in a 
similar manner as to how expression was compared post-strain (Figures 3.5.1 and 
3.6.1). Gene and protein expression appear to follow a closer pattern to one another, 
with protein expression in general being slightly higher than gene expression. Between 
3 and 6 hours, the similarity is less apparent. At 3 hours post-shear, relative gene 
expression is much higher than relative protein expression. Notably both expression 
levels still are greater than baseline static levels. At 6 hours, the Palladin protein 
expression is expressed at a greater level than the corresponding gene expression level. 
While both are greater than static levels, the protein expression is almost three-fold, 
whereas gene expression is roughly 1.5 times the static level. At 24-48 hours, relative 
gene and protein expression levels are once again closer with one another. 
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Figure 3.10: Palladin protein expression in HAECs subjected to Laminar Shear Stress at 
10 dynes/cm
2
. Following the allotted time point of LSS, the HAECs were lysed. Protein was 
extracted and quantified before being probed as before for Palladin and GAPDH. The multiple 
isoforms of Palladin are recognised by the antibody; however it is the 90kDa isoform which is 
subjected to analysis, its bands clearly changing more in intensity. Following Western Blotting 
of sheared HAEC lysates, the blot was analysed using ImageJ densitometric quantification 
software. The values given for intensity of each 90kDa-sized Palladin band is given here, 
following normalisation against the GAPDH control Western Blotting bands, and are expressed 
in comparison to the baseline zero hour shear. Data is representative of at least 5 independent 
experiments ±SEM.*p<0.05. **p<0.005. 
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Figure 3.10.1: Comparative trends of Palladin protein expression and PALLD gene 
expression in HAECs subjected to time points of Laminar Shear Stress. This figure 
compares the expression of Palladin expression following time points of laminar shear stress. 
The relative gene expression is plotted (Red) against relative protein expression (Blue).  
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After investigating the proteomic response of Palladin to laminar shear stress, the 
localisation of protein within the cells was next investigated. Immunofluorescence 
imaging (Figure 3.8) had shown that Palladin localised to the different areas within 
HAECs following shear. For a more precise and quantifiable method to characterise 
changes in Palladin expression, HAECs sheared for different time points were subjected 
to Proteocellular Fractionation. The different subsets of the sheared cell samples - 
Cytosol, Membrane/Organelles, Nucleus and Cytoskeleton were separately probed via 
Western Blotting methods and are illustrated in the subsequent figures. Figure 3.11 
illustrates the post-shear expression of Palladin in the cytosol. Notably for the first 3 
hours, Palladin is barely present at all. At 3 hours there is an increase in protein, and the 
bands appear darker, however by 6 hours the protein has reduced in expression. It is 
only at 24 hours where a more definitive band is observed; showing that Palladin 
expression in the cytosol has peaked at this time point. Densitometric analysis confirms 
this pattern, with the normalised Palladin expression at 24 hours showing a seven-fold 
increase compared to the static sample. 
Figure 3.12 demonstrates the post-shear expression of Palladin within the cell 
membrane and organelles. Here, the expression of bands appears fairly weakened. The 1 
hour and 6 hour 90kDa bands appear to be the most definitive one present in the blot. 
Interestingly, the 128kDa isoform bands appear much stronger than the 90kDa bands 
here, suggesting an aspect of future research to investigate. The idea of different 
expression patterns in different isoforms is discussed later in this thesis. When the 
90kDa isoform bands are analysed using densitometry and normalised, it is 
demonstrated that Palladin expression is in fact decreasing over the increased shear time 
points. There is a steady decrease in protein expression up to 3 hours of shear. After 6 
hours of shear, expression slightly increases (but remains below the static expression 
level), before it declines at 24 hours to half the protein amount present in static cells. 
Figure 3.13 continues the fractionation analysis experiment by displaying the expression 
of Palladin within the nuclei post shear. The 90kDa isoform of Palladin appears to 
steadily increase across the time points of shear. It looks similar to the pattern of 
expression in Figure 3.11, but without the drop in protein at 6 hours seen in the cytosol. 
The blot was analysed with densitometric software, and normalised against the PARP-1 
nuclear protein control. Analysis showed that Palladin expression did increase at a 
steady rate across the shear time points, with an almost five-fold increase within the first 
30 minutes of shear. At 6-24 hours the expression is ten to fifteen-fold compared to the 
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static level, however as a result of the differences in standard error and deviation, the 
results at these time points are not proven to be a statistically significant increase. 
However, given the steady increase pattern that has been observed up until then and that 
protein bands on the blot still remain quite intense, it is likely that protein level is close 
to the one presented. 
Figure 3.14 illustrates the cytoskeletal fraction. Given that Palladin is involved in 
cytoskeletal structure and organisation, it was hypothesised that there would be large 
amounts of Palladin present post-shear. While protein bands appear weak at 0 hours and 
30 minutes, strong bands are then observed at 1 hour post-shear stress. These bands 
appear weaker at 3 and 6 hours, before they increase again to the strongest intensity at 
24 hours. When the densitometric values of these bands are normalised against the 
corresponding Vimentin control bands, a clearer picture of expression within the 
vasculature can be observed. While protein expression is relatively stable at 0-30 
minutes of shear, there is a massive increase at 1 hour, reaching 10 times the baseline 
level. This expression slightly reduces at 3 hours, before increasing again at 6 hours. 
Peak expression is at 24 hours post-shear, where the relative Palladin expression is 
almost 20 times the static level.  
A final graph is presented at the end of this part of the study. Figure 3.14.1 collects and 
collates the data from all the 4 fractions taken, and expresses each result as a percentage 
of total volume of Palladin present in the cell at a given time. Precise results are 
expressed in Table 3.2. Therefore, at 0 hours, 75% of the total volume of Palladin in the 
static cell resides within the membrane, with the other fractions of the cells each 
comprising roughly 5-12% of total volume. These percentages begin to change as the 
cells are subjected to LSS. Within the first hour of shear, while the percentages of the 
cytosol and nucleus remain relatively unchanged, there is an increase in percentage of 
cytoskeletal expression of Palladin (36.5%) at the expense of membrane expression 
(42.4%). After this time point, the percentages change again. While it has been shown 
to increase over time points, by 24 hours cytoskeletal expression remains relatively 
unchanged (32.9%) as it is expressed as a percentage of total Palladin in the cell. 
Percentage of membrane expression continues decreasing up to 24 hours (13.9%). 
Meanwhile, there is now more Palladin found within the cytosol (comprising 21% of 
total Palladin at 24 hours post-shear) and within the nucleus (32.1% of total cellular 
Palladin at 24 hours post-shear). Palladin is therefore proven to be a protein which is 
relocated during cellular restructuring in response to shear stress. 
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Figure 3.11: Proteocellular Fractionation of HAECs: Fraction 1 – Cytosol. Proteocellular 
Fractionation was applied to sheared cells in order to observe the distribution of Palladin. 
Protein was acetone precipitated from fractions and subjected to a Western Blot as before, with 
the cytosol-specific HSP90a protein employed here as a control. The blot had to be stripped 
according to methods described in Chapter 2.2.5.1.8 and reprobed with this antibody to achieve 
control bands; hence the ladder marker is not shown (the HSP90a protein is 90kDa in size 
itself). The Western Blot was analysed using ImageJ densitometric quantification software and 
normalised against the Hsp90a controls. The resulting figures are expressed in comparison to 
the baseline zero hour shear. *p<0.05. **p<0.001. 
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Figure 3.12: Proteocellular Fractionation of HAECs: Fraction 2 – Membrane/ Organelle. 
Proteocellular Fractionation was applied to sheared cells in order to observe the distribution of 
Palladin. Protein was acetone precipitated from fractions and subjected to a Western Blot as 
before, with the membrane/organelle specific Calnexin protein employed here as a control. The 
blot had to be stripped according to methods described in Chapter 2.2.5.1.8 and reprobed with 
this antibody to achieve control bands; hence the ladder marker is not shown (the Calnexin 
protein is close to 90kDa). The Western Blot was analysed using ImageJ densitometric 
quantification software and normalised against the Calnexin controls. The resulting figures are 
expressed in comparison to the baseline zero hour shear. *p<0.05. **p<0.01. 
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Figure 3.13: Proteocellular Fractionation of HAECs: Fraction 3 – Nuclear. Proteocellular 
Fractionation was applied to sheared cells in order to observe the distribution of Palladin. 
Protein was acetone precipitated from fractions and subjected to a Western Blot as before, with 
the nucleus-specific PARP-1 protein employed here as a control. PARP-1 ranges from 87-
115kDa in size, so the blot had to be stripped according to methods described in Chapter 
2.2.5.1.8 and reprobed with this antibody to achieve control bands; hence the ladder marker is 
not shown. The Western Blot was analysed using ImageJ densitometric quantification software 
and normalised against the PARP-1 controls. The resulting figures are expressed in comparison 
to the baseline zero hour shear. *p<0.05.  
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Figure 3.14: Proteocellular Fractionation of HAECs: Fraction 4 – Cytoskeleton. Cells were 
subjected to laminar shear stress of 10 dynes/cm
2 
over a series of time points, followed by 
Proteocellular Fractionation. Protein was acetone precipitated from fractions, and subjected to a 
Western Blot to determine the presence of Palladin. Vimentin, a cytoskeletal protein was 
employed here as a control. Vimentin is 58kDa in size, but as the other 3 blots were stripped, 
this blot was stripped also in order to keep the experiment consistent. The Western Blot was 
analysed using ImageJ densitometric quantification software and normalised against the 
Vimentin controls. The resulting figures are expressed in comparison to the baseline zero hour 
shear. *p<0.001. 
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Table 3.2: Palladin Expression following time points of Laminar Shear Stress - 
comparative percentage total of combined fractions. The resulting data of Figures 3.11 – 
3.14 was collated and expressed comparing each fraction to each other, per time point of 
laminar shear stress. Results are listed as percentage total of combined fractions. 
 
   Time    
Fraction 
0 hour 
30 
minutes 1 hour 3 hours 6 hours 24 hours 
F1 - Cytosol 8.218548 7.837941 8.13956 18.56991 8.103904 21.02168 
F2 - 
Membrane 75.20914 72.15771 42.43948 24.78771 27.87159 13.89426 
F3 - Nucleus 11.19289 17.8008 12.88823 26.77485 25.96692 32.15588 
F4 - 
Cytoskeleton 5.379425 2.20355 36.53273 29.86753 38.05759 32.92818 
Total % 
100 100 100 100 100 100 
 
 
 
Figure 3.14.1: Expression of Palladin following time points of Laminar Shear Stress - 
comparative percentage total of combined fractions. This graph illustrates the percentage 
totals of Palladin protein in each fraction present in the cell. 
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Following these experiments, the expression of Palladin following shear stress of 
HAECs is assayed again, but in this case the cells have first been allowed to adhere to a 
variety of different extracellular matrices – fibrinogen, fibronectin or collagen - before 
being subjected to LSS. As discussed earlier, certain matrices can be permissive or 
nonpermissive, with the ECM types having different effects on the integrin signalling 
pathways - even more so following LSS. Through investigating the effects of these 
matrices on Palladin, it was theorised that this could help identify integrin pathways 
involved in gene and protein expression. 
Figure 3.15 (i) shows cells seeded onto a fibrinogen (FG) matrix and stained post-shear 
with AlexaFluor-488 conjugate bound to the Palladin antibody (Green), as well as 
staining actin with Phalloidin (Red), while in Figure 3.15 (ii) only the AlexaFluor 
conjugated Palladin stain is presented. At the edges of the cells, there appears to be a 
strong intensity of staining, indicating that Palladin is expressed more. Figure 3.15 (iii) 
similarly shows cells – this time seeded onto fibronectin (FN) - and stained post-shear 
with AlexaFluor-488 conjugate bound to the Palladin antibody and co-stained with 
Phalloidin, while Figure 3.15 (iv) is only the AlexaFluor conjugated Palladin stain. 
Finally, Figure 3.15 (v) shows cells seeded onto a collagen matrix (Coll). Again, the 
cells are co-stained post-shear for Palladin and actin. Figure 3.15 (vi) displays only the 
Palladin stain. In all figures, Palladin can be observed localising in the nucleus 
(designated as N), Focal adhesions (designated as FA) and to stress fibres (designated as 
SF). Direction of flow is also illustrated. The altered morphology of the cells is visible 
as they have realigned in the direction of flow.  
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(i) FG      (ii) FG
  
(iii) FN      (iv) FN 
  
(v) Coll      (vi) Coll
  
Figure 3.15: Immunofluorescence imaging of Palladin in HAECs on Extracellular 
Matrices subjected to Laminar Shear Stress at 10 dynes/cm
2
. HAECs were grown on an 
assortment of ECMs and allowed to reach confluency, following which they were subjected to 
24 hours of laminar shear stress. The matrices are fibrinogen (i-ii), fibronectin (iii-iv) and Type 
IV collagen (v-vi). Post-shear, cells were stained as outlined before. Cells are all viewed at 100x 
magnification. Direction of flow is also illustrated. Palladin is observed localising in the nucleus 
(N), Focal adhesions (FA) and to stress fibres (SF).  
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After showing the expression of Palladin within HAECs cultured on the different 
ECMs, the post-shear gene and protein expression was next investigated. First presented 
here are the expression patterns of cells grown on the permissive fibrinogen matrix. 
Figure 3.16 demonstrates the post-shear pattern is different on coated plates than that 
observed in Figure 3.9 (uncoated plates). Instead of increasing straight away, PALLD 
gene expression in fact declines within the first hour. However, this decline is reversed 
by 3 hours, where the expression peaks at over twice the baseline level. By the 6 hour 
time point, expression has declined to below-baseline levels again. The expression 
increases at 24-48 hours; but gene expression is still lower than the control static 
sample. This analysis appears to provide the first proper confirmation that post-shear 
Palladin expression is affected by culturing of cells on an extracellular matrix. 
Palladin protein expression was then investigated, results of which are highlighted in 
Figure 3.17. Protein bands are visible in the Western Blot, notably they all appear more 
intense than the “uncoated” sample (i.e. an equal amount of protein obtained from static 
cells grown on culture dishes without a cell matrix). Densitometric analysis of the bands 
was performed, and results are expressed relative to the static cells on uncoated i.e. 
standard cell culture dishes. Palladin expression increases over two-fold when 
comparing the static uncoated cells against the static cells on the fibrinogen matrix. 
After the cells are sheared, the expression remains close to a two-fold increase when 
compared to the uncoated sample. However, when comparing to the static cells cultured 
on fibrinogen, the expression of Palladin begins to slowly decline for the first hour. At 3 
hours expression has risen back to the level it was at 0 hours, and remains steady at this 
level at 6 hours also. Expression peaks at 24 hours, elevating to a higher level than the 0 
hour sample (and roughly 2.5 times the expression of the static uncoated cells). Notably, 
expression appears to decline rapidly following this peak. At 48 hours of shear the 
levels of Palladin on the coated plates has fallen sharply to roughly the same level on 
the static uncoated cells. 
Figure 3.17.1 provides a comparison of these gene and protein expression levels. By 
hour 1, relative protein expression is slightly higher than relative gene expression. At 3 
hours, the massive peak of gene expression is greater than respective protein expression. 
At 6 hours the levels look similar again, but protein expression is now much greater 
than gene expression. After this, the gene expression stays steady as protein expression 
begins declining; by 48 hours, the relative-to-baseline PALLD gene expression is 
greater than the relative-to-baseline protein expression. 
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Figure 3.16: Expression of the PALLD gene in HAECs seeded onto Fibrinogen Matrix and 
Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 10μg/ml fibrinogen 
and allowed to reach confluency. Following this, they were sheared for different time points 
between 0 – 48 hours. The mRNA was then extracted and synthesised into cDNA which was 
analysed using qRT-PCR with PALLD gene specific primers. Statistical analysis failed to show 
P<0.05. 
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Figure 3.17: Palladin protein expression in HAECs seeded onto Fibrinogen Matrix and 
Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 10μg/ml fibrinogen 
and allowed to reach confluency (18 hours post-seeding). Control HAECs were seeded at the 
same time onto an uncoated plate and also allowed to reach confluency. Following this, the cells 
on coated plates were sheared at the listed time points and then blotted for Palladin. The lysate 
from cells on a regular culture dish surface was also assayed as a control to illustrate the effect 
of the fibrinogen matrix itself on the expression of Palladin in cells. The blot was analysed using 
ImageJ densitometric quantification software. Results are listed relative to the static zero hours 
uncoated control, where cells were seeded onto regular culture plates and not subjected to 
laminar shear stress. *p<0.05. 
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Figure 3.17.1: Comparative trends of Palladin protein expression and the PALLD gene 
expression in HAECs seeded onto a Fibrinogen matrix and subjected to time points of 
Laminar Shear Stress. This figure serves to compare the expression of Palladin expression on 
HAECs seeded on a fibrinogen matrix following prolonged time points of laminar shear stress. 
The relative gene expression is plotted (Red) against relative protein expression (Blue). Results 
are listed relative to a static zero hour control, where cells were seeded onto the matrix but not 
subjected to laminar shear stress. 
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The second ECM protein investigated was fibronectin. Like fibrinogen, this matrix is 
permissive, so it was thought that the expression patterns should be similar. Once again, 
HAECs were seeded onto this matrix, sheared at different time points and the gene and 
protein expression was investigated. Figure 3.18 shows PALLD gene expression 
increases immediately following shear, with a nearly four-fold increase of within 30 
minutes of shear. This decreases at 1 hour, but expression still remains above the 
baseline levels, being still twice that of the control. At 3 hours, gene expression peaks 
(Again an over four-fold increase) before steadily declining over the next time points. 
By 48 hours, gene expression has regressed to almost-baseline level, with expression 
only slightly above that of the static cells. 
Following this, the protein expression is illustrated. Figure 3.19 shows the presence of 
bands in all the samples. The densitometric analysis of this blot showed that Palladin 
expression appears to be repressed to a degree, with all sheared cells cultured on a 
fibronectin matrix displaying less protein than the cells on an uncoated cell culture dish. 
Notably though, when observing the expression of Palladin following shear, the pattern 
appears to follow that of regularly sheared cells (Figure 3.10), albeit suppressed. Even 
though Palladin expression is relatively smaller than static uncoated cells, protein still 
elevates within the first hour of shear, before dropping back down at 3 hours. At 6 hours 
expression rises again, but this falls at 24-48 hours. 
Figure 3.19.1 collates the data from the gene and protein expression experiments in 
order to provide a comparative analysis of Palladin on sheared cells seeded on a 
fibronectin matrix. As shown, the relative-to-baseline gene expression level remains 
much more elevated than that of the relative-to-baseline protein expression. While gene 
expression post-shear immediately elevates to 4 times that of the static control, protein 
expression is only slightly above its respective control. This increased gene expression 
stays far more elevated than protein expression, until about 24-48 hours. At this point, 
gene expression is still greater, but it is reduced and much closer to protein expression. 
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Figure 3.18: Expression of the PALLD gene in HAECs seeded onto Fibronectin Matrix 
and Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 10μg/ml 
fibronectin and allowed to reach confluency. Following this, they were sheared for different 
time points between 0 – 48 hours. The mRNA was extracted and synthesised into cDNA which 
was analysed using qRT-PCR with PALLD gene specific primers. Statistical analysis showed 
p<0.05 for all samples. 
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Figure 3.19: Palladin protein expression in HAECs seeded onto Fibronectin matrix and 
Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 10μg/ml fibronectin 
and allowed to reach confluency (18 hours post-seeding). Following this, the cells grown on the 
matrix were sheared at the listed time points and then blotted for Palladin. Lysate from cells that 
were seeded onto a regular culture dish surface was also assayed as a control to illustrate the 
effect of the fibronectin matrix itself on the expression of Palladin in cells. The blot then was 
analysed using ImageJ densitometric quantification software. Results are listed relative to a 
static zero hour control, where cells were cultured on an uncoated culture plate and not 
subjected to laminar shear stress. *p<0.01. **p<0.05. 
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Figure 3.19.1: Comparative trends of Palladin protein expression and the PALLD gene 
expression of HAECs seeded onto a Fibronectin matrix and subjected to time points of 
Laminar Shear Stress. This figure serves to compare the expression of Palladin expression on 
HAECs seeded on a fibronectin matrix following prolonged time points of laminar shear stress. 
The relative gene expression is plotted (Red) against relative protein expression (Blue). Results 
are listed relative to a static zero hour control, where cells were seeded onto the matrix but not 
subjected to laminar shear stress. 
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Finally, Type IV collagen - a non-permissive, or passive, ECM - was investigated for its 
effects on Palladin expression. It was theorised to have a different influence on protein 
expression than that of the permissive fibrinogen or fibronectin matrices. As before, 
HAECs were seeded onto this matrix, sheared at different time points with the gene and 
protein expression then investigated. Figure 3.20 shows PALLD gene expression 
following shearing of cells seeded on collagen. Unusually, the expression does not 
appear to decline much within the first hour; staying relatively unchanged from baseline 
levels. At 3 hours there is an increase in gene expression, but this decreases back down 
again to baseline levels at 6 hours. At 24 hours, expression spikes again before dropping 
below the baseline level at 48 hours. 
The post-shear protein expression was subsequently analysed. Figure 3.21 shows how 
Palladin expression appears to increase when the cells are seeded onto the collagen 
matrix. Comparing the static uncoated to the static cells on the matrix shows how there 
is a significant increase in Palladin expression, with a two-fold increase in protein. 
There is a slight increase of Palladin expression then following the cells being subjected 
to shear stress. Interestingly, with the exception of a slight decline at 6 hours, the 
expression levels do not change in response to shear. It should be noted that this change 
in expression (or lack thereof) from 30 minutes to 6 hours does not have a p-value less 
than 0.05 when compared to either uncoated or 0 hour static cells, meaning it is not 
statistically significant of a change. (However, the p-values when comparing to the 
uncoated static cells all had values only slightly greater than 0.05. A higher number of 
repeat experiments may produce less of a standard error; and proof of a significant 
result).  
The collagen-influenced gene and protein expression were compared in Figure 3.21.1. 
They appear to retain a similar pattern. As shown, the relative-to-baseline protein 
expression is slightly higher than the respective gene expression for the first hour post-
shear. At 3 hours, gene expression peaks. Here, the gene expression overtakes the 
protein expression slightly. This continues until 48 hours, where protein expression 
once again is greater than gene expression. 
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Figure 3.20: Expression of the PALLD gene in HAECs seeded onto Collagen matrix and 
Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 20μg/ml collagen 
and allowed to reach confluency. Following this, they were sheared for different time points 
between 0 – 48 hours. The mRNA is extracted and synthesised into cDNA which was analysed 
using qRT-PCR with PALLD gene specific primers. Statistical analysis showed p<0.05 for all 
samples. 
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Figure 3.21: Palladin protein expression in HAECs seeded onto Collagen Matrix and 
Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 20μg/ml collagen 
and allowed to reach confluency (18 hours post-seeding). Following this, the cells were sheared 
at the listed time points and then blotted for Palladin. The lysate from uncoated matrix cells was 
also assayed as a control to illustrate the effect of collagen on the expression of Palladin in cells. 
Blots were probed for 30 seconds – probing at lower times showed no bands, and higher times 
over saturated the result. The blot was analysed using ImageJ densitometric quantification 
software. Results are listed relative to a static zero hour control, where cells were seeded onto 
the uncoated culture plates, and not subjected to laminar shear stress. *p<0.01. **p<0.05. 
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Figure 3.21.1: Comparative trends of Palladin protein expression and the PALLD gene 
expression in HAECs seeded onto a Collagen matrix and subjected to time points of 
Laminar Shear Stress. This figure serves to compare the expression of Palladin expression on 
HAECs seeded on a collagen matrix following prolonged time points of laminar shear stress. 
The relative gene expression is plotted (Red) against relative protein expression (Blue). Results 
are listed relative to a static zero hour control, where cells were seeded onto the matrix but not 
subjected to laminar shear stress. 
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3.3 DISCUSSION 
The blood vessels of the human body are subjected to haemodynamic forces due to the 
pressure and flow created by blood. Smooth muscle cells may be influenced by cyclic 
strain, with strain stimulating SMC proliferation and increasing expression of 
extracellular matrix proteins, leading to increased organisation of the cell type (Qi et al., 
2010; Von Offenberg Sweeney et al., 2004). The endothelial cell monolayer is also very 
susceptible to change in morphology as a result of its proximity to the constant flow of 
blood. Alterations to endothelial cell morphology are considered to be early steps in the 
development and progression of cardiovascular disease (Deanfield et al., 2007; Hadi et 
al., 2005). While factors such as age or diet can exacerbate the onset of morphological 
changes, it is the haemodynamic forces themselves such as cyclic strain and laminar 
shear stress which can facilitate these alterations. Increased blood flow, such as the type 
resulting from active sport and exercise may also elevate the haemodynamic forces 
applied to the blood vessels. 
As a result of haemodynamic forces, the cell can alter its actin cytoskeleton in order to 
reinforce itself and realign in response to the change in force. The thickening and re-
arrangement of actin filaments and stress fibres allows for the endothelial cell to absorb 
and transmit mechanical force throughout the cell – thus converting the physical 
pressures of haemodynamic force into biochemical signals that alter gene and protein 
expression. The purpose of this study was to investigate the presence and expression of 
the actin-binding Palladin protein, with this chapter focusing on the gene and protein 
response to these haemodynamic forces. Reasoning for this was the idea that if Palladin 
showed an elevated expression in cells subjected to increased haemodynamic forces, 
that it may provide a basis for understanding the change in cellular homeostasis in 
disease states. The protein itself could potentially show use as a disease marker, or it 
could indicate the expression patterns of actin-binding proteins in the cell – highlighting 
what proteins are upregulated or downregulated in response to disease. 
The Palladin protein is expressed in many multiple isoforms derived from a singular 
PALLD gene. It is believed to be phosphorylated predominantly on serines, which can 
modulate cytoskeletal organisation and motility of cells (Rönty et al., 2007). The 
different isoforms of the Palladin protein family possess multiple immunoglobulin-like 
domains. Most isoforms are transcribed from a series of nested promoters within the 
PALLD gene, resulting in at least three C-terminal Ig-like domains (Ig3, Ig4, and Ig5) 
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being present (Rachlin and Otey, 2006). Some of the other isoforms have additional Ig 
domains; the 140kda sized form has the Ig2 domain near the N-terminus, while the full 
200kDa form has the Ig1 and Ig2 domain (Figure 3.22). The difference in binding site 
can mean that the different isoforms of Palladin may bind with alternative proteins, 
depending on difference in presence or absence of Ig domains. The actin cytoskeletal 
component protein, Ezrin, for instance has been observed to interact with the Ig2 and 
Ig3 domain, but not Ig1 (Mykkänen et al., 2001). Proteins that can bind with Palladin 
are discussed in the next chapter. Filamentous actin itself however has been observed to 
bind to Palladin, via the Ig3 domain (Dixon et al., 2008). Ig domains appear to be 
capable of generating force through an “entropic spring” mechanism (Anderson et al., 
2013; Grützner et al., 2009). As a result of protein folding, the Ig domain can facilitate 
minute levels of tension on cell fibres. Several atomic force microscopy studies on other 
proteins with Ig-like folds indicate that Ig domains can have force-induced 
conformations (Kesner et al., 2010). Given the presence of similar domains within 
Palladin, it is suggestive that the protein may have a major function with regards to the 
cellular response to haemodynamic force. 
Figure 3.22: Palladin isoform structure. The Ig-like domains in this diagram are represented 
with a blue box. Proline-rich domains are represented with red boxes. The areas where each 
protein isoform is cleaved are also illustrated along with the molecular weight of each isoform. 
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Using an antibody that can bind to the Ig3-Ig5 domains, the expression of Palladin in 
HAECs was shown in Figure 3.2 via immunofluorescence imaging. Figure 3.2 (i) shows 
a co-stain of Palladin (stained green) along with Actin (red) and the nuclei of the cells 
(blue). This image shows how actin is quite plentiful in the cells, but mostly seen at the 
fibres at the edges of the cell. Being responsible for cytoskeleton structure, this follows 
expected results, as actin is needed to structure the cells. Palladin can be seen in the 
cytosol of the cell, but in Figure 3.2 (ii) – the same cells, without actin or nuclear stain – 
the protein is seen throughout the cell. Under higher magnification in Figure 3.2 (iii), 
the binding of actin fibres to Palladin can be observed in much closer detail. Palladin 
strongly binds to actin and other actin-binding structural proteins such as LASP-1 in the 
cell. These binding partners of Palladin are discussed in greater detail in Chapter 4.  
However, while this method of investigating Palladin in the cell shows the protein, it 
cannot distinguish the isoforms from one another. Western Blotting methods were 
thusly employed using the same antibody so the different isoforms in HAECs and other 
various cell types could be determined. Figure 3.3 shows how Palladin is strongly 
expressed in vascular cells, as demonstrated by the presence of the multiple isoforms in 
HAECs, HaoSMCs and RaoSMCs, and the absence of some of these isoforms in HEK-
293 cells. Isoforms appear differently expressed when comparing the human cell types 
to the rat cell type, indicating that Palladin may play different functions in the human 
vasculature. Figures 3.2 and 3.3 conclusively prove the presence of Palladin within 
Human Aortic Endothelial Cells. The HAECs appear to possess most of the major 
isoforms. Curiously, the 200kDa “complete” isoform is absent. This may suggest that 
the PALLD gene encoding for the protein is completely spliced to produce these other 
isoforms in HAECs. While the figure displays the known isoforms, there appears to be a 
light band visible at roughly 50-55kDa. This isoform has previously been identified 
(Luo et al., 2005) but the precise configuration of its structure has yet to be properly 
determined. Because of the PALLD gene possessing the ability to be alternatively 
spliced, there are potentially more isoforms of the protein yet to be discovered. 
In all cell types, the 90kDa isoform was the most strongly expressed band. In literature, 
this appears to be the most common isoform observed, so all ensuing results concern the 
characterisation of this isoform. Since it contains the Ig3-Ig5 domains, it shares many 
characteristics with some of the other isoforms (e.g. 122 or 128kDa sized) which are 
observed less and not completely characterised in literature. It is a likelihood that the 
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90kDa isoform might incorporate some of the functions of these lesser observed 
isoforms on account of their shared domains. 
This 90kDa isoform was investigated with regard to its gene and protein response to 
haemodynamic forces. Figures 3.4 and 3.4.1 display the result of an investigation of 
PALLD gene expression following physiological and pathological cyclic strain, 
respectively. When cells are subjected to 5% strain - mimicking physiological strain in 
the vasculature – Palladin is immediately responsive, becoming quickly upregulated but 
then appearing to reduce in expression after an hour. In Figure 3.4.1, following time 
points of 10% strain of the cells - a pathological strain model - the gene expression at 
first seems to follow the same pattern as that of the 5% strain. However, once it reaches 
3-24 hours of pathological strain, the PALLD expression levels elevate at a much 
sharper rate, reaching a two-fold increase of expression when comparing the 24 hour 
strained cells against the static cells. When the gene expression of the two strain models 
themselves are compared to one another in Figure 3.4.2, the increasing expression 
observed in pathological strain appears much more defined.  
The immediate expression in both models is suggestive that the cell undergoes 
remodelling as it goes from a static state to a state more indicative of that seen in the 
vasculature. Cyclic strain is able to influence HAECs early following strain, forming 
actin stress fibres and displaying a morphological alignment of cells perpendicular to 
the force vector (Estrada et al., 2011; Chien, 2007). As actin and actin-associated 
assemblies restructure in response to this immediate mechanical force, the actin-binding 
Palladin is immediately upregulated also. HAECs which have been subjected to cyclic 
strain produce Reactive Oxygen Species (ROS), which becomes increased under 
pathological conditions (Bundey, 2007). The accumulation of ROS can also initiate an 
inflammatory response which plays a part in development of atherosclerosis (Kou et al., 
2009). It may be that as the pathological strain increases, the inflammatory response 
initiated involves the Palladin protein. As will be discussed later this chapter, in laminar 
shear stress, the increase of expression of Palladin in cells is indicative of an 
inflammatory response.  
Once protein has been upregulated within the first hour of strain, post-transcriptional 
gene signalling mechanisms may be temporarily blocking the synthesis of protein as the 
cells do not require it anymore, hence the reduction in expression at 2 hours. Recent 
studies have investigated the role of microRNAs as post-transcriptional regulators 
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which control mRNA stability and act as key modulators of signal propagation 
(Avraham and Yarden, 2012). It may be that miRNAs regulate the cellular outcomes in 
response to the haemodynamic forces. Instead of regulating gene expression at the 
transcriptional and translational levels, miRNAs can associate with the target mRNAs to 
form a miRNA-induced silencing complex which causes the degradation of the target 
mRNAs and/or suppression of mRNA translation (Lewis et al., 2003). This may be 
occurring here under physiological strain, as the gene expression trends towards 
baseline levels again by 24 hours. The same signalling mechanisms appear to have less 
influence when cells are subjected to pathological strain, with elevated expression 
observed compared to the physiologically strained cells at the same time points. 
The almost instant elevation of expression following haemodynamic force is a recurring 
feature that is seen also in strain-induced protein expression, as well as the cellular 
response to laminar shear stress, which will be discussed later. As the cells adapt to 
chronic time points of force (at 3-24 hours), the cell undergoes a more adaptive change, 
necessitating an upregulation of Palladin once again. Comparing the difference in the 
5% and 10% strained cells in Figure 3.4.2 shows how the gene is expressed further 
when in a hypertensive state (e.g. higher pressure caused by exercise/ blocked arteries). 
This is suggestive that the PALLD gene is utilised for further function (such as 
continued cell remodelling) in a pathological state. Such a function may be switching 
off the potential post-transcriptional signalling methods that influence the 
physiologically strained cells. It should be noted that due to large error bars in the 
results, the changes in gene expression failed to prove completely significant. While the 
changes in expression are likely, a conclusion cannot be drawn that cyclic strain 
changes the gene expression. Possible repeat experiments may improve the results, 
providing a more conclusive change in gene expression post-strain. 
Consequently, the protein response to cyclic strain was investigated with the aim of 
strengthening the qRT-PCR data. Figure 3.5 shows the expression of Palladin at 5% 
strain appears to increase within the first hour, but then steadily drops to below baseline 
levels. Again, this is an observation of there being an immediate upregulation of protein 
following strain. Since the effects of strain can cause changes in cells within the first 15 
minutes (Cummins et al., 2007), it explains how the protein can also be appear 
upregulated at such an early time point. However, protein expression starts decreasing 
here after the 1 hour time point, suggesting possible downregulation or inhibition of 
protein. It should also be noted that these results did not show statistical significance 
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either (p>0.05). It may be that physiological strain has insignificant effects on Palladin 
protein expression. With that said, the trend appears to follow along the gene expression 
when comparing to protein expression (Figure 3.5.1) so the combined results may be 
representative of expression post-strain. Figure 3.5.1 further highlights how gene 
expression can stay elevated at 24 hours while protein expression is downregulated. A 
hypothesis for this could be that the protein is catabolised, being broken down into 
simple derivative compounds, while gene expression is still promoted as the cells 
realign to the cyclic strain. The lack of Palladin in strain-induced microparticles 
(observed in Chapter 5) suggests that the protein does not leave the cell through this 
manner. It could also be that the functional role of Palladin may be superseded by some 
other actin-binding protein in the physiological strain state. Experiments involving 
knocked-down cells (also in Chapter 5) appear to hint at this theory. 
Under the pathological 10% strain, the protein expression is elevated much more that 
the 5% strain; with a significant immediate two-fold increase in protein expression 
within the first two hours (Figures 3.6 and 3.6.1). This expression peaks in the second 
hour, before levels start declining in the 3-48 hour time points. This may be a sign of 
post-transcriptional gene signalling occurring again. The early expression may be a 
result of the static cells adapting to changes in state, but this fails to account for the 
elevated protein expression at 48 hours compared to the static baseline. A possible 
reason for the protein expression remaining elevated in the chronic hypertensive state is 
that the cells are producing more protein in an attempt to remodel further following the 
more pathological haemodynamic strain. The increased strain causes the cells to change 
in morphology to a greater degree, which necessitates a continual synthesis of the 
Palladin protein. 
Palladin expression in HaoSMCs under the same pathological strain models (Figure 3.7) 
was also investigated, with the results following a similar pattern of increase. However, 
the peak Palladin expression appears to take a longer time to occur, with expression 
levels finally peaking after 24 hours before reducing slowly. This further proves the 
presence of force responsive Palladin in the vasculature, with endothelial and smooth 
muscle cells upregulating the protein in different manners following cyclic strain. 
Palladin has previously been shown to be highly expressed in smooth muscle, playing 
an important role in cytoskeletal organisation, and may be used as a phenotypic marker 
for contractile smooth muscle (Jin et al., 2010).The fact that Palladin expression peaks 
earlier in strained endothelial cells compared to strained HaoSMCs is indicative of the 
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endothelial cells being more responsive to force, which would make sense given that 
they are in direct contact with the pulsatile force from the blood. 
The expression of Palladin following laminar shear stress (LSS) was also investigated 
because of the proximity of the cells to the blood showing a more direct effect of 
haemodynamic stimulation. Cells were stained post shear (Figure 3.8) in order to 
observe Palladin expression. Following shear, cellular structure has changed; with a 
pattern of flow across the cells being observed as the cells have started to re-align. It has 
been suggested that at this time, cells will not be fully re-aligned (Osborn et al., 2006), 
demonstrating that Palladin is still highly expressed following shear stress. This is a 
possible indication it is still playing a role in actin re-organisation. Investigation of 
Palladin following time points of shear stress appeared to show a similar pattern of 
expression to cyclic strain. Following the cells being subjected to LSS, the gene 
expression of Palladin greatly increases within 6 hours (Figure 3.9), before it starts to 
reduce. Expression remains above zero hour levels, and there is an increase at 24 hours, 
before the gene appears to be slowly becoming downregulated by 48 hours. This pattern 
is indicative of an acute inflammatory response. As the cells are immediately sheared, 
they again respond by remodelling which requires the upregulation of Palladin. 
A similar expression pattern is seen when looking at protein response to shear stress 
(Figure 3.10). Here, the protein significantly increases immediately following LSS, 
peaking at the first hour and then again from 6-24 hours, with declines in between. It 
appears that protein expression closely follows the pattern of gene expression where the 
peaks are early, and by 48 hours everything is returning to base-line levels (Figure 
3.10.1). The reduction at 3 hours is interesting. An explanation may be that the protein 
is actively downregulated following this time point of shear stress. It is also possible 
that the protein may be exported from the cells at this stage. As the cells undergo a 
conformational change, adapting from acute shear to chronic shear (which occurs by 3-6 
hours), it was hypothesised that the cells may be stimulated into releasing microparticles 
which contain Palladin. This hypothesis provided a foundation for experiments 
performed and then discussed in Chapter 5. It may also be that protein is degraded at 
this time, given that the cell is almost in a state of flux as it adapts from a response to 
acute shear to a settled adaptation to chronic shear stress (Resnick et al., 2003). 
The upregulation of Palladin in response to immediate shear stress or cyclic strain, 
followed by a drop in expression over time is indicative of an acute inflammatory 
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response. It must be remembered though that the two types of biomechanical forces – 
shear stress and cyclic strain - act upon the cell differently. Shear stress applies a 
continuous force parallel to the cell, whereas strain stretches and relaxes the cell in a 
periodic manner. Therefore it is not a surprise that the expression of Palladin elevated at 
different time points between the two types of force. Palladin appears to be upregulated 
in order to facilitate cell structure as they re-organise shape in response to strain or 
shear. Actin remodels very quickly in response to shear (Choi and Helmke, 2008) and in 
strain (Chien, 2007; Birukov, 2009) following a similar but slower pattern, indicating 
that Palladin is important for facilitating actin re-organisation following haemodynamic 
forces. 
While the immunofluorescence images of Figure 3.8 could highlight the presence of 
Palladin in sheared HAECs, the images were not useful for quantifying the precise 
localisation of protein. The altering expression of the protein following shear time 
points indicated that the protein re-localised to different areas post-shear. To investigate 
the post-shear localisation in a better context, Proteocellular Fractionation of HAECs 
was employed. This technique was utilised to extract different parts of cells (Cytosol, 
Membrane, Nucleus and Cytoskeleton) and determine the localisation of Palladin in 
each fraction following time points of LSS. Figure 3.11 illustrates the protein 
expression within the cytosol after LSS. Expression appears to be maintained at a steady 
increase until 6 hours, at which point there is a drop in protein expression. This almost 
correlates with the regular behaviour of Palladin in whole cell lysates, but with the ‘first 
peak’ that is normally observed at 1 hour being delayed and peaking at 3 hours instead. 
It is possible that following the 6 hours, as protein in whole cell lysates begins to 
reduce, that it gets released from other areas in the cell into the cytosol, resulting in this 
non-synchronous pattern.  
Figure 3.12 indicates that the release of protein into the cytosol possibly originates from 
the membrane. Palladin expression in the membrane slowly decreases for the first few 
hours, due to the necessary re-localisation of the protein to other areas (e.g. 
cytoskeleton) in response to shear. While there is a slight increase at 6 hours, this drops 
down again by 24 hours. There appears to be an almost inverse pattern between 
expression of Palladin in Cytosol and Membrane/Organelle fractions, especially 
between 6-24 hours – the point of which the cells begin to adapt to chronic shear stress. 
This possibly suggests that Palladin begins to be utilised differently following the early 
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shear time-points, strengthening the idea of it being involved in the inflammatory 
response.  
Figure 3.13 shows how Palladin expression in the nucleus is increased following LSS. 
There is a rapid increase of protein following 30 minutes (similar to the inflammatory 
response normally seen in whole cells) which remains sustained over the time course. 
Since Palladin is known to localise within the nucleus, it is perhaps unsurprising that 
this would be a site where significant increase in protein is observed. Multiple studies 
have shown how Palladin can localise to the nucleus in different cell lines where it can 
bind transcriptional regulators and influence gene expression patterns (Goicoechea et 
al., 2008; Jin et al., 2010). There is a possibility that the protein may affect signalling 
also in endothelial cells following LSS, but future investigation into the proteomic 
function inside the nucleus would be required to draw a conclusive observation. 
Since Palladin is also known to be hugely involved in cytoskeletal dynamics, the 
localisation to this area (Figure 3.14) was of great interest. There doesn’t appear to be 
an immediate increase following 30 minutes of shear stress, which could indicate that 
the Palladin expression in whole cells at this time point could be originating from other 
sources such as the nucleus or cytosol. Following an hour of shear, protein levels 
become significantly increased, and show an increasing trend over the whole time 
course. As Palladin plays such an important role in cell structure, the increasing relative 
levels here are perhaps unsurprising, due to the cell remodelling occurring following 
shear stress. This can help explain why protein expression is low at 24 hours in other 
fractions (Membrane/Organelle), as it is being relocated elsewhere.  
When collecting and graphing the percentage of Palladin in each fraction together in 
Figure 3.14.1 and Table 3.2, it demonstrates how protein starts out being most abundant 
in the membrane, but following shear, it becomes elevated in the nucleus and 
cytoskeleton instead; indicating that there is an increase in the amounts of Palladin 
produced and increased function in cell structure post-shear. The percentage of Palladin 
found in the membrane declines greatly, illustrating that Palladin is released from the 
unstable membrane and relocalised as the cells restructure. Another potential reason for 
the membrane having a lower protein expression level could be due to the external 
release of Palladin from the cells through endothelial microparticles. The role of 
endothelial microparticles and the release of protein within them shall be discussed 
further in Chapter 5.  
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Most of these results so far illustrating the force-induced expression of Palladin are 
observing cells cultured on regular cell culture dishes. While they do provide a good 
observation of the regulation of Palladin in response to haemodynamic force, it must be 
emphasized that within the vasculature, these cells are naturally in contact with a variety 
of different extracellular matrices. As discussed in detail earlier, the cell-matrix 
interaction was proposed to have an effect on the role of Palladin in cellular function. 
Previous studies have proven that the extracellular matrix can affect Palladin expression 
in Smooth Muscle Cells (Jin et al., 2010), so it was hypothesised that endothelial cells 
would be similarly affected. As stated earlier, certain matrices can be permissive or 
nonpermissive (i.e. passive); the type of matrix can have an effect on the integrin 
signalling pathways, even more so following laminar shear stress. By investigating the 
effects of these matrices on Palladin, it was theorised that this could help identify 
integrin pathways involved in protein expression. 
The next area of study was to therefore investigate expression of Palladin following 
LSS when cells are grown on an extracellular matrix - fibrinogen, fibronectin or Type 
IV collagen. Cells were cultured on a matrix, sheared and then probed using 
immunofluorescence (Figure 3.15). This proved that Palladin was still expressed in the 
sheared cells when in contact with these matrices. The subendothelial extracellular 
matrix is largely composed of Type IV collagen and laminins (Orr et al., 2005). Injury, 
inflammation or angiogenesis result in the degradation of the basement membrane 
leading to the deposition of extracellular matrix proteins such as fibronectin. In in vivo 
models, fibrinogen and fibronectin correlate with the expression of inflammatory 
markers such as ICAM-1 and VCAM-1 in endothelial cells (Hahn and Schwartz, 2008). 
HAECs grown on these matrices display a strong presence of Palladin when subjected 
to shear stress, suggesting that Palladin may act in a similar manner; having already 
been observed to show an inflammatory response to regular LSS without interaction 
with a ECM. The fibrinogen-seeded cells in Figure 3.15 (ii) appear to show a strong 
localisation of protein towards the stress fibres at the edge of the cells. Similar 
localisations are seen in the fibronectin or collagen-seeded cells, but of a lower 
intensity. These seeded cells were investigated for protein expression following an array 
of time points of LSS. 
As seen in Figure 3.16, when the fibrinogen matrix-seeded cells are subjected to LSS 
time points, the pattern of gene expression is different. Instead of a sharp immediate 
increase, the PALLD gene appears to be initially downregulated. There is a sudden rise 
 168 
 
in expression at 3 hours, which is similar to that seen in regularly sheared cells (Figure 
3.9) but otherwise expression is completely altered. A possible explanation of this 
unusual peak may be the effect of the adaptation of the cells to a chronic shear form. It 
appears there is a signalling mechanism responsible for repressing the gene expression 
at the other time points. Fibrinogen has been shown to affect gene expression (Weijers 
et al., 2010). However, as the cell morphology changes between 3-6 hours of shear, 
these changes in the cell may spur a sudden change in gene expression that briefly 
overrides the repressive signalling mechanism. This negation of the mechanism allows 
for the shear-induced upregulation of the gene to continue for the time point until the 
cell has finished restructuring at 6-24 hours. Investigation of these mechanisms specific 
to fibrinogen may be an area of future research to investigate. 
When looking at the protein expression in Figure 3.17, the matrix-seeded cells also 
show inhibition post-shear, with immediate downregulation occurring in a similar 
manner to the gene expression. At 3 hours (when gene expression became briefly 
upregulated) a small rise in Palladin expression is seen, but expression is slightly less 
than the baseline fibrinogen-seeded static cells. Following the theory that the gene is in 
fact being repressed and the repressive mechanism stopping as the cell adjusts, then it 
would follow that there isn’t enough time to synthesis a similar increase in protein 
before the gene repression continues again. When comparing the protein expression 
levels between cells on a matrix versus uncoated cells, it appeared that the matrix causes 
massive upregulated expression of Palladin. A comparison of the static cells grown on 
fibrinogen against static cells on an uncoated plate showed that the expression of 
Palladin is increased two-fold, due to interactions with the matrix. Fibrinogen has been 
proven to facilitate cell migration (Rybarczyk et al., 2003) and can induce chemotactic 
activity on endothelial cells (Seeger et al., 2002), indicating that as the cells migrate 
more on the matrix, the expression of Palladin increases as the static cells restructure 
and adapt to shear stress. An explanation for why in Figure 3.17 and 3.17.1 there is not 
so much protein expression could be that the fibrinogen stimulating the cells to produce 
Palladin results in a threshold being reached, leading to the cell to stop signalling for 
release of more protein. There may be some sort of specific inhibition of certain 
integrins by fibrinogen, preventing the signal that normally induces the synthesis of 
Palladin when cells are sheared. Fibrinogen (and fibronectin) inhibits the α2β3 integrin 
(Orr et al., 2006), which suggests a possible integrin pathway. However, since the levels 
are still higher than that of an uncoated sample, it may be that there is some method by 
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which the immediate shear response is inhibited, but expression is still promoted by 
virtue of cells interacting with the cell matrix (possibly from the cells being stimulated 
to migrate more). As stated, this is an area of research that future investigative work 
may be based upon. 
In Figure 3.18, cells seeded next on a fibronectin matrix and subjected to shear appear 
to have a relatively similar pattern of gene expression as the regularly sheared cells 
(Figure 3.9). There is a less of an increase in expression though at 24 hours in the cells 
on the matrix. Again, the cells may be adapting differently to growing on the matrix; in 
that they don’t require upregulation of Palladin in order to adapt to chronic shear 
conditions. Protein expression however seems to follow the same expression pattern as 
seen in cells grown on uncoated plates in Figure 3.10. When comparing the gene and 
protein expression in Figure 3.19.1, it appears that gene expression of Palladin is much 
higher than protein expression. An explanation for this is that there may be elevated 
release of protein through endothelial microparticles. Alternatively, there could be 
protein deregulation occurring between 3-6 hours of shear.  
Notably, all time points show much lower expression when compared to the static 
sample of cells on an uncoated plate. It may be a case where Palladin expression is 
inhibited to a certain threshold in cells by fibronectin. As mentioned before, some 
integrins such as α2β3 are inhibited by fibronectin, which suggests that the same 
integrins may be involved in the signalling pathway of Palladin. Figure 3.23 highlights 
how α5β1 and αVβ3 integrins binding to fibronectin specifically activate the 
transcription factor NF-κB (Orr et al., 2005). Shear stress also activates the p21-
activated kinase (PAK) in fibronectin-seeded cells. It is possible that either of these 
interactions may inhibit Palladin expression. Notably the PAK activation pathway is 
linked to increased endothelial monolayer permeability in response to shear of cells on 
this matrix (Orr et al., 2007; Hahn and Schwartz, 2008), so the expulsion of protein 
from cells during shear is a possibility. However, the molecular mechanisms involved in 
flow-induced endothelial permeability are still under investigation. This is a curious 
overall result since fibronectin also plays a strong role in the migration of cells, so it 
would be expected that Palladin expression would increase also. It could be that the 
matrix on its own in this manner has a negative effect on Palladin expression; whereas 
in the vasculature the other matrices may counteract the protein downregulation. 
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When observing the cells seeded onto a collagen IV matrix (Figure 3.20), gene 
expression appears to also be restrained. Only at 3 hours of shear stress does PALLD 
gene expression becomes upregulated, compared with the immediate response observed 
in regularly cultured cells in Figure 3.10. Furthermore, while the pattern of expression is 
similar (decreasing at 6 hours, increasing at 24, decreasing again at 48 hours), in regular 
cells, the overall expression stays above zero hour baseline levels. In comparison, cells 
seeded onto a collagen matrix show an expression pattern that declines below baseline 
levels at 6 and 48 hours, demonstrating that gene expression appears to be restricted to a 
degree by the collagen matrix.  
 
Figure 3.23: Model for flow-mediated integrin suppression. For cells seeded on a passive 
matrix such as collagen, the onset of flow stimulates the junctional mechanoreceptor complex to 
trigger activation of integrins such as α2β1 through PI 3-kinase. The binding of integrins to 
collagen stimulates Protein Kinase A (PKA) activation which initiates a pathway that acts upon 
the talin protein to suppress αVβ3. This may be an integrin which affects the expression of 
Palladin. For cells on the permissive fibronectin or fibrinogen matrix, the onset of flow 
stimulates the PI3-K dependent activation of the α5β1 and the αVβ3 integrins. The binding of 
these integrins stimulates the activation of Protein Kinase C (PKC), which initiates a pathway 
that acts upon talin to suppress the α2β1 integrin (Orr et al., 2006). 
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Figure 3.21 demonstrates the expression of protein following LSS on a collagen matrix. 
The restriction of gene expression appears to result in the Palladin protein expression to 
be relatively sustained despite the shear stress. It would seem that there is little to no 
increase of protein expression for the first 24 hours of shear stress, before the levels 
reduce at 48 hours, most likely as the cells have fully adapted to chronic shear stress at 
this point. While the 30 minutes to 6 hour results fail to prove to be a significant result, 
the 0 and 24 hour samples are, which highlights the little to no change in the samples. 
Results of statistical analysis showed scores that were just outside the 0.05 threshold, so 
repeat experiments may provide more definitive results at these time points. 
This lack of change indicates that the collagen matrix may possess some kind of method 
to block the signal that normally stimulates Palladin expression. The α5β1 and αVβ3 
integrins are activated on fibronectin and fibrinogen, but not collagen (Orr et al., 2006), 
which suggests that Palladin expression may be modulated through one such integrin. 
Flow is also observed to induce α2β1 integrin activation on collagen-plated cells, but 
not on fibronectin and fibrinogen. An alternative hypothesis is that an integrin such as 
this may act as an inhibitor of the protein expression under flow. Notably though, 
expression of the protein is once again higher in the cells on a coated plate as opposed 
to an uncoated plate. This could suggest that maybe protein levels are elevated to a 
threshold level following collagen stimulation, but then this doesn’t account for the lack 
of change in protein expression following LSS time points. Again, this could suggest 
that the shear response is inhibited, but expression is upregulated by virtue of cells 
interacting with the cell matrix, migrating and necessitating the use of actin-binding 
proteins such as Palladin.  
In conclusion, a proper specific integrin-inhibition assay would need to be performed on 
sheared HAECs in order to determine the precise integrin responsible for the expression 
of Palladin. Investigation through Western Blotting and qRT-PCR methods are limited 
in the sense that they can identify expression of the protein and gene, but cannot 
pinpoint the integrins involved in expression. However, some of the integrins suggested 
here would be an ideal starting point for investigation to achieve this goal. It is 
noteworthy that in the three different matrix-seeding experiments, expression of 
Palladin appears to reduce by 48 hours of shear stress. It’s possible that at this point the 
cells have reached their maximum potential for spreading across the culture dish area. 
The matrices can enhance cell migration, so by 48 hours it’s likely that the cells aren’t 
remodelling anymore and as a result, Palladin is no longer required. Consequently, a 
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question was raised of where unwanted protein goes. Chapter 5 discusses the expulsion 
of Palladin from cells post-shear, through endothelial microparticle release.  
This chapter however, has shown how Palladin is expressed within the vasculature, with 
special focus on the characterisation of gene and protein expression following both 
acute and chronic haemodynamic forces. It has been demonstrated how the protein is 
subject to upregulation and downregulation in different areas of the cell, and when in 
contact with extracellular matrices. The next chapter discusses the interacting proteins 
LASP-1 and Drebrin, and how they also function under haemodynamic force, with a 
focus on their shear-induced expression on extracellular matrices. 
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CHAPTER FOUR 
 
 
PROTEIN-PROTEIN 
INTERACTIONS OF PALLADIN 
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4.1: INTRODUCTION 
 
The connections and interactions one protein has with another can be conceptualized as 
being part of an interconnecting 3-dimensional signalling and regulatory network within 
the cell (Szklarczyk et al., 2011). By observing the whole interconnecting network as 
opposed to observing individual proteins, one can have a “bigger picture” view; 
gathering better information and an understanding of how a protein functions and 
interacts with other proteins, as well as how it functions in different locations of the cell. 
Palladin has already been determined to be an important actin-binding protein (Beck et 
al., 2013; Dixon et al., 2008). It has also shown to bind to other actin-associated 
proteins such as VASP (Boukhelifa et al., 2004), profilin (Boukhelifa et al., 2006) and 
LASP-1(Rachlin and Otey, 2006). Based on the understanding that Palladin is part of a 
protein network, the next area of research concerned investigating the related protein 
interactions of Palladin within endothelial cells and the role these interacting proteins 
may play within the vasculature. To identify the protein interactions, mass spectrometry 
identification was utilised. This entailed performing immunoprecipitation of Palladin 
from static HAECs using a Co-Immunoprecipitation kit. Co-IP works by covalently 
coupling antibodies onto an amine-reactive resin and then immunoprecipitating the 
antigen (also known as bait protein), pulling this protein from the cell lysate and 
simultaneously co-immunoprecipitating any related proteins which interact with it (also 
known as prey proteins). Then, using the mass spectrometric analysis, proteins found 
within the complex containing Palladin could be identified. Protein is digested into 
smaller peptides. Mass spectrometers measure the molecular weights of these peptides. 
Specialised software then can compare the weights to a database of known peptides, 
providing a probability score that the identified peptide is present in the sample. All 
mass spectrometry was performed courtesy of the National Institute for Cellular 
Biotechnology, DCU. 
Following LSS, the cell undergoes functional and morphological changes (Noria et al., 
2004). It has been determined that Palladin plays a role in the reorganisation of the cell 
in response to shear. The upregulation of Palladin in order to remodel the cell requires 
communication with other actin-binding proteins. With these observations made, it was 
hypothesised that differential proteins interact with Palladin at different time points of 
LSS. Again, Palladin was immunoprecipitated from HAECs, but this time, HAECs were 
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initially sheared for different time points. It was theorised that certain proteins interact 
with Palladin, but at specific time points of shear stress only.  
Protein interactions were further characterised and illustrated using the Search Tool for 
the Retrieval of Interacting Genes (STRING®) database. This is a database which 
quantitatively integrates interaction data from a number of sources and calculates a 
confidence score for known and predicted protein interactions. The score is derived by 
separately benchmarking the associations against the classification scheme of another 
database – the Kyoto Encyclopaedia of Genes and Genomes (KEGG) database. The 
score represents an estimate of the likelihood that a given association describes a 
functional link between two proteins, which is at least as specific as that between an 
average pair of proteins annotated on the same pathway in the KEGG database.  
In this case particular regard was given to visualising the interactions of LASP-1 and 
Drebrin, two actin-binding proteins which were indicated following mass spectrometric 
analysis of Palladin. This chapter aims to further investigate the presence of LASP-1 
and Drebrin within whole endothelial cells and the potential protein interactions with 
Palladin. With both of them being actin-binding proteins as well, we proposed that these 
proteins would show a response to haemodynamic force.  
LASP-1 is ubiquitously expressed and is involved in cytoskeletal architecture. It has 
been reported to localise within multiple sites of dynamic actin assembly such as focal 
contacts, focal adhesions, lamellipodia, membrane ruffles, and pseudopodia, suggesting 
that it plays an essential role in actin cytoskeleton organisation, especially at the leading 
edges of migrating cells (Lin et al., 2004). As mentioned, LASP-1 and Palladin interact 
with one another. The siRNA knockdown of Palladin leads to loss of LASP-1 at actin 
stress fibres and redirection to focal contacts without changing actin filaments, 
highlighting how Palladin and LASP-1 interact with one another. Palladin appears to 
bind and recruit α-actinin to stress fibres where it then binds with LASP-1 via its poly-
proline segments (Rachlin and Otey, 2006). In order to further understand the 
interactions of these two proteins, immunoprecipitation of LASP-1 from HAECs was 
performed. Mass spectrometric analysis was subsequently performed to indicate the 
binding partners of LASP-1. By doing so, a comparison between LASP-1 and Palladin 
Co-IP data could be made, indicating the shared binding partners of the two proteins. 
To further characterise the LASP-1 protein, its cellular response to laminar shear stress 
(LSS) was investigated. Subjecting HAECs to LSS has already shown that Palladin can 
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be upregulated immediately, indicating an inflammatory response in the cells. After 
later time points of shear (6 hours), the expression increases further, on account of the 
actin fibres further restructuring – this time to the chronic LSS. Since the Palladin 
protein changes because of this haemodynamic force it was hypothesised that the 
Palladin-associated LASP-1 protein would express a similar pattern when it was 
investigated.  
Following this hypothesis, the expression of LASP-1 in response to shear stress was 
investigated further, with regards to the potential signalling pathways involved. Chapter 
3 has already detailed how Palladin expression changes when cells are grown on various 
permissive and non-permissive extracellular matrices. HAECs were again cultured on 
fibrinogen, fibronectin or Type IV collagen, before being subjected to time points of 
LSS. Through observation of the patterns of LASP-1 expression within the matrix 
seeded cells, and the comparison to cells on uncoated culture dishes, the potential 
integrin-mediated signalling pathways involved in LASP-1 expression can be explored 
further. 
Similar experiments were performed on the actin-binding protein Drebrin. Co-IP of 
Drebrin was performed to observe similar binding proteins to the ones that bind with 
Palladin or LASP-1. The E2 isoform of this protein is observed within cells of a non-
neuronal origin and is believed to play a role within cell migration (Keon et al., 2000). 
The protein binds to filamentous actin and competes with F-actin stabilising proteins 
such as α-actinin and tropomyosin (Chew et al., 2005; Ishikawa et al., 1994). In 
addition to its ability to interact with F-actin, Drebrin has been observed to form a 
complex with proteins such as myosin (Ishikawa et al., 2007). It also has been observed 
interacting directly with profilin (Gordón-Alonso et al., 2013; Mammoto et al., 1998); a 
protein which itself is observed to bind to Palladin (Boukhelifa et al., 2006). 
Furthermore, Drebrin appears to play a role in induction of podosomes in the cells 
(Linder and Aepfelbacher, 2003), structures which Palladin has been observed to 
localise to (Goicoechea et al., 2006). This suggests that the two proteins, if not linked 
together, may at least be closely associated within the same network. 
As a result of this association, the response of Drebrin to haemodynamic forces (laminar 
shear stress) was also investigated. It was hypothesised that this protein would respond 
in a similar pattern as Palladin or LASP-1, with immediate upregulation in response to 
shear. The LSS-induced expression of Drebrin on cells grown on ECMs was 
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investigated also. By repeating the similar experiments as performed in Chapter 3, only 
investigating Drebrin, it was hoped to gain an understanding of the function and 
expression of the protein as the cell interacts with ECMs. The experiments also were 
performed in an effort to understand the potential integrin-mediated signalling involved 
in Drebrin expression. As discussed previously, when the sheared cells are in contact 
with the matrices certain integrins can be differentially expressed. Determining the 
patterns of expression for Drebrin in this manner could provide an idea of the signalling 
pathways involved in the regulation of the protein.  
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4.1.1 Study Aims 
 
The work carried out in this chapter sets out to determine the proteins which interact 
with Palladin. Two of these proteins – LASP-1 and Drebrin - are investigated in further 
detail. Their regulation by haemodynamic forces at the protein level is investigated, as 
is their proteomic response following interactions between cells and extracellular 
matrices. Therefore the overall aims of this chapter include: 
 To immunoprecipitate the Palladin protein from Human Aortic Endothelial Cells 
and analyse the immunoprecipitated protein using Mass Spectrometry methods 
to determine other interacting proteins. 
 To investigate specific interactions with Palladin that may occur when HAECs 
are subjected to Haemodynamic Force, i.e. laminar shear stress. 
 Observation of the haemodynamic LASP-1 protein and its characterisation in 
HAECs following laminar shear stress stimulation. 
 Investigation of the expression of LASP-1 and potential signalling pathways of 
this protein through interactions of the cells with permissive and nonpermissive 
extracellular matrices - fibrinogen, fibronectin and Type IV collagen - following 
laminar shear stress. 
 Observation of the Drebrin protein and its characterisation in HAECs following 
laminar shear stress stimulation. 
 Investigation of the expression of Drebrin and its potential signalling pathways 
through interactions of the cells with permissive and nonpermissive extracellular 
matrices - fibrinogen, fibronectin and Type IV collagen – again following 
laminar shear stress. 
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4.2: RESULTS 
Co-immunoprecipitation experiments were performed on HAECs using the methods 
listed in Chapter 2.2.5.2. Eluted protein was assayed on a Western Blot in order to 
confirm presence of target protein. When a column is prepared with antibodies coupled 
to an activated amine-reactive resin, two control columns are prepared also – one where 
the activated resin has been deactivated using a provided quenching buffer, and a 
second where the resin was not activated in the first place. These negative controls are 
created to confirm that the antibody is bound to the resin, and that immunoprecipitation 
of protein does occur. The blot in Figure 4.1 shows that only the first eluted sample – 
the sample with activated resin and antibody – is Palladin protein, as the other results do 
not show any bands. 
Furthermore, the lysate that flowed through each of the columns was also analysed by 
Western Blot (to confirm that Palladin was in the cells to begin with, and had been 
pulled out by the IP column). These flow-through samples were also run on the same 
Western Blot and these bands are also shown in Figure 4.1. The figure also shows a 
residual amount remaining un-precipitated. However the band visible is much fainter 
than the ones produced from the lysate flow-through from the control columns, showing 
that the IP was efficient. The remaining volume of the eluted sample from (i) was then 
analysed using Mass Spectrometry methods.  
These methods entail the digestion of protein into smaller peptides, which are measured 
and compared to the MASCOT™ database of known peptides. Results are returned in a 
tabled and ranked format, listing the proteins observed within the sample (Table 4.1). 
Results are presented with peptide counts and probability scores, showing the likelihood 
that the result given is for a protein listed. All proteins are identified with probability 
<0.05. This is one of the parameters for the software used to analyse potential peptides 
in the database.  
Palladin is one of the results returned, as expected. For convenience and visibility, the 
entry for it is presented first in the table. Other proteins listed include actin, and various 
other actin-associated proteins such as Myosin, Tubulin isoforms or LASP-1. The role 
and function of these binding proteins are detailed in Chapter 4.3.  
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Figure 4.1: Validation of Immunoprecipitated Palladin with Western Blotting techniques. 
This figure demonstrates the validity of immunoprecipitation. The Palladin protein complex was 
precipitated from HAEC lysate and a portion of the sample was probed using Western Blotting 
methods. Also probed were the eluted samples from control IP columns. As observed, the 
control samples did not show any Palladin binding to those columns, and only appeared in the 
immunoprecipitated sample where antibody was bound to the activated resin.   
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Table 4.1: List of Proteins observed following Mass Spectrometry of Palladin Co-
Immunoprecipitated from HAECs. The table below displays the results seen from a 
MASCOT™ search, following analysis of the eluted Palladin sample on a Mass Spectrometer.  
Key to table headings: 
UI = Unique Identifier, referring to the primary accession number of the UniProtKB database. 
EN = Entry Name, refers to the entry name of the UniProtKB entry.  
PN = Protein Name. 
Pro = Probability for peptides. A lower number means a higher probability of a match. 
SF = Score Final. This is the value of observed vs. theoretical peptide fragment mass spectrum. 
P = Peptides, i.e. the total number of peptide matches. 
 
 
 
  
UI EN PN Pro SF P 
Q8WX93 PALLD_HUMAN  Palladin  2.56E-05 2.63 3 
P35579 MYH9_HUMAN  Myosin-9  2.68E-09 25.10 27 
P08670 VIME_HUMAN Vimentin  5.81E-10 13.64 15 
P21980 
TGM2_HUMAN  
Protein-glutamine 
gamma-
glutamyltransferase 2  1.03E-08 11.11 13 
P62736 
ACTA_HUMAN 
Actin, aortic smooth 
muscle  1.84E-09 6.42 7 
P19105 
ML12A_HUMAN  
Myosin regulatory light 
chain 12A  2.48E-09 5.72 6 
P35580 
MYH10_HUMAN Myosin-10 2.72E-12 4.61 
5 
 
P60660 
MYL6_HUMAN 
Myosin light polypeptide 
6  1.94E-09 4.66 5 
Q13885 TBB2A_HUMAN Tubulin beta-2A chain 1.05E-06 3.83 4 
P35749 MYH11_HUMAN Myosin-11 1.19E-08 2.84 3 
P17661 DESM_HUMAN Desmin 3.13E-08 2.85 3 
P68371 TBB2C_HUMAN  Tubulin beta-2C chain 1.43E-05 2.57 3 
Q9H4B7 TBB1_HUMAN Tubulin beta-1 chain  4.61E-08 2.60 3 
Q16643 DREB_HUMAN Drebrin 2.26E-11 1.95 2 
P07065 
CKAP4_HUMAN  
Cytoskeleton-associated 
protein 4  4.78E-05 1.83 2 
P14649 MYL6B_HUMAN Myosin light chain 6B 1.17E-07 1.89 2 
Q9BYX7 ACTBM_HUMAN Beta-actin-like protein 3  4.53E-06 1.71 2 
Q71U36 TBA1A_HUMAN  Tubulin alpha-1A chain  5.16E-06 1.60 2 
Q14847 
LASP1_HUMAN  
LIM and SH3 domain 
protein 1  2.45E-06 0.95 1 
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Palladin was identified through mass spectrometric analysis of static HAECs. Chapter 3 
demonstrates how Palladin responds to haemodynamic force, with particular regards to 
laminar shear stress. Since the protein is upregulated immediately following shear, but 
changes over time points, it was believed that Palladin behaves differently depending on 
acute or chronic shear. With that in mind, it was hypothesised that the binding partners 
of Palladin may change also in response to time points of LSS. Specifically, it was 
believed that there may be proteins that only bind with Palladin at certain time points. 
The Palladin protein complex was then immunoprecipitated from HAECs which were 
subjected to shear time points. Again, samples were analysed using mass spectrometry 
and the MASCOT™ database.  
The lists of proteins extracted after each time point were compared against each other to 
observe if there were any new and specific proteins expressed after time points of shear. 
Results are presented in Table 4.2, showing the unique proteins observed at specific 
time points. Most unique proteins appear to bind to Palladin at 30 minutes to 3 hours, or 
else at 24 hours – times of acute shear stress and chronic shear stress, respectively. At 
early time points, results appear to be groups of various histones and actin-binding 
proteins. At 24 hours, there are still histones and actin-binding proteins, but also a 
number of kinases and RNA-binding proteins. The roles of these proteins are discussed 
in Chapter 4.3.  
 
  
 183 
 
Table 4.2: Unique proteins observed in Mass Spectrometric analysis of Palladin 
Immunoprecipitated from HAECs sheared at various time points. Palladin was co-
immunoprecipitated from different time points of sheared HAECs. The immunoprecipitated 
complexes were again analysed using Mass spectrometry and a MASCOT™ search. The table 
below lists the unique proteins observed at specific time points, the roles of which are discussed 
in Chapter 4.3. On account of the analysis software used in the National Institute for Cellular 
Biotechnology being upgraded between the performance of other analyses and this analysis, the 
presentation of results is slightly different. As such, final score is now replaced by a general 
Score, and the probability for peptides is no longer presented. Results in Table 4.4 and 4.5 are 
presented in the older format. 
Key to table headings: 
UI = Unique Identifier, referring to the primary accession number of the UniProtKB database. 
Entry Name refers to the entry name of the UniProtKB entry.  
S = Score, a cross-correlation value of observed vs. theoretical peptide fragment mass spectrum. 
P = Peptides, i.e. the total number of peptide matches.  
30 Minutes     
UI Entry Name Protein Name S P 
P06454 PTMA_HUMAN Prothymosin alpha 8.83  5 
P07355 ANXA2_HUMAN Annexin A2 5.20  3 
Q14764 MVP_HUMAN Major Vault Protein 4.83  2 
Q13470 TNK1_HUMAN Non-receptor tyrosine-protein 
kinase 
2.27  1 
     
3 Hours     
UI Entry Name Protein Name  S P 
O75531 BAF_HUMAN 
Barrier-to-autointegration 
factor 
4.61  1 
P68032 ACTC_HUMAN Actin, alpha cardiac muscle 1 31.10  13 
P68366 TBA4A_HUMAN Tubulin alpha-4-A chain 13.25  4 
P09382 LEG1_HUMAN Galectin-1 2.23  1 
P62805 H4_HUMAN Histone H4 2.59  1 
P67809 YBOX1_HUMAN 
Nuclease-sensitive element-
binding protein 1 
3.07  1 
Q01449 MLRA_HUMAN 
Myosin regulatory light chain 
2 
2.49  1 
P16401 H15_HUMAN Histone H1.5 4.82  2 
P22492 H1T_HUMAN Histone H1t 5.93  3 
P05141 ADT2_HUMAN ADP/ATP translocase 2 2.65  1 
O43791 SPOP_HUMAN Speckle-type POZ protein 2.89  1 
P35637 FUS_HUMAN RNA-binding protein FUS 2.61  1 
Q00839 HNRPU_HUMAN 
Heterogeneous nuclear 
ribonucleoprotein U 
5.05  1 
Q9NZN4 EHD2_HUMAN 
EH domain-containing protein 
2 
7.02  3 
Q9P1Z9 CI174_HUMAN 
Uncharacterized protein 
C9orf174 
3.80  1 
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6 Hours     
UI Entry Name Protein Name S P 
P60953 CDC42_HUMAN 
Cell division control protein 
42 homolog 
2.09  1 
P27658 CO8A1_HUMAN Collagen alpha-1(VIII) chain 2.09  1 
     
24 Hours     
UI Entry Name Protein Name S P 
P52943 CRIP2_HUMAN Cysteine-rich protein 2 5.01  2 
Q96KK5 H2A1H_HUMAN Histone H2A type 1-H 8.40  3 
Q562R1 ACTBL_HUMAN Beta-actin-like protein 2 12.01  5 
P23528 COF1_HUMAN Cofilin-1 4.16  2 
O60814 H2B1K_HUMAN Histone H2B type 1-K 2.29  1 
P98179 RBM3_HUMAN 
Putative RNA-binding protein 
3 
2.04  1 
P25705 ATPA_HUMAN 
ATP synthase subunit alpha, 
mitochondrial 
6.86  3 
Q8NC51 PAIRB_HUMAN 
Plasminogen-activator 
inhibitor-1 RNA-binding 
protein 
2.92  1 
P23246 SFPQ_HUMAN 
Splicing factor, proline and 
glutamine-rich 
2.83  1 
Q13724 MOGS_HUMAN 
Mannosyl-oligosaccharide 
glucosidase 
3.14  1 
P49411 EFTU_HUMAN 
Elongation factor Tu, 
mitochondrial 
3.47  1 
P12956 XRCC6_HUMAN 
X-ray repair cross-
complementing protein 6 
2.65  1 
Q6ZS86 GLPK5_HUMAN Putative glycerol kinase 5 2.65 1 
Q5TAX3 TUT4_HUMAN Terminal uridylyltransferase 4 3.46  1 
Q14152 EIF3A_HUMAN 
Eukaryotic translation 
initiation factor 3 subunit A 
3.06  1 
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Palladin had been shown to interact with a variety of proteins at this stage. The protein 
interactions which occur with Palladin were next illustrated using the Search Tool for 
the Retrieval of Interacting Genes (STRING®) database. This database collects 
different data from a number of sources to compare numbers of proteins together. In 
doing so, it can calculate a confidence score for known and predicted protein 
interactions. The score represents an estimate of the likelihood that a given association 
describes a functional link between two proteins, which is at least as specific as that 
between an average pair of proteins annotated on the same pathway in the KEGG 
database. The data from Table 4.1 was inputted into the STRING® search to highlight 
the network that all the immunoprecipitated proteins exist in. Results are shown in 
Figure 4.2, along with a visual map (also produced by the software) of the pathways and 
connections involved between proteins. Options exist for adding more predicted protein 
partners in order to observe more interacting pathways, but most have been omitted so 
as to show a clearer diagram. Palladin (PALLD) and LASP-1 appear to show a direct 
interaction, with a link between the two proteins having been documented and 
characterised (Rachlin and Otey, 2006). Palladin and Drebrin (DBN1) appear to have an 
interaction, via noted second-degree links between the Ezrin and/or α-actinin proteins.  
Figure 4.2.1 illustrates the probing of immunoprecipitated Palladin which was probed 
separately for (i) LASP-1 and (ii) Drebrin. Bands for Palladin are shown on the same 
sample to confirm that this protein was initially present. The resulting bands show that 
LASP-1 is present in a large amount. However, bands for Drebrin are weak, suggesting 
that Drebrin is less associated with Palladin than LASP-1. 
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Figure 4.2: STRING® analysis of predicted protein-protein interactions. STRING® 
(Search Tool for the Retrieval of Interacting Genes/proteins) is a database of known and 
predicted protein interactions. It was used to generate a simple diagram to highlight how the 
Palladin, LASP-1 and Drebrin proteins most likely interact with each other and other proteins. 
Table 4.3 lists a key to the results. The different coloured lines represent the types of evidence 
for associations between proteins, as indicated. The software also provides a brief summary of 
the predicted functional partners of the listed main proteins, based on compilation of existing 
evidence, to which it assigns a score based on probability of interaction. Scores closer to 1.0 
represent that interactions are more likely to occur. 
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Table 4.3: STRING® Diagram colour key. This key accompanies the STRING® created 
diagram in Figure 4.2. The coloured images represent specific proteins. 
Colour  Protein Colour  Protein 
 ACTA2 
Actin, Alpha 2 
 ACTB 
Actin, Beta 
 MYL6 
Myosin Light Chain 6 
 MYL6B 
Myosin Light Chain 6B 
 MYL12A 
Myosin, Light Chain 12A 
 MYH9 
Myosin, Heavy Chain 9 
 MYH10 
Myosin Heavy Chain 10 
 MYH11 
Myosin, Heavy Chain 11 
 TUBA1A 
Tubulin Alpha 1a 
 TUBB1 
Tubulin, Beta 1 
 TUBB2A  
Tubulin, Beta 2A 
 TUBB2B 
Tubulin, Beta 2B 
 CKAP4 
Cytoskeleton-associated protein 4 
 DBN1 
Drebrin 
 DES 
Desmin 
 LASP1 
Lim and SH3 Protein 1  
 TGM2 
Transglutaminase 
 VIM 
Vimentin 
 PALLD 
Palladin 
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Figure 4.2.1: Western Blotting of Immunoprecipitated Palladin to probe for LASP-1 and 
Drebrin. In Figure 4.2.1 (i), the immunoprecipitated Palladin sample was analysed using 
Western Blotting methods and probed for both Palladin (at 140kDa) and LASP-1 (37kDa). The 
figure shows that the eluted Palladin also contained LASP-1 within the same protein complex. 
Figure 4.2.1 (ii) shows the probing of eluted Palladin, which was confirmed by Western Blot. 
The blot was stripped and then reprobed for Drebrin. Faint bands are present, confirming 
presence of Drebrin.  
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When investigating the links between proteins, particular regard was given to 
visualising the interactions of LASP-1 and Drebrin, two actin-binding proteins which 
were indicated following mass spectrometric analysis of Palladin. LASP-1 has been 
shown to be a known binding partner of Palladin, so its presence in HAECs was of 
interest. The Drebrin protein was intriguing, as it is a protein normally observed in the 
brain. However, like Palladin, it is actin-binding and plays a major role in cellular 
development. This chapter aims to further investigate the presence of LASP-1 and 
Drebrin within whole endothelial cells and the potential protein interactions with 
Palladin. With both of them being actin-binding, we proposed that these proteins would 
show a response to haemodynamic force.  
Using LASP-1 specific antibodies, this protein was first immunoprecipitated and 
investigated using mass spectrometric analysis. Figure 4.3 validates the 
immunoprecipitation as being successful; a band is visible for the eluted LASP-1 
sample, but not the control samples. When probing the lysate flow-through, a weak 
band is visible for the eluted LASP-1 protein, but it is much weaker than the controls – 
showing that most of the protein present was pulled out from the cells. 
Table 4.4 highlights the actin-binding proteins that LASP-1 was found to interact with. 
For convenience and visibility, its entry is presented at the top of the table. Notably, 
Palladin does not appear in the results. However, LASP-1 did appear in table 4.1 as did 
proteins such as Vimentin and other actin and tubulin isoforms – showing they share a 
connection. Some proteins such as caveolin are highlighted as they appear to bind to 
LASP-1, but do not appear bound to Palladin in Table 4.1. The role and function of 
these LASP-1 binding proteins are detailed in Chapter 4.3.  
The same specific antibodies were used to obtain immunofluorescence images of the 
protein within fixed HAECs (Figure 4.4). LASP-1 can be observed localising to stress 
fibres (designated as SF), but appears reduced in the nucleus (designated as N). This is 
discussed later in Chapter 4.3. 
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Figure 4.3: Validation of Immunoprecipitated LASP-1 with Western Blotting techniques. 
After the immunoprecipitation of LASP-1 from Human Aortic Endothelial Cell lysate, some of 
the protein sample eluted from the spin columns was taken and run on a Western Blot to verify 
the presence of protein. Again, this sample was analysed along with the eluted samples from the 
control IP columns – one column with the activated binding resin having being quenched, and 
one column with an inactivated resin used instead. As shown above, the controls did not bind 
any LASP-1 protein to the columns. As implemented before, lysate that flowed through the 
columns was also analysed afterwards by Western Blot to verify that LASP-1 was present in the 
cell lysate to begin with. Again, a small amount of LASP-1 failed to be precipitated; but most of 
it was successfully collected in the eluted sample. This eluted sample was analysed using Mass 
Spectrometry. 
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Table 4.4: List of Proteins observed following Mass Spectrometry of LASP-1 
Immunoprecipitated from HAECs. This table displays the results seen from a MASCOT™ 
search, following analysis of an eluted LASP-1 sample on a Mass Spectrometer. As seen, 
multiple other hits for other proteins are observed in the table. Many of the ones listed are actin-
binding and responsible for cell structure. Proteins listed in bold do not appear in Table 4.1. 
Key to table headings: 
UI = Unique Identifier, referring to the primary accession number of the UniProtKB database. 
EN = Entry Name, refers to the entry name of the UniProtKB entry.  
PN = Protein Name. 
Pro = Probability for peptides. A lower number means a higher probability of a match. 
SF = Score Final. A value of observed vs. theoretical peptide fragment mass spectrum. 
P = Peptides, i.e. the total number of peptide matches. 
 
  
UI EN PN Pro SF P 
      
Q14847 LASP1_HUMAN  LIM and SH3 
domain protein 1  2.37E-07 5.57 6  
P08670 VIME_HUMAN Vimentin  6.22E-14 16.43 18  
P62736 ACTA_HUMAN Actin, aortic smooth 
muscle  2.45E-11 11.47 13  
P60709 ACTB_HUMAN Actin, cytoplasmic 
1 1.00E-30 7.67 8 
P17661 DESM_HUMAN Desmin 2.18E-05 2.62 3 
Q03135 CAV1_HUMAN Caveolin 1.44E-07 1.73 2 
Q9BYX7 ACTBM_HUMAN Beta-actin-like 
protein 3  1.51E-09 1.88 2 
Q71U36 TBA1A_HUMAN  Tubulin alpha-1A 
chain  1.48E-05 1.58 2 
Q9NQC3 RTN4_HUMAN Reticulon-4 4.77E-11 1.58 2 
Q562R1 ACTBL_HUMAN Beta-actin like 
protein 2 1.35E-04 1.26 2 
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(i) 
 
(ii) 
 
Figure 4.4: Immunofluorescence imaging of LASP-1 in static HAECs. In Figure 4.4 (i), the 
cells are stained with DAPI (a blue nucleus stain), Phalloidin (a red actin stain) and an 
AlexaFluor-488 conjugate that binds with the LASP-1 antibody (Green). These cells are viewed 
at 100x magnification. The cells in Figure 4.4 (ii) are prepared according to the same conditions 
- but without a DAPI nuclear stain or Phalloidin actin stain , so as to allow better viewing of 
LASP-1 in the cells.  
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Since LASP-1 is an actin-binding protein and it binds to Palladin, it was hypothesised 
that it may also be haemodynamic and therefore it follows a similar expression model. 
Figure 4.5 shows that, while not an exact match to Palladin, LASP-1 does have an 
analogous pattern. Immediately following shear, LASP-1 is significantly upregulated, 
increasing over 60% in expression. After this increase, it declines at 2-3 hours post-
shear – not unlike how Palladin experiences a decline at the same time point. However, 
the decline in LASP-1 expression is not as sharp as that seen in Palladin (Figure 3.10). 
Protein expression stays almost steady, before increasing again at 6 hours. At 24 hours 
onwards, the amount of LASP-1 expressed declines again. This pattern is again similar 
to the expression of Palladin. However it appears that the shear-induced changes in 
LASP-1 protein regulation are not as drastic as that seen with Palladin. 
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Figure 4.5: LASP-1 protein expression in HAECs subjected to Laminar Shear Stress at 10 
dynes/cm
2
. Following probing for LASP-1 in sheared HAECs, the Western Blot was stripped 
and reprobed for GAPDH to use as an endogenous control. All bands were analysed using 
ImageJ Densitometric quantification software. The values given for intensity of each LASP-1 
band is given here, following normalisation against the GAPDH control bands, and are 
expressed in comparison to the baseline zero hour shear. Data is representative of at least 4 
independent experiments ±SEM.*p<0.05. 
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The parallels between Palladin and LASP-1 expression were examined in more detail, 
with the probing for LASP-1 in cells cultured on extracellular matrices and then 
subjected to laminar shear stress. As stated previously, endothelial cells subjected to this 
have been shown to have specific integrins inactivated (Orr et al., 2006). It was 
postulated that LASP-1 may be subject to the same integrin signalling mechanisms as 
Palladin. While we are not able to pinpoint the precise signalling mechanisms involved, 
through investigating the expression with these ECMs, we can at least gain an insight 
into what may be occurring.  
Analysis involving the fibrinogen matrix (Figure 4.6) shows that the matrix alone 
causes LASP-1 expression to be significantly increased. Comparing static uncoated to 
static cells on fibrinogen shows that the matrix causes an over two-fold increase of 
LASP-1 expression. This increase slowly declines after longer periods of shear (albeit 
still remaining above baseline levels), and doesn’t appear to increase any further at later 
time points. Investigation with the second matrix, fibronectin, showed that initially 
seeding the cells onto the matrix causes an upregulation in protein again. Once the cells 
are sheared, the expression declines back to baseline levels. It peaks at 24 hours before 
declining again at 48 hours. It should be noted that these results did not prove to be 
significant, so a definitive conclusion cannot be drawn from these results. Finally, 
LASP-1 expression when cells are in contact with collagen is demonstrated. LASP-1 is 
shown to increase when comparing the static cells cultured on this matrix to those 
cultured on regular dishes. The LASP-1 expression increases further post-shear, peaking 
at 1 hour of LSS. Afterwards, it declines at a steady rate until 24 hours, where protein 
expression rises again. This is not unlike the expression pattern seen following regular 
shear stress experiments, although the differences in expression are more disparate, and 
appear to be delayed with peak expression happening later than usual. 
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Figure 4.6: LASP-1 protein expression in HAECs seeded onto Fibrinogen Matrix and 
Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 10μg/ml fibrinogen 
and allowed to reach confluency. They were then sheared at the listed time points and then 
blotted for LASP-1 protein. Lysate from regular HAECs was also used as a control to illustrate 
the effect of the fibrinogen matrix alone on the expression of LASP-1. Western Blots were 
analysed using ImageJ densitometry software. Results are listed relative to the static zero hour 
control, where cells were seeded onto regular uncoated culture dishes and not subjected to LSS. 
*p<0.05. 
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Figure 4.7: LASP-1 protein expression in HAECs seeded onto Fibronectin Matrix and 
Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 10μg/ml fibronectin 
and allowed to reach confluency. Following this, they were sheared at the listed time points and 
then blotted for LASP-1. Lysate from regular HAECs was also used as a control to illustrate the 
effect of the fibronectin matrix alone on the expression of LASP-1. All bands were analysed 
using ImageJ software. Results are listed relative to the static zero hour control, where cells 
were seeded onto regular uncoated culture dishes and not subjected to laminar shear stress. 
Statistical analysis failed to show p<0.05, so a definitive conclusion cannot be deduced. 
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Figure 4.8: LASP-1 protein expression in HAECs seeded onto Collagen Matrix and 
Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 20μg/ml Type IV 
collagen and allowed to reach confluency. Following this, they were sheared at the listed time 
points and then blotted for LASP-1 Lysate from regular HAECs was also used as a control to 
illustrate the effect of the collagen matrix alone on the expression of LASP-1. All bands were 
analysed using ImageJ software. Results are listed relative to the static zero hour control, where 
cells were seeded onto regular uncoated culture dishes but not subjected to laminar shear stress. 
*p<0.05. However, some results had too large of a variance in standard error to allow statistical 
analysis to prove them to be significant changes. 
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Another result following the immunoprecipitation of Palladin merited further 
investigation. The Drebrin protein is typically a protein found within the brain, where it 
plays a role in cell structure and development, but it has been found in other cell types. 
Recently this protein has been determined to be present within HUVECs (Rehm et al., 
2013) so it was hypothesised that the protein should be present within HAECs also. 
Investigations involving immunoprecipitation showed that the protein was pulled out of 
HAECs and indeed present in this cell type (Figure 4.9). However, the mass 
spectrometric analysis did not prove as successful as hoped, in that a result for Drebrin 
was not returned (Table 4.5). This may be due to the protein being obscured by other, 
more ubiquitous proteins within the eluted protein complex. Some of the results from 
the mass spectrometric analysis did show a shared number of proteins with Palladin and 
LASP-1. Proteins such as Vimentin, or Myosin Light Chain 12A were shown to be 
shared among the three proteins of interest. When investigating the Vimentin and 
Myosin proteins in Figure 4.2, it is shown how these proteins are part of the same 
network, with them being connected to Palladin, Drebrin and LASP-1 via different actin 
and myosin isoforms. The immunoprecipitated Drebrin sample also returned results for 
other actin-binding proteins in Table 4.5. Such proteins include Galectin or Calmodulin, 
the roles of which are discussed later in this chapter. 
To prove the presence of Drebrin within HAECs, immunofluorescence experiments 
were also performed, results of which are demonstrated in Figure 4.10. Drebrin is 
confirmed within HAECs, where it can be observed localising to stress fibres (SF), but 
appears depleted in the nucleus (N). Notably, strong clusters of Drebrin appear at the 
edges of the cells. Images are provided with or without a Phalloidin actin stain, or with 
and without a DAPI nuclear stain. A more detailed image at 200X was obtained with 
Figure 4.10 (iii) illustrating a clearer picture of Drebrin localising to the stress fibres.  
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Figure 4.9: Validation of Immunoprecipitated Drebrin with Western Blotting techniques. 
The Drebrin sample immunoprecipitated from HAECs was analysed on a Western Blot along 
with the eluted samples from the control IP columns – one with the activated binding resin 
having being quenched, and one with an inactivated resin used instead. As shown above, there 
did not appear to be any immunoprecipitation of the protein to the controls, but a clear band 
could be seen in the Eluted protein sample. A HAEC lysate was probed on the same band for a 
separate investigation - care was taken for the sample not to spill into surrounding wells, where 
it could provide a false positive. As before, lysate flow-through was probed for Drebrin, so to 
verify the extraction of the protein from the cells. The eluted sample was analysed using Mass 
Spectrometry. 
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Table 4.5: List of Proteins observed following Mass Spectrometry of Drebrin 
Immunoprecipitated from HAECs. This table displays the results seen from a MASCOT™ 
search, following analysis of the eluted Drebrin sample on a Mass Spectrometer. While a result 
for Drebrin did not appear, it is certain the protein is present (Figure 4.9) - the signal may be just 
drowned out by the presence of the more prominent actin-binding proteins. Proteins listed in 
bold do not appear in Table 4.1. 
Key to table headings: 
UI = Unique Identifier, referring to the primary accession number of the UniProtKB database. 
EN = Entry Name, refers to the entry name of the UniProtKB entry.  
PN = Protein Name. 
Pro = Probability for peptides. A lower number means a higher probability of a match. 
SF = Score Final. A value of observed vs. theoretical peptide fragment mass spectrum. 
P = Peptides, i.e. the total number of peptide matches. 
 
 
 
 
 
 
  
UI EN PN Pro SF P 
P08670 VIME_HUMAN Vimentin  6.66E-15 3.55 4 
P60709 ACTB_HUMAN  Actin, Cytoplasmic 1 1.73E-12 2.86 3 
P09382 LEG_HUMAN Galectin-1 5.47E-12 0.99 1 
P04406 G3P_HUMAN Glyceraldehyde-4-
phosphate 
dehydrogenase  
8.42E-12 0.98 1 
Q71U36 TBA1A_HUMAN  Tubulin alpha-1A chain  1.84E-11 1.94 2 
P06733 ENOA_HUMAN Alpha-enolase 5.88E-11 1.84 2 
P21333 FLNA_HUMAN Filamin-A 3.15E-10 0.96 1 
P02768 ALBU_HUMAN Serum Albumin 5.80E-10 3.52 4 
P62736 ACTA_HUMAN Actin, aortic smooth 
muscle  
2.16E-09 5.68 6 
P62158 CALM_HUMAN Calmodulin 1.22E-08 0.96 1 
P19105 ML12A_HUMAN  Myosin regulatory light 
chain 12A  
1.98E-08 1.88 2 
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(i) 
 
(ii) 
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(iii) 
 
Figure 4.10: Immunofluorescence imaging of Drebrin in static HAECs. In Figure 4.10 (i), 
HAECs are stained with just Phalloidin (a red actin stain) and an AlexaFluor-488 conjugate that 
binds with the Drebrin antibody (Green). These cells are viewed at 100x magnification. The 
cells in Figure 4.10 (ii) are prepared without the Phalloidin actin stain, so as to allow better 
viewing of Drebrin in the cells. Drebrin can be observed localising to stress fibres (SF), but 
appears less present in the nucleus (N). Figure 4.10 (iii) shows the cells with a nuclear stain 
(DAPI) and stained with the Drebrin-AlexaFluor-488 conjugate stain. It is also under a higher 
definition and at a closer magnification (200x). Notably, strong clusters of Drebrin appear at the 
edges of the cells. 
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Drebrin has been proven to be an actin-binding protein (Gordón-Alonso et al., 2013; 
Worth et al., 2013; Mikati et al., 2013). Since Drebrin was here shown to localise along 
stress fibres (Figure 4.10), it was hypothesised that it may also be haemodynamic and 
therefore it follows a similar expression model to LASP-1 and Palladin when cells are 
subjected to LSS. Results of post-shear lysates probed for Drebrin are shown in Figure 
4.11 show that this may not be the case. This graph appears to follow a contrasting 
pattern as that seen in Figure 3.10 and Figure 4.5, where a post-shear increase of protein 
was displayed for Palladin and LASP-1, respectively. Drebrin is initially downregulated 
post-shear. A significant decline is observed within the first 3 hours of LSS, with the 
amount of Drebrin protein roughly halving. There appears to be a slight increase at 6 
hours, but this still stays below the baseline static expression. Drebrin expression is then 
seen to decline again from 24-48 hours.  
The potential signalling pathways of Drebrin were investigated using extracellular 
matrices, similarly to how they were investigated in Palladin and LASP-1 expression 
previously. Since Drebrin was downregulated in regular cells after shear stress, it was 
thought that the protein may follow that pattern here.  
Cells cultured on a fibrinogen matrix were first investigated to observe their post-shear 
expression (Figure 4.12). When comparing the static cells on a regular culture dish 
against cells on the matrix, there appears to be a slight matrix-induced increase; 
similarly to how the other proteins were upregulated by virtue of cell-matrix contact. 
However, this increase does not appear as elevated as with the other previously 
investigated proteins. LSS appears to induce downregulation here though, with Drebrin 
expression declining within the first hour post-shear. At 3-24 hours, Drebrin has been 
shown to be upregulated again, to such a degree that is greater than that expressed in 
static cells. This upregulation remains steady up to 48 hours, where it begins to decline 
again. However, it should be noted that these results failed to prove to be significant, 
meaning that this may not be wholly representative of Drebrin expression on a 
fibrinogen matrix. 
Figure 4.13 appears to show contact with the fibronectin matrix causes an initial 
downregulation of protein in the cell. Similar downregulation was observed with 
Palladin (Figure 3.19) where protein was downregulated but still expressed the same 
pattern of post-shear expression, albeit repressed to a degree. A similar observance is 
made with Drebrin expression in Figure 4.13. Immediately following LSS, Drebrin is 
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further downregulated, where for 3 hours expression reaches a plateau – being 
downregulated, but barely changing in relative expression levels. With regular LSS 
(Figure 4.11), Drebrin was shown to plateau at these time points also, before increasing 
at 6 hours. This increase at 6 hours is seen with the fibronectin-seeded cells. Drebrin 
expression increases up to 24 hours, before declining at 48 hours. This expression is 
greater than the static cells on the matrix, but less than the static cells on an uncoated 
matrix. 
Finally, the expression of Drebrin in contact with the collagen matrix was investigated 
in Figure 4.14. Comparing the expression between static cells cultured on an uncoated 
vs. a coated culture dish shows that collagen appears to promote Drebrin expression, 
with a three-fold increase observed in cells on collagen compared to those on a regular 
dish. Following LSS, the expression declines, where by at 1-3 hours it is reduced to 
lower than the static cells without the collagen matrix. The expression increases at 6 
hours, but declines again from 24-48 hours, with all these time points showing lower 
expression than that of static cells cultured on collagen. Notably, these results failed to 
prove significant so a definitive result cannot be determined.  
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Figure 4.11: Drebrin protein expression in HAECs subjected to Laminar Shear Stress at 
10 dynes/cm
2
. Following Western Blotting of sheared HAEC lysates, the blot was probed with 
antibodies for Drebrin and GAPDH (as a control) and analysed using ImageJ Densitometric 
quantification software. The values given for intensity of each Drebrin band is given here, 
following normalisation against the GAPDH control Western Blotting bands, and are expressed 
in comparison to the baseline zero hour shear. *p<0.05.  
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Figure 4.12: Drebrin protein expression in HAECs seeded onto Fibrinogen Matrix and 
Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 10μg/ml fibrinogen 
and allowed to reach confluency. Following this, they were sheared at the listed time points and 
then blotted for Drebrin. Lysate from cells that were seeded onto a regular culture dish surface 
was also used as a control to illustrate the effect of the fibrinogen matrix on the expression of 
Drebrin. Western Blots were analysed using ImageJ software. Results are listed relative to the 
static zero hour control, where cells were seeded onto regular uncoated culture dishes and not 
subjected to LSS. Statistical analysis indicated p>0.05 – results are not significant. 
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Figure 4.13: Drebrin protein expression in HAECs seeded onto Fibronectin Matrix and 
Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 10μg/ml fibronectin 
and allowed to reach confluency. Following this, they were sheared at the listed time points and 
then blotted for Drebrin. Lysate from cells that were seeded onto a regular culture dish surface 
was also used as a control to illustrate the effect of the fibronectin matrix on the expression of 
Drebrin in cells. Western Blots were analysed using ImageJ software. Results are listed relative 
to the static zero hour control, where cells were seeded onto regular uncoated culture dishes and 
not subjected to LSS.*p<0.05. 
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Figure 4.14: Drebrin protein expression in HAECs seeded onto Collagen Matrix and 
Sheared at 10 dynes/cm
2
. HAECs were seeded onto a matrix consisting of 20μg/ml Type IV 
collagen and allowed to reach confluency. Following this, they were sheared at the listed time 
points and then blotted for Drebrin. Lysate from cells that were seeded onto a regular culture 
dish surface was also used as a control to illustrate the effect of the collagen matrix on the 
expression of Drebrin in cells. Western Blots were analysed using ImageJ software. Results are 
listed relative to the static zero hour control, where cells were seeded onto regular uncoated 
culture dishes and not subjected to LSS. Statistical analysis failed to show p<0.05, so a 
definitive conclusion cannot be deduced. 
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4.3: DISCUSSION 
Following on from the characterisation of Palladin in HAECs in Chapter 3, and the 
observation of its upregulation in response to haemodynamic stimuli, 
immunoprecipitation experiments were performed in order to analyse Palladin using 
mass spectrometric analysis. Table 4.1 shows that Palladin is one of the results returned, 
proving that the immunoprecipitation was successful. Through pulling out Palladin, the 
interacting protein complex was also extracted, and the proteins within this complex 
were able to be also identified. Protein-glutamine gamma-glutamyltransferase 2, an 
important protein cross–linking catalyst was identified, indicating that protein binding 
was occurring. Two results – LASP-1 and Drebrin – were identified as potential 
proteins within the Palladin complex. Their role within the vasculature, with regards to 
response to haemodynamic forces (laminar shear stress), was further investigated.  
While Palladin appears to show a low number of peptides (3) compared to proteins such 
as myosin (27), this is due to the ubiquitous nature of the other proteins in comparison 
to Palladin. Palladin has been proven to be present in the cells, but the amount present is 
dwarfed by that of major proteins such as myosins or actins in the cell. Some of the 
results in Table 4.1 list isoforms of actin, or actin like proteins. Because Palladin is 
involved in binding to actin, these results are expected. Most of the other proteins listed 
in Table 4.1 are also actin-binding in nature. Many results are also for various isoforms 
of Myosin. Myosins are proteins highly involved in cell motility. Actin and myosin, 
along with other various actin-binding proteins, form stress fibre bundles that apply 
tension between adhesive structures on the plasma membrane (Bershadsky et al., 2006). 
These adhesive structures are used in cell-cell or cell-matrix adhesion, and can be 
modified through various manipulations of the filaments bound to them. As Palladin 
plays a role in cell migration, it associates with Myosin in this regard. The Ig domains 
of Palladin may provide rigidity for the Myosin proteins and help separate the structural 
components during reorganization in the cell (Mykkänen et al., 2001; Otey et al., 2009). 
Also listed in Table 4.1 is Vimentin, an intermediate filament protein. Intermediate 
filaments, along with tubulin based microtubules and actin based microfilaments, 
comprise the cytoskeleton. Vimentin plays an important role then in maintaining cell 
integrity and adhesion (Tsuruta and Jones, 2003). Since Vimentin is one of the 
cytoskeletal control proteins used for proteocellular fractionation (Figure 3.14), it is 
unsurprising that it can be observed and identified in the proteomic screening. The 
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protein itself can be suitable as a normalising control in the fractionation experiments as 
it may not bind directly to Palladin, instead linking via a secondary protein such as 
Ezrin or α-actinin. Figure 4.2 later maps out these protein connections, demonstrating 
how Palladin and Vimentin are not directly linked. Another result of the Mass 
Spectrometric data, Desmin, is an intermediate filament protein as well. It is more 
commonly seen in muscle cells, but it can also found in endothelial cells, where it plays 
a similar role (Costa et al., 2004). Multiple isoforms of a further protein listed – Tubulin 
- appear to associate with Palladin. This is an important protein as it polymerises into 
long filaments that form microtubules – another major component of the cytoskeleton 
which also play a huge role in transporting of molecules in the cell (Craddock et al., 
2012). Further strengthening the association of this complex to microtubule function is 
the cytoskeleton-associated protein (CKAP4) which is also listed in Table 4.1. CKAP4 
is believed to be a protein involved in mediating the anchoring of the endoplasmic 
reticulum to microtubules. These proteins confirm that Palladin is part of a network of 
structural proteins within HAECs. 
However, following LSS, the cells undergo a change in structure. As they do so, 
different proteins are utilised and alternative protein binding occurs in order to remodel 
the cell (Li et al., 2005). By performing immunoprecipitation of HAECs after different 
time points of shear, the proteins can be visualised. Through a cross-comparison of 
Mass Spectrometry data, it was hypothesised that a variety of proteins can be observed 
to be uniquely expressed alongside Palladin at each time point of LSS. 
At 30 minutes post-shear, Prothymosin-α appears to associate with Palladin. This 
protein, while usually observed to be overexpressed under hypoxic conditions, is also 
suggested to be related to cell proliferation (Roland et al., 2003). Annexin A2 is a 
calcium-dependent phospholipid-binding protein which aids in organization of 
intracellular proteins to the extracellular domain. As the cells begin to shear, the 
membrane is disrupted and increased microparticle release occurs (discussed later in 
Chapter 5). Another form of Annexin, Annexin V, has already been discussed regarding 
its use in microparticle detection methods (Chapter 1). Annexin A2 also plays a role in 
cell motility and linkage of membrane proteins to the actin cytoskeleton. It would make 
sense that such a protein would be upregulated as an immediate response to stress. MVP 
– Major Vault Protein – is also presented as a protein result in Table 4.2. This protein is 
required for vault structure. Vaults are multi-subunit structures that may act as scaffolds 
for signal transduction proteins (Kolli et al., 2004). MVP has been observed to be a 
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dominant PTEN binding protein (Yu et al., 2002). As discussed in Chapter 1, PTEN 
serves as a negative component of the PI3-K / Akt signalling pathway, suggesting a 
potential link. Interestingly, there is also expression of Non-receptor tyrosine-protein 
kinase TNK1. This is a protein with tumour suppressor properties, which means it is 
capable of downregulating cell growth. It perhaps works as a preventative measure to 
keep cells in check as they restructure. 
By 3 hours the cells are more remodelled. Here a variety of other proteins are uniquely 
expressed. Some are alternative isoforms of proteins already expressed (e.g. Tubulin α-
4-A, or α-Actin 1). One result, barrier-to-autointegration factor, is a highly expressed 
protein which acts in bridging DNA. At this time point, PALLD gene expression peaks 
(Figure 3.9). Therefore it is possible that the barrier-to-autointegration factor is 
upregulated as the cells continue their remodelling and Palladin gene expression 
increases. Many of the other results - various histones, speckle type POZ protein, FUS 
protein, Ribonucleoprotein U, or translocases can be categorized as being normally 
observed in regular protein synthesis.  
Results of the MASCOT™ analysis at this time point show a variety of histones 
present. Histones are highly alkaline proteins found in the nucleus which package DNA 
into chromatin and order it into structural nucleosome subunits. These subunits can 
compact into higher order structures to affect gene expression. The nucleosomes are 
composed of DNA wrapped in histone octamers (composed of two H2A, H2B, H3, and 
H4) and are connected by a linker DNA, which associates with histone H1 to form 
heterochromatin, which has many functions including gene regulation and chromosome 
integrity (Yan et al., 2010). Methylation and/or hyper-activation of the histones have 
been implicated in epigenetic modification (Vo and Millis, 2012; Phillips, 2008). 
Histone phosphorylation is additionally involved in the transcriptional control of gene 
expression. Furthermore, histone deacetylase enzymes exist within the cell, and are 
responsible for regulation of the chromatin structure and function. Evidence suggests 
that these enzymes are involved in shear-mediated gene expression and function in 
endothelial cells (Chiu and Chien, 2011). Histone H4 in particular (observed in Table 
4.2) is strongly associated with transcriptional activation when hyperacetylated (Matouk 
and Marsden, 2008) suggesting that it may significantly affect Palladin expression. 
Laminar shear stress elicits both global and gene-specific histone modification changes 
in cultured endothelial cells (Illi et al., 2003). Many of the histone modifications are 
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known to play functional roles in transcription (Yan et al., 2010). It is proposed that the 
combination of posttranslational histone modifications encode regulatory information 
interpretable by the cell. Cellular dysfunction initiated by disease and increased shear 
stress is believed to be associated with increased epigenetic modification (Aird, 2007). 
As these cells are subjected to LSS, there appears to be an increase in the presence of 
histones, indicating that they are involved in the modification of the cell function in 
response to shear, and also interacting with the Palladin protein complex. 
Another interacting protein, observed in Table 4.2, is for Galectin-1. This isoform 
appears later in Table 4.5, where it is shown to be part of the Drebrin protein complex. 
The protein possesses a variety of functions. It is known to be upregulated in activated 
endothelial cells (Upreti et al., 2013). This upregulation stimulates both endothelial cell 
proliferation and cell migration. It may be that as the cells are re-organising in response 
to sustained shear, that they are utilising different pathways in order to remodel. 
Nuclease-sensitive element-binding protein 1 is seen to also stimulate proliferation and 
migration. The EH domain-containing protein 2 and C9orf174 protein are observed to 
be within the cell membrane. It is likely that these proteins are utilized in cell 
proliferation also, or else they could also play a role in the release of microparticles 
from the cell at this time. 
At 6 hours, many previously listed proteins are observed to bind to the Palladin 
complex. Two new proteins are observed at this time point however. The collagen α-1 
(VIII) chain is observed to be upregulated during injury (Gerth et al., 2007). This may 
be upregulated as the cells adjust to chronic shear conditions. CDC42 plays a role in the 
extension and maintenance of the formation of filopodia (Gauthier-Campbell et al., 
2004). These structures are rich in actin, so the association of Palladin to this protein 
could be a further sign that the cells are undergoing a different form of remodelling after 
6 hours, one which up regulates Palladin. 
Finally, following 24 hours of shear stress, the cells have restructured and now express 
different proteins as they react to chronic shear stress. There are multiple Palladin-
associate proteins that are exclusive to this time point. Again, many of them are simply 
various histones, RNA binding proteins or alternative isoforms of actin. However some 
of the protein results show different function. Cysteine-rich protein 2 (CRIP2) is a 
protein highly expressed within the vasculature (Zhang et al., 2005). Like LASP-1, it 
contains a LIM domain. The LIM domain is found within a variety of proteins which 
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have may different functions, including being a component of adhesion plaques and the 
actin cytoskeleton (Li et al., 2012b). The protein may be utilised here in response to the 
chronic shear stress. Another protein that appears to associate with Palladin under 
chronic shear is Cofilin, a filamentous actin-binding protein responsible for regulation 
of actin cytoskeleton dynamics. It plays an important role in organization of the 
cytoskeleton and the regulation of cell morphology, especially as it has actin 
depolymerisation abilities (Bai et al., 2011). 
At 24 hours of shear the cells are fully adapted to chronic shear stress. It is possible they 
now have less of a need for Palladin and remodelling of the cells, hence the association 
of actin depolymerisation proteins. Many of the other protein results (Putative RNA-
binding protein 3, Plasminogen-activator inhibitor-1 RNA-binding protein, Eukaryotic 
translation initiation factor 3 subunit A proline and glutamine rich splicing factor, and 
Terminal uridylyltransferase 4) all play a role in stabilizing mRNA, and capping 
expression levels. The rest of the proteins play similar minor roles in DNA and tRNA 
binding.  
Many of the proteins listed in the static HAEC analysis were compared on a database to 
provide an image of how they proteins exist alongside one another. The STRING® 
version 9.0 database is an online database of known and predicted protein interactions. 
The proteins were inputted into the database in order to generate a diagram showing the 
known links and interactions between one another. These interactions displayed are 
derived from four integrated sources of data: Genomic Context (a comparative approach 
between two proteins), High-throughput Experiments, (Conserved) Co-expression and 
Previous Existing Knowledge (i.e. published results). The database then assigns a 
confidence score for the protein interactions. This score is obtained by comparing the 
associations against the results from another database (KEGG database) and the results 
are presented as a visual map between pathways.  
The software was used with particular regard to investigating two other proteins of 
interest – LASP-1 and Drebrin. Figure 4.2 details some of the interactions between 
these proteins and Palladin. Palladin (PALLD) and LASP-1 show a direct interaction, 
whereas Palladin and Drebrin (DBN1) appear to interact via the Ezrin and/or α-actinin 
proteins. It should be noted that some protein interactions are not always physical 
interactions. Two proteins may be linked through genetic interaction or being part of a 
metabolic pathway (Szklarczyk et al., 2011). Because of this, the fundamental unit 
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stored in STRING® is the ‘functional association’, i.e. the specific and biologically 
meaningful functional connection between two proteins. It is this association which is 
documented by STRING®. As Figure 4.2 highlights, there are some cytoskeletal 
proteins which show an overlap in associations. Ezrin and α-actinin 2 not only interact 
with each other, but also with Palladin and Drebrin. LASP-1, which binds to Palladin, 
shows interactions with β-Actin – another protein that interacts with Ezrin, which in 
turn associates with Palladin.  
The proteins listed are not the only ones to associate with these proteins. Other proteins 
exist with more tenuous connections between these ones listed. For instance, 
Vasodilator-stimulated phosphoprotein (VASP) has a VCAM-1 mediated association 
with Ezrin (Barreiro et al., 2002), while still being associated with Palladin (Boukhelifa 
et al., 2004) and LASP-1 (Keicher et al., 2004). VASP furthermore displays a zyxin-
mediated interaction α-actinin 1 (Rottner et al., 2001), a protein also known to bind with 
Palladin (Beck et al., 2011). The proteins are part of a network where they are all 
connected either with one another, or through a degree of separation. Alteration of one 
protein homeostasis can therefore have a knock-on effect on a large part of its network. 
Figure 4.2.1 shows Western Blotting experiments that indicate the link between Palladin 
and (i) LASP-1 and (ii) Drebrin. Immunoprecipitated Palladin is probed with antibodies 
for these two proteins and show resulting bands for the respective protein targets. This 
illustrates how both LASP-1 and Drebrin are part of the Palladin protein complex. 
Presence of LASP-1 appears stronger than Drebrin, highlighting that Drebrin may be 
less closely associated to Palladin. Notably the 90kDa isoform of Palladin is not 
present; LASP-1 is known to bind to the other isoforms (Rachlin and Otey, 2006).  
Further investigation followed in investigating LASP-1 itself using mass spectrometric 
methods. By investigating the LASP-1 binding partners and comparing the results to 
those of Palladin, an overlap of other shared proteins could be observed, and other 
proteins specific to LASP-1 binding could be determined. Comparing the results of 
Table 4.4 against those of Table 4.1 showed that Reticulon-4 and Caveolin are the only 
LASP-1 associating proteins different to those associating with Palladin (and which is 
not simply an isoform of another protein listed). Reticulon-4 is a simple membrane 
protein involved in intracellular transport (Yang and Strittmatter, 2007). Meanwhile, 
Caveolin is thought to act as a scaffolding protein within the membranes of caveolae - 
small plasma membrane infoldings found in endothelial cells (Cohen et al., 2003). It has 
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been hypothesised that the compartmentalisation of certain signalling molecules into 
caveolar membranes can allow for a faster and more efficient coupling of activated 
receptors to more than one effector system (Patel et al., 2008). Such molecules may be 
transported by Reticulon-4, demonstrating why it appeared as a result. Caveolin also 
regulates NO signalling through inhibition of eNOS (Minshall et al., 2003). The protein 
furthermore plays a role in cell migration (Nohata et al., 2011). LASP-1 appears to have 
some sort of exclusive interaction with Caveolin that Palladin or Drebrin do not have. 
This may be due to some sort of role in signalling that LASP-1 displays. It is thought 
that both LASP-1 and uPAR are both part of the PI3-K signalling pathway (Salvi et al., 
2009). uPAR plays a role in such as cell migration, cell cycle regulation and cell 
adhesion. Caveolin, along with vitronectin and integrins, is needed by uPAR to initiate 
intracellular signalling. The connection between these two proteins may be via this 
signalling pathway. 
Following on from the observance of LASP-1 in HAECs, expression of the protein was 
investigated under LSS conditions. The presence of the protein within HAECs is 
confirmed in Figure 4.4. While the expression appearing to reduce in the nucleus, this 
result may be the localisation of the protein out from the nucleus to the edge of the cells 
as they adhere to the glass slide. LASP-1 expression was quantified using Western 
Blotting methods. This method also helped to observe the post-shear changes in 
expression better. It was hypothesised that since Palladin is a protein which shows an 
increase in expression immediately following shear, that the associated LASP-1 protein 
would follow the same expression patterns.  
Figure 4.5 illustrates how LASP-1 indeed is immediately upregulated following shear. 
This upregulation is similar to that of Figure 3.10, where the expression of Palladin also 
increases 1 hour post-shear. This appears to again be a part of the inflammatory 
response of the cells as they go from a static to haemodynamic state. Figure 4.5 appears 
to continue along a similar trend, whereby protein expression rapidly increases for the 
first hour, but then slowly declines and peaks again at hour 6 before being 
downregulated. This pattern of expression is indicative of LASP-1 being 
haemodynamically regulated in a similar manner to that of Palladin. This is likely due to 
LASP-1 facilitating actin re-organisation following shear stress. The binding of LASP-1 
to actin stress fibres is mediated through its interaction with Palladin that binds to the 
SH3 domain of LASP-1. The actin-binding domains of LASP-1 itself mediate a direct 
interaction between LASP-1 and actin at the cell membrane extensions. It is understood 
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that LASP-1 and Palladin have an important role in working together. Without Palladin, 
there is a loss of LASP-1 at actin stress fibres and redirection to focal contacts without 
changing actin filaments (Rachlin and Otey, 2006). Again, when subjected to chronic 
haemodynamic forces, the expression of LASP-1 slowly decreases over time. Some of 
this protein is exported through microparticle release (discussed in Chapter 5), while 
some is likely downregulated as the cells adapt to the forces and the cytoskeleton 
restructures. 
The expression of LASP-1 was also investigated in cells that were sheared after seeding 
onto ECMs. As before, this was performed in order to understand their integrin-
mediated signalling pathways and to gain a better understanding of how the protein 
functions within an in vivo setting. Comparative results for all proteins are summarized 
in Table 4.6.  
The effect of fibrinogen on post-shear expression levels of LASP-1 is first illustrated in 
Figure 4.6. It appears that expression significantly increases when cells are in contact 
with a matrix. However when the cells are subjected to laminar shear stress, there is a 
slight decrease in LASP-1 expression, which doesn’t appear to change much over 
increased time points of shear. It is likely that seeding the cells onto fibrinogen causes 
some integrin inhibition, preventing the signal that normally causes post-shear 
upregulation of LASP-1. Alternatively, the integrins engaged by fibrinogen may not 
elicit the necessary response for upregulation. This is similar to the expression pattern 
seen with Palladin in Figure 3.17. In both figures, expression levels are still higher than 
that of the uncoated sample, suggesting there is some event occurring whereby 
expression is promoted as a result of interactions with the matrix, which at the same 
time inhibits a response to haemodynamic force.  
When investigating LASP-1 expression under shear conditions after seeding cells on a 
fibronectin matrix (Figure 4.7), there is a different expression trend. While expression is 
upregulated when cells are cultured on the matrix, LASP-1 expression slowly decreases 
following immediate shear. A slight peak is seen at 24 hours, not unlike that seen at 6 
hours with cells on an uncoated culture dish. The pattern suggests some signalling event 
that prevents the inflammatory response and delays the chronic response. Protein kinase 
Cα is shown to be activated on fibronectin, where it mediates suppression of the α2β1 
integrin (Orr et al., 2006). Such an integrin may be responsible for LASP-1 signalling 
here. However, initial protein expression still remains slightly higher when compared to 
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the uncoated sample. Again this could be some sort of matrix mediated stimulation of 
LASP-1 expression. When this figure is compared to Palladin expression under the 
same conditions (Figure 3.19), the pattern of expression is different. LASP-1 expression 
doesn’t sharply decrease at 48 hours; however this could be attributed to the delayed 
response to chronic stress. LASP-1 is downregulated within 3 hours, whereas Palladin is 
upregulated. This suggests that the two proteins could in fact be affected by different 
signalling methods. Also of note is that LASP-1 expression is higher in coated samples 
as opposed to uncoated samples, whereas the opposite applies for Palladin. It appears 
that fibronectin may have opposing effects on the proteins; initiating an upregulation of 
LASP-1, but also the downregulation of Palladin. At the same time this stops LASP-1 
from responding to LSS, but allows Palladin to follow the normal profile it displays 
following shear (Figure 3.10). An explanation may be that Palladin and LASP-1 take 
over each other’s functions if one protein is prevented from being expressed. It must be 
pointed out that the statistical analysis failed to show p<0.05, so patterns of LASP-1 
expression may not be affected to such a degree by the fibronectin matrix. However, the 
possible alternative patterns in two closely-linked proteins deserve further investigation 
in future work. 
Lastly, the expression of LASP-1 on a collagen matrix (Figure 4.8) showed a different 
result in comparison to the pattern of expression on uncoated cells (seen in Figure 4.5). 
Up to 1 hour post-shear on a collagen matrix, LASP-1 expression appears to increase, 
indicative of an inflammatory response. This expression starts to decrease where, with 
the exception of a slight increase at 24 hours, stays in a declining trend. The 24 hour 
slight increase is reminiscent of that seen in the expression pattern of the fibronectin 
seeded cells; however it is not as sharp a peak, suggesting that collagen is less inhibitive 
of protein synthesis. When comparing this figure to Palladin expression under the same 
conditions (Figure 3.21), again a difference between the two proteins is seen. LASP-1 
shows a change in expression when seeded on collagen; however Palladin doesn’t 
register a change until 48 hours, where it drops sharply. Similarly to how comparison of 
the two proteins on a fibronectin matrix shows different results, it is probable that there 
are different matrix-related signalling pathways influencing the two proteins in different 
ways. Here though, it allows for LASP-1 to be expressed in response to shear, while 
preventing a Palladin response. As the shear and matrix-induced cell spreading is a Rac 
GTPase mediated response, the interaction of the cell with the matrix may stimulate a 
pathway that LASP-1 is a member of, but Palladin is not. The precise mechanisms 
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involved in this specific protein signalling merits further investigation to characterise 
them in full detail.  
The developmentally regulated brain protein (Drebrin) was investigated also following 
its observation in Mass Spectrometric analysis of immunoprecipitated Palladin protein. 
Again, by investigating the Drebrin binding proteins and comparing the results to the 
binding partners of Palladin, it was hoped that a list of their shared proteins could be 
observed. The E2 isoform of Drebrin is involved in remodelling of the actin 
cytoskeleton and in formation of cell processes. Overexpression of Drebrin in different 
cell types induces formations of long actin filament-rich cell processes (Keon et al., 
2000). As seen in Table 4.5, when performing an immunoprecipitation of Drebrin itself, 
some proteins appeared which also appeared alongside Palladin (Table 4.1) and LASP-1 
(Table 4.4). These proteins (Tubulin α-1A chain, Actin and Vimentin) help give an 
insight into how Palladin, LASP-1 and Drebrin can all be a part of the same network of 
proteins. 
Some proteins were pulled out along with Drebrin which appeared unique to Table 4.5. 
Many of these proteins are just different isoforms of proteins already observed (e.g. 
Cytoplasmic Actin 1) but some of alternative proteins were observed. Galectin-1 is a 
highly conserved protein that plays a role in modulating cell-cell and cell-matrix 
interactions, as well as migration and adhesion (Camby et al., 2006; Elola et al., 2007). 
It has been shown that it also facilitates increased adhesion of cells to the ECM via 
cross-linking integrins on the cell surface with the functional groups of other ECM 
components (Sanchez-Ruderisch et al., 2011). Activation of cells results in increased 
expression of Galectin-1, which in turn leads to the translocation of protein to the outer 
membrane. Drebrin is suggested to interact with gap junctions in cell-cell contact zones 
in response to extracellular signals (Butkevich et al., 2004) so it is possible Drebrin and 
Galectin-1 interact at the outer membrane. Cementing this hypothesis is the observation 
of Filamin-A in the results. It anchors transmembrane proteins to the actin cytoskeleton, 
while working as a scaffold for signalling proteins within the cytoplasm (Yue et al., 
2013). Furthermore, protein kinases dependent on Calmodulin – another result from the 
mass spectrometric analysis - are observed to play a role in the regulation of the cell 
barrier function (Borbiev et al., 2000). Calmodulin itself is used as a binding site for 
Caveolin-1 (seen in the LASP-1 immunoprecipitation) for inhibition of endothelial 
Nitric Oxide Synthase (Davignon and Ganz, 2004). Immunofluorescence imaging of 
Drebrin in HAECs (Figure 4.10) appears to show the larger clusters of protein near the 
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membrane edges. Drebrin is known to be most plentiful at junctional plaques (Peitsch et 
al., 1999; Rehm et al., 2013) so it is expected that these clusters would be closer to the 
edge of the cells. 
The actin-binding Drebrin was investigated under the same LSS conditions as before 
with the other proteins. It was initially thought that Drebrin may follow a similar post-
shear expression pattern as Palladin or LASP-1. Figure 4.11 shows the response of 
Drebrin in HAECs to similar time-points of LSS on regular uncoated cell culture dishes. 
The bands for Drebrin appear weaker – suggesting that Drebrin is scarcer in HAECs 
than other proteins. The protein notably had a lower number of peptides when extracted 
as part of the Palladin protein complex (Table 4.1), suggesting it may not be as 
ubiquitous within the cell. Drebrin expression unusually decreases immediately 
following LSS. This is in contrast to the previous investigations of Palladin and LASP-
1, which both showed an increase of protein immediately following shear stress. 
Drebrin expression showing a slight increase at 3-6 hours is reminiscent of the pattern 
seen in the other proteins however. This is suggestive that the change in morphology at 
6 hours shear causes an increase of many of the cytoskeletal proteins, even in ones such 
as Drebrin which were steadily being downregulated.  
The production of Drebrin may reduce as a result of actin remodelling post-shear. It is 
possible though that there may be some sort of regulatory effect with Drebrin, where it 
is downregulated as Palladin and LASP-1 are upregulated. Drebrin has been seen to act 
against α-actinin – an actin-binding cytoskeletal protein, where it is observed inhibiting 
the actin-binding and cross-linking activity of both α-actinin and tropomyosin (Ishikawa 
and Kohama, 2007; Li et al., 2011; Ishikawa et al., 1994). As stated, α-actinin itself has 
a known association with Palladin (Rachlin and Otey, 2006), so it is possible that some 
sort of competition occurs via the protein interactions here. Since Palladin knockout 
mice result in embryonic lethality and Drebrin is developmentally regulated, the early 
growth phase of the cells may be when this competition of the proteins occurs. Further 
investigation into the precise protein interactions at different growth phases could 
provide interesting results. 
The expression of Drebrin following LSS on extracellular matrices was also 
investigated in an effort to understand the signalling pathways involved in the protein’s 
expression. Figure 4.12 shows how Drebrin still decreases following LSS of cells on a 
fibrinogen matrix, albeit at a slower decline. The same upturn in protein expression at 3-
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6 hours is seen here, before declining. Notably, when compared to the static control 
sample where cells were grown on an uncoated culture dish, expression levels are 
elevated, and subsequently stay higher than the control, despite the shear induced 
downregulation. The graph is similar to the expression of Palladin in Figure 3.17. In 
both figures, protein expression reduces following shear, while still remaining elevated 
compared to cells without the fibrinogen matrix. While it is expected that 
downregulation of Drebrin occurs because of shear stress, the matrix-related 
upregulation may be due to the increasing cell migration induced by fibrinogen. It must 
be noted that these results did not prove to be statistically significant, so this cannot be 
stated for certain. 
While fibrinogen appears to stimulate an upregulation of Drebrin, Figure 4.13 shows 
how Drebrin is severely downregulated when cells are seeded onto fibronectin. There is 
a significant decrease in Drebrin expression between the matrix-seeded samples when 
compared to the control cells on an uncoated matrix. When compared against the 
investigation of Palladin on a fibronectin matrix (Figure 3.19), a similar matrix-induced 
inhibition of protein expression can be seen. It is an interesting result considering 
fibronectin aids cell migration, and there did not seem to be any inhibition of LASP-1 
when comparing coated and uncoated culture dishes (in Figure 4.7). It could be that 
fibronectin selectively inhibits some cytoskeletal proteins, but not others in the same 
network. As mentioned earlier, certain protein kinases such as PKCα are activated on 
fibronectin, where it mediates suppression of the α2β1 integrin (Orr et al., 2006) so such 
inhibition may be affecting the Drebrin expression here. The change in expression as a 
result of shear stress on this matrix in Figure 4.13 appears negligible though. There is a 
slight decrease within the first 3 hours of LSS, which is then followed by an increase at 
6-24 hours before dropping again. These results follow a similar pattern as seen in cells 
without a matrix (Figure 4.11). Therefore if fibronectin does inhibit protein, it is more 
likely through signalling mechanisms affecting cell-matrix interactions, and less likely 
through the cell-cell interactions that result from shear stress induced remodelling. 
Figure 4.14 shows that Drebrin inhibition does not appear to occur with collagen. Here, 
protein expression is elevated in samples seeded on a collagen matrix compared to the 
sample on a regular cell culture dish. This matrix-assisted increase of expression is 
similar to that seen occuring with Palladin (Figure 3.21) and LASP-1 (Figure 4.8), 
highlighting how collagen plays a role in the increase of cytoskeletal protein expression. 
From observing the pattern of Drebrin expression in the shear time points of Figure 
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4.14, it appears to follow the regular pattern where expression decreases steadily, with a 
small upturn between 6-24 hours as the cells adapt to chronic shear, before beginning to 
decrease again at 48 hours. It seems that collagen doesn’t have much of an effect on the 
shear pattern in Drebrin. However, statistical analysis failed to show p<0.05, so a 
definitive conclusion cannot be deduced.  
Interestingly, the matrix doesn’t affect the shear-related expression pattern of LASP-1 
either, but does affect the Palladin expression in an inhibitory manner. This comparative 
study highlights how these three proteins can be differently affected by the extracellular 
matrices, even though they all remain part of the same protein network in the 
vasculature. It suggests that while they are all part of this network, they can be mediated 
by different signaling pathways, and subsequently can be affected differently by 
haemodynamic forces. 
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Table 4.6: Expression patterns of proteins of interest following Cell-Matrix interactions 
and subsequent Laminar Shear Stress. This table compares the results found from Chapter 3 
(Figures 3.10, 3.16-3.21) for Palladin; and from this chapter for LASP-1 (Figures 4.5-4.8) and 
Drebrin (Figures 4.11-4.14), summarising how they are regulated during LSS when grown on 
different extracellular matrices.  
 Palladin LASP-1 Drebrin 
No Matrix Immediate increase 
with shear 
Decreases at 3 hours 
Peaking at 6-24 hours 
Decreases at 48 hours 
Immediate increase with 
shear 
Decreases at 3 hours 
Peaking at 6 hours 
Decreases at 24-48 hours 
Immediate decrease with 
shear 
Slight increase at 3-6 
hours, still below baseline 
Decreases at 24-48 hours  
Fibrinogen Promoted expression 
Immediate decrease 
with shear 
Increases to near-
baseline levels at 3-24 
hours 
Decreases at 48 hours 
Promoted expression 
Slight reduction in 
expression, but no major 
expressional change at 0-
48 hours 
 
Promoted expression 
Immediate decrease with 
shear 
Increases above baseline 
levels at 3-24 hours 
 
Decreases at 24-48 hours 
Fibronectin Inhibited expression 
Immediate increase 
with shear 
Declines at 3 hours 
before peaking at 6-24 
hours 
Decreases at 48 hours 
Promoted expression 
Immediate decrease with 
shear 
Increases to near-baseline 
levels at 24 hours 
 
Decreases at 48 hours 
Reduced expression 
Immediate decrease with 
shear 
Slight increase at 6-24 
hours, not much above 
baseline 
Decreases at 48 hours 
Collagen Promoted expression 
Shear has no effect on 
expression at 0-24 
hours 
 
 
Decreases at 48 hours 
Promoted expression 
Immediate increase until 
1 hour 
Declines at 3-6 hours 
before increasing slightly 
at 24 hours 
Decreases at 48 hours 
Promoted expression 
Immediate decrease with 
shear 
Slight increase at 3-6 
hours, but still below 
baseline 
Decreases at 48 hours 
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CHAPTER FIVE 
 
 
FUNCTIONAL ROLE OF 
PALLADIN: CELL MIGRATION 
AND ENDOTHELIAL 
MICROPARTICLE RELEASE 
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5.1: INTRODUCTION 
 
The actin cytoskeleton plays pivotal roles for many fundamental processes such as cell 
structure and migration. Such processes are facilitated by a dynamic remodelling of the 
actin cytoskeleton, which itself is regulated by various actin-binding proteins, one of 
which is Palladin (Asano et al., 2011). Having investigated the response of this protein 
to haemodynamic force, where it was seen to restructure the cytoskeleton, the functional 
role of Palladin was investigated in more detail. There is strong evidence suggesting 
that Palladin plays a role in cell migration: it appears to have a conserved function in 
cell and tissue remodelling in response to injury; with a strong correlation existing 
between high levels of Palladin expression and increased cell migration (Goicoechea et 
al., 2008; Jin et al., 2007). The production of a genetically modified Palladin knock-out 
mouse was reported to result in embryonic lethality, due to defects of cranial neural tube 
closure and herniation of vital organs (Luo et al., 2005). Palladin was shown to be 
expressed in the cranial neural folds of the wild-type embryos. The closure of these 
folds requires the active migration of the cells, suggesting that the closure defect of 
Palladin-null embryos was caused by the disturbance of cell migration. Suppression of 
the protein in fibroblasts and carcinoma cell lines has also been documented to result in 
the disruption of the cytoskeleton (Goicoechea et al., 2009; Parast and Otey, 2000). 
Furthermore, knockdown of Palladin in vascular Smooth Muscle Cells results in the 
decrease and disorder of stress fibres associated with the diminished F-actin to G-actin 
ratio (Goicoechea et al., 2006; Jin et al., 2011).  
However, there have been very few studies observing the effects of a similar 
knockdown of Palladin in vascular endothelial cells, or even observations of the role of 
Palladin in endothelial cell migration. It was hypothesised that knockdown of Palladin 
in endothelial cells should noticeably affect HAEC migration as it did with other 
vascular cell types. This was therefore investigated in this chapter, with the employing 
of siRNA knockdown of Palladin in HAECs, followed by the subjecting of these cells to 
a scratch wound assay. It was theorised that cells transfected with siRNA would display 
a reduced migratory profile over the observed time course. Through a cross-comparison 
with non-transfected cells in the same assay, this experiment can demonstrate how 
Palladin plays a role in facilitating the migration of HAECs, coupled with how the 
repression or deletion of this protein may affect migration. Further investigations on 
knocked-down cells and the effect Palladin has on cell migration used the 
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xCELLigence™ system, which records the real-time migratory patterns of these cells. 
To determine the role of Palladin on cell migration following haemodynamic force, the 
siRNA-transfected cells were subjected to cyclic strain before being analysed with the 
system. 
It has already been demonstrated that Palladin displays a biphasic response to 
mechanical stimuli, playing a role in structural reorganisation of the cells as they adapt 
to haemodynamic forces. Chapter 3 has illustrated that immediately following LSS or 
cyclic strain there is an increase in Palladin expression, likely due to an inflammatory 
response in the cells. This spike in expression is relatively short-lived however; by 3 
hours of sustained strain or shear the levels have peaked and start to decline. The levels 
increase at 6 hours (likely due to the cells adapting to chronic haemodynamic forces), 
but they end up declining further again by 48 hours. While the protein may be simply 
catabolised in these instances, a hypothesis for the reduction in expression levels was 
that the protein may be exported from the cells via Endothelial Microparticle release. 
This hypothesis of microparticle release could also explain why there is a massive 
reduction of Palladin documented within the cell membrane following LSS (Figure 
3.12), as membrane bound protein is readily exported from the cell. Much of this 
chapter therefore focuses on investigating the release of Palladin via Endothelial 
Microparticles shed from HAECs.  
While cyclic strain can initiate microparticle release (Vion et al., 2013), the primary 
focus of the investigation of microparticles is given to those induced by shear stress. 
The reasoning for this is that firstly, a greater volume of these shear-induced 
microparticles are released from cells than strain-induced, owing to the flow vs. pulse 
effect of stimulating disruption of the membrane and subsequent particle release. 
Secondly, there is a vast difference in the content of each type of induced microparticle, 
since different agonists can result in different particles from a single cell type (vanWijk 
et al., 2003). With regard to the observations of Palladin in strain-induced EMPs, results 
displayed here show that Palladin is absent from this subsection of microparticles 
(Figure 5.3), indicating that there may be a different signalling method involved in the 
release of protein from the cells.  
Microparticles that are released from the cell have been shown to contain various 
mRNAs, miRNAs or proteins (Diehl et al., 2012; Diamant et al., 2004). Recent data 
indicates that microRNAs (miRNAs) in endothelial cells can play an essential role in 
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shear stress-regulated responses (Vion et al., 2013). Shear stress can induce miRNAs 
that inhibit mediators of oxidative stress and inflammation while promoting those 
involved in maintaining vascular homeostasis (Marin et al., 2013). The release of such 
signalling molecules via EMP shedding can seriously alter cell fate and function. As the 
EMPs are released from cells, they are free to travel downstream and transfer such 
mRNA, miRNA and also proteins to other cells, affecting their state as a result. 
Experiments were performed whereby HAECs were incubated with conditioned media 
i.e. cell media which was taken from a previously sheared plate of cells and therefore, 
contain a large volume of EMPs. By adding these EMPs to new static cells, it was 
thought that an observation could be made of Palladin expression in HAECs being 
altered by an influx of shear-induced microparticles through specific signalling 
pathways. 
In an additional method to characterise how signalling methods are involved in 
microparticle release, the release of shear-induced EMPs from cells cultured on ECMs 
was also investigated. As detailed in Chapter 3, nonpermissive matrices such as 
collagen may interfere with integrin signalling (Orr et al., 2006) and appear to affect 
Palladin expression in HAECs. Collagen can alter endothelial cell function following 
shear stress (Kemeny et al., 2011), so it is possible that it may also have an effect on the 
activation of the cell membrane and subsequent particle release. The permissive 
matrices – fibrinogen and fibronectin – are also investigated for shear-induced 
microparticles. Since these matrix proteins are observed to increase in response to 
elevated shear stress, it was hypothesised that they may also influence the increased 
EMP release which also occurs as a result of elevated shear. As these matrices have 
already been shown to affect protein expression in the cell via interactions with 
integrins, they were investigated to observe if they affected EMP-facilitated protein 
release in the same way.  
Most of the microparticles used in these experiments were obtained after extracting 
them from harvested cell media. However, the presence of Palladin in EMPs extracted 
from human blood post-exercise was also investigated, to highlight the presence within 
an in vivo environment as well as an in vitro one. Exercise increases shear stress in 
vessels, which in turn increases microparticle number (Tinken et al., 2010). Blood was 
obtained after subjects were subjected to exercise, following the methods of Chapter 
2.2.2.4. Through investigation of EMPs obtained from these blood samples, a clearer 
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understanding of the in vivo expulsion of Palladin from cells within the vasculature 
could be obtained. 
Finally, this chapter further investigates the presence of the two other actin-binding 
proteins, LASP-1 and Drebrin, within shear-induced EMPs. Chapter 4 showed that 
these two actin-binding proteins play different roles within the vasculature while 
appearing to exist in the same network as Palladin. LASP-1 is a structural protein which 
appears to regulate actin cytoskeleton organisation at the edges of cells (Lin et al., 
2004), whereas Drebrin appears to be involved in actin cytoskeleton remodelling and in 
the formation of cell processes. Having observed how LASP-1 follows a similar post-
shear pattern of expression as Palladin, whereby it increases expression, then decreases 
at later time points, it was hypothesised that it may also follow a similar pattern of 
release via microparticles. The Drebrin protein showed an alternative post-shear 
expression pattern; whereby it immediately became downregulated. Shear-released 
EMPs were probed for Drebrin to determine if there was protein also released via this 
mechanism. By doing so, it could be shown if downregulation of Drebrin was a result of 
release from the cells, or else active repression of the protein within the cell itself. 
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5.1.1 Study Aims 
The work performed out in this chapter firstly sets out to determine the functional role 
of the Palladin protein with regards to cell migration in endothelial cells. Secondly, the 
work also investigates the release of Palladin via Endothelial Microparticle release. 
Therefore the overall aims of this chapter include: 
 To observe the cell migratory patterns of cells where Palladin has been knocked 
down, and to determine the protein function in cell migration. 
 To investigate the release of Palladin within EMPs after the subjecting of 
HAECs to the haemodynamic forces of cyclic strain and laminar shear stress. 
 Determining the change in Palladin expression when incubating regular HAECs 
with conditioned cell media containing elevated volumes of EMPs.  
 Investigation of the release of Palladin protein via EMPs released from 
interactions of the cells with permissive and nonpermissive extracellular 
matrices following laminar shear. 
 Observing the release of Palladin via Endothelial Microparticles taken from 
human blood samples post-exercise. 
 Characterisation of the related actin-binding proteins – LASP-1 and Drebrin in 
shear-induced EMPs. 
 230 
 
5.2: RESULTS 
The first experiment demonstrated here shows the imaging of static HAECs which were 
transfected with a Palladin-specific siRNA and subjected to a scratch wound assay as 
described in Chapter 2.2.4.2. Controls were also prepared - either transfected with 
scrambled siRNA, or else non-transfected cells. Cells were photographed for a number 
of time points up until 6 hours (after this point, cells cannot be differentiated between 
migrating and proliferating). The measured distance between each set of cells is 
measured in size of pixels across the image - to show the rate of migration between 
samples as the wound closed over. Within 1 hour post scratch, the cells transfected with 
Palladin siRNA have barely closed, while the scrambled and the non-transfected have 
already lost roughly 25% of the space between cells. The scrambled siRNA transfected 
cells appear to migrate slightly slower than the non-transfected. This divide between the 
two controls is more prominent at 3 hours. Here, the scratch wound in the non-
transfected cells is roughly 1/3 of the size it was at 0 hours. Meanwhile the distance in 
the scrambled cells is around half the size it was immediately post-wound. The cells 
transfected with Palladin siRNA are migrating also, but they are much slower to migrate 
than the control cells. At 3 hours, they have the same distance as the scrambled cells did 
at 1 hour. This slowdown in migration is confirmed when the cells are imaged at 6 
hours. Here, the Palladin siRNA cells have migrated only 50% of the distance created 
by the wound at 0 hours. Both sets of the control cells at the same time point have 
migrated fully across the initial wound. 
The measured distances between cells is quantified in Figure 5.1.1, showing the relative 
migration pattern between the three groups of cells. This highlights how the Palladin 
siRNA transfected cells demonstrate less migration. Figure 5.1.2 shows Western 
Blotting of HAECs transfected with Palladin siRNA performed against control lysate 
samples to prove the knockdown of protein. Lysate was also obtained from cells 
transfected with a GFP-tagged Palladin plasmid and it was used here as a secondary 
positive control (as well as demonstrating relative over-expression of Palladin). As 
shown by the absence of protein bands, knockdown of Palladin was achieved with both 
25nM and 50nM of siRNA. The lower amount was used for subsequent experiments. 
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Palladin siRNA      Scrambled siRNA                       Non-transfected 
(0 hours post scratch wound) 
 
 (1 hour post scratch wound) 
 
 (3 hours post scratch wound) 
 
 (6 hours post scratch wound) 
 
Figure 5.1: Cell Migration following Scratch Wound Assay in HAECs subjected to siRNA-
mediated knockdown of Palladin. HAECs transfected with either: Palladin siRNA, scrambled 
siRNA or non-transfected, were allowed to adhere to the culture dish. Optimisation proved that 
knockdown was first seen to occur at 30 hours post-transfection. At this time point, a 1mm in 
diameter line of cells was scraped away. Cells were imaged at the time points listed. Diameter 
between the cells in the images was measured and is expressed in length of pixels (px). All 
images are taken at 100X magnification.  
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Figure 5.1.1: Expression of Cell Migration in Palladin Knockdown HAECs vs. Control 
HAECs. The diameter of the scratch wound from each image from Figure 5.1 was calculated 
and is expressed here relative to the diameter observed in the 0 Hour (immediately post-scratch 
wound) cell migration images. Relative diameter is expressed in this graph, indicating how 
much of a distance there was between cells at each time point post scratch wound. In Scrambled 
siRNA cells and Non-transfected HAECs, cells had fully migrated across the wound at 6 hours. 
As such, they were then recorded as zero in the above graph. 
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Figure 5.1.2: Optimisation of siRNA-mediated knockdown of Palladin. This figure 
demonstrates the efficacy of siRNA knockdown of Palladin. Regular HAEC lysate was analysed 
via Western Blot methods as described previously. At 30 hours post-transfection, cells 
transfected with siRNA were also lysed and analysed. The sample designated ‘+’ was lysate 
obtained from cells transfected with a GFP-tagged Palladin plasmid. It was used here as a 
secondary positive control and to also show over-expression of Palladin compared to the other 
lysates. The sample designated ‘-‘ is representative of lysate taken from HAECs transfected 
with 25nM of siRNA. The double negative ‘--‘ sample represents HAECs transfected with 
50nM of siRNA. As observed, both achieved knockdown, so 25nM was employed for cell 
migration experiments.  
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Transfected cells were also assayed using the xCELLigence™ system, a novel method 
that allows monitoring of cell migration and adhesion real-time without any labelling. 
The system works by measuring the electrical impedance across the integrated micro-
electrodes at the base of specialised cell culture plates (Ke et al., 2011). The impedance 
is measured using a dimensionless parameter called the Cell Index (CI) which is derived 
from the relative change in electrical impedance. The CI is characteristically set at zero 
when cells are absent or not-adhered to the electrodes. Under the same physiological 
conditions, when more cells are attached (from adhesion or migration), the impedance is 
larger, leading to increased CI value. Additionally, change in a cell status, such as cell 
morphology, or cell viability will lead to a change in CI. Change in CI is represented as 
the slope of the curves calculated over a two hour time frame. This time frame was 
picked as initial results showed the greatest changes in impedance occurring up to this 
time point. 
Knocked-down cells were analysed for cell migration. Cells were transfected as before, 
with the relevant controls. In an effort to understand the role of Palladin in cell 
migration following haemodynamic stimulation, cells transfected with Palladin siRNA 
were subjected to 3 hours of cyclic strain post-transfection. This time point was 
determined to be the optimum time to observe changes in cell morphology. These cells 
were all then seeded in triplicate into the CIM plate, as described in Chapter 2.2.4.3. 
Results are displayed in Figure 5.2 (i) where the events have been graphed at each 5 
minute recording of impedance. As a negative control, some wells of the CIM plate 
contained standard cell media (Red). Results appear to show that differences in 
impedance events are very miniscule, owing to the closeness of the curves. The slope of 
the migration curve for each sample was calculated using the RTCA 1.2 Software and 
results are shown in Figure 5.2 (ii). This indicates the degree of migration that each set 
of treated cells are experiencing. Results indicate that strained non-transfected cells 
(with the lowest slope) unusually experience the least migration. They are followed by 
scrambled siRNA cells and then Palladin siRNA cells. Migration is faster in strained 
knockdown cells than static. This indicates that the strain induces migration further on 
cells lacking in Palladin.  
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 (i) 
 
(ii) 
 
Figure 5.2: xCELLigence™ Assay of Cell Migration in Palladin Knockdown Cells. HAECs 
were transfected as per previous methods. Cells were also subjected to cyclic strain at 10% for 3 
hours. A control knockdown sample, where cells were transfected with Palladin siRNA and not 
strained is also provided. Cells were seeded in triplicate on an xCELLigence™ CIM plate for 
assaying of migration. The recorded CI results for the first two hours are presented here in 
Figure 5.2 (i). Two hours was determined to be an optimum time to observe immediate cellular 
events before cells started to proliferate, affecting results. Empty wells on the plate were filled 
with media to provide a negative control. The recorded impedance for this baseline is 
highlighted in red. The slope of the migration curve for each sample was calculated using the 
RTCA 1.2 Software, with results shown in Figure 5.2 (ii). The increase in the slope is indicative 
of an increase in cellular migration. Results are representative of three independent experiments. 
Statistical analysis failed to show P<0.05. 
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The effect of haemodynamic force on the release of endothelial microparticles is next 
demonstrated. Figure 5.3 illustrates the Western Blot analysis of EMPs released after a 
number of time points of cyclic strain at both (i) physiological and (ii) pathological 
levels. Whole cell lysates are probed on the same blot as a positive control. As shown 
below, only the lysates returned showed bands. This indicates that Palladin is absent in 
the EMPs that are released following either types of cyclic strain. Because of this, 
subsequent microparticle experiments focused exclusively on shear-induced EMPs. 
 
(i) 
 
(ii) 
 
Figure 5.3: Investigation of Palladin within Cyclic Strain-derived Endothelial 
Microparticles. Following time points of cyclic strain of (i) 5% physiological and (ii) 10% 
pathological strain, microparticles were extracted from harvested cell, using the methods 
described in Chapter 2.2.2.3. Cell lysate was loaded into the same gel, and is displayed here as a 
positive control. Ponceau S staining of the membrane and Coomassie Blue staining of the gel 
post transfer (not shown) showed that microparticles completely transferred across to the 
membrane during the process. 
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Endothelial microparticles were obtained from cells subjected to 24 hours of LSS as 
well as static cells. Both sets were assayed using an APC-conjugated antibody for 
VCAM-1 (Vascular cell adhesion molecule 1, also known as CD106). VCAM-1 is a 
noted endothelial cell marker, so this was used to indicate that the microparticles 
obtained following shear stress were endothelial in nature. Samples were prepared as 
described in Chapter 2.2.3.1 and analysed using the Millipore® Guava system. The 
illustrated results (Figure 5.4) show that a small amount of APC-positive microparticles 
are recorded in the sheared sample, which are not present in the control static sample. 
The result confirms that a number of microparticles are released from cells post-shear 
are indeed endothelial in origin. 
.  
Figure 5.4: Characterisation of Shear-derived Endothelial Microparticles through FACS 
analysis. Microparticles obtained from cells subjected to 24 hours of LSS were analysed using 
the Millipore® Guava system. The microparticles were probed using an APC-conjugated 
antibody for VCAM-1, a noted endothelial cell marker, so this was used to indicate that the 
microparticles observed were endothelial in nature. 
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Having determined that shear-induced microparticles are indeed endothelial in origin, 
experiments were repeated to extract them from sheared cell media. Results had shown 
that Palladin expression in whole cells increased immediately within the first hour post-
shear, before declining at 3 hours (Figure 3.10). A second peak is seen then at 6 hours, 
but this declines after later time points. It was hypothesised that this decline in protein 
could be explained by the release of protein through EMPs. To confirm this theory, the 
microparticles were themselves probed for Palladin using Western Blotting methods, 
results of which are shown in Figure 5.5. As observed, Palladin is almost absent within 
EMPs from static cells. The protein bands appear to increase in intensity following 
increased shear time points. One isoform, either 122kDa or 128kDa in size, is observed 
to become more prominent at 1 hour than the 90kDa isoform. However it declines in 
intensity by 6-24 hours. Densitometric analysis of the 90kDa isoform shows that there is 
a significant amount of Palladin released at 6 hours, where expression reaches a peak. A 
slight decline in expression is observed at 24 hours, but protein remains significantly 
more expressed at this time. 
Figure 5.5.1 compares the relative expression of Palladin in whole cells (as determined 
in Figure 3.10) with the expression in microparticles (as shown in Figure 5.5). As 
shown, within the first hour of LSS, the relative protein expression within the 
microparticles follows the same pattern as protein expression from whole cells. There 
are differences between the two sets of data from 3-24 hours. Here, there is a higher 
relative-to-baseline expression of Palladin within the EMPs. This experiment confirms 
that there is a higher release of Palladin from HAECs at longer time points of LSS. 
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Figure 5.5: Observation of Palladin release in Shear-induced Endothelial Microparticles 
from HAEC media samples. Microparticles obtained from cells subjected to different time 
points of shear were probed for Palladin using Western Blot methods. GAPDH was used as a 
control marker, and microparticles were extracted from equal volumes of cell media. The blot 
was analysed using ImageJ densitometric quantification software. The values given for intensity 
of each 90kDa sized Palladin band is given here, following normalisation against the GAPDH 
control protein bands, and are expressed in comparison to the microparticle release at the 
baseline zero hour shear. *p<0.05. 
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Figure 5.5.1: Comparative trends of Palladin protein expression in HAECs subjected to 
Laminar Shear Stress vs. Palladin protein expression in Shear-induced Endothelial 
Microparticles. Here, the data from Figure 3.10– Palladin expression in whole cell lysates of 
cells subjected to shear – is compared to the similar expression of Palladin in shear-induced 
Endothelial Microparticles from Figure 5.5. Whole cell lysates are designated by the light blue 
columns, while Endothelial Microparticles are designated by the dark blue columns. The values 
given for intensity of each 90kDa sized Palladin band is given here, following normalisation 
against the GAPDH control Western Blotting bands, and are expressed in comparison to the 
relevant protein expression at the baseline zero hour shear. 
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The experiments confirmed that Palladin was released in larger amounts from HAECs 
that had been subjected to LSS. An experiment was devised with the intentions of 
investigating the effects that these microparticles may have on Palladin expression in 
healthy cells. Cells were incubated with conditioned cell media – either completely 
fresh new media (designated as Static 0 hour), media that was already on static cells for 
24 hours prior (Static 24 hour), or else the media that was on cells sheared for 24 hours 
(Sheared 24 hour) which would contain a larger number of Endothelial Microparticles. 
All three plates were incubated as normal for an additional 24 hours, before the media 
was harvested and the cells were lysed. Figure 5.6 here displays the expression of 
Palladin observed with the HAECs following incubation with these different media 
samples. As shown, the incubation had negligible effects on expression in cells 
incubated with either the fresh media or media obtained from static cells. However, 
there was a significant decline in Palladin expression with cells that were incubated with 
media taken from previously sheared cells. Palladin expression is roughly half that of 
the static control cell lysate. 
When these experiments were performed, the media was retained following the second 
incubation with new cells. EMPs were subsequently extracted and probed via Western 
Blotting methods for Palladin, to observe if there was any Palladin present in these 
microparticles at post-incubation. Figure 5.6.1 demonstrates that there are strong bands 
present in the microparticles extracted from the sheared media sample. The two other 
samples – static 0 hours and static 24 hours – show only miniscule amounts of Palladin. 
This demonstrates that the previous sample was indeed incubated with EMPs containing 
Palladin, while also illustrating that there is very little protein released from cells that 
remain static. 
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Figure 5.6: Expression of Palladin in HAECs incubated with conditioned Static vs. 
Sheared media samples. Figure 5.6 here displays the expression of Palladin observed with the 
HAECs following incubation with different media samples - fresh new media (Static 0 hour), 
media incubated with static cells for 24 hours prior (Static 24 hour), or else media from cells 
sheared for 24 hours (Sheared 24 hour). HAEC lysate from static cells was also analysed to use 
as a comparative control. GAPDH is used as a control to ensure equal loading of protein. The 
Western Blot was analysed using ImageJ densitometric quantification software. The values 
given for intensity of each Palladin band is given here, following normalisation against the 
GAPDH control Western Blotting bands, and are expressed in comparison to the baseline zero 
hour shear. *p<0.05. 
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Figure 5.6.1: Observation of Palladin release from Endothelial Microparticles extracted 
from conditioned cell media post-incubation with HAECs. Following the aforementioned 24 
hour incubation with the cells, the different conditioned cell media samples used in the 
experiments – Static 0 hour, Static 24 hour, and Sheared 24 hour - were harvested and 
Endothelial Microparticles were extracted from equal volumes of the media as per previously 
described methods. The microparticles were subsequently probed for Palladin, with GAPDH 
used as a control. The Western Blot was analysed using ImageJ densitometric quantification 
software. The values given for intensity of each Palladin band is given here, following 
normalisation against the GAPDH control Western Blotting bands, and are expressed in 
comparison to the baseline zero hour shear. *p<0.05. 
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The shear induced release of EMPs was investigated in greater detail, with the 
investigation of Palladin in cells cultured on extracellular matrices. As detailed in 
Chapter 3, these cells were sheared and the presence of Palladin within the whole cells 
was investigated. The sheared media was also retained, with microparticles being 
extracted from the samples. These microparticles were assayed for Palladin using 
Western Blotting methods.  
Figure 5.7 first demonstrates Palladin expression following cells that were cultured on a 
fibrinogen matrix. While bands for the GAPDH control are visible at all of the time 
points and increase in intensity, there is only Palladin observed at 24 hours post-shear. 
None of the other earlier time points demonstrate a release of Palladin through EMPs. 
The protein released is also a clearly smaller amount than that present in the whole cell 
lysate control. 
Unusually, this lack of expression is observed within the microparticles extracted from 
cells on other cell matrices. Figure 5.8 illustrates the expression in microparticles from 
cells cultured on a fibronectin matrix and then sheared. Here, similarly to Figure 5.7, 
there is a lack of Palladin expression until 24 hours, where a faint band is finally visible. 
Again, this is miniscule compared to that of the whole cell lysate control sample. 
The microparticles extracted from cells cultured on Type IV collagen also fail to show 
any early expression of Palladin (Figure 5.9). A band is visible at 24 hours, but this is 
very faint also. This is in stark contrast to the control cell lysate, or the GAPDH control 
– both of which demonstrate very strong bands for protein. The reasoning for this active 
repression of release of Palladin in EMPs from cells on these matrices is discussed in 
Chapter 5.3.  
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Figure 5.7: Observation of Palladin release from Shear-induced Endothelial 
Microparticles derived from HAECs seeded onto a Fibrinogen Matrix and Sheared at 10 
dynes/cm
2
. HAECs were cultured on dishes coated with 10μg/ml fibrinogen. Upon reaching 
confluency, the cells were subjected to LSS for different time points. Endothelial Microparticles 
were subsequently extracted from the cell media and then probed for Palladin using Western 
Blot methods. GAPDH was used as a control marker, and equal volumes of cell media were 
used for microparticle extraction. HAEC whole cell lysate was also probed on the Western Blot, 
to use as a positive control. 
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Figure 5.8: Observation of Palladin release from Shear-induced Endothelial 
Microparticles derived from HAECs seeded onto a Fibronectin Matrix and Sheared at 10 
dynes/cm
2
. HAECs were cultured on dishes coated with 10μg/ml fibronectin. Upon reaching 
confluency, the cells were subjected to LSS for different time points. Endothelial Microparticles 
were subsequently extracted from the cell media and then probed for Palladin using Western 
Blot methods. GAPDH was used as a control marker, and equal volumes of cell media were 
used for microparticle extraction. HAEC whole cell lysate was also probed on the Western Blot, 
to use as a positive control. 
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Figure 5.9: Observation of Palladin release from Shear-induced Endothelial 
Microparticles derived from HAECs seeded onto a Collagen Matrix and Sheared at 10 
dynes/cm
2
. HAECs were cultured on dishes coated with 20μg/ml Type IV collagen. Upon 
reaching confluency, the cells were subjected to LSS for different time points. Endothelial 
Microparticles were subsequently extracted from the cell media and then probed for Palladin 
using Western Blot methods. GAPDH was used as a control marker, and equal volumes of cell 
media were used for microparticle extraction. HAEC whole cell lysate was also probed on the 
Western Blot, to use as a positive control. 
 
 
  
 248 
 
The results from investigating the release of microparticles on cells in contact with 
extracellular matrices showed an apparent repression of Palladin in EMPs, with only 
miniscule amounts of protein present. A better model of in vivo release of Palladin in 
shear-induced EMPs is demonstrated with Figure 5.10. Here, plasma was extracted (as 
described in Chapter 2.2.2.4) from subjects post-exercise and the EMPs were extracted, 
as were the exosomes – a smaller class of particle. Probing these samples on a Western 
Blot indicated that Palladin was indeed present in an in vivo model, with an elevation in 
protein in samples taken post-exercise compared to samples from a relaxed state. There 
appeared to be a selective localisation of the Palladin isoforms to different particle 
subsets – the 90kDa and 128kDa isoforms were visible in the microparticles, whereas 
the 43kDa isoform remained exclusive to the exosomes. In samples obtained from the 
relaxed state, this 43kDa isoform was visible in the exosomes also. However the 90kDa 
and 128kDa isoforms were absent in the corresponding microparticle sample. 
 
Figure 5.10: Observation of Palladin release in Shear-induced Endothelial Microparticles 
and Exosomes from Healthy Blood Plasma Samples. Equal volumes of blood were drawn 
from a healthy male immediately following active exercise – quantified as reaching 15-20 on 
the Borg Scale (Borg, 1982). Samples were also taken from the subject at a relaxed state (6-7 on 
the Borg Scale). The Endothelial Microparticles (MPs) and Exosomes (Exs) extracted from the 
plasma are presented here after probing on a Western Blot for Palladin. GAPDH was used as a 
control. 
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Palladin has been shown to be expressed in shear-induced EMPs, shedding light on the 
mechanisms of protein release from the cell post-shear. The two other proteins of 
interest in this thesis – LASP-1 and Drebrin – were investigated to observe how they are 
released within EMPs also. Given that Palladin is released from the cells as a coping 
mechanism to cope with excess protein, it was hypothesised that the same may happen 
with LASP-1. Since Drebrin is shown to decrease immediately following shear, it was 
thought that some of this protein may be exported from cells via an endothelial 
microparticle release mechanism. 
LASP-1 was initially shown to increase in whole cells post-shear. In Figure 5.11, the 
expression of LASP-1 in microparticles shows that following LSS, the amount of 
LASP-1 appears to decline. Western Blot protein bands are visible in the initial time 
points, but they appear to fade. Densitometric analysis shows that LASP-1 release in 
EMPs is significantly deplete within the first 3 hours of shear. An increase in LASP-1 
release is seen at 6 hours, but this declines again at 24 hours. Comparing the expression 
of LASP-1 in whole cells to the expression in EMPs (Figure 5.11.1) shows that the 
release of protein in microparticles appears to follow the pattern of the expression in 
whole cells; however the expression in EMPs is relatively lower than that of the whole 
cell lysates. 
Drebrin is investigated in release of microparticles also. Figure 5.12 demonstrates that 
there is a significant increase in the amount of protein released from the microparticles. 
Protein bands appear much more prominent in microparticle samples than that of the 
bands illustrated in Figure 4.11. Densitometric analysis of the blot in this figure 
highlights how there is a steady increase of Drebrin released within the EMPs for the 
first 6 hours post-shear. At 24 hours, there is a decline in the amount of protein 
expressed, although this remains elevated compared to the static baseline expression. A 
comparative figure is provided (Figure 5.12.1) to show post-shear expression of Drebrin 
in both microparticles and whole cell lysates. Here, the relative expression of protein 
within the EMPs greatly outweighs that of the whole cell lysates. For the first 6 hours, 
expression in EMPs increases as expression in lysates decreases. At 24 hours, the 
expression in lysates decreases further, but so does the expression in microparticles. 
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Figure 5.11: Observation of LASP-1 release in Shear-induced Endothelial Microparticles 
from HAEC media samples. Microparticles were extracted from the media of HAECs that 
were subjected to time points of LSS at 10 dynes/cm
2
. Following this, they were analysed on a 
Western Blot and probed for LASP-1. Blots were stripped and probed again for GAPDH for use 
as an endogenous control. Following probing, the bands were analysed using ImageJ 
densitometric quantification software. The values given for intensity of each LASP-1 band is 
given here, following normalisation against the GAPDH control Western Blotting bands, and 
are expressed in comparison to expression in the zero hour static cells. *p<0.01. 
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Figure 5.11.1: Comparative trends of LASP-1 protein expression in HAECs subjected to 
Laminar Shear Stress vs. LASP-1 protein expression in Shear-induced Endothelial 
Microparticles. Here, the data from Figure 4.6 - LASP-1 expression in whole cell lysates of 
sheared cells – is compared to the similar expression of LASP-1 in shear-induced Endothelial 
Microparticles from Figure 5.11. Whole cell lysates are designated by the light blue columns, 
while Endothelial Microparticles are designated by the dark blue columns. The values given for 
intensity of each LASP-1 band is given here, following normalisation against the GAPDH 
control Western Blotting bands, and are expressed in comparison to the relevant protein 
expression at the baseline zero hour shear. 
  
 252 
 
 
 
 
Figure 5.12: Observation of Drebrin release in Shear-induced Endothelial Microparticles 
from HAEC media samples. HAECs were subjected to time points of LSS at 10 dynes/cm
2
, 
with EMPs being extracted from the cell media post-shear. Following this, they were analysed 
on a Western Blot and probed for Drebrin. GAPDH was also probed as an endogenous control. 
The blot was analysed using ImageJ densitometric quantification software. The values given for 
intensity of each Drebrin protein band is given here, following normalisation against the 
GAPDH control protein bands, and are expressed in comparison to expression in the zero hour 
static cells. *p<0.01. 
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Figure 5.12.1: Comparative trends of Drebrin protein expression in HAECs subjected to 
Laminar Shear Stress vs. Drebrin protein expression in Shear-induced Endothelial 
Microparticles. Here, the data from Figure 4.11 - Drebrin expression in whole cell lysates of 
cells subjected to LSS – is compared to the similar expression of Drebrin in shear-induced 
Endothelial Microparticles from Figure 5.12. Whole cell lysates are designated by the light blue 
columns, while EMPs are designated by the dark blue columns. The values given for intensity 
of each Drebrin band is given here, following normalisation against the GAPDH control 
Western Blotting bands, and are expressed in comparison to the relevant protein expression at 
the baseline zero hour shear. 
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5.3: DISCUSSION 
Palladin is a protein with many functional roles, one of which has been observed to be 
its involvement in cellular remodelling in response to injury. The protein has been 
observed to be upregulated in different cell types along wound edges (Boukhelifa et al., 
2003). In vascular smooth muscle, Palladin has been seen to play a role in cell motility 
and contractility (Goicoechea et al., 2006). The closing of wounds typically requires an 
increased contractility and motility to bring the edges together and fill the wound; 
suggesting that Palladin is likely an essential protein for these processes. 
It is thought that the knockdown of Palladin in other cell types results in disruption in 
cell migration, caused by the depolymerisation of filamentous actin and disarrangement 
of stress fibres (Jin et al., 2009; Brentnall et al., 2012). Knockdown of Palladin in in 
vitro models has also been observed to result in the loss of LASP-1 from stress fibres in 
cells (Rachlin and Otey, 2006), highlighting how it is part of a functional network (as 
documented in Chapter 4). The silencing of Palladin appears to have a negative 
downstream effect on some of the related proteins in this manner. Palladin silencing 
was investigated before in an in vivo setting, with knockout mice being developed. 
However, the phenotype of these mice was embryonic lethality at about 15-16 days 
(Luo et al., 2005), which further highlights the importance of Palladin within the cell. 
While literature has discussed the protein knockdown in various cell types resulting in 
decreases in migratory patterns (Goicoechea et al., 2009; Otey et al., 2009), studies on 
the effects of Palladin knockdown on endothelial cell migration have yet to be reported. 
It was hypothesised that knocking down of Palladin in HAECs would result in a 
decrease of cell migration. Figure 5.1 displays the results of a scratch wound assay on 
HAECs transfected with Palladin siRNA. For use as comparative controls, an equal 
number of cells either (i) transfected with scrambled siRNA or else (ii) non-transfected, 
were both seeded onto culture dishes at the same time and subjected to the same scratch 
wound assay. Palladin knockdown efficiency is quantified in Figure 5.1.2, where 
Western Blot methods showed knockdown of protein within the cells. 
Within the first hour post-scratch, the non-transfected control cells are already migrating 
across the wound. By 3 hours, these same cells have almost completely formed a 
monolayer, one which is fully evident by 6 hours. In comparison, the transfected cells 
(both Palladin siRNA and scrambled) are slower to migrate across the wound area. 
Cells transfected with Palladin siRNA do not show much migration within the first 3 
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hours of investigation. At 6 hours, some migration has occurred, but a monolayer 
phenotype has yet to be achieved. In comparison, the scrambled siRNA transfected cells 
at first appear to follow a similar pattern, showing slower migration at 1 hour post-
scratch wound compared to the non-transfected cells. However, at 3 hours the cells 
appear to have migrated further than the Palladin siRNA knockdown cells, and are 
closer to achieving the same phenotype as the non-transfected cells. At 6 hours, they 
have completely formed a monolayer. When this measured and expressed in a graphed 
format (Figure 5.1.1), the decrease in migration in Palladin siRNA-transfected cells 
over the time points is more noticeable. Morphologically, control and knockdown cells 
also looked similar throughout the time course. 
The results appear to indicate that there is a general delay in migration when comparing 
transfected cells to the non-transfected cells. This is likely due to the reduction in 
stability of the transfected cells, owing to the microporation process and the insertion of 
foreign molecules (siRNA) into the cell. Despite this, the cells are still viable, and 
capable of cell migration, albeit at a slower rate. At 3 hours following the scratch 
wound, all the cells appear to show movement; however the Palladin siRNA transfected 
cells appear the slowest to migrate when compared to the other sets of cells. This 
illustrates how Palladin is an important protein for cell migration, since knockdown has 
a delayed effect on the cell movement across the wound. Six hours post-scratch wound 
appears to be the point at which cells migrate regardless of knockdown, demonstrating 
that there is only a small window of time to observe post-knockdown effects before cell 
proliferation occurs, making the migration of cells tougher to determine. 
Initial experiments were performed with similarly transfected cells using the novel 
xCELLigence™ system. The cells were strained to investigate the effect of 
haemodynamic force on cells lacking in Palladin. The silicon membrane of the BioFlex 
plates means it is harder to image cells for using in a wound healing assay; hence the 
xCELLigence™ system was used. Strain increases cell migration (Von Offenberg 
Sweeney et al., 2005), and it is shown in Figure 5.2 that migration increases in cells 
where Palladin is knocked down compared to the non-transfected cells. However, the 
rate of migration appears elevated after general transfection (the scrambled siRNA cells 
show elevated migration also) suggesting that this rise may be due to the transfection 
process causing the cells to alter in morphology and migrate quicker. There is a small 
increase in knocked-down cells that were strained versus those that were static, 
indicating that the removal of Palladin followed by haemodynamic force affects cell 
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migration. However, statistical analysis failed to show a significant change, so a 
conclusion based on this study cannot be reached. 
A possible reason for the removal of Palladin resulting in increased migration post-
strain may be that the role of Palladin in cell migration could be compensated by a 
different protein. This could also explain the delay in cell migration in the scratch 
wound assay occurring instead of a complete halt. It indicates that the cell could have a 
functional overlap mechanism for proteins involved in migration. While some proteins 
show a decline when Palladin is knocked down (e.g. LASP-1), there are other proteins 
in the same network that may be able to take over the role of Palladin (Goicoechea et 
al., 2009). Palladin expression appears to be tightly controlled to allow for transitions 
from non-motile to motile phenotypes. If it is tightly controlled in such a manner, then 
there may be other proteins that exist to compensate for its loss in the cell. The strong 
binding interaction between Palladin and its binding partners (e.g. α-actinin), coupled 
with their high degree of co-localization in cells and tissues, suggest that these proteins 
may have a shared function in motility and adhesion.  
An alternative reason for the short time frame for observing knockdown could also be 
on account of the excretion of the siRNA from the cells themselves, and subsequent 
normalisation of Palladin expression once again. As shown earlier, cells possess a 
method of exporting protein, RNA and miRNA out through microparticles; it is not 
unreasonable to think that the transfected siRNA can be exported in the same way. The 
cell membrane is already in a fragile state post-transfection, which in theory would 
make microparticle release easier. The fact that Palladin is a vitally important protein 
for cell development and function suggests that the microparticle excretion hypothesis 
may be likely. 
Endothelial Microparticles vary in size, phospholipid and protein composition. They 
promote coagulation, have a pro-inflammatory effect and affect vascular function. 
These processes are all involved in the pathogenesis of cardiovascular disease and it is 
suggested that microparticles may play also a role in the pathogenesis of CVDs. As 
discussed in Chapter 1, they may also show potential use as a biomarker for the disease 
state, potentially being used as a quantitative method of detecting CVD symptoms 
(Viera et al., 2012). EMPs are also known to be elevated in severe hypertension and 
other conditions associated with endothelial injury (Diamant et al., 2004). As well as 
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endothelial function, some haemodynamic force has an effect on stimulation of 
microparticle release. 
Shear stress modulates the integrity and permeability of endothelial cells, largely 
through its effects on intercellular junctional proteins such as connexins and VE-
Cadherin. These proteins are used as unique antigenic signatures that can differentiate 
the endothelial microparticles from other microparticles (Dignat-George and Boulanger, 
2011). Notably, these proteins can be upregulated in response to increased blood flow 
(Marin et al., 2013), not unlike how Chapter 3 showed the same upregulation occurring 
with Palladin. Shear stress may also elicit mechanotransduction pathways to induce or 
silence the transcription of miRNAs along with their parental genes (Wang et al., 2010). 
Despite an apparent lack of data on shear stress regulation of the junctional proteins 
through miRNAs, both connexins and VE-Cadherin are shown to be targeted by 
miRNAs (Muramatsu et al., 2013; Li et al., 2012) and therefore may contribute to the 
shear stress-regulated endothelial permeability, which in turn allows for increase of 
microparticle release. 
This release of microparticles is one which is induced differently by different signals 
(Shai and Varon, 2011). In particular, there appears to be a difference in the EMPs 
released through cyclic strain and from LSS. Figure 5.3 illustrates the probing of 
Palladin within cyclic strain-induced EMPs. Western Blots were used instead of ELISA 
methods for cost reasons and for easier comparison to protein expression from the 
whole cell lysates used in Chapter 3. Notably, with both (i) 5% physiological and (ii) 
10% pathological strain, there is an absence of Palladin. While bands appear for the 
positive control lysates, there is no protein detected in any of the microparticle samples 
released at any time point, from either 5% or 10% strain. There are reasons for this 
peculiar result. Firstly, there are only a relatively smaller volume of EMPs released 
from cells following cyclic strain when compared to those released from shear stress, 
due to the flow vs. pulse effect of stimulating membrane disruption and particle release 
(Brodsky et al., 2004). Cells are more prone to release microparticles when the flow 
causes a friction across the membrane, as opposed to the repetitive pulsing of blood (or 
media) pushing into the cells. Because of the reduction in microparticle number, it 
would follow that there is a reduction of levels of Palladin being released too. 
Secondly, since LSS and cyclic strain have a different effect on microparticle number, 
there may be differential regulation of what gets exported through the released 
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microparticles, depending on type of haemodynamic force. Different agonists have been 
shown to result in the release of different particles subsets from a single cell type 
(vanWijk et al., 2003); shear and strain may affect release in a similar way. There may 
also be different signalling methods (such as miRNA) prohibiting the release of Palladin 
from strain-induced microparticles while allowing release in shear-induced 
microparticles, but this is something that merits future investigation. We have shown 
that there is a localisation of Palladin to different areas of the cell following LSS (Figure 
3.14.1); it is likely that there is a similar localisation following cyclic strain, one which 
relocates the protein away from the membrane and reduces the chance of release 
through strain-induced microparticles. A similar relocalisation mechanism is suggested 
later on HAECs sheared on extracellular matrices 
Because Palladin appears to be absent from strain-induced microparticles, which 
themselves also appeared in lower numbers, the rest of the studies were based on 
microparticles released due to shear stress. Figure 5.4 characterises these shear-induced 
particles as being endothelial in nature, having being subjected to FACS analysis using 
VCAM-1 as an endothelial specific marker. There are a number of VCAM-1 particles 
present, confirming the particle type. Figure 5.5 subsequently demonstrates the presence 
of Palladin in EMPs following time points of laminar shear. It appears that the amount 
of the 90-kDa isoform of Palladin protein released within the microparticles increases in 
a steady trend following the conditions of shear stress, significantly peaking at 6 hours – 
the same time point of peak protein expression in whole cell lysates (Figure 3.10), 
demonstrating that as Palladin is upregulated in the cell, protein is exported from the 
cell at the same time.  
Figure 5.5.1 illustrates how, for the first 3 hours of LSS, the relative protein expression 
within the microparticles follows the same pattern as protein expression from whole 
cells. This pattern is suggestive that following the inflammatory response, HAECs 
compensate for excess protein production through microparticle secretion. However, the 
relative levels of protein expression become disparate between the two sets of data at 6-
24 hours, showing higher expression of Palladin within microparticles. As the cells 
adapt to chronic shear stress, the cells begin remodelling further, resulting in an increase 
of Palladin, but also destabilisation of the membrane as the cell morphologically 
changes. This destabilisation can result in an increase of EMP release, which results in 
the elevated Palladin levels. The 24 hour time point shows a slight reduction in 
microparticles, suggesting that the cells may have a phagocytic mechanism for cells to 
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internalise surrounding microparticles and the protein found within (Terrisse et al., 
2010). Also of note is the apparent expression of the other isoforms of Palladin 
appearing in the microparticles. Figure 5.5 demonstrates that either the 122kDa or 
128kDa isoform appears to be present in EMPs at 1-6 hours. This is an interesting 
occurrence; it appears that there may be a selective mechanism in the cells to release 
Palladin isoforms at different time points of shear, while retaining others. The selective 
release of Palladin is observed later in Figure 5.10 when Palladin is investigated in 
microparticles from plasma samples. 
The effect of the internalisation of EMPs on HAECs was investigated first however. 
Endothelial cells with high levels of microparticles in vitro have been already observed 
to play an inhibitory effect on cell growth and function (Mezentsev et al., 2005; 
Taraboletti et al., 2002). Having observed this, an experiment was designed where cell 
media containing shear-induced EMPs would be added to new, static plates of HAECs 
(Figure 5.6). It was performed to investigate if these extra EMPs may have an inhibitory 
effect on Palladin production, or if the extra Palladin in the EMPs create overexpression 
of protein in the cells. Lysates from static HAECs, HAECs cultured in new media and 
HAECs cultured with 24 hour-old media from other static cells were also assayed. The 
addition of either fresh or 24 hour-old media to static HAECs does not appear to 
significantly affect the expression of Palladin. This is expected, as the HAECs remain 
static the whole time, without any haemodynamic force stimulating an increase of 
Palladin expression. In HAECs cultured with media from 24-hour sheared cells 
(containing a large volume of EMPs), the expression level of Palladin significantly 
decreases.  
Curiously, when the media from these cells is assayed in Figure 5.6.1, the level of 
Palladin-containing EMPs outside of the cell remains high – indicating that the protein 
is not re-absorbed into the cells. It appears that the addition of EMPs to HAECs causes 
Palladin downregulation; even though these microparticles themselves contain Palladin 
and could be absorbed, they don’t increase the protein level within the cell, and may in 
fact reduce it. A reasoning for this may be that the cells identify they are surrounded by 
a massive supply of Palladin, and therefore are signalled (Likely through RNA or 
miRNA transfer) to halt production of protein, resulting in a downregulation of 
endogenous levels in the static cells (Mause, 2010). Microparticles are observed to carry 
a specific subset of cellular mRNA or miRNA, not just a random sample (Mause and 
Weber, 2010). Therefore it may be that this may be a specialised signal that the cell 
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actively secretes from microparticles, to initiate downregulation of Palladin in 
neighbouring cells. The mechanisms for this selectivity still remain to be characterised, 
but it is suggested that the “packaging” of microparticles with specific RNA depends on 
the activating stimulus and that the transferred levels of RNA are regulated by specific 
nucleases in the recipient cell (Yuan et al., 2009). As discussed earlier in Chapter 1, the 
elevated levels of microparticles released can be a result of endothelial dysfunction, but 
also worsen the said dysfunction (Brodsky et al., 2004). This downregulation of 
Palladin appears to be a further example of how elevated microparticle levels may be 
detrimental for endothelial cell morphology. 
It should be noted that this media may contain other factors apart from microparticles 
which may affect protein expression. It must be considered that the signalling that 
influences Palladin expression may occur from other substances, such as vWF or other 
cytokines and chemokines which are released post-shear (Urschel et al., 2012). For now 
we cannot conclusively prove the effects of microparticles on protein expression in 
neighbouring cells, but this provides the groundwork for future investigation. 
The signalling effects involved in Palladin expression were investigated further, through 
observation of protein within shear-induced EMPs released from HAECs cultured on 
extracellular matrices: fibrinogen, fibronectin or collagen. Figure 5.7 first demonstrates 
the expression of Palladin in EMPs when cells are seeded on the permissive fibrinogen 
matrix and subjected to time points of LSS. Palladin expression appears to be halted for 
the first set of time points, with faint bands only appearing at 24 hours. When observing 
the protein expression of the whole cells (Figure 3.17) expression of Palladin stays 
relatively steady until there is a decrease in protein from 24-48 hours, suggesting that 
the reduction in protein at that time is likely due to it being exported through EMPs. It 
appears that the fibrinogen matrix has an effect on the cells where it promotes Palladin 
upregulation, but also retains the protein within the cell, most likely to utilise in cell 
adhesion and migration as the HAECs adapt to the matrix and subsequent shear stress. 
Fibrinogen binding to the receptors of endothelial cells appears to activate MAP kinase 
signalling, which then triggers alterations in protein transport within the cell (Patibandla 
et al., 2010). It is conceivable that Palladin may be transferred towards the base of the 
cell, in order to adhere the cells better to the ECM, and help the cells migrate better 
across this matrix; therefore keeping the protein away from the apical membrane, where 
it could be lost through microparticle release. When the cells have completely adapted 
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to chronic shear by 24 hours i.e. stopped migrating, it is only then that they start 
exporting Palladin through microparticles. 
This pattern of retaining Palladin within the cell is observed again when the cells are 
seeded on a fibronectin matrix – as demonstrated in Figure 5.8. Here, Palladin is once 
again retained within the cells and is only exported following an extended period of 
shear stress. Protein expression from whole cells (Figure 3.19) is shown reducing 
slightly from 3-6 hours - explaining the slight presence of bands in the 6 hour time point 
of Figure 5.8 - before significantly decreasing at 24-48 hours of shear stress, where the 
Palladin protein is firmly exported from the cells. The α5β1 integrin is initially present 
in focal adhesions formed on a fibronectin substrate, but unless the fibronectin is 
immobilized it may cause formation of exaggerated α5β1-containing focal adhesions 
(Katz et al., 2000). The increase of α5β1 may result in repression of Palladin. The 
expression of Palladin within cells was observed in Figure 3.19 to be inhibited on the 
permissive fibronectin matrix compared against an uncoated matrix; however this did 
not appear to affect the microparticle release in a significantly different way. Since 
Palladin expression would be muted in whole cells because of interactions with the 
ECM, it follows that the protein would be retained within cells for an extended period 
as the cells needed it to help remodel in response to the subsequent shear stress.  
When observing Palladin expression of whole cells seeded onto the nonpermissive 
collagen matrix (Figure 3.21), the protein expression appeared to be sustained for the 
first 24 hours, before it started to reduce. As observed in Figure 5.9, Palladin is not 
exported from the cells via EMPs until the 24 hour time point of LSS. It was already 
suggested that, while the collagen matrix causes total upregulation of Palladin from just 
seeding cells onto the matrix, it also blocks the signal for Palladin upregulation 
following shear stress. Here, Figure 5.9 seems to indicate that growing the cells on the 
matrix also blocks the release of Palladin from the cells until they have completely 
adapted to chronic shear. Collagen is seen to increase cell adhesion (Kemeny et al., 
2013); this theoretically may cause Palladin to localise from one area of the cell to 
another (such as from the membrane to the cytoskeleton) to aid cell adhesion, indicating 
why the protein is not released from the cell. As discussed in Chapter 3, the ECMs can 
also enhance cell migration, so by 24-48 hours the cells have finished remodelling and 
do not require Palladin in such quantities. Figures 5.7-5.9 jointly appear to confirm that 
the protein is retained by the cells up to this time point before it is exported via EMP 
release. ECMs have also been shown to cause adhesion of microparticles to the basal 
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matrix, indicating that a small number of particles themselves may have been retained 
(Keuren et al., 2007). 
While these matrices help to better characterise the release of EMPs, they are still only 
an in vitro model. It must be noted that the increasing densitometric values of Palladin 
within EMPs may be due to the simple accumulation of microparticles in media. In 
regular conditions in the vasculature, the blood which creates shear stress would 
inherently move over further distances through the aorta, carrying the released 
endothelial microparticles with it as it moves through the vessels. An in vivo 
observation of the EMPs was then sought. Microparticles are observed in the blood of 
healthy individuals but can elevate from shear stress (Vion et al., 2013). In Figure 5.10, 
the probing for Palladin within EMPs and exosomes extracted from blood is 
demonstrated. Equal volumes of blood were drawn from a young and healthy patient 
immediately following active exercise – quantified as reaching 15-20 on the Borg Scale 
(Borg, 1982). Samples were also taken from the same person at a relaxed state (6-7 on 
the Borg Scale). Samples were pre-spun; doing so separated the plasma (which contains 
EMPs) from platelets and blood cells. Plasma was subjected to the extraction methods 
detailed in Chapter 2.2.2.4, allowing for the separate collection of both microparticles 
and exosomes, which were probed on a Western Blot. As observed in Figure 5.10, there 
was a strikingly different pattern of expression than that observed with endothelial cells 
– namely that out of all the isoforms observed in endothelial cells, only the 90kDa and 
122kDa isoforms appeared in microparticles, with the 43kDa isoform appearing in 
exosomes. This is similar to the release of different isoforms at different time points of 
shear that was observed in Figure 5.5. Alternative gene splicing has been observed to 
happen following exercise (Tonevitsky et al., 2009), so it may be that the PALLD gene 
undergoes such splicing into different isoforms under exercise induced stress. These 
shear-induced microparticles are also reduced in a relaxed state, resulting in there being 
less Palladin observed. In the resting state, only the 43kDa isoform is seen, indicating 
that Palladin is upregulated following the increased shear stress that arises from 
exercise. This helps confirms that Palladin is upregulated following haemodynamic 
stimulation in an in vivo environment, following the characterisation of the response of 
Palladin to haemodynamic force in in vitro models in Chapter 3. 
Also of note is that the 43kDa isoform only shows in the smaller exosomes, whereas the 
90 and 122kDa isoforms appear in the slightly larger microparticles. This may be an 
isoform specific response of the cells as they re-structure under shear conditions, with 
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specific isoforms having individualised functions. The smaller isoform may be 
differently regulated and only export via exosomes, as opposed to the other isoforms 
appearing in microparticles. As microparticles play an important role in inflammation 
(Martínez et al., 2005) and Palladin itself is shown to have many isoform specific 
functions (Goicoechea et al., 2010), a further research area may be observing the 
specific functions in endothelial microparticles. Unusually, GAPDH fails to register a 
result with exosomes. It might simply be that the GAPDH is lost through the filtration 
process, but it is something which may require future investigation. 
The presence of two other actin-binding proteins within shear-induced EMPs is also 
illustrated in this chapter. LASP-1 and Drebrin are two proteins that appear to show a 
link to Palladin within HAECs (as discussed in Chapter 4). Here in this chapter, their 
release in EMPs following time points of LSS is presented. Figure 5.11 first shows the 
expression of LASP-1 in shear-induced EMPs. LASP-1 is a protein known to bind with 
Palladin, but here it appears to follow a differential expression pattern, with the volume 
of microparticles containing LASP-1 generally decreasing under shear. This occurs 
despite an upregulation of LASP-1 within whole cell lysates following laminar shear 
(Figure 5.11.1). The patterns of regulation in both EMPs and whole cell lysates appear 
to follow a similar trend, suggesting that the amount of particles lost post-shear is 
directly related to the production of protein within the cell.  
It already has been demonstrated that Palladin knockdown leads to loss of LASP-1 at 
actin stress fibres (Rachlin and Otey, 2006). This raises a question as to why LASP-1 
decreases in EMPs when a binding partner increases. The reasoning for this occurrence 
may be that LASP-1 is simply more conserved than Palladin within the cells following 
shear. The LASP-1 protein is highly conserved (Grunewald and Butt, 2008), and has 
other functions with regards to the remodelling of endothelial cells under shear stress; 
therefore the cell may be retaining LASP-1 while exporting Palladin. Having observed 
that isoform specific cleavage of Palladin can occur when the protein is released in 
microparticles (Figure 5.10) it is possible that cleavage is also responsible for the 
separation of the two proteins, allowing for LASP-1 to remain within the cell while 
Palladin is exported. However further investigation into the interactions of LASP-1 and 
Palladin in MPs may be required to understand the signalling effect that causes this to 
happen.  
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The second actin-binding protein of interest, Drebrin, and its presence within EMPs was 
illustrated in Figure 5.12. Drebrin appears to be steadily expressed in the microparticles 
of sheared cells, increasing over the first 6 hours, before declining at 24 hours. This 
decline at 24 hours may be due to reabsorption of the protein within the cells or else the 
breakdown of microparticles. This result is noticeably different from the patterns seen in 
Palladin or LASP-1 expression in similar experiments. In whole cells the Drebrin 
protein is downregulated in response to shear. The increasing expression within EMPs 
observed here in Figure 5.12 suggests that the reduction in whole cells could be caused 
by the protein being exported through microparticles. Figure 5.12.1 highlights the 
expression of protein in EMPs compared against the protein expression of whole cell 
lysates (Figure 4.11). A correlation in results is seen; as relative amounts of protein 
decrease in the whole cell, they increase in the microparticles.  
There may be some sort of signalling method occurring that stimulates Drebrin to be 
exported from the cells immediately in response to LSS. Chapter 4 has already 
discussed the possibility of Palladin upregulation resulting in the downregulation of 
Drebrin. Such signalling pathways may also be the reason for the expulsion of the 
protein through EMPs. In both EMPs and protein, expression drops by 24 hours, 
signifying that Drebrin may be downregulated entirely within the cells in response to 
chronic shear stress. Since it is a developmentally regulated protein (Majoul et al., 
2007; Ishikawa et al., 1994), and the cells are fully remodelled by this time point, it 
follows that less protein is produced, hence there is less protein exported via EMPs.  
In conclusion, the release of protein – Palladin, LASP-1 and Drebrin - through EMPs 
has been documented here, explaining why there were declines in protein expression in 
whole cells subjected to shear stress (Chapter 3). Analysis of in vivo samples indicates 
that isoforms of Palladin can be selectively released in different types of particles, 
showing that they may have specialised functions. The results also indicate that Palladin 
localises to different sides of the cell (basal instead of apical) in response to 
extracellular matrices, which affect the protein function and its release through EMPs. 
We have documented some of the functions of Palladin in cells, showing that absence of 
Palladin can have an inhibitory effect on cell migration, but notably that the cell 
eventually compensates for the loss of protein. This compensation may include the 
synthesis of the otherwise exported Drebrin protein, which appears to be in competition 
with the Palladin protein, showing an alternative expression pattern to Palladin.  
 265 
 
 
 
 
 
CONCLUSIONS AND 
FUTURE WORK 
  
 266 
 
This thesis examined the actin cytoskeletal adaptor protein Palladin and exhibited its 
presence within the vasculature. Palladin is a known actin-binding protein (Dixon et al., 
2008), having been observed in structures containing actin filament bundles (Parast and 
Otey, 2000). Expression is altered by the haemodynamic forces of the vascular system, 
which include cyclic strain and laminar shear stress and result in a change within actin 
dynamics (Kris et al., 2008). We have shown for the first time that these forces cause 
Palladin to be upregulated immediately in Human Aortic Endothelial Cells, at both the 
gene transcription and proteomic levels. This apparent inflammatory response occurs as 
the cells change from a static to a haemodynamically stimulated state. Notably, the 
protein expression increases rapidly – Palladin protein is upregulated just as quick as the 
PALLD gene. The upregulation of the LASP-1 binding partner protein also follows a 
similar pattern (Figure 4.6). This immediate increase of protein suggests that there may 
some mechanism by which the already-existing endogenous RNA present in static cells 
is immediately stimulated into transcribing protein as soon as the cell is subjected to 
force.  
Several studies have demonstrated that microRNAs (miRNAs) play important roles not 
only in cardiovascular development, but also in cardiovascular disease, the types of 
which are characterised by an aberrant cell function (Zhang, 2008). It is possible that the 
stimulatory signal that causes upregulation of Palladin may be microRNA based, with 
mechanosensitive microRNA controlling both the transcription and translation of the 
endogenous protein-coding RNAs. The transcription factors which normally regulate 
gene and protein expression (by either activating or inhibiting transcription) function 
primarily within the nucleus, requiring a direct interaction with DNA (Thiel et al., 
2004). The miRNAs may act upon the target RNAs within the cytoplasm, affecting their 
function, and initiating an earlier protein response (Tuccoli et al., 2006). It has been 
demonstrated that the application of haemodynamic force can regulate the expression of 
microRNAs in endothelial cells, for example miR-19b and miR-23b – both of which are 
involved in the flow mediated regulation of endothelial cell growth and function (Qin et 
al., 2010; Wang et al., 2010). Other microRNAs such as miR-126 and miR-296 have 
also been indicated in playing a role in the regulation of cell migration (Wu et al., 2009; 
Würdinger et al., 2008). In particular, the knockdown of miR-126 in in vivo models has 
resulted in the loss of vascular integrity and haemorrhage during embryonic 
development, similarly to how knockout of Palladin may also cause embryonic lethality. 
As already stated in Chapter 1, mir-126 has also been observed within apoptotic bodies 
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(Zernecke et al., 2009) and potentially could be found within microparticles, as is 
Palladin following shear stress. Of course, it is more speculative than definitive to say 
that mir-126 and Palladin expression therefore are linked, but it would be a microRNA 
target that would be worth investigating with future microarray analysis. As a single 
gene may be regulated by multiple microRNAs, further in depth studies would be 
required to analyse the precise interactions between the microRNAs and Palladin 
following mechanical stimulation. 
It should also be noted that an increase of microRNA commonly results in actually 
repressing protein expression (Baek et al., 2008; Selbach et al., 2008), which hints that 
Palladin could perhaps be increasing in expression at another proteins expense. Drebrin 
may be such a protein, having been observed within the same networks as Palladin 
(Table 4.1) and in this thesis, having been found to be downregulated in response to 
shear stress (Figure 4.11), unlike Palladin or LASP-1 which are upregulated. Drebrin 
has been previously shown to inhibit the actin-binding activity of α-actinin (Mikati et 
al., 2013; Ishikawa et al., 1994), and as α-actinin itself associates with Palladin (Rachlin 
and Otey 2006), they appear to be linked via a potential interaction here. As mentioned, 
knocking out of Palladin displays an embryonically lethal phenotype, and since Drebrin 
is developmentally regulated, it hints that their interaction in cells could mainly occur 
within the early growth phase, such as during cellular remodelling. The expressional 
changes of these proteins were shown here when the HAECs remodel in response to 
haemodynamic force; further cementing this argument. If the Drebrin protein is indeed 
being downregulated, a hypothesis is that Drebrin may in fact be actively repressed by 
mechanosensitive microRNAs.  
Considering that miR-126 may then play a role in Palladin expression, it therefore may 
in fact be inhibitory of Drebrin. It has been shown that when particles containing this 
microRNA were transferred into endothelial cells, they resulted in the production of the 
anti-inflammatory CXCL12 chemokine (Pérez-Martínez et al., 2010). The abundance of 
miR-126-mediated CXCL12 subsequently enhanced CXCR4-mediated functions, such 
as recruitment of other cells. This CXCR4 chemokine is notably essential for cell 
migration and inflammation (Müller, et al., 2001). CXCR4 signalling induces a rapid 
increase in the affinity and mobility of adhesion molecules, including the integrin LFA-
1, which interacts with the shear-responsive ICAM-1 protein (Kinashi, 2005). Of 
particular note is that Drebrin is seen to co-localise with the CXCR4 receptor. 
Knockdown of Drebrin in cells has been shown to result in a redistribution of CXCR4 
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and inhibits actin polymerization in immune synapses (Pérez-Martínez et al., 2010). It 
may very well be that the microRNA miR-126 mediates the downstream regulation of 
Drebrin, alterations of which may result in the sudden upregulation of Palladin (and to 
an extent, LASP-1). Experiments on microRNA analysis of cells with Drebrin or 
Palladin knockdown and subjected to haemodynamic forces would further characterise 
this potential link between the proteins. If a microRNA screening of both Drebrin and 
Palladin was performed, a comparison of the results could be performed to observe any 
overlapping microRNAs involved in the expression of the proteins. By doing so, it 
could potentially narrow the list of target miRNAs involved in regulating the proteins. 
When the cells are subjected to longer time points of cyclic strain, protein expression 
appears to decrease, indicative of Palladin being responsible for the initial remodelling 
of the cell in response to force. However, when cells are subjected to time points of 
laminar shear stress, we have shown that there is an increase in expression at 6-24 hours 
where the protein is upregulated a second time. It is proposed that this upregulation of 
Palladin occurs as the cells further adapt to chronic shear stress. At this time point 
Palladin is required for further function e.g. binding actin for cellular remodelling. This 
expression may be more traditional, resulting from the PALLD gene synthesis of new 
protein. It is a curiosity then that there is not a similar 6 hour spike in protein expression 
as the cells remodel to chronic cyclic strain, especially considering how strain-induced 
PALLD gene expression appears to be on the increase (Figure 3.4.2).  
It must be considered though that, under cyclic strain, the cell is required to contract and 
decrease in size in response to the transmural force periodically stretching and relaxing 
it. In contrast, under shear stress, elongation and spreading of the cell have been 
documented to be the responses of this parallel force acting only across its luminal 
surface. Since cell contraction and cell spreading are differentially mediated (cell 
contraction is a Rho GTPase mediated response and cell spreading is a Rac GTPase 
mediated response) the interaction of the cell with extended time points of one bio-
mechanical force may simply be stimulating a pathway that Palladin may not be a 
member of, hence the different expression patterns (Nakamura, 2013; Coleman and 
Olson, 2002). 
Based on the understanding of how pathological strain conditions elicit a higher protein 
expression than physiological strain, and also how strain and shear differently affect the 
protein expression, an area of future research may be the characterisation of Palladin 
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expression under pathological shear conditions and non-uniform laminar shear stress. 
Non-uniform laminar shear stress occurs in vivo at branching bifurcation sites and at 
other regions of disturbed blood flow in vessels. Experimentally, non-uniform LSS can 
be achieved by spatially varying flow rates. In more complex experiments, it can be 
used for studying cells and cellular signalling when the cells are exposed to areas of 
strongly varying shear stress. The different types of shear stress have different effects on 
endothelial cells (Kadohama et al., 2007) so it would prove interesting to observe how 
this affects Palladin expression. 
The IBIDI® flow System is a novel perfused flow system for subjecting endothelial 
cells to higher levels of shear stress through use of specialised Y-shaped Ibidi® μ-slides 
(Figure 6.1). These slides are designed to mimic the bifurcation of blood vessels. The 
system itself works by using controlled air pressure to continuously flow media over the 
cell surface in the smaller area of these μ-slides, allowing for a higher level of shear (20 
dynes/cm
2
). This pressure can be controlled to subject the cells to low shear also (2 
dynes/cm
2
). Using this system to observe Palladin, LASP-1 and Drebrin expression 
levels under the alternate shear levels should prove to show further results. 
Under the higher shear stress, we hypothesise that expression of Palladin may be rapidly 
increased even further. While HAECs in regions of high laminar shear have a quiescent, 
anti-inflammatory phenotype, they also must align in the direction of flow. This 
alignment would require the reorganisation of actin as the cell remodelling takes place. 
Such a reorganisation would necessitate actin-binding proteins such as LASP-1 or 
Palladin. Endothelial cells in regions of disturbed flow however, have also shown an 
activated, pro-inflammatory phenotype with poor cell alignment, oxidative stress and 
expression of inflammatory genes. If Palladin and LASP-1 upregulation is in fact an 
inflammatory response, then the proteins may be upregulated in this cell phenotype too. 
Also of interest may be the observation of Drebrin expression following high rates of 
shear stress. Since the Drebrin protein is significantly downregulated when the cell is 
subjected to regular LSS (Figure 4.11), it likely could be downregulated with other 
shear levels also. A future noteworthy area of research would be the investigation of 
Palladin, LASP-1 and Drebrin expression following these models of altered shear stress. 
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(A)                                               (B) 
 
(C)              (D)  
 
Figure 6.1: The Ibidi® Flow System. Figure 6.1 (A) shows the setup of the Ibidi ® system 
itself, designed for shear of cells. Figure 6.1 (B) displays the Y-shaped slides used. Media is 
pumped from one reservoir to the other, flowing over the cells and generating shear stress, and 
mimicking flow at bifurcations in blood vessels. To avoid wasting media, it gets pumped back 
and forth between reservoir L and reservoir R through switching of the four-fold valve V1. In 
Figure 6.1(C), the pressured air is guided to reservoir L, with reservoir R connected to the 
ambient air pressure. In the second state – Figure 6.1 (D) this is the other way around. The 
switching between these two states generates a flow of medium between the reservoirs while 
ensuring they do not run dry. In order to keep the flow unidirectional, a fluidic rectifier pinch 
valve V2 is placed between the reservoirs and the slide. This valve clamps off two branches of 
the perfusion set while leaving the other two open. The synchronous manner in which these 
valves open and close ensure the flow stays in one direction. 
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Chapter 3 documented the localisation of Palladin to different areas of the cell following 
the different time points of LSS. Although Palladin was originally described as a 
cytoplasmic F-actin-binding protein, multiple studies have shown that it can also 
partially localize to the nucleus in certain cell lines (Goicoechea et al., 2008; 
Niedenberger et al., 2013), where it can bind transcriptional regulators and influence 
patterns of gene expression (Jin et al., 2010). It has been illustrated here that Palladin 
undergoes a major relocation in sheared HAECs as they change morphology (Figure 
3.14.1). Protein expression within the cytosol and the nucleus slowly increase following 
shear – as hypothesised since there is an increase in gene transcription and translation 
regularly observed. It may also be binding transcriptional regulators and influence 
patterns of gene expression. The more noticeable change in localisation occurs within 
the membrane, which massively decreases in Palladin, and the cytoskeleton which 
increases in protein. The movement of Palladin towards the cytoskeleton is 
understandable, given that the cell is undergoing structural remodelling at these time 
points, necessitating the need for actin-binding proteins such as Palladin (or LASP-1) to 
facilitate organisation.  
An examination of the Drebrin and LASP-1 localisation in HAECs following LSS 
would also prove interesting. LASP-1 is an actin and membrane associated protein and 
functions as a cytoskeletal scaffold. It and Palladin have been seen to localise in actin 
rich lamellipodia, highlighting its role in actin cytoskeleton organisation (Chew et al., 
2002; Lin et al., 2004). LASP-1 has previously been observed to localise to the 
peripheral edge of non-motile cells. Subsequent exposure to migration-stimulating 
growth factors causes a rapid localisation to the focal adhesions, followed by a later 
localisation towards the membrane ruffles. It is expected that its localisation patterns 
following shear stress may follow that of Palladin. Localisation towards the membrane 
may account for the increase in LASP-1 within microparticles that is observed at 6 
hours post shear (Figure 5.11). Drebrin has already been observed to redistribute to the 
membrane upon the establishment of cell-cell contacts (Li et al., 2011; Peitsch et al., 
1999). Drebrin has also been noted to associate with the actin filaments located at 
adherens junctions in regular endothelial cells (Rehm et al., 2013; Keon et al., 2000). It 
is probable that following the subjecting of HAECs to haemodynamic forces, this 
localisation of Drebrin may change. While Drebrin was characterised before in 
endothelial cells (Rehm et al., 2013), it had not been shown until now to be responsive 
to mechanical forces in HAECs. 
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The patterns of Palladin expression following haemodynamic force, and the alternative 
localisation in response to LSS, all suggest that there may be some epigenetic regulation 
of protein expression. Epigenetic pathways have received increasing attention in 
embryonic development and cellular differentiation. However, it is only in recent times 
that these pathways have been explored in vascular endothelial cells (Matouk and 
Marsden, 2008). Epigenetics refers to chromatin-based mechanisms important in the 
regulation of gene expression, which do not involve changes to the sequence of the 
DNA (Bird, 2007). These include DNA methylation, histone density and 
posttranslational modifications, and RNA-based mechanisms. With epigenetic 
regulation, DNA is observed to be part of a DNA-protein complex. The fundamental 
repeating unit of this complex, termed chromatin, is the nucleosome comprising a group 
of core histone proteins which are intertwined with DNA. Each nucleosome comprises 2 
molecules of H2A, H2B, H3, and H4 (Matouk and Marsden, 2008). Laminar shear 
stress elicits both global and gene-specific histone modification changes in cultured 
endothelial cells (Illi et al., 2003). Having performed immunoprecipitation of Palladin 
following different shear time points (Table 4.2), many results post-shear stress 
indicated that histones were involved within the Palladin network. It is quite possible 
that the histone regulation plays a major function within Palladin expression. 
Alternatively, Palladin may play a role in the remodelling of chromatin. Using 
Chromatin Immunoprecipitation (ChIP) combined with further quantitative qRT-PCR, a 
future area of research is to investigate histone posttranslational modifications and how 
they may affect the expression of Palladin, and to an extent, LASP-1 and Drebrin.  
While a majority of the Palladin protein may be utilised within the cytoskeletal 
remodelling, it appear that was still a large amount lost from the membrane. Our 
hypothesis to account for this massive loss in membrane protein was that Palladin was 
released via Endothelial Microparticles (EMPs). The data for shear-induced 
microparticle release from HAECs (Figure 5.5) indicated that there was a steady stream 
of Palladin released via these vesicles. The membrane loses some of its integrity in its 
remodelling phase, resulting in an increased number of EMPs to be released, which 
generally leads to an increase in the amount of protein lost. Interestingly, it is suggested 
that these particles carry other signals such as RNA or microRNA (Diehl et al., 2012; 
Vion et al., 2013), indicating that they may pass signals to other cells which change 
protein expression. 
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The release of microparticles from HAECs was investigated in detail within Chapter 5, 
in order to further understand how Palladin, LASP-1 and Drebrin function within the 
whole cell. An interesting result was the disparate expression of LASP-1 and Palladin 
release from EMPs. As expected, protein was released from both. However, LASP-1 
appears to decrease in expression within the EMPs, as opposed to Palladin which 
generally increases. This is an indication that the two proteins may not be as closely 
linked as first thought. It should be expected that they differ in some manner regarding 
their role within the vasculature. This alternative expression in microparticles may shed 
light on how they differ. LASP-1 is ostensibly retained within the cell following LSS, 
serving further functions that Palladin does not. The highly conserved LASP-1 protein 
evidently has other functions with regards to the remodelling of endothelial cells under 
shear stress (Grunewald and Butt, 2008). 
Also of note was the release of Drebrin through microparticles. The protein is observed 
to be decreased when cells are sheared. But it is also observed that there is a steady 
increase of protein release through EMPs (Figure 5.12). If Drebrin is in fact inhibitory 
of Palladin, then it may be that Drebrin is not so much downregulated in response to 
shear, more that it is released through microparticles. The loss in this protein from the 
cell may allow the upregulation of Palladin then as a result. Notably this Drebrin 
microparticle level drops at 24 hours, which suggests that the protein may be reabsorbed 
into the cell. We see that Drebrin expression within the cell stays level at this time 
instead of reducing further (Figure 4.11), but the expression of Palladin also starts 
reducing (Figure 3.10). It may be that Drebrin works here as a sort of inhibitory 
mechanism if reabsorbed back into the cell. Further investigation into the interactions of 
Drebrin, LASP-1 and Palladin and their different release mechanisms through EMPs 
may be required to understand the signalling effect that causes this to happen. 
The signalling effects involved in Palladin expression within whole cells was 
investigated in this thesis, through use of cell-matrix interactions. Interactions with 
different endothelial matrices via distinct receptors can trigger distinct cellular 
responses (Geiger and Yamada, 2011). By culturing cells on different matrices, we 
observed distinct expression levels of protein following LSS. Protein release from the 
matrix-seeded cells via shear-induced microparticle release was also analysed. In 
HAECs sheared on regular culture dishes, the Palladin expression levels in whole cells 
decline after 3 hours (Figure 3.10), typified by an increase in the amount of 
microparticle-bound Palladin being released from the cells (Figure 5.5.1). This method 
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of release – derived from shear-induced remodelling and the loss of cellular integrity – 
appears to change when cells are in contact with ECMs, with Palladin protein retained 
in the cell until 24 hours post-shear, suggesting that some signalling method occurs that 
causes Palladin to be utilised within the cell for a newer function. 
When first looking at the protein response to the fibrinogen matrix, we observe that 
interactions with the matrix cause an immediate upregulation in the expression of 
Palladin. As the static cells are allowed to adhere to a fibrinogen matrix, the expression 
of Palladin is greatly increased, compared to cells adhering at the same time to a regular 
culture dish. Increased fibrinogen content in the vasculature leads to increased binding 
to its endothelial receptors, such as the α5β1 integrin (Plow et al., 2000) – which itself 
increases in response to LSS (Urbich et al., 2000). Increased fibrinogen also results in 
the increased formation of filamentous actin (Tyagi et al., 2008). This increase in actin 
results from the cell spreading across the matrix, stiffening the cells and retracting some 
actin filaments. Since the cell undergoes such a remodelling, it requires the rapid 
upregulation of Palladin, which may be brought on through some stimulatory, possibly 
integrin based signal. Curiously, fibrinogen has been characterised as increasing cellular 
permeability (Tyagi et al., 2008) which would suggest that there would be an increase 
of Palladin release from the microparticles, since the cell loses its integrity. However, 
while microparticle content may increase, the release of Palladin through these particles 
does not, appearing to be instead retained for further purposes. It has been suggested 
that fibrinogen binding to its endothelial receptors may activate MAP kinase signalling, 
triggering alterations in the cellular transport mechanism (Patibandla et al., 2010). This 
may be a mechanism which Palladin is localised through, preventing its release through 
the microparticles. We have already seen that Palladin is localised to different areas 
following LSS (Figure 3.14.1). The expression of Palladin following LSS when the cells 
are in contact with fibrinogen has a different pattern. Palladin appears downregulated 
following immediate shear, but still stays more prevalent than expression in an uncoated 
matrix. The expression only increases past the static baseline levels at 24 hours of LSS 
(Figure 3.17) but then drops sharply at 48 hours – the point at which protein begins to 
be exported from the cell (Figure 5.7). This suggests to us that the protein is retained 
within the cells post-shear. It is likely that the localisation patterns within HAECs are 
different as a result of cell-matrix contact. Since Palladin does not appear within early 
time points to be released via EMPs, it may therefore be retained within the membrane, 
or alternatively increase in localisation towards the cytoskeleton. This localisation of 
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protein may occur as the protein moves to different areas of the cell itself; relocating 
from the apical side of the cell towards the basal side instead. Integrins located on the 
basal side of the membrane can recognise and bind the different components of the 
basement membrane ECMs. There, they link a chain of actin-binding proteins 
(Yurchenco et al., 2011) which may include Palladin, illustrating why there is an 
upregulation of protein, but lack of release through microparticles. 
The actin-binding proteins they link may also include LASP-1 or Drebrin. In contact 
with fibrinogen, the (normally upregulated) protein is observed to decrease following 
LSS. In comparison, the (normally downregulated) Drebrin appears upregulated when 
in contact with fibrinogen. This upregulation of Drebrin again could account for the 
downregulation of the other proteins – it may be that Drebrin is increased because of 
microRNA signalling and integrin signalling pathways initiated by the fibrinogen 
matrix. Interestingly though, the protein expression pattern of Drebrin appears close to 
the regular pattern when cells are initially seeded on fibronectin (although it does 
increase after 6 hours), indicating that if there is such a specific signal that causes a 
Drebrin increase, it may be influenced more by the fibrinogen matrix.  
A retention of Palladin is seen though when the cells are seeded onto a fibronectin 
matrix (Figure 3.19). Fibronectin and certain polypeptide regions of this adhesive 
glycoprotein mediate cell attachment and spreading on various substrates. Here, the 
post-shear expression is similar to the normal expression observed within cells on an 
uncoated culture dish. However, this expression appears inhibited to a degree. 
Comparison with the static uncoated cells showed that fibronectin drastically reduced 
the levels of Palladin observed within the cells. This suggests that fibronectin may have 
inhibitory qualities on protein expression. Notably LASP-1 expression is also withheld 
because of cell-matrix contact (Figure 4.7). As stated in Chapter 3, the α5β1 integrin is 
initially present in focal adhesions formed on a fibronectin substrate, along with αvβ3, 
but is lost from these adhesions unless the fibronectin is immobilized, in which case it 
forms exaggerated α5β1-containing focal adhesions (Katz et al., 2000). It may be that 
the increase of α5β1 may affect Palladin and LASP-1 in a repressive manner. The α5β1 
and αVβ3 integrins binding to fibronectin specifically activate the transcription factor 
NF-κB (Orr et al., 2005). Flow-induced NF-κB activation is downstream of 
conformational activation of integrins, resulting in new integrin binding to the 
subendothelial extracellular matrix and subsequent signalling mechanisms occurring. 
These signalling mechanisms may be repressing the expression of Palladin and LASP-1 
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instead. NF-κB triggers inflammatory gene expression in the endothelium in response to 
the onset of flow or disturbed flow. This lends more weight to the alternative hypothesis 
that Palladin is in competition with another protein (i.e. Drebrin) which may be 
upregulated instead by the activation of NF-κB. Importantly, there is little fibronectin or 
fibrinogen beneath the endothelium in most of the vasculature, but these proteins are 
found at sites of disturbed flow in vivo (Orr et al., 2006). This indicates that it may not 
be accurate to compare the patterns of expression to the one seen on regular uncoated 
cells following LSS. Investigating the protein expression following high shear using 
Ibidi® slides may provide a better comparison with the expression on these matrices. 
Collagen also affects the expression of Palladin, but differently – while protein is 
upregulated compared to growth on an uncoated matrix, it appears to halt shear-induced 
expression of the protein. Cells on collagen are observed to inhibit the α5β1 and αVβ3 
integrins (Orr et al., 2006). The inhibition of these integrins, which as hypothesised may 
halt the expression of Palladin, could theoretically cancel out Palladin inhibition - 
leaving protein expression levels to remain level as the time points of shear continue, as 
observed in Figure 3.21. Downstream flow-induced NF-κB activation, which may also 
play a role in repression, is prevented from the activation of the integrins. Notably, this 
appeared to also inhibit the release of Palladin through microparticles in these cells too. 
The protein appears to be more conserved and halted from being released in this 
manner. Given that post-shear expression remains stable, this might be expected. It is 
evident that there is some mechanism which keeps Palladin from leaving the cell when 
the cell-matrix interactions are occurring.  
Collagen increases cell adhesion (Kemeny et al., 2013); which could cause Palladin to 
localise from one area of the cell to another (such as from the membrane to the 
cytoskeleton) in order to increase cell adhesion. Such relocation may explain why there 
initially is no Palladin in the shear-induced microparticles. At 24 hours the protein is 
finally released through EMPs. At this time point, cells should be fully adhered and 
fully realigned in response to shear stress, which would mean Palladin is no longer 
required for adhering of cells, hence the release of some protein through microparticles.  
Strangely, the seeding of HAECs onto collagen didn’t appear to alter the expression 
patterns of LASP-1 and Drebrin (Figures 4.8 and 4.14 respectively). If anything, the 
culturing of the cells on these matrices made protein expression patterns more 
exaggerated – LASP-1 is upregulated to a higher degree while Drebrin is downregulated 
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more. If the cells on collagen inhibit the α5β1 and αVβ3 integrins, then perhaps that 
means that these integrins play a role in increasing Drebrin expression and also 
repressing LASP-1 expression. It is an aspect of the research which needs definite 
assays to be performed before a conclusive result can be determined, but it is something 
which further investigations can build on. 
These studies demonstrate that Palladin does play a significant role in cell and ECM 
interaction, as does LASP-1 and Drebrin. Cellular behaviours related to this cell-matrix 
interaction, such as cell adhesion and cell migration, can be compromised by the 
disruption of Palladin. The impaired cell adhesion and spreading may result from a 
disorganized actin cytoskeleton and decreased expression of specific integrin proteins. 
Further cell migration and cell adhesion assays will also needed to be performed on 
Palladin and its related proteins to characterise these interactions further. This study can 
be performed using cells with Palladin knocked down using gene-specific siRNA. 
Initial results show that Palladin knockout affects cell migration, slowing it down 
(Figure 5.1); however this is from an observational assay. Use of the xCELLigence™ 
system with knockdowns and regular cells illustrated migration events in real-time. 
Initial experiments have investigated adhesion of the knocked-down cells on ECMs, 
results of which are attached in the Appendix. The cells with Palladin knockdown can 
also be utilised in order to study the interactions with LASP-1 and Drebrin, observing 
these protein functions when Palladin is not present. Determining further how the cells 
function without Palladin when subjected to haemodynamic forces should provide a 
further insight into the role of Palladin under mechanical stimulation.  
The investigation of Endothelial Microparticles is a relatively new area of research that 
has started yielding results. In this report, we have demonstrated how Palladin is present 
in microparticles released from shear stress, but not cyclic strain. Further 
characterisation of these particles could be performed using FACS analysis, generating 
a proper characterisation of Palladin in EMPs, in both in vitro and in vivo models. More 
research on blood samples, taken from different time points following exercise, 
differently healthy subjects, or at a resting rate, merit probing for Palladin, with special 
regards to the apparent isoform specific localisation to smaller exosomes. While we 
speculate that this alternative localisation of isoforms may depend on different functions 
of the isoforms in the vasculature, a precise characterisation should prove to yield some 
interesting results.  
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Immunoprecipitation data for Palladin has led to research on two other interesting actin-
binding proteins: LASP-1 and Drebrin. While some work has been performed already in 
our laboratory on LASP-1, Drebrin is a newly examined protein. Furthermore there 
hasn’t been much investigation into their presence in microparticles within the in vivo 
blood samples following exercise. Investigation of the response of these proteins 
following other haemodynamic force (LSS has been performed, but not oscillatory 
shear or cyclic strain) using Western Blotting, Immunofluorescence, Proteocellular 
Fractionation and qRT-PCR could provide a new area of research. Furthermore, if 
determining the response of these proteins to Palladin siRNA knockdown yields some 
results, it would be interesting to try observe what happens following LASP-1 or 
Drebrin knockdowns, and to see if the proteins are upregulated or downregulated in 
response. Considering how Drebrin seems to act in a different way to Palladin and 
LASP-1 following LSS, we have theorised that there may be some inhibitory effect 
occurring, with α-actinin potentially having a role in this effect. Knockout models of 
Drebrin especially could confirm the competition between it and Palladin. 
Immunoprecipitation results here showed that both Palladin and Drebrin bind to 
Galectin, so this protein could also be part of the complex. The Co-IP results also 
suggested that Palladin, LASP-1 and Drebrin all share an interaction with Vimentin and 
the α-1A chain of Tubulin. Investigation of these proteins through various methods such 
as immunoprecipitation, immunofluorescence or even Yeast-2-hybrid analysis could 
help further determine the protein-protein interactions that appear to be occurring. 
While we could observe Palladin within in vivo models, a final aspect of Palladin 
expression that may also prove fruitful is the observation of this protein within other in 
vitro cell models. While a brief characterisation of the expression within HaoSMCs 
under cyclic strain was provided, it may be worth investigating this cell type and others 
in greater detail. Characterisation of the proteins within embryonic cell types for 
instance could show different results, especially as Drebrin is a developmentally 
regulated protein and Palladin plays a major role in embryonic development; their 
pathways and interactions may be different than in the adult form. Considering that 
Palladin has this connection with Drebrin – a protein which is largely observed within 
the brain, research may also branch into the characterisation of these proteins within the 
microvasculature. LASP-1 is also highly expressed in the central nervous system where 
it is prominently expressed in the cortex, hippocampus, and cerebellum and is densely 
concentrated at the postsynaptic membrane of dendritic spines. With regard to the 
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endothelial cells lining the blood vessels of the brain, interactions between the proteins 
would be quite interesting to characterise.  
Further to this avenue of research involving the brain, one of the major problems with 
drug delivery mechanisms in the brain is the blood-brain barrier (BBB) preventing the 
crossing over of other molecules. Investigations of the proteins here showed they were 
released through microparticles and exosomes, which are capable of travelling through 
the vessel to other cells. Alvarez-Erviti et al., (2011) demonstrated a novel method of 
using exosomes in a therapeutic manner. Using encapsulation by exosomes, they were 
able to transport siRNA across the BBB. The exosome surface protein LAMP2b was 
used to display a targeting peptide which ensured binding to the nicotinic acetylcholine 
receptor on neurons and the vascular endothelium of the BBB. The method showed up 
to 60% knockdown of target RNA and protein, with little or no toxicity, demonstrating 
the efficiency of using microvesicles in a therapeutic setting. By harnessing the 
capabilities of these particles, perhaps in the future they might be utilised as a future 
method of bypassing this selectively restrictive barrier. Having already shown they can 
carry other signals, they might one day be used in the area of targeted therapeutics and 
theranostics. 
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6.1 SUMMARY OF FUTURE AREAS OF RESEARCH 
 
This thesis documented the role of the actin-binding cytoskeletal protein Palladin and its 
response to haemodynamic forces within the vasculature, as well as investigating 
potential protein interactions it may have. However, there are still many areas of this 
research that merit future work. They include: 
 
 Investigation of the microRNA pathways involved within the upregulation of 
Palladin following haemodynamic force. Focus may be given on mir-126 and its 
potential links to Palladin. 
 Further research on the microRNA pathways involved in the interactions of 
Palladin with LASP-1 and Drebrin; particularly into how the Drebrin protein is 
downregulated following haemodynamic forces, possibly through competition 
between the proteins to bind to actin. 
 Use of Drebrin knockdown models to observe effects on Palladin and LASP-1 
expression. Similarly, using LASP-1 knockdown models to observe the effects 
on expression of other proteins.  
 Characterisation of the expression of Palladin, LASP-1 and Drebrin when 
subjected to pathological shear stress rates (>20 dynes/cm
2
) through the use of 
the Ibidi® shear system. Also, the investigation of the protein expression at 
bifurcations of cells using the Y-shaped Ibidi® μ-slides. Techniques such as 
Western Blotting, Immunofluorescence, Proteocellular Fractionation or qRT-
PCR can be used to characterise this. ELISA methods may also be used to 
characterise expression. 
 Using ChIP assays to investigate histone posttranslational modifications across 
the PALLD gene, as well as the modifications of LASP-1 and Drebrin, coupled 
with the cellular localisation of these proteins in response to haemodynamic 
forces.  
 Further cell adhesion assays to be performed, through the use of siRNA 
knockdown cells, and the xCELLigence™ system to monitor migration and 
adhesion events in real-time. Particular regard will be given to observation on 
knockdown cells subjected to cyclic strain, shear stress, and knockdown cells 
cultured on the passive and permissive extracellular matrices.  
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 Further research into the release of Palladin through microparticles from in vivo 
models. Drebrin and LASP-1 may also be investigated within in vivo samples. 
Transfer of these proteins via microparticles may also be studied. 
 Determination of the precise integrin signalling pathways involved within the 
shear-induced expression of the Palladin, LASP-1 and Drebrin proteins. Coupled 
with this, the interactions of these proteins within these pathways may be 
understood further.  
 Characterisation of these proteins and their potential interactions within other 
cell types: HaoSMCs, HBMVECs and embryonic stem cells.  
 Potential use of Endothelial Microparticles or Exosomes as delivery vesicles for 
protein, microRNA signals or as drug delivery mechanisms for therapeutic uses.  
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A brief study investigating the effects of the knockdown of Palladin on endothelial cell 
adhesion to extracellular matrices is provided here. As shown, the endothelial cells can 
be affected by culturing on the ECMs, with protein expression greatly increased. 
Furthermore, it was suggested in this thesis that Palladin is relocalised in response to the 
cell-matrix interactions, given that the protein appeared retained in microparticles 
harvested from sheared cells cultured on these extracellular matrices. 
Cells subjected to knockdown were cultured on a variety of ECMs – fibrinogen, 
fibronectin and collagen. They were again analysed using the xCELLigence™ system, 
which demonstrated in real time how the knockdown of Palladin affected cells adhering 
to the ECMs. It was proposed that the retention of Palladin was in part caused by a 
relocalisation of protein to the basal side of the cell. Such relocalisation subsequently 
would have a knock on effect on the adhesive capabilities of the cell – increased protein 
causing increased adhesion. By knocking down the Palladin protein, it was hypothesised 
that adhesion events would be greatly affected.  
Results show that cells knocked down are indeed affected with adhesion appearing to in 
fact increase in response to knockdown; however the response appears matrix-specific. 
Results are indicative of one independent experiment, so a definitive conclusion cannot 
be stated. 
  
 C 
 
Protocol for Cell Adhesion Assay of Transfected siRNA Knockdown Cells 
For Palladin knock-down adhesion assays, 6-well plates were prepared and coated as 
described previously in Chapter 2.2.2.2.1. HAECs were transfected with siRNA, also 
using the same methods as described previously in Chapter 2.2.4.1, and seeded onto the 
wells of the 6-well plate. The plates were incubated at 30 hours, which was previously 
determined to be the optimal time for knockdown. Meanwhile, the wells of a 16-well 
xCELLigence™ E-plate were also pre-coated in triplicate with a extracellular matrix: 
fibronectin or fibrinogen at a concentration of 10 µg/ml or Type IV collagen at a 
concentration of 20 µg/ml. Uncoated wells were also used as a control. The E-plates 
resemble the CIM-plate, being sealed at the base with a micro-porous membrane 
containing micro-fabricated gold electrode arrays on the base of the membrane. Each 
individual well on an E-Plate incorporates a sensor electrode array that allows cells in 
the well to be monitored and assayed. Plates were covered and then incubated overnight 
as per the usual methods. 
At the 30 hour time point, the wells of the E-plate were aspirated and 100 µl of serum 
free medium was added into each well. It was important to ensure no air bubbles were 
introduced and also be careful not to touch the electrodes on the bottom of the well with 
the tips. This equilibrates the plate to the media. 300 µl of de-ionized water was added 
to the troughs surrounding the wells which helped humidify the plate. The plate was 
covered and then incubated at 37
o
C for 30 minutes before it was placed in the plate 
holder. The E-plate background was then scanned and used to calibrate the software. 
During this time, the transfected cells were trypsinised and counted. Upon completion 
of the E-plates 30 minute incubation and subsequent calibration, 30,000 cells per 
experimental condition (i.e. culturing on the different matrices) were then added to the 
appropriately coated well of the E-Plate. This plate was incubated for another 30 
minutes at 17-20
o
C allowing the cells to acclimatise to the media. The plate was 
covered and then loaded into the plate docking port of the xCELLigence™ system. 
Initial adhesion of cells was measured at 5 minutes intervals from 0-24 hours. The 
resulting readings were analysed using the software provided. 
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Figure A: xCELLigence™ Assay of Cell Adhesion in Palladin Knockdown Cells Cultured 
on a Fibrinogen Matrix. HAECs were transfected with Palladin siRNA as per previous 
methods, and cultured on a fibrinogen matrix. Control samples (scrambled siRNA or non-
transfected) were prepared also. These cells were seeded on an xCELLigence™ E-plate for 
assaying of adhesion as described. The recorded Cell Index results for the first hours of analysis 
are presented here in Figure A (i). Two hours was determined to be an optimum time to observe 
immediate cellular events before cells started to proliferate, affecting results. The slope of the 
adhesion curve for each sample at 2 hours was calculated using the RTCA 1.2 Software, with 
results shown in Figure A (ii). The increase in size of the slope is indicative of an increase in 
cellular adhesion.  
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Figure B: xCELLigence™ Assay of Cell Adhesion in Palladin Knockdown Cells Cultured 
on a Fibronectin Matrix. HAECs were transfected with Palladin siRNA as per previous 
methods, and cultured on a fibronectin matrix. Control samples (scrambled siRNA or non-
transfected) were prepared also. These cells were seeded on an xCELLigence™ E-plate for 
assaying of adhesion as described. The recorded Cell Index results for the first hours of analysis 
are presented here in Figure B (i). Two hours was determined to be an optimum time to observe 
immediate cellular events before cells started to proliferate, affecting results. The slope of the 
adhesion curve for each sample at 2 hours was calculated using the RTCA 1.2 Software, with 
results shown in Figure B (ii). The increase in size of the slope is indicative of an increase in 
cellular adhesion. 
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Figure C: xCELLigence™ Assay of Cell Adhesion in Palladin Knockdown Cells Cultured 
on a Collagen Matrix. HAECs were transfected with Palladin siRNA as per previous methods, 
and cultured on a collagen matrix. Control samples (scrambled siRNA or non-transfected) were 
prepared also. These cells were seeded on an xCELLigence™ E-plate for assaying of adhesion 
as described. The recorded Cell Index results for the first hours of analysis are presented here in 
Figure C (i). Two hours was determined to be an optimum time to observe immediate cellular 
events before cells started to proliferate, affecting results. The slope of the adhesion curve for 
each sample at 2 hours was calculated using the RTCA 1.2 Software, with results shown in 
Figure C (ii). The increase in size of the slope is indicative of an increase in cellular adhesion. 
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Figure A first illustrates adhesion of transfected cells to a fibrinogen matrix. The slopes 
of adhesion indicate that knockdown of Palladin causes cell adhesion to decrease, with a 
lower slope observed compared to the non-transfected cells. However, the adhesion 
remains less than that of the scrambled siRNA control, which suggests that the 
transfection itself of cells causes a reduction in adhesion and that loss of Palladin boosts 
adhesion on this matrix. We have previously discussed how knockdown of Palladin may 
possibly result in the compensation of other closely related proteins taking over the role 
of the protein; this may be further proof of such an occurrence.  
Investigation of the knockdown cells on a fibronectin matrix (Figure B) showed a 
different result. Here, the transfection of cells appears to increase cell adhesion to the 
matrix, with the scrambled siRNA transfected cells showing greater adhesion than the 
non-transfected cells. It may be that the fibronectin matrix is able to promote adhesion 
in the transfected cells. Given that fibronectin can be seen at sites of cell dysfunction, 
the matrix may function in increasing the adherence of damaged cells – a result which is 
reflected in the increased adhesion of transfected cells here. Cells transfected with 
Palladin specific siRNA show an even greater adhesion to the matrix within the first 
two hours of analysis. Again, this appears suggestive of the loss of Palladin causing 
compensation from other proteins, which may in turn overcompensate, causing the 
increased adhesion visualised here. 
Finally, Figure C demonstrates the adhesion of knocked-down cells interacting with a 
collagen matrix. In this figure, the adhesion stayed relatively similar comparing the 
Palladin siRNA transfected cells with the non-transfected cells. However, these cells 
showed greater adhesion than the scrambled siRNA cells, indicating that transfection 
reduced adhesion, but the lack of Palladin resulted in an increase of adhesion back to 
baseline levels. Collagen is seen to increase cell adhesion (Kemeny et al., 2013); this 
may cause proteins, such as ones replacing the function of Palladin, to localise from one 
area of the cell to another (such as from the membrane to the cytoskeleton) to aid 
adhesion.  
In conclusion, it appears that the knockdown of Palladin affects cells, but may be 
compensated by other proteins within the cell which have a functional overlap with 
Palladin. This in turn can lead to overcompensation, which increases adhesion in the 
cell. Figure 5.1 similarly showed that this may occur with regards to migration, albeit at 
a slower turnover of protein function being taken over by other proteins.  
